<SEC-DOCUMENT>0001493152-23-042105.txt : 20231120
<SEC-HEADER>0001493152-23-042105.hdr.sgml : 20231120
<ACCEPTANCE-DATETIME>20231120161557
ACCESSION NUMBER:		0001493152-23-042105
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		52
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231120
DATE AS OF CHANGE:		20231120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aurora Technology Acquisition Corp.
		CENTRAL INDEX KEY:			0001883788
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41250
		FILM NUMBER:		231422949

	BUSINESS ADDRESS:	
		STREET 1:		4 EMBARCADERO CENTER SUITE 1449
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94105
		BUSINESS PHONE:		6143650143

	MAIL ADDRESS:	
		STREET 1:		4 EMBARCADERO CENTER SUITE 1449
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94105
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10-q.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ATAK="http://auroraspac.com/20230930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_ATAK_auroraspac.com_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230101_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001883788 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentFiscalPeriodFocus_Q3 -->
<!-- Field: Set; Name: xdx; ID: xdx_070_XDX_form10%2Dq.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityCentralIndexKey">0001883788</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0093" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-09-30" id="xdx2ixbrl0113" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-09-30" id="xdx2ixbrl0142" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0143" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-09-30" id="xdx2ixbrl0206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" id="xdx2ixbrl0207" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability" contextRef="From2022-07-012022-09-30" id="xdx2ixbrl0239" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0240" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-07-012022-09-30" id="xdx2ixbrl0244" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0342" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0344" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-03-31" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0359" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-04-012023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-04-012023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0378" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0386" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0419" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0439" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0446" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0448" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0486" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0522" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0530" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0555" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" id="xdx2ixbrl0561" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:AllocationOfDeferredOfferingCostsForWarrantLiability" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0605" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireRestrictedInvestments" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl0639" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0653" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl0657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0659" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl0666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0683" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:DeferredUnderwritingFeePayable" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0689" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:ForfeitureOfRepresentativeShares" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0695" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATAK:DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl0701" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1201" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember" id="xdx2ixbrl1219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1223" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember" id="xdx2ixbrl1229" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1235" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember" id="xdx2ixbrl1241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember" id="xdx2ixbrl1253" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember_custom_TrancheTwoMember" id="xdx2ixbrl1259" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1269" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember" id="xdx2ixbrl1271" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1275" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1277" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1279" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember" id="xdx2ixbrl1283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1285" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1287" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1289" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember" id="xdx2ixbrl1295" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1297" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" id="xdx2ixbrl1305" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember" id="xdx2ixbrl1317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1319" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1325" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1331" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember" id="xdx2ixbrl1335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1339" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-08-05_custom_PublicWarrantsMember" id="xdx2ixbrl1345" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-08-05_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-08-05_custom_DerivativeWarrantLiabilityMember" id="xdx2ixbrl1349" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-08-062021-12-31_custom_PublicWarrantsMember" id="xdx2ixbrl1351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-08-062021-12-31_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-08-062021-12-31_custom_DerivativeWarrantLiabilityMember" id="xdx2ixbrl1355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-12-31_custom_PublicWarrantsMember" id="xdx2ixbrl1357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1359" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-12-31_custom_DerivativeWarrantLiabilityMember" id="xdx2ixbrl1361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="atak-20230930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CapitalUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_RightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-20_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-20_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-032023-02-03_custom_AmendmentNoOneToInvestmentManagementTrustAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:AmendmentNoOneToInvestmentManagementTrustAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-03</xbrli:startDate>
        <xbrli:endDate>2023-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-272023-07-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-27</xbrli:startDate>
        <xbrli:endDate>2023-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_IfWeDoNotCompleteOurInitialBusinessCombinationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ATAK:PeriodAfterWhichSharesAreRedeemableAxis">ATAK:IfWeDoNotCompleteOurInitialBusinessCombinationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_AbsentOurCompletingAnInitialBusinessCombinationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ATAK:PeriodAfterWhichSharesAreRedeemableAxis">ATAK:AbsentOurCompletingAnInitialBusinessCombinationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-092023-02-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-09</xbrli:startDate>
        <xbrli:endDate>2023-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-01_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-282023-07-28_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-28</xbrli:startDate>
        <xbrli:endDate>2023-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-282023-07-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-28</xbrli:startDate>
        <xbrli:endDate>2023-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-28_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_IPOMember_custom_PrivatePlacementWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_WarrantMember68552781">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_CommonClassASubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-07</xbrli:startDate>
        <xbrli:endDate>2021-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-07_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TriggeringEventAxis">ATAK:SharePriceMoreThanOrEqualsToUsdTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-07</xbrli:startDate>
        <xbrli:endDate>2021-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-07_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-072021-08-07_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-07</xbrli:startDate>
        <xbrli:endDate>2021-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-08_custom_FirstWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FirstWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-08_custom_FirstExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FirstExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-03_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-072023-03-07_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-07</xbrli:startDate>
        <xbrli:endDate>2023-03-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-062023-04-06_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-06</xbrli:startDate>
        <xbrli:endDate>2023-04-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-052023-05-05_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-05</xbrli:startDate>
        <xbrli:endDate>2023-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-022023-06-02_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-02</xbrli:startDate>
        <xbrli:endDate>2023-06-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-052023-07-05_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-05</xbrli:startDate>
        <xbrli:endDate>2023-07-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-06_custom_SecondWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-02_custom_ThirdWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:ThirdWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-14_custom_FourthWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FourthWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-10_custom_FifthWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FifthWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_FifthWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FifthWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-312023-07-31_custom_ThirdExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:ThirdExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-31</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-01_custom_ThirdExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:ThirdExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-01_custom_FifthWorkingCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FifthWorkingCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WorkingCapitalNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:WorkingCapitalNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_SecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WorkingCapitalAndSecondExtensionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:WorkingCapitalAndSecondExtensionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WorkingCapitalLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:WorkingCapitalLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RelatedPartyMember68554234">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RelatedPartyMember68554250">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-092022-02-09_custom_OfficeSpaceAdministrativeAndSupportServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:OfficeSpaceAdministrativeAndSupportServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-09</xbrli:startDate>
        <xbrli:endDate>2022-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_AdministrativeSupportAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_AdministrativeSupportAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_AdministrativeSupportAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_custom_AdministrativeSupportAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_FounderSharesMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:RedemptionOfWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:RedemptionOfWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SponsorMember_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember_custom_TrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember_custom_TrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember_custom_TrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-05_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-05_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-05_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-062021-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-06</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-062021-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-06</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-062021-12-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-06</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_DerivativeWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_MeasurementInputSharePriceMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_MeasurementInputExercisePriceMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_MeasurementInputPriceVolatilityMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_MeasurementInputExpectedTermMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_custom_MeasurementInputProbabilityMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ATAK:MeasurementInputProbabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-09_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ATAK:MeasurementInputProbabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ATAK:MeasurementInputProbabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-232023-10-24_us-gaap_SubsequentEventMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ATAK:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-23</xbrli:startDate>
        <xbrli:endDate>2023-10-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-17_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 46.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20230101__20230930_zJ4BPqjSCIk9"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(MARK
ONE)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--DocumentQuarterlyReport_c20230101__20230930_zKmfHrXARbAh"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUARTERLY
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the quarter ended <span id="xdx_90C_edei--DocumentPeriodEndDate_c20230101__20230930_zHDdzBcoeUij"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">September 30, <span id="xdx_902_edei--DocumentFiscalYearFocus_c20230101__20230930_zhmwjLdxQWVk"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--DocumentTransitionReport_c20230101__20230930_zt7rZBoEnfY"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from_____________ to _____________</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number: <span id="xdx_907_edei--EntityFileNumber_c20230101__20230930_zz1o2pd6RJSk"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityFileNumber">001-41250</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_903_edei--EntityRegistrantName_c20230101__20230930_zS589gqEqwM9"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityRegistrantName">AURORA
TECHNOLOGY ACQUISITION CORP.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
Name of Registrant as Specified in Its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20230101__20230930_zBjUZUfk25Cj"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Cayman
    Islands</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20230101__20230930_zrxfwsSb9EIl"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityTaxIdentificationNumber">98-1624542</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation
    or organization)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S.
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aurora
Technology Acquisition Corp.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20230101__20230930_zotQrPP4Ifj"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityAddressAddressLine1">4
Embarcadero Center</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine2_c20230101__20230930_zhntVa6aRKSd"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityAddressAddressLine2">Suite
1449</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20230101__20230930_z9ZfQ6v7eBnd"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityAddressCityOrTown">San
Francisco</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20230101__20230930_z1BPTmZdvpxb"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20230101__20230930_zkq1jR2lErvd"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityAddressPostalZipCode">94105</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of principal executive offices)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--CityAreaCode_c20230101__20230930_zq5rIHoH0ltg"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:CityAreaCode">(650)</ix:nonNumeric></span>
<span id="xdx_90E_edei--LocalPhoneNumber_c20230101__20230930_zK8q09qvD7v8"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:LocalPhoneNumber">550-0458</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Issuer&#8217;s
telephone number)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; padding: 0pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--Security12bTitle_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--CapitalUnitsMember_zDwOT32Lg9a3"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember" name="dei:Security12bTitle">Units,
    each consisting of one Class A Ordinary Share, par value $0.0001 per share</ix:nonNumeric></span>, one Redeemable Warrant to acquire one-half of one Class
    A Ordinary Shares, and one Right to acquire one-tenth of one Class A Ordinary Share</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--TradingSymbol_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--CapitalUnitsMember_zOYngh0edZTe"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember" name="dei:TradingSymbol">ATAKU</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    <span id="xdx_902_edei--SecurityExchangeName_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--CapitalUnitsMember_z5hkbbUt9Bp"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--Security12bTitle_c20230101__20230930_zPzpLHvDjcff"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:Security12bTitle">Class
    A Ordinary Share, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--TradingSymbol_c20230101__20230930_zGUutwBaouk3"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:TradingSymbol">ATAK</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    <span id="xdx_90F_edei--SecurityExchangeName_c20230101__20230930_zvehptjtqVXg"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--Security12bTitle_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--WarrantMember_zjz96VA9UB06"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" name="dei:Security12bTitle">Redeemable
    Warrants, exercisable for Class A Ordinary Shares at an exercise price of $11.50 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--TradingSymbol_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--WarrantMember_zTOqf80vEzrh"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" name="dei:TradingSymbol">ATAKW</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    <span id="xdx_904_edei--SecurityExchangeName_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--WarrantMember_zZmPFde0Yuh1"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--Security12bTitle_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--RightsMember_zqk19xkk9NG7"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_RightsMember" name="dei:Security12bTitle">Rights
    to one-tenth of one Class A Ordinary Share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--TradingSymbol_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--RightsMember_zgE9tpYM7v4e"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_RightsMember" name="dei:TradingSymbol">ATAKR</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    <span id="xdx_906_edei--SecurityExchangeName_c20230101__20230930__us-gaap--InvestmentTypeAxis__us-gaap--RightsMember_zG09MwznAoHh"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_RightsMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. <span id="xdx_900_edei--EntityCurrentReportingStatus_c20230101__20230930_zvspAdInLn18"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <span id="xdx_90E_edei--EntityInteractiveDataCurrent_c20230101__20230930_zRdXDmqJqH9k"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller
reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--EntityFilerCategory_c20230101__20230930_zKdzJyUXVCl5"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_90A_edei--EntitySmallBusiness_c20230101__20230930_z1XmvocvWya8"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20230101__20230930_zda8CIedCUlj"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_903_edei--EntityExTransitionPeriod_c20230101__20230930_zy9hCW6t0mz"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <span id="xdx_90D_edei--EntityShellCompany_c20230101__20230930_zYMSeSjM51qc"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleantrue" name="dei:EntityShellCompany">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 20, 2023, <span id="xdx_90D_edei--EntityCommonStockSharesOutstanding_iI_pid_c20231120__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zd4es442WIif"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-11-20_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,610,292</ix:nonFraction></span> Class A ordinary shares, par value $0.0001 per share, and <span id="xdx_903_edei--EntityCommonStockSharesOutstanding_iI_pid_c20231120__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zehqCD1WKNR9"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-11-20_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></span> Class B ordinary shares, par value
$0.0001 per share, were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURORA
TECHNOLOGY ACQUISITION CORP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; width: 0.25in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Part I. Financial Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">Item 1. Condensed Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Condensed Statement of Changes in Shareholders&#8217; Deficit for the Three and Nine Months Ended September 30, 2023 and 2022 (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">Notes to Unaudited Condensed Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center">8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Controls and Procedures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part II. Other Information</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Legal Proceedings</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A. Risk Factors</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Defaults Upon Senior Securities</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Mine Safety Disclosures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5. Other Information</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6. Exhibits</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top"><a href="#ss_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signatures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_001"></span>PART
I - FINANCIAL INFORMATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_002"></span>Item1.
Interim Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>AURORA
TECHNOLOGY ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_111_zCtsmWC9JA0f" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230930_zzk9Y2ZVOUdc" style="padding: 0pt; font-weight: bold; text-align: center">September 30,</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20221231_zN22YMNKm6uf" style="padding: 0pt; font-weight: bold; text-align: center">December 31,</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2023</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2022</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(unaudited)</b></span></td><td style="padding: 0pt; font-weight: bold; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center">&#160;</td>
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsAbstract_iB_zj2PhM6Nv54" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold">Assets:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsCurrentAbstract_i01B_zx8TIZLepn6e" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Current assets:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--Cash_i02I_maACzYgB_z3MWmK90YOjd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 60%">Cash</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td style="padding: 0pt; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,943</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td style="padding: 0pt; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,103</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PrepaidExpenseCurrent_i02I_maACzYgB_zThiEi21BaV1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Prepaid expenses</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,118</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">284,597</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrent_i02TI_mtACzYgB_maAzFTC_zDnYDvlmE8W3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left">Total current assets</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,061</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">475,700</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsNoncurrentAbstract_i01B_zqbbNBwgM6H9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Non-current assets:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsHeldInTrustNoncurrent_i02I_maANzcOT_zJklKZUtWWe8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Marketable securities held in trust account</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,481,369</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,879,903</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsNoncurrent_i02TI_mtANzcOT_maAzFTC_zdTyG6wZ5QUe" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left">Total non-current assets</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,481,369</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,879,903</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--Assets_i01TI_mtAzFTC_zkHPkgYEvHt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Total Assets</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,536,430</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,355,603</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zMNvFxJ6DhQk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesCurrentAbstract_i01B_zU832Fo1pcjk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Current liabilities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i02I_maLCzCLk_zmHdVMCSVqA1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Accounts payable</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,980,439</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,132</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCzCLk_z3TGt92Qw1Ch" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Accrued expenses</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,362</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,026</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccruedOfferingCosts_i02I_maLCzCLk_zwDtBP43BRj9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Accrued offering costs</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:AccruedOfferingCosts" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:AccruedOfferingCosts" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzCLk_ziwVaNOTV0bb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Promissory note &#8211; related party</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-09-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,405,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0093">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzCLk_maLzHOR_z08HTK4rasOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left">Total current liabilities</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,650,801</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">437,158</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zwwTyk9MqROd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Non-current liabilities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DerivativeLiabilitiesNoncurrent_i02I_maLNzVgj_zsPISe82QyTg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Warrant liabilities</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">441,300</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,420</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredUnderwritingCommissionsNoncurrent_i02I_maLNzVgj_zWbesfuJpAIj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Deferred underwriting commissions</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:DeferredUnderwritingCommissionsNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,070,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:DeferredUnderwritingCommissionsNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,070,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrent_i02TI_mtLNzVgj_maLzHOR_zeBnVJBNQmx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left">Total non-current liabilities</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,511,300</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,659,420</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_mtLzHOR_maLASEzc2c_zwlGiZrUqg9k" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt -10pt; font-weight: bold; text-align: left">Total Liabilities</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,162,101</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,096,578</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzc2c_z86wLFBYmKWa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Commitments and Contingencies (Note 8)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0113">-</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maLASEzc2c_zbZNGESssaD1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Class A ordinary shares, $<span id="xdx_905_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, par or stated value per share"><span id="xdx_90A_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, par or stated value per share"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90C_eus-gaap--TemporaryEquitySharesAuthorized_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, shares authorized"><span id="xdx_906_eus-gaap--TemporaryEquitySharesAuthorized_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, shares authorized"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_900_eus-gaap--TemporaryEquitySharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztbHBPNfv25e" title="Temporary equity, shares issued"><span id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,307,292</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_901_eus-gaap--TemporaryEquitySharesIssued_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, shares issued"><span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></ix:nonFraction></span> </span>shares subject to redemption issued and outstanding, at redemption value of $<span id="xdx_909_eus-gaap--TemporaryEquityRedemptionPricePerShare_c20230930_pdd" title="Temporary equity, redemption price per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.83</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--TemporaryEquityRedemptionPricePerShare_c20221231_pdd" title="Temporary equity, redemption price per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.24</ix:nonFraction></span> per share, as of September 30, 2023 and December 31, 2022, respectively</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,481,369</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,879,903</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquityAbstract_i01B_z4VbjQi7hNEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Shareholders&#8217; Deficit:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockValue_i02I_maSEzXL2_zBEKuSBmIH5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Preference shares, $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_c20230930_pdd" title="Preferred stock, par or stated value per share"><span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20221231_pdd" title="Preferred stock, par or stated value per share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_c20230930_pdd" title="Preferred stock, shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20221231_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_dn_c20230930_zoWUuRs5xs1e" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20230930_zAS8GTiGnVX7" title="Preferred stock, shares outstanding"><span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_dn_c20221231_zGk5hYkYMHG3" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20221231_z4Th8BlPrD0h" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-09-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-09-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0142">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0143">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommonStockValue_i02I_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGHJm2O5geZa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Class A ordinary shares, $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQOpT8mBu7G1" title="Common stock, par or stated value per share"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zW7LKZiFHvmj" title="Common stock, par or stated value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztgGWCbvPtYi" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zvMpd8aSHN3b" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_901_eus-gaap--CommonStockSharesIssued_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, shares, issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, shares, outstanding"><span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, shares, issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding (excluding <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zTLxnPp5mGQ6" title="Temporary equity, shares outstanding"><span title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,307,292</ix:nonFraction></span> </span>and <span id="xdx_90D_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zmTvK6mHvknk" title="Temporary equity, shares outstanding"><span title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></span></span> shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockValue_i02I_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdhXwqC7ziTf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Class B ordinary shares, $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z5ZQyOq9vTi4" title="Common stock, par or stated value per share"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, par or stated value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares, issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares, outstanding"><span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares, issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding as of September 30, 2023 and December 31, 2022</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockValue_i02I_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_maSEzXL2_z1y6fE6A1eR6" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_maSEzXL2_zezgPZ4sHC73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Additional paid-in capital</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0206">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0207">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzXL2_zu9EgPIdPMHl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Accumulated deficit</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,107,575</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,621,413</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_i02TI_maLASEzc2c_mtSEzXL2_zAKIzPHdDorb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Total Shareholders&#8217; Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,107,040</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,620,878</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzc2c_z2HupsLROahg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,536,430</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,355,603</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>AURORA
TECHNOLOGY ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENTS OF OPERATIONS<br />
(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_113_z30pCdRoEMjg" summary="xdx: Statement - Condensed Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20230930_z3jnBIrlbe4d" style="padding: 0pt; font-weight: bold; text-align: center">For the Three</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20220701__20220930_zMLSnjV3Ipuh" style="padding: 0pt; font-weight: bold; text-align: center">For the Three</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20230930_zrM4s2piQh6k" style="padding: 0pt; font-weight: bold; text-align: center">For the Nine</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220930_zaGYul1OhGAd" style="padding: 0pt; font-weight: bold; text-align: center">For the Nine</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Months Ended</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Months Ended</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Months Ended</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Months Ended</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center; font-weight: bold">September 30,</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">September 30,</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">September 30,</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">September 30,</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2023</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2022</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2023</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2022</td><td style="padding: 0pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FormationAndOperatingCosts_msOILz7Sn_zCuqykRrKwrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 44%; text-align: left; text-indent: 0pt">Formation and Operating expense</td><td style="padding: 0pt; width: 2%; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 10%; text-align: right; text-indent: 0pt"><ix:nonFraction name="ATAK:FormationAndOperatingCosts" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">479,300</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; width: 2%; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 10%; text-align: right; text-indent: 0pt"><ix:nonFraction name="ATAK:FormationAndOperatingCosts" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219,330</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; width: 2%; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 10%; text-align: right; text-indent: 0pt"><ix:nonFraction name="ATAK:FormationAndOperatingCosts" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,868,531</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; width: 2%; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; width: 10%; text-align: right; text-indent: 0pt"><ix:nonFraction name="ATAK:FormationAndOperatingCosts" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,210,401</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILz7Sn_maNILzuZW_zBDt2JqOg63l" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: 0pt">Loss from operations</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">479,300</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">)</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">219,330</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">)</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,868,531</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">)</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,210,401</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpenseAbstract_i01B_z7uqc0nxZwq" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">Other income (loss):</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i02N_pp0p0_di_msNIEzJMJ_zqHSekLd99bb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: 0pt">Change in fair value of warrant liability</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,480</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">)</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">471,500</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">148,120</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,247,547</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--GainsLossesOnExtinguishmentOfOverAllotmentLiability_i02_pp0p0_maNIEzJMJ_zhh7td9nLB8c" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: 0pt">Gain on extinguishment of over-allotment liability</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span style="-sec-ix-hidden: xdx2ixbrl0238">&#8212;</span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span style="-sec-ix-hidden: xdx2ixbrl0239">&#8212;</span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span style="-sec-ix-hidden: xdx2ixbrl0240">&#8212;</span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258,440</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02_pp0p0_maNIEzJMJ_zhJCgQTVejU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: 0pt">Gain on extinguishment of liability</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">314,248</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span style="-sec-ix-hidden: xdx2ixbrl0244">&#8212;</span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">314,248</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span style="-sec-ix-hidden: xdx2ixbrl0246">&#8212;</span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentIncomeDividend_i02_pp0p0_maNIEzJMJ_z3uNuJa74JIf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: 0pt">Dividend income on marketable securities held in Trust Account</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">751,668</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">902,675</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,717,772</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,155,816</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NonoperatingIncomeExpense_i02T_pp0p0_maNILzuZW_mtNIEzJMJ_zDb1FCZYRox5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: 0pt">Other income, net</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,001,436</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,374,175</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,180,140</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,661,803</ix:nonFraction></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_iT_pp0p0_mtNILzuZW_zlUFOnsQWOn5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: 0pt">Net income</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">522,136</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,154,845</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">311,609</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,451,402</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjXX1oywaJl4" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRNhsvzw2TBj" title="Diluted weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,413,775</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,659,431</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zizkCfLOjJyd" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,314,286</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.24</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Diluted weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,353,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zedMd7iOr5fd" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTLxZmUZ5une" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,353,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zIYsWlzuOq5e" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zmrm84Ns4bIa" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,353,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z6Acj6kdGb68" title="Diluted weighted average shares outstanding, non-redeemable ordinary shares" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,302,571</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: right; text-indent: 0pt">&#160;</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">Basic and diluted net income per share, non-redeemable ordinary shares</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right; text-indent: 0pt"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Diluted net (loss) income per share, Class A ordinary shares subject to redemption" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.24</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>AURORA
TECHNOLOGY ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; DEFICIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_114_zgMpENgjJ3p2" summary="xdx: Statement - Condensed Statements of Changes in Shareholders&apos; Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember_zBiwbFhQYCNe" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zKIzdmi24ief" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_ziVaxQW7cqW" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z0Whsa7yMAcf" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Capital</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zrJ53zZLkzE8" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B2_z2SUEMO8IHD7" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">Class A</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">Class A</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">Class B</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Additional</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Temporary Equity</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Ordinary Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Ordinary Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Shareholders&#8217;</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Capital</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43E_c20230101__20230331_eus-gaap--StockholdersEquity_iS_z9o9qNrk5Pyc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 28%; font-weight: bold">Balance as of January 1, 2023</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zYSzL9tfKpK4" title="Balance, shares" style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,879,903</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuNMx13lWoua" title="Balance, shares" style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7X2nDqZAqF8" title="Balance, shares" style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0330">&#8212;</span></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,621,413</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,620,878</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_zCUaTuTJQcHf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Redemption of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_iN_di_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zB2piU2LX2v3" title="Redemption of Class A ordinary shares, shares" style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,529,877</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">149,322,133</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0341">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0342">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0344">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0345">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RemeasurementOfRedemptionValue_zIfCVa5qv2b3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares to redemption value</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,538,885</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0352">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,538,885</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,538,885</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zSCSlNP6ESuf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Net loss</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0356">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0358">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0359">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">361,371</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">361,371</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_433_c20230401__20230630_eus-gaap--StockholdersEquity_iS_zH07RgM83igd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">Balance as of March 31, 2023 (unaudited)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z2vMuaP3qQh" title="Balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,670,123</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,096,655</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20230401__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3RJMXKVU7X2" title="Balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20230401__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzjDS0xR817i" title="Balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,521,669</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,521,134</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--RemeasurementOfRedemptionValue_zoMhfzGDeM6c" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares to redemption value</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-04-012023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,102,219</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0378">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,102,219</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,102,219</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zj05YKmr4ir8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0383">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0386">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,844</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,844</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20230701__20230930_eus-gaap--StockholdersEquity_iS_zD2L0IKcQda" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Balance as of June 30, 2023 (unaudited)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zitCOezhin5d" title="Beginning balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,670,123</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,198,874</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTbUlYEogbai" title="Beginning balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5a143k4MjJ1" title="Beginning balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,473,044</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,472,509</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_zE5taLKrImXj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Redemption of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_iN_di_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zjBIiaC5QNt" title="Redemption of Class A ordinary shares, shares" style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">362,831</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,874,172</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0406">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RemeasurementOfRedemptionValue_zA3tWIUA4tXi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares to redemption value</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,156,667</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0414">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,156,667</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,156,667</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zd1r5qWEunE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0419">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0420">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0421">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">522,136</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">522,136</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20230701__20230930_eus-gaap--StockholdersEquity_iE_z2yfS6u0wCvc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold">Balance as of September 30, 2023 (unaudited)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbNoKats6MG5" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,307,292</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,481,369</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWDOTpfayCV9" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjCdSNAApZVf" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0429">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,107,575</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,107,040</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">Class A</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">Class A</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">Class B</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center"><b>Additional</b></td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Temporary Equity</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Ordinary Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Ordinary Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="padding: 0pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid-in</b></span></p></td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center">Shareholders&#8217;</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Shares</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Amount</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Capital</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">Deficit</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43E_c20220101__20220331_eus-gaap--StockholdersEquity_iS_zRC3KKJvNaF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 28%; font-weight: bold">Balance as of January 1, 2022</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zC3R00vm5DI3" title="Balance, shares" style="padding: 0pt; width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0446">&#8212;</span></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td style="padding: 0pt; width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZwBfA7oXZGg" title="Balance, shares" style="padding: 0pt; width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#8212;</span></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td style="padding: 0pt; width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0440">&#8212;</span></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNUr0zD1VZah" title="Balance, shares" style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,750,000</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">575</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,425</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,963</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; width: 2%; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">$</td><td style="padding: 0pt; width: 4%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,037</ix:nonFraction></td><td style="padding: 0pt; width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z7yp7DwgMW0c" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Issuance of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zydfmSFU3Era" title="Issuance of Class A ordianry shares, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,013,413</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0454">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RemeasurementOfRedemptionValue_zk05f0OMvj21" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares to redemption value</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,006,587</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0462">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0463">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,650,885</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,355,702</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,006,587</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zoMj05iReBRg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Forfeiture of Class B shares issued to Sponsor</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0468">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zubAz1Z9kJWi" title="Forfeiture of Class B shares issued to Sponsor, shares" style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">700,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">70</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0472">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_zSmJeMXlfX32" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">Issuance of Representative Shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssued_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zvZMcZNR9Gaf" title="Issuance of Representative Shares, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssued" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,029,970</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,030,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RightsUnderlyingTheUnitsValue_zFD0z1hR8tQi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Rights underlying the Units</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0486">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0487">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,596,420</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,596,420</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zS9KWRuUh87b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,097,637</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,097,637</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20220401__20220630_eus-gaap--StockholdersEquity_iS_zOjPZZQ7GT0l" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Balance as of March 31, 2022 (unaudited)</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zyoUtilczLlh" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,020,000</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOupjuegHsQe" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYD8DswK4s4g" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,268,028</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,267,493</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--RemeasurementOfRedemptionValue_z5kzap30YJ1f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares to redemption value</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-04-012022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">253,141</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">253,141</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">253,141</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zMAExA6iiUob" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Net income</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0522">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,198,920</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,198,920</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
<tr id="xdx_433_c20220701__20220930_eus-gaap--StockholdersEquity_iS_zKIv48stsEsi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 2.5pt">Balance as of June 30, 2022 (unaudited)</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPMVDGsdvhl5" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,273,141</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaa4VyOoAAZ7" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJeLCYoGuM61" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0530">&#8212;</span></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,322,249</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">)</td><td style="padding: 0pt 0pt 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,321,714</ix:nonFraction></td><td style="padding: 0pt 0pt 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43E_c20220701__20220930_eus-gaap--StockholdersEquity_iS_zV1VYuvLA5O5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Beginning balance</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpRoyW0kvz3l" title="Beginning balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,273,141</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSHgP3dXI2e7" title="Beginning balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3lmvyrF1Cx2" title="Beginning balance, shares" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,322,249</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,321,714</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
<tr id="xdx_405_ecustom--RemeasurementOfRedemptionValue_zrKNJtUGbnr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares to redemption value</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-07-012022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">902,675</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0554">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0556">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">902,675</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:RemeasurementOfRedemptionValue" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">902,675</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zTJP89lf7Ctl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Net income</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0560">&#8212;</span></td><td style="border-right: Black 1.5pt solid; padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0561">&#8212;</span></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right">&#8212;</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0562">&#8212;</span></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8212;</span></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,154,845</ix:nonFraction></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,154,845</ix:nonFraction></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20220701__20220930_eus-gaap--StockholdersEquity_iE_zFoT0ZQrHN27" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold">Balance as of September 30, 2022 (unaudited)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zZceqW0CuOwd" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,175,816</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgAsG9qky95a" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzsK03ynmLt" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,070,079</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,069,544</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20220701__20220930_eus-gaap--StockholdersEquity_iE_z8kB25hIDYp" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold">Ending balance </td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z2DegXHUEe5a" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,175,816</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkVJxlVmR8kj" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zx0hSgqkBLbg" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0583">&#8212;</span></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,070,079</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,069,544</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>AURORA
TECHNOLOGY ACQUISITION CORP.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENTS OF CASH FLOWS<br />
(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_112_z5mjorrRGmL6" summary="xdx: Statement - Condensed Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20230930_zxr8L8IE4ZDl" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2023</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_zGmMNP83ZVv5" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2022</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding: 0pt; font-weight: bold; text-align: center">For the Nine Months Ended</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">September</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2023</td><td style="padding: 0pt; font-weight: bold">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; font-weight: bold; text-align: center">2022</td><td style="padding: 0pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_i01_pp0p0_maNCPBUzUIV_zXFughQMbJid" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; width: 60%; text-align: left">Net income</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td style="padding: 0pt; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">311,609</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td style="padding: 0pt; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,451,402</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z90KyDP4ZUz6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--Investmentincomedividends_i02N_pp0p0_di_msNCPBUzUIV_zboWPNW8uX0i" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Dividend income on marketable securities held in Trust Account</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:Investmentincomedividends" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,717,772</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:Investmentincomedividends" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,155,816</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--AllocationOfDeferredOfferingCostsForWarrantLiability_i02_pp0p0_maNCPBUzUIV_z2xhepI44xji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Allocation of deferred offering costs for warrant liability</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:AllocationOfDeferredOfferingCostsForWarrantLiability" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">516,746</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FairValueAdjustmentOfWarrants_i02_pp0p0_maNCPBUzUIV_zSgaDfTESbIa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Change in fair value of warrant liabilities</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">148,120</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,247,547</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--GainsLossesOnExtinguishmentOfOverAllotmentLiability_i02N_pp0p0_di_msNCPBUzUIV_zl0CQ7pv0mn2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Gain on extinguishment of over-allotment liability</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0611">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258,440</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_pp0p0_di_msNCPBUzUIV_zvQTorlyTCAk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Gain on extinguishment of liability</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">314,248</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0615">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zMw4g8BY0MHb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Changes in current assets and current liabilities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_pp0p0_di_msNCPBUzUIV_z4aXUpytZC35" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Prepaid expense</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">258,479</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">432,070</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_pp0p0_maNCPBUzUIV_zXQ0d8myMcsb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Accounts payable and accrued expenses</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,122,892</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,275</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUzUIV_maCCERCz4ID_zL4zOvrbYE48" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; font-weight: bold; text-align: left">Net cash used in operating activities</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">487,160</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,044,450</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_i01B_zSGo1SxWI869" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Cash Flows from Investing Activities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsToAcquireRestrictedInvestments_i02N_di_msNCPBUzdZK_zMXItaR1aNTl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Investment of cash in Trust Account</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0632">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireRestrictedInvestments" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,020,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsToAcquireMarketableSecurities_i02N_di_msNCPBUzdZK_zcdgrYXOvHlk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Purchase of marketable securities held in Trust Account</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,080,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0636">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_i02_maNCPBUzdZK_zw9sRuFcrp91" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Redemption of marketable securities held in Trust Account</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,196,305</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0639">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i02T_mtNCPBUzdZK_maCCERCz4ID_zmqgCXvUKGu6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; font-weight: bold; text-align: left">Net cash provided (used) in investing activities</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,116,305</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">204,020,000</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_i01B_zrZNhB5yntra" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfCommonStock_i02_pp0p0_maNCPBUz8f8_z6lx3Ej0jGA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Proceeds from issuance of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0647">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,000,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i02_pp0p0_maNCPBUz8f8_zV8a1xtTLM5c" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Proceeds from sale Private Warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0650">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,470,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsOfStockIssuanceCosts_i02N_pp0p0_di_msNCPBUz8f8_zX6DYRKBiQj8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Payment of underwriting fee</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0653">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,525,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromRelatedPartyDebt_i02_pp0p0_maNCPBUz8f8_z3nBzJfDpyw1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Proceeds from promissory note &#8211; related party</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,405,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0657">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RepaymentsOfLongTermDebt_i02N_pp0p0_di_msNCPBUz8f8_z61JwRBYNMXk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Payment of promissory note &#8211; related party</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0659">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">242,801</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsOfFinancingCosts_i02N_pp0p0_di_msNCPBUz8f8_zLa54fYchk78" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Payment of deferred offering costs</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0662">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">446,002</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsForRepurchaseOfCommonStock_i02N_pp0p0_di_msNCPBUz8f8_zg4ALe2uXYSl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left">Payment of redemption on Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">153,196,305</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0666">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i02T_pp0p0_maCCERCz4ID_mtNCPBUz8f8_zIs9idGFY8o" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; font-weight: bold; text-align: left">Net cash (used) provided by financing activities</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">151,791,305</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">)</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,256,197</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCz4ID_zDora6ja3Ock" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Net Change in Cash</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">162,160</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,747</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_pp0p0_ze0n9S2Hrx64" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">Cash &#8211; Beginning of the period</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,103</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,373</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_pp0p0_zC4394dJBrLg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold">Cash &#8211; End of the period</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,943</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">257,120</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_i01B_z9Xuuu7mDYF8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Non-cash Investing Financing Activities:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption_i02_pp0p0_zavdoxDrVA5a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Initial measurement of Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0683">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">174,013,413</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants_i02_pp0p0_zIgoPBMhNDCa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Initial measurement of public warrants and private placement warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0686">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,780,547</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredUnderwritingFeePayable_i02_pp0p0_zh6UK1TBWdna" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Deferred underwriting fee payable</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0689">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:DeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,070,000</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption_i02_pp0p0_zKZK0Bly1rhl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Remeasurement of Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,797,771</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,162,403</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--ForfeitureOfRepresentativeShares_i02_pp0p0_zUxI3WwhxJ3d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt">Forfeiture of Representative Shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0695">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:ForfeitureOfRepresentativeShares" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">70</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_i02_pp0p0_zcORSXhYtkq8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Issuance of Representative Shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0698">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts_i02_pp0p0_zxYOdPfqW1Mc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Deferred offering costs included in accrued offering costs</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0701">&#8212;</span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><ix:nonFraction name="ATAK:DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,512</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_007"></span>AURORA
TECHNOLOGY ACQUISITION CORP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zD94sDycK0Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
1. <span id="xdx_820_zeRplP3cU0xh">ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
and General</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aurora
Technology Acquisition Corporation (the &#8220;Company&#8221;) was incorporated as a Cayman Islands exempted company on August 6, 2021.
The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization, recapitalization or similar business combination with one or more businesses (a &#8220;Business Combination&#8221;).
The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor
and Initial Financing</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company&#8217;s
formation, the initial public offering (the &#8220;Initial Public Offering&#8221; or &#8220;IPO&#8221;), which is described below, and
identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its
initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Initial Public Offering was declared effective on February 7, 2022. On February 9, 2022, the Company consummated
the Initial Public Offering of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zdCSM9XRn5R2" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></span> units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in
the Units sold, the &#8220;Public Shares&#8221;), which includes the exercise by the underwriter of its over-allotment option in the
amount of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXM6yznwqmXe" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-092022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span> Units, at $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuDeOHcTeEDl" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-02-09_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOBkgWAcScR9" title="Proceeds from issuance initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-02-092022-02-09_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,000,000</ix:nonFraction></span>, which is described in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zguyyM1M9iT8" title="Class of warrants or rights warrants issued during the period units"><ix:nonFraction name="ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,470,000</ix:nonFraction></span> warrants (each, a &#8220;Private Placement
Warrant&#8221; and, collectively, the &#8220;Private Placement Warrants&#8221;) at a price of $<span id="xdx_900_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_z09YtLjJjS2i" title="Class of warrants or rights warrants issued issue price per warrant"><ix:nonFraction name="ATAK:ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per Private Placement Warrant in
a private placement to ATAC Sponsor LLC (the &#8220;Sponsor&#8221;), generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zuBNKU2ixrVh" title="Proceeds from issuance of warrants"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,470,000</ix:nonFraction></span>, which is described in Note
4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs related to the consummation of the IPO on February 9, 2022, amounted to $<span id="xdx_90A_ecustom--TransactionCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxxSiWwQvMtd" title="Transaction costs"><ix:nonFraction name="ATAK:TransactionCosts" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,192,787</ix:nonFraction></span>, consisting of $<span id="xdx_90C_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTosweShAQ8" title="Underwriting discount"><ix:nonFraction name="us-gaap:OtherUnderwritingExpense" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,525,000</ix:nonFraction></span> of underwriting discount,
$<span id="xdx_905_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWMOSOO2o2Rf" title="Deferred underwriting fees"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,070,000</ix:nonFraction></span> of deferred underwriting fees, over-allotment option liability of $<span id="xdx_904_ecustom--OverallotmentOptionLiability_c20220209__20220209_zen3ggiPemR2" title="Over-allotment option liability"><ix:nonFraction name="ATAK:OverallotmentOptionLiability" contextRef="From2022-02-092022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">258,440</ix:nonFraction></span>, $<span id="xdx_90B_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zS7yJMYeyja" title="Issuance of representative shares"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-02-092022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,030,000</ix:nonFraction></span> for issuance of representative shares,
$<span id="xdx_90B_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zak6DtBwWPn8" title="Rights underlying the Units"><ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-02-092022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,596,420</ix:nonFraction></span> fair value of rights underlying the Units, and $<span id="xdx_90E_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEIjCexT5do5" title="Actual offering costs"><ix:nonFraction name="ATAK:ActualOfferingCosts" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">712,927</ix:nonFraction></span> of actual offering costs. In addition, on February 9, 2022, cash
of $<span id="xdx_909_eus-gaap--Cash_iI_c20220209_z5VCIgCy3Hh5" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,468,333</ix:nonFraction></span> was held outside of the Trust Account (as defined below) and was available for the payment of offering costs and for working
capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust Account</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 9, 2022 (&#8220;IPO Closing Date&#8221;), an amount of $<span id="xdx_90A_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDV5d72fIcec" title="Net proceeds amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireRestrictedInvestments" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,020,000</ix:nonFraction></span> ($<span id="xdx_909_eus-gaap--SharePrice_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuQvc8w5Bthi" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></span> per
Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was
placed in a trust account (the &#8220;Trust Account&#8221;). The funds in the Trust Account is invested only in U.S. government treasury
bills with a maturity of <span id="xdx_903_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrqgJSTHhH55" title="Term of restricted investments"><ix:nonNumeric contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt-sec:durday" name="ATAK:TermOfRestrictedInvestments">185</ix:nonNumeric></span> days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions
under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal
or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account
will not otherwise be released from the trust account until the earliest of: (i) the Company&#8217;s completion of a Business Combination;
(ii) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s Amendment
No. 1 to the Amended and Restated Memorandum of Association, and (iii) the redemption of the Company&#8217;s Public Shares if the Company
is unable to complete the initial Business Combination within <span id="xdx_907_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MinimumMember_zf3RK8G4coW6" title="Period within which business combination shall be consummated from the consummation of initial public offer"><ix:nonNumeric contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MinimumMember" format="ixt-sec:durmonth" name="ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer">12</ix:nonNumeric></span> months (or up to <span id="xdx_905_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MaximumMember_zgxHZscZMJ93" title="Period within which business combination shall be consummated from the consummation of initial public offer"><ix:nonNumeric contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MaximumMember" format="ixt-sec:durmonth" name="ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer">24</ix:nonNumeric></span> months, if applicable) from the IPO Closing Date
(the &#8220;Combination Period&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023 in connection with its Extraordinary General Meeting held on February 3, 2023 (the &#8220;February Extraordinary General
Meeting&#8221;), the Company and Continental Stock Transfer &amp; Trust Company (the &#8220;Trustee&#8221;) entered into Amendment No.
1 to the Investment Management Trust Agreement dated February 7, 2022 to allow the <span id="xdx_904_ecustom--DescriptionOfBusinessCombinationExtendedPeriodTerms_c20230203__20230203__us-gaap--TypeOfArrangementAxis__custom--AmendmentNoOneToInvestmentManagementTrustAgreementMember_zztFMc7vxu3j" title="Description of business combination extended period terms"><ix:nonNumeric contextRef="From2023-02-032023-02-03_custom_AmendmentNoOneToInvestmentManagementTrustAgreementMember" name="ATAK:DescriptionOfBusinessCombinationExtendedPeriodTerms">Company to extend the date by which it has to consummate
a business combination six times for an additional one month each time from February 9, 2023 to August 9, 2023, extending the Combination
period up to 24 months, if applicable, by depositing into the Trust Account for each one-month extension the lesser of $135,000 or $0.045
per share multiplied by the number of public shares then outstanding</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2023, <span id="xdx_904_eus-gaap--SubsequentEventDescription_c20230727__20230727_zZJ2wWKUpwd8" title="Subsequent event, description"><ix:nonNumeric contextRef="From2023-07-272023-07-27" name="us-gaap:SubsequentEventDescription">the Company held an extraordinary general meeting of shareholders (the &#8220;July Extraordinary General Meeting&#8221;),
to, among other things, approve (i) a special resolution to amend the amended and restated articles of association of the Company (the
&#8220;Articles&#8221;) giving the Company the right to further extend the Business Combination Period six (6) times for an additional
one (1) month each time, from August 9, 2023 to February 7, 2024 (the &#8220;Second Extension Amendment&#8221;) and (ii) the proposal
to approve the Second Trust Amendment (as defined below). All proposals at the July Extraordinary General Meeting were approved by the
shareholders of the Company. As such, the Company and Transfer Agent entered into Amendment No. 2 to the Investment Management Trust
Agreement, to allow ATAK to extend the Business Combination Period six (6) times for an additional one (1) month each time from August
9, 2023 to February 9, 2024 by depositing into the Trust Account for each one-month extension the lesser of: (x) $135,000 or (y) $0.045
per share multiplied by the number of public shares then outstanding (the &#8220;Second Trust Amendment&#8221;). In addition, on July
27, 2023, the Company adopted the Second Extension Amendment, amending the Company&#8217;s Articles. As of September 30, 2023, the Company
exercised eight of the one-month extensions, depositing a total of $1,080,000 into the Trust Account to fund the extensions</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Combination</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds from the Initial Public
Offering, although substantially all of the net proceeds from the Initial Public Offering are intended to be generally applied toward
consummating a Business Combination with (or acquisition of) a Target Business. As used herein, &#8220;Target Business&#8221; means one
or more target businesses that together have an aggregate fair market value equal to at least <span id="xdx_909_ecustom--PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_iI_pid_dp_uPure_c20230930_zkPXN1U2MIlf" title="Percentage of fair market value of target business to asset held in trust account"><ix:nonFraction name="ATAK:PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>% of the value of the assets held in
the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at
the time of the signing of a definitive agreement in connection with a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
there is no assurance that the Company will be able to successfully effect a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination, either (i) in connection with a shareholder meeting called to approve such Business Combination or (ii) by
means of a tender offer. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in
the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount
to be distributed to the public shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the
Company will pay to the underwriter in connection with the IPO (as discussed in Note 6). There will be no redemption rights upon the
completion of a Business Combination with respect to the Company&#8217;s warrants. As a result, shares are recorded at their redemption
amount and classified as temporary equity, in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting
Standards Codification (&#8220;ASC&#8221;) 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decision as to whether the Company will seek shareholder approval of a Business Combination or will allow shareholders to sell their
shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing
of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a
vote is required by law or stock exchange listing requirements. If the Company seeks shareholder approval, it will complete its Business
Combination only if a majority of the Company&#8217;s ordinary shares entitled to vote thereon are voted in favor of such Business Combination.
However, in no event will the Company redeem its Public Shares in an amount that would cause the Company&#8217;s net tangible assets
to be less than $<span id="xdx_903_eus-gaap--MinimumNetWorthRequiredForCompliance_iI_c20230930_z2kftrzYbf7b" title="Banking regulation, mortgage banking, net worth, minimum"><ix:nonFraction name="us-gaap:MinimumNetWorthRequiredForCompliance" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span> upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption
of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has until February 9, 2024, to complete its initial Business Combination, if we exercise out right to extend as approved in
the Extraordinary General Meeting held on July 27, 2023; provided the Company, by resolution of the board of directors if requested
by the Sponsor, <span id="xdx_90F_ecustom--BusinessCombinationExtensionOfBusinessCombinationPeriod_c20230101__20230930_zugRDHTIsT9j" title="Business combination extension of business combination period"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="ATAK:BusinessCombinationExtensionOfBusinessCombinationPeriod">extends
the period of time to consummate the initial Business Combination up to six times, each by an additional one month (for a total of
up to 24 months from the date of the Initial Public Offering to complete the Business Combination)</ix:nonNumeric></span>, subject to the Sponsor
depositing additional funds into the Trust Account (each one month period individually, an &#8220;Extension Period&#8221;) pursuant
to the Company&#8217;s Amendment No. 1 to the Amended and Restated Memorandum of Association. If the Company does not complete a
Business Combination by such date (or such longer period as described above), the Company shall (i) cease all operations except for
the purposes of winding up; (ii) as promptly as reasonably possible but not more than <span id="xdx_903_ecustom--NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_dtD_c20230101__20230930_zdOjOTw5ggb3" title="Number of days within which public shares shall be redeemed"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:durday" name="ATAK:NumberOfDaysWithinWhichPublicSharesShallBeRedeemed">10</ix:nonNumeric></span>
business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account, including interest (less up to $<span id="xdx_90F_eus-gaap--LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_iI_c20230930_zumsHR8pvfg2" title="Expenses payable on dissolution"><ix:nonFraction name="us-gaap:LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span>
of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and
outstanding Public Shares, which redemption will completely extinguish public shareholders&#8217; rights as shareholders (including
the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#8217;s remaining shareholders and its board of directors, liquidate and
dissolve, subject in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors and
the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the
Company&#8217;s warrants, which will expire worthless if the Company fails to complete its initial Business Combination by February
9, 2024, or within any applicable Extension Period. The Company&#8217;s &#8220;initial shareholders&#8221; (as defined below) have
entered into a letter agreement with the Company, pursuant to which the initial shareholders have waived their rights to liquidating
distributions from the Trust Account with respect to their Founder Shares (as defined in Note 5) if the Company fails to complete
its initial Business Combination by February 9, 2024, or within any applicable Extension Period. However, if any initial
shareholders acquire Public Shares, such initial shareholders will be entitled to liquidating distributions from the Trust Account
with respect to such Public Shares if the Company fails to complete its initial Business Combination by February 9, 2024, or within
any applicable Extension Period. As used herein, the term &#8220;initial shareholders&#8221; refers to the holders of Founder Shares
prior to the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company&#8217;s
independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company
has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $<span id="xdx_900_ecustom--MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_iI_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zgxBM8LRjpwl" title="Minimum Public Share price due to reductions in the value of the trust assets less taxes payable"><ix:nonFraction name="ATAK:MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" contextRef="AsOf2023-09-30_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></span> per Public Share
or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions
in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the
Company&#8217;s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not
be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including,
but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target
businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest
or claims of any kind in or to any monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2023 (the &#8220;Signing Date&#8221;), Aurora Technology Acquisition Corp., a Cayman Islands exempted company (which shall
migrate to and domesticate as a Delaware corporation prior to the Closing, as defined below) (&#8220;ATAK&#8221;), entered into a Business
Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the &#8220;Business
Combination Agreement&#8221;), among ATAK, Aurora Technology Merger Sub Corp., a Nevada corporation and a direct, wholly-owned subsidiary
of ATAK (&#8220;Merger Sub&#8221;), and DIH Holding US, Inc., a Nevada corporation (&#8220;DIH&#8221;). ATAK and DIH are each individually
referred to herein as a &#8220;Party&#8221; and, collectively, the &#8220;Parties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement has been approved by the board of directors of each of ATAK and Merger Sub and DIH, respectively. The
transactions contemplated by the Business Combination Agreement are referred to as the &#8220;Business Combination.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the time of the closing of the Business Combination (the &#8220;Closing,&#8221; and the date on which the Closing occurs, the &#8220;Closing
Date&#8221;), the combined company will be organized as a Delaware corporation, in which substantially all of the assets and the business
of the combined company will be held by DIH. The combined company&#8217;s business will continue to operate through DIH and its subsidiaries.
In connection with the Closing, ATAK will change its name to &#8220;DIH Holding US, Inc.&#8221; (such company after the Closing, &#8220;New
DIH&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Going Concern</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, the Company had $<span id="xdx_905_eus-gaap--Cash_iI_c20230930_zaSmhoIONvP2" title="Operating cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,943</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--Cash_iI_c20221231_za52WYHshWy1" title="Operating cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,103</ix:nonFraction></span> in operating cash, respectively, and working capital
(deficit) of $<span id="xdx_901_ecustom--NetWorkingCapitalSurplusDeficit_iI_c20230930_zkTX3tqGrMni" title="Working capital (deficit)">(<ix:nonFraction name="ATAK:NetWorkingCapitalSurplusDeficit" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,595,740</ix:nonFraction>)</span> and $<span id="xdx_90A_ecustom--NetWorkingCapitalSurplusDeficit_iI_c20221231_zUHgSaU9Wxz6" title="Working capital (deficit)"><ix:nonFraction name="ATAK:NetWorkingCapitalSurplusDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,542</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s liquidity needs up to September 30, 2023 had been satisfied through a payment from the Sponsor of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZnJ2slI5uNh" title="Stock shares issued during the period for services shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> for Class B
ordinary shares, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zW5T3OYnHGZ2" title="Common stock, par or stated value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (see Note 5), and proceeds from the Initial Public Offering and the issuance of the Private
Placement Warrants. Additionally, the Company drew on unsecured promissory notes to pay certain offering costs and extension payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company
may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or
third parties. The Company&#8217;s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to
time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company&#8217;s working capital needs.
Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may
be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
and Uncertainties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of operations and the Company&#8217;s ability to complete an Initial Business Combination may be adversely affected by various factors
that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could
be impacted by, among other things, downturns in the financial markets or in economic conditions, inflation, increases in interest rates,
adverse developments affecting the financial services industry, and geopolitical instability, such as the military conflict in the Ukraine.
The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent
to which they may negatively impact our business and our ability to complete an Initial Business Combination. The unaudited condensed
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation
Reduction Act</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic
(i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the
repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1%
of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of
stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury
(the &#8220;Treasury&#8221;) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or
avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination may be subject to the excise
tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination would depend
on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination,
extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any &#8220;PIPE&#8221; or other
equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued
within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In
addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#8217;s ability to complete a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will continue to monitor for updates to the Company&#8217;s business along with guidance issued with respect to the IR Act to
determine whether any adjustments are needed to the Company&#8217;s tax provision in future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zO2S0twikXdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2. <span id="xdx_829_zK33lbDmrij6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5c7ZQjccLqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zQx4h1dnoTW1">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements should be read in conjunction with the Annual Report on Form 10-K for the year
ended December 31, 2022 as filed with the SEC on April 19, 2023, which contains the audited financial statements and notes thereto. The
financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company&#8217;s Annual
Report on Form 10-K. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the
results to be expected for the year ending December 31, 2023 or for any future interim periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zob0Lry84z67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zlQrHyqu40K3">Emerging
Growth Company</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are
not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new
or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard
at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements
with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84B_eus-gaap--UseOfEstimates_z2eKLJz4ABVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zGi4D2n12B3l">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject
to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziHEdcElBAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_z3HLudZMAYg4">Cash
and Cash Equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did <span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230930_zGqSKr38mMO4" title="Cash equivalents"><span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zIy2dmr9Ltxd" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2023-09-30" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span>t have any cash equivalents as of September 30, 2023 and December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:MarketableSecuritiesPolicy"><p id="xdx_848_eus-gaap--MarketableSecuritiesPolicy_zgSim9l0fWV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zM7u8FDrjVRe">Marketable
Securities Held in Trust Account</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 9, 2022, an amount of $<span id="xdx_903_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEh1TfD0NkMd" title="Net proceeds amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireRestrictedInvestments" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,020,000</ix:nonFraction></span> from the net proceeds of the sale of the Units
in the Initial Public Offering and the sale of the Private Placement Warrants were placed in the Trust Account and is invested only in
U.S. government securities with a maturity of <span id="xdx_904_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRtH5s5xBKf5" title="Term of restricted investments"><ix:nonNumeric contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt-sec:durday" name="ATAK:TermOfRestrictedInvestments">185</ix:nonNumeric></span> days or less or in money market funds meeting certain conditions under Rule 2a-7 under
the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding
place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any
public shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s Amended and Restated Memorandum of
Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have
their shares redeemed in connection with our initial business combination or to redeem <span id="xdx_908_ecustom--PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_iI_pid_dp_uPure_c20230930_z5CkJ6FaHeZ3" title="Percentage of public shares to be redeemed in case business combination is not consummated"><ix:nonFraction name="ATAK:PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of our public shares if we do not complete
our initial business combination within <span id="xdx_902_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--IfWeDoNotCompleteOurInitialBusinessCombinationMember_zNTRLhQvUsWh" title="Period within which business combination shall be consummated from the consummation of initial public offer"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_IfWeDoNotCompleteOurInitialBusinessCombinationMember" format="ixt-sec:durmonth" name="ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer">24</ix:nonNumeric></span> months from the closing of the IPO (with exercise of six one-month extensions) or (B) with
respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an initial
business combination within <span id="xdx_90D_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--AbsentOurCompletingAnInitialBusinessCombinationMember_z1VIgxwm0mwb" title="Period within which business combination shall be consummated from the consummation of initial public offer"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_AbsentOurCompletingAnInitialBusinessCombinationMember" format="ixt-sec:durmonth" name="ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer">24</ix:nonNumeric></span> months from the closing of our initial public offering (with exercise of six one-month extensions), our
return of the funds held in the trust account to our public shareholders as part of our redemption of the Public Shares. As of September
30, 2023, substantially all of the assets held in the Trust Account were held in money market funds which invest in United States Treasury
securities. All of the investments held in the Trust Account are classified as trading securities. Trading securities are presented on
the balance sheet at fair value at the end of each reporting period. The estimated fair values of investments held in Trust Account are
determined using available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zUuvblWO2gIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zkwmhAaGaN53">Offering
Costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A&#8212;&#8221;Expenses
of Offering&#8221;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the IPO. Offering costs are charged to shareholders&#8217; deficit or the statement of operations based on the relative
value of the Public Warrants and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the
IPO. Accordingly, on February 9, 2022, offering costs totaling $<span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zewwkQpvfngi" title="Offering costs"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,192,787</ix:nonFraction></span> (consisting of $<span id="xdx_904_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJeIEabnl2Gd" title="Underwriting fees"><ix:nonFraction name="us-gaap:OtherUnderwritingExpense" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,525,000</ix:nonFraction></span> of underwriting fees, $<span id="xdx_909_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zolMxtUxdHze" title="Deferred underwriting fees"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,070,000</ix:nonFraction></span>
of deferred underwriting fees, over-allotment option liability of $<span id="xdx_905_ecustom--OverallotmentOptionLiability_c20220209__20220209_zPA2zHE7oZpj" title="Overallotment option liability"><ix:nonFraction name="ATAK:OverallotmentOptionLiability" contextRef="From2022-02-092022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">258,440</ix:nonFraction></span>, $<span id="xdx_909_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zsOkxRHx08ef" title="Issuance of representative shares"><ix:nonFraction name="ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue" contextRef="From2022-02-092022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,030,000</ix:nonFraction></span> for issuance of representative shares, $<span id="xdx_902_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zJ0MIuZXt5Nh" title="Rights underlying the Units"><ix:nonFraction name="ATAK:RightsUnderlyingTheUnitsValue" contextRef="From2022-02-092022-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,596,420</ix:nonFraction></span>
fair value of rights underlying the Units, and $<span id="xdx_907_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvVYeyWQ04Cl" title="Actual offering costs"><ix:nonFraction name="ATAK:ActualOfferingCosts" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">712,927</ix:nonFraction></span> of actual offering costs), with $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzJjDfu5bgU9" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,808</ix:nonFraction></span> included in accumulated deficit as an
allocation for the Public Warrants, and $<span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDrOv6Q1wwqb" title="Adjustments to additional paid in capital, warrant issued"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,300,559</ix:nonFraction></span> included as a reduction to proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:TemporaryEquityPolicyTextBlock"><p id="xdx_846_ecustom--TemporaryEquityPolicyTextBlock_zYEWZ5qlFjle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zDS8A7r8180i">Class
A Ordinary shares Subject to Possible Redemption</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Conditionally redeemable ordinary shares
(including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times,
ordinary shares is classified as shareholders&#8217; equity. The Company&#8217;s Class A ordinary shares features certain redemption
rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. On February
9, 2023, certain investors redeemed <span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230209__20230209_z3aSo4Uxbfma" title="Redemption of Class A ordinary shares, shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2023-02-092023-02-09" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,529,877</ix:nonFraction></span> shares of Class A ordinary shares for $<span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230209__20230209_zk0KFCtSx2S" title="Redemption of Class A ordinary shares, value"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-02-092023-02-09" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149,322,133</ix:nonFraction></span>, resulting in a reduction to shares
of Class A ordinary shares outstanding to <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230201__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9ciN1oB9pAe" title="Shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-02-01_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,670,123</ix:nonFraction></span>. On July 28, 2023, certain investors redeemed <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230728__20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuUpwzym4ULj" title="Redemption of Class A ordinary shares, shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2023-07-282023-07-28_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">362,831</ix:nonFraction></span> shares of Class A ordinary
shares for $<span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230728__20230728_zsjVqqQdtzH" title="Redemption of Class A ordinary shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-282023-07-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,874,172</ix:nonFraction></span>, resulting in a reduction to shares of Class A ordinary shares outstanding to <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVXXzYx9gEX" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-07-28_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,307,292</ix:nonFraction></span>. Accordingly, at September
30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary
equity, outside of the shareholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the
absence of additional capital, in accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:DisclousreOfTemporaryEquityTextBlock"><p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zHcf6nR58UCi" style="display: none">SUMMARY OF TEMPORARY EQUITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 79%; text-align: left">Gross proceeds from initial public offering</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" title="Gross proceeds from initial public offering" style="padding: 0pt; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,000,000</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Less:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to public warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" title="Proceeds allocated to public warrants" style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepurchaseOfEquity" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,521,870</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Offering costs allocated to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" title="Offering costs allocated to Class A ordinary shares subject to possible redemption" style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,079,620</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Fair value allocated to rights</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" title="Fair value allocated to rights" style="padding: 0pt; text-align: right">(<ix:nonFraction name="ATAK:FairValueAllocatedToRights" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,596,420</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Plus:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to private warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" title="Proceeds allocated to private warrants" style="padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepurchaseOfEquity" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,211,323</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Redemption of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" title="Redemption of Class A ordinary shares" style="padding: 0pt; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">153,196,305</ix:nonFraction></td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Re-measurement of Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" title="Re-measurement of Class A ordinary shares subject to possible redemption" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,664,261</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Class A ordinary shares subject to possible redemption, September 30, 2023</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">$</td><td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" title="Class A ordinary shares subject to possible redemption, September 30, 2023" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-09-30_custom_CommonClassASubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,481,369</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table><div style="clear: both"></div>

</ix:nonNumeric><p id="xdx_8A5_zoCVqASZ9NG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zN6ihQlobsm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zsXoHBhnjAK1">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;).
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30,
2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be subject to potential examination by U.S. federal, U.S. state or foreign taxing authorities in the area of income taxes.
These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions
and compliance with U.S. federal, U.S. state and foreign tax laws. There is currently no taxation imposed on income by the Government
of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently,
deferred tax assets and income taxes are not reflected in the Company&#8217;s financial statements. The Company&#8217;s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zlDhTOoQNTf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zMEqkd0zGo82">Net
income per Ordinary Share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding
during the period. Ordinary shares subject to possible redemption at September 30, 2023, which are not currently redeemable and are not
redeemable at fair value, have been excluded from the calculation of basic net income per ordinary share since such shares, if
redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of the warrants
sold in the Initial Public Offering and the private placement to purchase an aggregate of <span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zH8O5cB0wZM7" title="Class of warrants or rights warrants issued during the period units"><ix:nonFraction name="ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" contextRef="From2023-01-012023-09-30_us-gaap_IPOMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,470,000</ix:nonFraction></span> Private Placement Warrants in the
calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events and the
inclusion of such warrants would be anti-dilutive. As a result, diluted net income (loss) per ordinary share is the same as basic net
income per ordinary share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s statement of operations includes a presentation of net income per ordinary share subject to possible redemption
and allocates the net income into the two classes of stock in calculating net earnings per ordinary share, basic and diluted.
For redeemable Class A ordinary shares, net income per ordinary share is calculated by dividing the net income by the weighted
average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. For non-redeemable Class
A ordinary shares, net income per share is calculated by dividing the net income by the weighted average number of non-redeemable
Class A ordinary shares outstanding for the period. Non-redeemable Class A ordinary shares include the representative shares issued to
Maxim at the closing of the initial public offering. For non-redeemable Class B ordinary shares, net income per share is calculated
by dividing the net income by the weighted average number of non-redeemable Class B ordinary shares outstanding for the period.
Non-redeemable Class B ordinary shares include the founder shares as these shares do not have any redemption features and do not participate
in the income earned on the Trust Account. As of September 30, 2023, the Company did not have any dilutive securities or other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
net income per ordinary share is the same as basic net income per ordinary share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none">SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Three Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,542</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">912,921</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,413,775</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">259,594</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,924</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,353,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,353,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Nine Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,421</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,173,309</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,659,431</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,314,286</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.24</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,188</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,278,093</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,353,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,302,571</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.24</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zD9STglapad3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:RelatedPartiesPolicyTextBlock"><p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zn6txi3e7Jra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zbNK8Mc6pn8a">Related
Parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z0rL5e341nuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zu9h4xeAzRWj">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zUsDGM9cFSA7" title="Federal depository insurance coverage"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbRiclSaBLi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_ztH9AGXbx30c">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value Measurement&#8221;
(&#8220;ASC 820&#8221;), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to
their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z0mtbpTsBPQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_ziYGfXBKh0la">Fair
Value Measurements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:WarrantyLiabilityPolicyTextBlock"><p id="xdx_847_ecustom--WarrantyLiabilityPolicyTextBlock_ziGdbr12fuBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zGlNU7vkEWq9">Warranty
Liability</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the <span id="xdx_907_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDtZFfYhB441" title="Class of warrants or rights warrants issued during the period units"><ix:nonFraction name="ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember68552781" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,670,000</ix:nonFraction></span> warrants issued in connection with the Initial Public Offering and the Private Placement Warrants
(collectively, the &#8220;Warrants&#8221;) as either equity-classified or liability-classified instruments based on an assessment of
the Warrant&#8217;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, &#8220;Derivatives and Hedging&#8221;
(&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the company&#8217;s own ordinary shares, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as
a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon
the closing of the Initial Public Offering. Accordingly, the Company will classify each warrant as a liability at its fair value and
the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This liability is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with
the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each
balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the
date of the event that causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmVqWsEk1uzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zp1njrD6GmUg">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in
an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020- 06&#8221;), which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results
of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions&#8221; (&#8220;ASU 2022-03&#8221;), which amends ASC 820 to clarify that a contractual sales restriction is not considered
in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual
sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities
measured at fair value. The amendments are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods
within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued
or made available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial
position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s condensed financial statements.</span></p>
</ix:nonNumeric><p id="xdx_856_zZPQaKExVd55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:DisclosureOfInitialPublicOfferingTextBlock"><p id="xdx_80A_ecustom--DisclosureOfInitialPublicOfferingTextBlock_zjdp5Jc8pFwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
3. <span id="xdx_824_zMzbHbOg1Ooj">INITIAL PUBLIC OFFERING</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2022, pursuant to the Initial Public Offering, the Company sold <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPbYym7mU6a" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></span> Units, which includes the partial exercise by
the underwriter of its over-allotment option in the amount of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zh5AD6Nt1L6a" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-092022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span> Units, at a price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrmRWzmQUlL2" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. <span id="xdx_90A_eus-gaap--CommonStockConversionBasis_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zu7F6RRFHpp4" title="Common stock, conversion basis"><ix:nonNumeric contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember" name="us-gaap:CommonStockConversionBasis">Each Unit consists of one
Class A ordinary share, one redeemable warrant (each whole warrant, a &#8220;Public Warrant&#8221;), and one right to receive one-tenth
of one Class A ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Each two Public Warrants entitle
the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8)</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aggregate of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVUCN9zPjfef" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-02-09_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></span> per Unit sold in the IPO was held in the Trust Account and invested in U.S. government securities, within the meaning
set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of <span id="xdx_90E_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaFI22ntpuzd" title="Term of restricted investments"><ix:nonNumeric contextRef="From2022-02-092022-02-09_us-gaap_IPOMember" format="ixt-sec:durday" name="ATAK:TermOfRestrictedInvestments">185</ix:nonNumeric></span> days or less or in any open-ended investment company
that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:DisclosureOfPrivatePlacementTextBlock"><p id="xdx_80E_ecustom--DisclosureOfPrivatePlacementTextBlock_zacKhridVzTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
4. <span id="xdx_823_zVGa5FoW5c4l">PRIVATE PLACEMENT</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of <span id="xdx_902_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zxgjobz3yxVf" title="Class of warrants or rights warrants issued during the period units"><ix:nonFraction name="ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,470,000</ix:nonFraction></span> Private Placement Warrants at a price
of $<span id="xdx_908_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zJaPvnW6kerh" title="Class of warrants or rights warrants issued price per warrant"><ix:nonFraction name="ATAK:ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per warrant ($<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zjKAX5VZXL4k" title="Proceeds from issuance of warrants"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,470,000</ix:nonFraction></span> in the aggregate) in a private placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
two private placement warrants (the &#8220;Private Placement Warrants&#8221;) are exercisable for <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_dc_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zO5cda13vAVh" title="Class of warrant or right, number of securities called by each warrant or right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">one</ix:nonFraction></span> whole Class A ordinary share at
a price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zh8YzzQTryyf" title="Class of warrant or right, exercise price of warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial
Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period,
the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public
Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zHmrxzUsi456" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
5. <span id="xdx_82D_zHVu4KGAWXF">RELATED PARTY TRANSACTIONS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder
shares</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2021, the Sponsor was issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zg9TpWN6Jph9" title="Stock issued during period, shares, issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,750,000</ix:nonFraction></span> of the Company&#8217;s Class B ordinary shares (the &#8220;Founder Shares&#8221;) for
an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zaytSPsSwQj5" title="Stock issued during period, shares, issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember" format="ixt:numunitdecimalin" decimals="0" unitRef="USD">25,00</ix:nonFraction></span>0. Due to the underwriters&#8217; partial exercise of the over-allotment option, the Sponsor forfeited
<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zBYbyTLNHo1k" title="Shares issued, shares, share based payment arrangement, forfeited"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span> Founder Shares back to the Company. As a result, the Sponsor currently has <span id="xdx_90A_eus-gaap--TemporaryEquitySharesIssued_iI_c20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zUZKmB3eRoth" title="Temporary equity shares issued"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></span> Founder Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier
of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported
sale price of the Class A ordinary shares equals or exceeds $<span id="xdx_902_ecustom--ShareTransferTriggerPricePerShare_iI_c20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQWEKqyr12M4" title="Share transfer, trigger price per share"><ix:nonFraction name="ATAK:ShareTransferTriggerPricePerShare" contextRef="AsOf2021-08-07_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></span> per share (as adjusted for share sub-divisions, share reorganizations,
recapitalizations and the like) for any <span id="xdx_907_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zpr8BtdXaPg6" title="Number of consecutive trading days for determining share price"><ix:nonNumeric contextRef="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember" format="ixt-sec:durday" name="ATAK:NumberOfConsecutiveTradingDaysForDeterminingSharePrice">20</ix:nonNumeric></span> trading days within any <span id="xdx_907_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zU1cHOnyQUT" title="Number of trading days for determining share price"><ix:nonNumeric contextRef="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember" format="ixt-sec:durday" name="ATAK:NumberOfTradingDaysForDeterminingSharePrice">30</ix:nonNumeric></span>-trading day period commencing at least <span id="xdx_903_ecustom--ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zvG3vG7Ngt7l" title="Threshold number of trading days for determining share price from date of business combination"><ix:nonNumeric contextRef="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember" format="ixt-sec:durday" name="ATAK:ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination">150</ix:nonNumeric></span> days after a Business
Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction
that results in all of the Company&#8217;s shareholders having the right to exchange their Class A ordinary shares for cash, securities
or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
notes &#8211; related party</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2021, the Company issued an unsecured promissory note to the Sponsor (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDkxqAr7TwFb" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-08-07_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. The Promissory Note was <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_do_c20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zLO5BkKYYNI5" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-08-07_custom_PromissoryNoteMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Pure">no</ix:nonFraction></span>n-interest bearing and payable on the
earlier of <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20210807__20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zkObZI5rf114" title="Debt instrument, maturity date"><ix:nonNumeric contextRef="From2021-08-072021-08-07_custom_PromissoryNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">March 31, 2022</ix:nonNumeric></span>, or the completion of the IPO. At the time of repayment, there was $<span id="xdx_903_eus-gaap--NotesPayable_iI_c20220209__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zBqY1O5GB598" title="Aggregate debt"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-02-09_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">242,801</ix:nonFraction></span> outstanding under the Promissory
Note. On February 9, 2022, the Company repaid the Sponsor for amounts outstanding under the Promissory Note. As of September 30, 2023
and December 31, 2022, there were <span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_do_c20230930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDN8qx6k29Q3" title="Long-term debt"><span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_do_c20221231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zdNNQlJYLV85" title="Long-term debt"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-09-30_custom_PromissoryNoteMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-12-31_custom_PromissoryNoteMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts outstanding under the Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2023, the Company issued and drew fully against a promissory note in the amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230208__us-gaap--DebtInstrumentAxis__custom--FirstWorkingCapitalMember_zDSdRIr3YZag"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-02-08_custom_FirstWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></span> to fund working capital needs
(the &#8220;First Working Capital Note&#8221;). Additionally, on February 8, 2023, the Company issued a promissory note in the amount
of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230208__us-gaap--DebtInstrumentAxis__custom--FirstExtensionNoteMember_zVVYSFJ4UIC5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-02-08_custom_FirstExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></span> to fund the Company&#8217;s first extension payment (the &#8220;First Extension Note&#8221;), which has not been drawn against.
On March 3, 2023, the Company issued a promissory note in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230303__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z8OplOF2dAlc"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-03-03_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">810,000</ix:nonFraction></span> to pay for up to six additional one-month extension
payments (the &#8220;Second Extension Note&#8221;). On each of March 7, 2023, April 6, 2023, May 5, 2023, June 2, 2023, and July 5, 2023,
the Company drew $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20230307__20230307__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_ztYlaXEonttf"><span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20230406__20230406__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zWY7nl8EIxEi"><span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_c20230505__20230505__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zRNuq3xMakYg"><span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20230602__20230602__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zZv8A9haGfVa"><span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20230705__20230705__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zcH4jFNcb13k"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-03-072023-03-07_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-04-062023-04-06_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-05-052023-05-05_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-06-022023-06-02_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-07-052023-07-05_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span>, $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfDebt_c20230101__20230930__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zgTDU1IOCS64"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-01-012023-09-30_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,000</ix:nonFraction></span> in the aggregate, against the Second Extension Note to pay for each additional one-month extension.
On April 6, 2023, the Company issued and drew fully against a promissory note in the amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230406__us-gaap--DebtInstrumentAxis__custom--SecondWorkingCapitalMember_zXKnu1p4b6A3"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-04-06_custom_SecondWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> to fund working capital needs
(the &#8220;Second Working Capital Note&#8221;). On May 2, 2023, the Company issued and drew fully against a promissory note in the amount
of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230502__us-gaap--DebtInstrumentAxis__custom--ThirdWorkingCapitalMember_zCG4yRjUbWW"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-05-02_custom_ThirdWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> to fund working capital needs (the &#8220;Third Working Capital Note&#8221;). On June 14, 2023, the Company issued and drew
fully against a promissory note in the amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230614__us-gaap--DebtInstrumentAxis__custom--FourthWorkingCapitalMember_zSzU34Wlraa6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-06-14_custom_FourthWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></span> to fund working capital needs (the &#8220;Fourth Working Capital Note&#8221;).
On July 7, 2023, the Company issued and subsequently on July 10, 2023, drew fully against a promissory note in the amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20230710__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_zxyAbe9VWS45"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-07-10_custom_FifthWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>
to fund working capital needs (the &#8220;Fifth Working Capital Note&#8221;). On July 31, 2023, the Company issued a promissory note
in the amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230731__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_zY7esLkv7ubk"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-07-31_custom_FifthWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">810,000</ix:nonFraction></span> to pay for up to six additional one-month extension payments (the &#8220;Third Extension Note&#8221;). On each
of July 31, 2023, and September 1, 2023, the Company drew $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20230731__20230731__us-gaap--DebtInstrumentAxis__custom--ThirdExtensionNoteMember_zSYoxcxFoiA2"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-07-312023-07-31_custom_ThirdExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></span>, $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfDebt_c20230901__20230901__us-gaap--DebtInstrumentAxis__custom--ThirdExtensionNoteMember_zNCoE5nB7iMf"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-09-012023-09-01_custom_ThirdExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,000</ix:nonFraction></span> in the aggregate, against the Third Extension Note to pay
for each additional one-month extension. On September 1, 2023, the Company issued and drew fully against a promissory note in the amount
of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20230901__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_z9ejbSx2bdA4" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-09-01_custom_FifthWorkingCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span> to fund working capital needs (the &#8220;Sixth Working Capital Note&#8221; and together with the First Working Capital Note,
the Second Working Capital Note, the Third Working Capital Note, the Fourth Working Capital Note, and the Fifth Working Capital Note
collectively, the &#8220;Working Capital Notes&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
First Extension Note does not bear interest, and matures (subject to the waiver against trust provisions) upon the earlier of (i)
two (2) days following the date on which the Company&#8217;s initial business combination is consummated or liquidation and (ii)
August 31, 2023. The Company did not draw funds against the First Extension Note. The Second Extension Note bears no interest and is
repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#8217;s
initial business combination, or (ii) the date of the Company&#8217;s liquidation. The Third Extension Note bears no interest and is
repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#8217;s
initial business combination, or (ii) the date of the Company&#8217;s liquidation. The Working Capital Notes do not bear interest,
and mature (subject to the waiver against trust provisions) upon the earlier of (i) two (2) days following the date on which the
Company&#8217;s initial business combination is consummated and (ii) the date of the liquidation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, there was $<span id="xdx_903_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalNotesMember_zAI4x6b2eOye" title="Outstanding value under the note"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-09-30_custom_WorkingCapitalNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">460,000</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_z5fTc5BRuuIi" title="Outstanding value under the note"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-09-30_custom_SecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">945,000</ix:nonFraction></span> outstanding ($<span id="xdx_905_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalAndSecondExtensionNoteMember_zEY7LcPwBN93" title="Outstanding value under the note"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-09-30_custom_WorkingCapitalAndSecondExtensionNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,405,000</ix:nonFraction></span> in the aggregate) under the Working Capital Notes and
Extension Notes, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
Capital Loans</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor, certain of the Company&#8217;s officers, directors
or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;).
If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital
Loans would either be repaid upon completion of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to
$<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_iI_c20230930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember_zdC0B3VBw5Zh" title="Debt instrument convertible into warrants"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="AsOf2023-09-30_custom_WorkingCapitalLoanMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember_zokEJpwibXNh" title="Debt instrument conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2023-09-30_custom_WorkingCapitalLoanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span>
per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2023 and December 31, 2022, <span id="xdx_908_eus-gaap--OtherLiabilitiesCurrent_iI_do_c20230930__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zYuVkhxvtqd" title="Due to related parties current"><span id="xdx_90E_eus-gaap--OtherLiabilitiesCurrent_iI_do_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zxONTowyS17e" title="Due to related parties current"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-09-30_us-gaap_RelatedPartyMember68554234" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember68554250" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> Working
Capital Loans were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administrative
support agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on February 9, 2022, the Company agreed to pay the Sponsor a total of $<span id="xdx_90F_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220209__20220209__us-gaap--RelatedPartyTransactionAxis__custom--OfficeSpaceAdministrativeAndSupportServicesMember_zvs6CnLtAKke" title="Related party payments"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2022-02-092022-02-09_custom_OfficeSpaceAdministrativeAndSupportServicesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span> per month for office space, secretarial and administrative
services provided to the Company. Upon completion of the initial Business Combination or the Company&#8217;s liquidation, the Company
will cease paying these monthly fees. The Company has incurred and paid $<span id="xdx_905_eus-gaap--OperatingCostsAndExpenses_c20230701__20230930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zXu4ZRto1x4k" title="Administrative support agreement expenses"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-07-012023-09-30_custom_AdministrativeSupportAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--OperatingCostsAndExpenses_c20230101__20230930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zBFPSbsn84q7" title="Administrative support agreement expenses"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2023-01-012023-09-30_custom_AdministrativeSupportAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction> </span>in administrative support agreement expenses
for the three and nine months ended September 30, 2023. The Company has incurred and paid $<span id="xdx_908_eus-gaap--OperatingCostsAndExpenses_c20220701__20220930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zh1fpnF9i0Bl" title="Administrative support agreement expenses"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2022-07-012022-09-30_custom_AdministrativeSupportAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_c20220101__20220930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zOWpqOKAhyVl" title="Administrative support agreement expenses"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2022-01-012022-09-30_custom_AdministrativeSupportAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></span> in administrative support
agreement expenses for the three and nine months ended September 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliate
investment in potential target</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was in discussions with a number of potential target companies. Through introductions by the Company, an affiliate of one of
the Company&#8217;s directors invested in one potential target&#8217;s latest private fundraising round. The result of which benefited
the Company through deeper discussions of a potential transaction. However, the Company did not enter into a business combination agreement
with the aforementioned potential target.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zs3sBPKp5erj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
6. <span id="xdx_82E_zMwbKLSNPAIl">SHAREHOLDERS&#8217; DEFICIT</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preference
shares-The Company is authorized to issue up to <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930_z7CGsX9PRedd" title="Preferred stock, shares authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zXCnH47jsw06" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></ix:nonFraction></span></span> preference shares with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230930_zl5KwixPfN73" title="Preferred stock, par or stated value per share"><span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_z4VZjfQlljz2" title="Preferred stock, par or stated value per share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> per share with such designation,
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At September 30, 2023 and December
31, 2022, there were <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_do_c20230930_zz7t2rGETm" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zxGrpLslRMH4" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20230930_zy3w6SDHrhX3" title="Preferred stock, shares outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zzIG9iZN4dd6" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-09-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-09-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
A ordinary shares- The Company is authorized to issue up to <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zag3slqfd6Yb" title="Common stock shares authorized"><span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRhI1JJlK2yk" title="Common stock shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></ix:nonFraction></span></span> Class A ordinary shares with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zODbl7b0BFPd" title="Common stock par value per share"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCFUHmHZPUu2" title="Common stock par value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> per share.
Holders of the Company&#8217;s Class A ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31,
2022, there were <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjKaNmolG7t8" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGnkAVIAdEdc" title="Common stock shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zO0ECWyHTZzl" title="Common stock shares outstanding"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zgSCs5d1zQMc" title="Common stock shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> Class A Ordinary Shares issued or outstanding, excluding <span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z28P1MY1PgXd" title="Temporary equity shares outstanding"><span id="xdx_902_eus-gaap--TemporaryEquitySharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWBwkdnG7KKi" title="Temporary equity shares issued"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,307,292</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGtqq33G8Br4" title="Temporary equity shares outstanding"><span id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8447AoSn7qd" title="Temporary equity shares issued"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></ix:nonFraction></span></span> shares subject to possible
redemption as presented in temporary equity as of September 30, 2023 and December 31, 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
B ordinary shares- The Company is authorized to issue up to <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zf4eWPkDIOR3" title="Common stock shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeoORmZmwFy2" title="Common stock shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></ix:nonFraction></span></span> Class B ordinary shares with a par value of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zVD3y9mndx4k" title="Common stock par value per share"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zNnwh3yDYCn" title="Common stock par value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction> </span></span>per share.
At September 30, 2023 and December 31, 2022, there were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHQwMnotGCqd" title="Common stock shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjiDbNK1f2Yf" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpP0l5WQodj5" title="Common stock shares outstanding"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z1w589LFjhc" title="Common stock shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,050,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> Class B ordinary shares issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and holders of Class
A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the
shareholders except as required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
so long as any Class B ordinary shares remain outstanding, we may not, without the prior vote or written consent of the holders of a
majority of the Class B ordinary shares then outstanding, voting separately as a single class, amend, alter or repeal any provision of
our memorandum and articles of association, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would
alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B ordinary shares.
Any action required or permitted to be taken at any meeting of the holders of Class B ordinary shares may be taken without a general
meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed
by the holders of the outstanding Class B ordinary shares having not less than the minimum number of votes that would be necessary to
authorize or take such action at a general meeting at which all Class B ordinary shares were present and voted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Class B ordinary shares will convert into Class A ordinary shares automatically at the time of a Business Combination, or at an earlier date at the option of the holder, on a
one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are
issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of a Business Combination, the ratio
at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of
the outstanding Class B ordinary shares to waive such adjustment with respect to any such issuance or deemed issuance) so that the
number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an
as-converted basis, <span id="xdx_901_ecustom--CommonStockThresholdPercentageOnConversionOfShares_iI_dp_c20230930__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zsntYgtuPLG1" title="Common stock, threshold percentage on conversion of shares"><ix:nonFraction name="ATAK:CommonStockThresholdPercentageOnConversionOfShares" contextRef="AsOf2023-09-30_custom_FounderSharesMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>%
of the sum of the total number of all ordinary shares outstanding upon the completion of the IPO plus all Class A ordinary shares
and equity-linked securities issued or deemed issued by the Company in connection with or in relation to the completion of the
initial Business Combination, any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A
ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any private placement warrants issued
to the Sponsor upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary
shares at a rate of less than one to one.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights-
Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive
one-tenth (1/10) of one Class A ordinary share upon consummation of a Business Combination, even if the holder of a right redeemed all
shares held by him, her or it in connection with a Business Combination or an amendment to the Company&#8217;s Amended and Restated Memorandum
of Association with respect to its pre-business combination activities. In the event that the Company will not be the surviving company
upon completion of a Business Combination, each holder of a right will be required to affirmatively exchange his, her or its rights in
order to receive the one-tenth (1/10) of a share underlying each right upon consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the
nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders
of the rights must hold rights in multiples of 10 in order to receive shares for all of the holders&#8217; rights upon closing of a Business
Combination. If the Company is unable to complete an initial Business Combination within the Combination Period and the Company redeems
the Public Shares for the funds held in the Trust Account, holders of rights will not receive any of such funds for their rights and
the rights will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="ATAK:WarrantsDisclosureTextBlock"><p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zUdDtwnj54Kd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
7. <span id="xdx_826_zO3usRGWeXha">WARRANTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930_zvhl8PcTU1rh" title="Number of warrants or rights outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,670,000</ix:nonFraction></span> warrants that were issued in the IPO (representing <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMDTVyzCh1Vk" title="Number of warrants or rights outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,200,000</ix:nonFraction></span> Public Warrants and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHrChTdYI8f1" title="Number of warrants or rights outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,470,000</ix:nonFraction></span> Private
Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not
meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify
each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such
re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s
statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
&#8212; Public Warrants may only be exercised for a whole number of Class A ordinary shares. No fractional warrants have been or will
be issued upon separation of the Units and only whole warrants will trade. Accordingly, unless holders purchase at least two Units, they
will not be able to receive or trade a whole warrant. The Public Warrants will become exercisable <span id="xdx_90C_ecustom--WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z3jvh60RdGEf" title="Warrants exercisable term from the date of completion of business combination"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_PublicWarrantsMember" format="ixt-sec:durday" name="ATAK:WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination">30</ix:nonNumeric></span> days after the completion of a Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any Class A Ordinary Shares pursuant to the exercise of a Public Warrant and will have no obligation
to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary
Shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company
satisfying its obligations with respect to registration, or a valid exemption from registration is available. No Public Warrant will
be exercisable, and the Company will not be obligated to issue any Class A Ordinary Shares upon exercise of a Public Warrant unless the
Class A Ordinary Share issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities
laws of the state of residence of the registered holder of the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed that as soon as practicable, but in no event later than <span id="xdx_901_ecustom--MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z8sdNreSzCVa" title="Minimum lock in period for SEC registration from date of business combination"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_PublicWarrantsMember" format="ixt-sec:durday" name="ATAK:MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination">20</ix:nonNumeric></span> business days after the closing of a Business Combination,
it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which
this prospectus forms a part or a new registration statement covering the registration under the Securities Act of the Class A Ordinary
Shares issuable upon exercise of the Public Warrants, and the Company will use its commercially reasonable efforts to cause the same
to become effective within <span id="xdx_907_ecustom--MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zdCx8PPjteAj" title="Minimum lock in period to become effective after the closing of the initial business combination"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_PublicWarrantsMember" format="ixt-sec:durday" name="ATAK:MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination">60</ix:nonNumeric></span> business days after the closing of a Business Combination, and to maintain the effectiveness of such registration
statement and a current prospectus relating to those Class A Ordinary Shares until the Public Warrants expire or are redeemed, as specified
in the warrant agreement; provided that if the Class A Ordinary Shares is at the time of any exercise of a Public Warrant not listed
on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of
the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless
basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be
required to file or maintain in effect a registration statement, but it will use its commercially reasonably efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class
A Ordinary Shares issuable upon exercise of the Public Warrants is not effective by the 60th day after the closing of a Business Combination,
Public Warrant holders may, until such time as there is an effective registration statement and during any period when the Company will
have failed to maintain an effective registration statement, exercise Public Warrants on a &#8220;cashless basis&#8221; in accordance
with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonably efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
of warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the warrant become exercisable, the Company may redeem the outstanding warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $<span id="xdx_904_ecustom--ClassOfWarrantsRedemptionPricePerUnit_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJ44vU4heVk" title="Class of warrants redemption price per unit"><ix:nonFraction name="ATAK:ClassOfWarrantsRedemptionPricePerUnit" contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per warrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than <span id="xdx_908_ecustom--ClassOfWarrantsRedemptionNoticePeriod_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPF6wiANdyr9" title="Class of warrants, redemption notice period"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember" format="ixt-sec:durday" name="ATAK:ClassOfWarrantsRedemptionNoticePeriod">30</ix:nonNumeric></span> days&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the last sale price of our ordinary shares equals or exceeds $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHTWRmQveZFi" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share (as adjusted for share sub-divisions,
    share dividends, reorganizations, recapitalizations and the like) for any <span id="xdx_904_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWiSLcfc7wEb" title="Number of consecutive trading days for determining share price"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember" format="ixt-sec:durday" name="ATAK:NumberOfConsecutiveTradingDaysForDeterminingSharePrice">20</ix:nonNumeric></span> trading days within a <span id="xdx_90B_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zp0g45qXbhVe" title="Number of trading days for determining share price"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember" format="ixt-sec:durday" name="ATAK:NumberOfTradingDaysForDeterminingSharePrice">30</ix:nonNumeric></span>-trading day period ending on
    the third trading day prior to the date on which we send the notice of redemption to the warrant holder.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 57.2pt; text-align: justify; text-indent: -21.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection
with the closing of a Business Combination at an issue price or effective issue price of less than $<span id="xdx_90F_ecustom--ShareRedemptionTriggerPrice_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zLEPK7fjdJH8" title="Share redemption trigger price"><ix:nonFraction name="ATAK:ShareRedemptionTriggerPrice" contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.20</ix:nonFraction></span> per Class A Ordinary Share (with
such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of
any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent
more than <span id="xdx_906_ecustom--MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_iI_pid_dp_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zzrdqJgGB63b" title="Minimum percentage gross proceeds required from issuance of equity"><ix:nonFraction name="ATAK:MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of
the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary
shares during the <span id="xdx_902_ecustom--ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_dtD_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zMTc7WOpep6" title="Class of warrant right minimum notice period for redemption"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" format="ixt-sec:durday" name="ATAK:ClassOfWarrantOrRightMinimumNoticePeriodForRedemption">20</ix:nonNumeric></span> trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination
(such price, the &#8220;Market Value&#8221;) is below $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zZaaNwnlFSH6" title="Class of warrant or right, exercise price of warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.20</ix:nonFraction></span> per share, then the exercise price of the warrants will be adjusted (to the
nearest cent) to be equal to <span id="xdx_90F_ecustom--ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_iI_pid_dp_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zth1LSnxGk29" title="Class of warrant or right exercise price adjustment percentage higher of market value"><ix:nonFraction name="ATAK:ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" contextRef="AsOf2023-09-30_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">115</ix:nonFraction></span>% of the higher of the Market Value and the Newly Issued Price, the $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zbRC6ir0bWsg" title="Class of warrant or right, exercise price of warrants or rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share redemption trigger
price described above (to the nearest cent) to be equal to <span id="xdx_904_ecustom--ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_iI_pid_dp_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_z83t3IroCtji" title="Class of warrant or right exercise price adjustment percentage higher of market value"><ix:nonFraction name="ATAK:ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" contextRef="AsOf2023-09-30_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">180</ix:nonFraction></span>% of the higher of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private
Placement Warrants and the Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants will not be transferable,
assignable or saleable until <span id="xdx_90C_ecustom--MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_dtD_c20230101__20230930_zowVYBtcXPP8" title="Minimum lock In period for transfer, assign or sell warrants after completion of IPO"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:durday" name="ATAK:MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo">30</ix:nonNumeric></span> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally,
the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder&#8217;s option, and be non-redeemable
so long as they are held by the initial purchasers or their permitted transferees (except for a number of Class A Ordinary Shares as
described above under Redemption of warrants for Class A Ordinary Shares). If the Private Placement Warrants are held by someone other
than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption
scenarios and exercisable by such holders on the same basis as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:CommitmentsDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsDisclosureTextBlock_z41seqf91WRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
8. <span id="xdx_827_zY8C7MwxeNn">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
right and Shareholder Rights</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Warrants, warrants that may be issued upon conversion of Working Capital Loans (and
any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion
of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration
rights agreement that was signed on the effective date of the IPO, requiring the Company to register such securities for resale. The
holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule
415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a <span id="xdx_900_ecustom--OverAllotmentOptionPeriod_dtD_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zXaZ7EgDntOa" title="Over allotment option period"><ix:nonNumeric contextRef="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember" format="ixt-sec:durday" name="ATAK:OverAllotmentOptionPeriod">45</ix:nonNumeric></span>-day option from the date of the IPO to purchase up to <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_ziSDkUgLazZd" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> additional Units to cover over-allotments
at the IPO price less the underwriting discount. The underwriters partially exercised the over-allotment option, generating an additional
$<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zvrc9dspmfOk" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> in gross proceeds. As a result of the over-allotment being exercised in part, the Sponsor forfeited <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230101__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zNfXNwpxp3O4" title="Shares issued, shares, share-based payment arrangement, forfeited"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-01-012023-09-30_custom_SponsorMember_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span> Founder Shares
back to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were paid a cash underwriting discount of $<span id="xdx_90D_eus-gaap--PaymentsForUnderwritingExpense_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zU7PbOgvdQF4" title="Deferred underwriting fees"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-01-012023-09-30_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,525,000</ix:nonFraction></span> in the aggregate at the closing of the IPO. In addition, $<span id="xdx_905_ecustom--DeferredUnderwritingCommissionPerUnit_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z31Vosa8wMP7" title="Deferred underwriting commission per unit"><ix:nonFraction name="ATAK:DeferredUnderwritingCommissionPerUnit" contextRef="From2023-01-012023-09-30_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction> </span>per
Unit, or $<span id="xdx_907_ecustom--DeferredUnderwritingCommissionsNoncurrent_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z0nVCBKhx3Ni" title="Deferred underwriting commissions"><ix:nonFraction name="ATAK:DeferredUnderwritingCommissionsNoncurrent" contextRef="AsOf2023-09-30_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,070,000</ix:nonFraction></span> in the aggregate is payable to the underwriters for deferred underwriting commissions. The deferred fee is payable
to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a contingent fee arrangement with their legal counsel, in which the deferred fee is payable to the Company&#8217;s legal
counsel solely in the event that the Company completes a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
of First Refusal</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain conditions, the Company granted Maxim, for a period beginning on the closing of the IPO, and ending on the earlier of 18 months
after the date of the consummation of the Business Combination and February 7, 2025, the three year anniversary of the effective date
of the registration statement filed in connection with the IPO (the &#8220;S-1 Effective Date&#8221;), a right of first refusal to act
as book-running managing underwriter or placement agent for any and all future public and private equity, convertible and debt offerings
for us or any of our successors or subsidiaries. In accordance with FINRA Rule 5110(g)(6), such right of first refusal shall not have
a duration of more than three years from the commencement of sales of securities in the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative&#8217;s
Ordinary Shares</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued to Maxim and/or its designees, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyKt45ksxOR9" title="Maxim IPO shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">303,000</ix:nonFraction></span> Class A ordinary shares upon the consummation of the IPO. Maxim has agreed not
to transfer, assign or sell any such shares until the completion of the Company&#8217;s initial Business Combination. In addition, Maxim
has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company&#8217;s initial
business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if
the Company fails to complete its initial business combination within 12 months (or up to 18 months if we extend the period of time to
consummate a business combination by the full amount of time) from the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the
S-1 Effective Date. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative,
put or call transaction nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following
the commencement of sales of securities in the IPO, except to any underwriter and selected dealer participating in the offering and their
officers or partners, associated persons or affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_z5ZkIR5Pk3vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
9. <span id="xdx_82D_zbNoGHWbrnaf">FAIR VALUE MEASUREMENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2023 and December 31, 2022, the Company&#8217;s warrant liability was valued at $<span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_c20230930_zx1ws3UGbRX6" title="Warrant liability"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">441,300</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--DerivativeLiabilities_iI_c20221231_zMLFMXd6RrZb" title="Warrant liability"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,420</ix:nonFraction></span>, respectively. Under
the guidance in ASC 815-40, the Public Warrants and the Private Placement Warrants do not meet the criteria for equity treatment. As
such, the Public Warrants and the Private Placement Warrants must be recorded on the balance sheet at fair value. This valuation is subject
to re-measurement at each balance sheet date. With each re-measurement, the valuations will be adjusted to fair value, with the change
in fair value recognized in the Company&#8217;s statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fair value information as of September 30, 2023 and December 31, 2022, of the Company&#8217;s financial assets
and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques
the Company utilized to determine such fair value. The Company&#8217;s warrant liability is based on a valuation model utilizing management
judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets.
Significant deviations from these estimates and inputs could result in a material change in fair value The Company transferred the fair
value of Public Warrants and Private Placement Warrants from a Level 3 measurement to a Level 1 and Level 2 measurement, respectively,
in 2022. The measurement of the Public Warrants as of September 30, 2023 is classified as Level 1 due to the use of an observable market
quote in an active market under the ticker ATAKW. The measurement of the Private Placement Warrants as of September 30, 2023 is classified
as Level 2 as its value is derived from the directly observable quoted prices of the Public Warrants in active markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" continuedAt="ConU001197-01" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"><p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-CPH_zD5cUhCEa5G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zTQjK1biSbR9">SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Private</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Public</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Placement</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Warrant</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Liability</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Derivative warrant liabilities at December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAAW9yvaFCI5" title="Derivative warrant liabilities, beginning balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBJzhpVJpDW6" title="Derivative warrant liabilities, beginning balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zjkR2Mp5EXyi" title="Derivative warrant liabilities, beginning balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1203">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Initial fair value at issuance of public and private placement warrants</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcautWchdM11" title="Initial fair value at issuance public and private placement warrants" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,521,870</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPUaYY8buI58" title="Initial fair value at issuance public and private placement warrants" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,258,677</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwi5VWCHxiK7" title="Initial fair value at issuance public and private placement warrants" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780,547</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zJ6ACioAM5C5" title="Change in fair value" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,905,870</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zYWePiQpVVgf" title="Change in fair value" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,730,725</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zaQWyTYRhrh" title="Change in fair value" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,636,595</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Transfer of public warrants to Level 1 measurement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zR4yEiDOuKkg" title="Transfer of public warrants to Level 1 measurement" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,616,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_z9W2JM0r1QC9" title="Transfer of public warrants to Level 1 measurement" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1219">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zIplz2uZgEY6" title="Transfer of public warrants to Level 1 measurement" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,616,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk35ZPQJCoX7" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1223">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuiqX6BjD9A5" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">527,952</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z2vE14XdjkQl" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">527,952</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0lzc9YO1OB4" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1229">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVSK2fdxPwu2" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">280,952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zaBexgiz6SD4" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">280,952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmJTHnEftI1j" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1235">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlGdKKEfZs3i" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_ztHgU0al2dre" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zvbpohzSkmE5" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1241">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbit6K09oeg6" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">118,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zxtkvJDzYeZa" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">118,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of September 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNfqDo9nRbVf" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1247">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z62F0CUYCOo3" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zeY4B19DBa66" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMXPPrCSeCHj" title="Change in fair value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1253">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVJzQGYcYjxc" title="Change in fair value" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zsutCbF2VPb5" title="Change in fair value" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Transfer of Private Placement Warrants to Level 2 measurement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_z4EZ1dRZY6oa" title="Transfer of private placement warrants to level 2 measurement" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1259">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_zsoZT2Mvnmdi" title="Transfer of private placement warrants to level 2 measurement" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember_custom_TrancheTwoMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">143,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__custom--TrancheAxis__custom--TrancheTwoMember_zfINuQwZ7j99" title="Transfer of private placement warrants to level 2 measurement" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember_custom_TrancheTwoMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">143,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5rkpQNhkq3" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1265">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZS2C3AJDrkf" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1267">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zrjaYmZ89xzc" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1269">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTqEyRStrWk3" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z2rlvsLI1no1" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1273">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zOFg2Kn1tMC8" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1275">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of March 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5s8rddgc5h" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1277">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zItxLcHXcHa7" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1279">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zTF7FfZOHWub" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zLxLA71OMLLj" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1283">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUypW4OnZY1g" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1285">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zCiEM6DJpA22" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1287">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzHseD5ond3g" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIpO0PQXXyK" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1291">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z1ahTQKItRh6" title="Derivative warrant liabilities, beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1293">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zEQyCr1lmi27" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1295">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zIcy9iXVC5ff" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zoW9aiFeNFM" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1299">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Level 3 derivative warrant liabilities as of September 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGMd85PfYbol" title="Derivative warrant liabilities, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1301">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zA84LOaPHYB8" title="Derivative warrant liabilities, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1303">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zo8I0YtjQoUj" title="Derivative warrant liabilities, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1305">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zOl6j2TvERhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxL5juBT1i5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that were accounted for
at fair value on a recurring basis at September 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zjDZeVmZNQj8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY
OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Cash and marketable securities held in trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4gawblzyND5" title="Cash and marketable securities held in trust account" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,481,369</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjL6ihv07bGi" title="Cash and marketable securities held in trust account" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKfKmzxa0mKj" title="Cash and marketable securities held in trust account" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1313">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUpVGrwowabe" title="Public Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">333,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z2UzQA5ORCXk" title="Public Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1317">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zmX9FjgKRCIf" title="Public Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1319">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5rPXzSJlan7" title="Private Placement Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1321">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zlq4icCL71K5" title="Private Placement Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUeBNa89tspk" title="Private Placement Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1325">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that were accounted for
at fair value on a recurring basis at December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Cash and marketable securities held in trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKO5NLuAMp7k" title="Cash and marketable securities held in trust account" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206,879,903</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgIGL1Zf3wId" title="Cash and marketable securities held in trust account" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1329">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqnmllIx2U" title="Cash and marketable securities held in trust account" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1331">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziIb67mCZpRe" title="Public Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">446,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAp98Oyxi5E3" title="Public Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1335">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zC3EnF8U5du7" title="Public Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1337">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxyU81j4Q092" title="Private Placement Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1339">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDbWrxtK1Era" title="Private Placement Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUhcMt9t0x7d" title="Private Placement Warrants" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zEsOHpHNFfgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the fair value of derivative warrant liabilities as of September 30, 2023 and December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C05_gL3FVLMORBUIR-CPH_zNkZBCkxBfA9"><ix:continuation continuedAt="ConU001197-02" id="ConU001197-01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<div id="xdx_C0E_gL3FVLMORBUIR-CPH_zoQfsLwwIdX5"><ix:continuation continuedAt="ConU001197-03" id="ConU001197-02"><table cellpadding="0" cellspacing="0" id="xdx_300_134_zXvobzVu7bj4" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Public Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Private Placement <br /> Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total Derivative Warrant <br /> Liability</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Fair value at August 6, 2021 (inception)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoHDbRua9gO6" title="Fair value at August 6, 2021 (inception)" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1345">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zaDW6fPMSV3j" title="Fair value at August 6, 2021 (inception)" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1347">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zEtGHsMFZuE8" title="Fair value at August 6, 2021 (inception)" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1349">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Change in fair value" id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zfGLRHvw1C53" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Change in fair value" id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zCpInILvqkAb" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1353">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Change in fair value" id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z2TLeaOuA2P1" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Derivative warrant liabilities as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaPoTc5OGa72" title="Beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1357">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zvTJB4eFFOrj" title="Beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1359">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z5NGqrpyZjq6" title="Beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1361">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Initial fair value at issuance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zusAqYCMyzJe" title="Initial fair value at issuance" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,521,870</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z1DwZtMuWkli" title="Initial fair value at issuance" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,258,677</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zlWxhKHlVtD2" title="Initial fair value at issuance" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="From2022-01-012022-03-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780,547</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zxwm5JtkoSxi" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,905,870</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxKYSGFygD4f" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,730,725</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z3MTrlLBzOrb" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-03-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,636,595</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMjpHJPMYFCh" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-03-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,616,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5RX6lbVUhqk" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">527,952</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zsnrp3pkvSui" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-03-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,143,952</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcqo6J3Iufd3" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-04-012022-06-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">858,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbus30l94wfd" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-04-012022-06-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">280,952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zPZIPMXD5OSg" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-04-012022-06-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,139,452</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgAtIztGvnJa" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-06-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">757,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zAinMA6aMoLk" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zoi4DoxsH0g" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-06-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,004,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7iD7sBnVLB1" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-012022-09-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">353,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zg5ZLeIj6He3" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-012022-09-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">118,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zihHLQZOYDZd" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-012022-09-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">471,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of September 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z22mlIrpvDzi" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-09-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zMTyxZ0la7Mb" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zvkWjznTQL6k" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-09-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">533,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zm0OF5ZcsLgg" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-10-012022-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,420</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ztq2KfsXNqi1" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-10-012022-12-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zU8nnSUYWGU4" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-10-012022-12-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,420</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuNRYsE2pMv9" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">446,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zOnBX3nNM0f7" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zAjBDQ3RdICk" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-12-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,420</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zhlIcHSpkWoe" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-03-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,580</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zgXpwvXdwbS8" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z8CfLV9zo6Da" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-03-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,580</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of March 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z747OAysoByl" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-03-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zPvSDxXFfYVi" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zG5ctc2KhBwf" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-03-31_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">668,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zsCjyvl8T6o7" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-04-012023-06-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">220,180</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zJ5V073Zrfk1" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-04-012023-06-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zMWBTSKhBbbg" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-04-012023-06-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">291,180</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUavEazgfMoi" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-06-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">284,820</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zsdGhl7zi4je" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zIz0ZrdIElo7" title="Beginning balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-06-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,820</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSuc8wJCxUj8" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-07-012023-09-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,480</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z70Dx1pLPZzd" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-07-012023-09-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z0nBpgYbN8hj" title="Change in fair value" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-07-012023-09-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,480</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Derivative warrant liabilities as of September 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7XGXEv1FLrd" title="Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-09-30_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">333,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDSizcf5br8k" title="Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zkIkdqCM81Yb" title="Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-09-30_custom_DerivativeWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">441,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C05_gL3FVLMORBUIR-CPH_zZKsCxvjiaNk"><ix:continuation id="ConU001197-03"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Measurement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company established the initial fair value for the warrants on February 9, 2022, the date of the completion of the Company&#8217;s IPO.
The Company used a Black Scholes Merton model to value the warrants. The Company allocated the proceeds received from (i) the sale of
Units (which is inclusive of one Class A Ordinary Share, one Public Warrant and one right to receive one-tenth of a Class A ordinary
share upon consummation of an initial business combination), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class
B Ordinary Shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds
allocated to Class A Ordinary Shares subject to possible redemption (temporary equity), Class A Ordinary Shares (permanent equity) and
Class B Ordinary Shares (permanent equity) based on their relative fair values at the initial measurement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" continuedAt="ConU001456-01" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-TZRS_zQShlPTDOnU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key inputs into the Black Scholes Merton model formula were as follows at February 9, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zt5f0kGmw2Z6" style="display: none">SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Private Placement</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Ordinary Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zuktzM4J1VX1" title="Warrants and Rights Outstanding, Measurement Input" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_us-gaap_MeasurementInputSharePriceMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">9.08</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zp0zHjqqyWq4" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_us-gaap_MeasurementInputExercisePriceMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate of interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ziRclMY3UQvk" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.80</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHj8xkDcreh" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_us-gaap_MeasurementInputPriceVolatilityMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">9.43</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zENdeyDcOmib" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_us-gaap_MeasurementInputExpectedTermMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.99</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant to buy one share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zBPRmOTVN4j2" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_custom_MeasurementInputProbabilityMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zSrI2W5Ump7h" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-02-09_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zLHFwktJOZLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
Measurement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values the Private Placement Warrants relative to the market prices of ordinary share and the Public Warrants, which are both actively
traded on a public market. The valuation model for the Private Placement Warrants is a risk-neutral Monte Carlo simulation. As of September
30, 2023, the measurement of the Public Warrants was valued using an observable market quote in an active market under the ticker ATAKW.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key inputs into the Monte Carlo simulation model were as follows at September 30, 2023 and December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C07_gL3FVAALMORAN-TZRS_zcX8P1iueOb6"><ix:continuation continuedAt="ConU001456-02" id="ConU001456-01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<div id="xdx_C0C_gL3FVAALMORAN-TZRS_zdmMpGs5GbJf"><ix:continuation continuedAt="ConU001456-03" id="ConU001456-02"><table cellpadding="0" cellspacing="0" id="xdx_306_134_zq0JWE1vTZ6" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">September 30,</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">December 31,</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Ordinary Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMdUV0T19Iif" title="Warrants and Rights Outstanding, Measurement Input" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">10.85</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk02Y9p3unUl" title="Warrants and Rights Outstanding, Measurement Input" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">10.23</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ztp1y6L9hRP4" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcajHRr5ONx5" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate of interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpnBjcQSIfM8" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.55</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zDLfN9CWdDdh" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.94</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z1LF6V0RVsAf" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zXoC6C2Pss8g" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zw7FkrY1Uw1d" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTX7fIxpqkA5" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant to buy one share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zow9dOFzrUe" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.02</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIGyt4fTbSN2" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.02</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziOxtRzZN6Ai" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSQiBRQBJN4" title="Warrants and Rights Outstanding, Measurement Input" style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C0F_gL3FVAALMORAN-TZRS_zrGVFZkIFN74"><ix:continuation id="ConU001456-03"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
risk-free interest rate assumption was based on the linearly interpolated Treasury Constant Maturity Rate Curve between five and seven
year rates, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) six years after the
completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in
isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zzDMwwIEYqG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
10. <span id="xdx_82B_zqeghYTWnHpc">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or
disclosure in the condensed financial statements, other than the below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On October 9, 2023, the Company extended the Combination
Period from October 9, 2023 to November 9, 2023 by depositing $<span id="xdx_90C_eus-gaap--AssetsHeldInTrustCurrent_iI_c20231009__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztsZl6Kuh6Pe" title="Trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2023-10-09_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></span> into the Trust Account on October 2, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On October 24, 2023, the Company issued an unsecured
promissory note (the &#8220;Seventh Working Capital Note&#8221;) in the amount of $<span id="xdx_901_ecustom--UnsecuredPromissoryNote_c20231023__20231024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zea3ezA55Tt3" title="Unsecured promissory note"><ix:nonFraction name="ATAK:UnsecuredPromissoryNote" contextRef="From2023-10-232023-10-24_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span> to the Sponsor. The Seventh Working Capital
Note does not bear interest, and matures upon the earlier of two days following the date on which the Company&#8217;s initial business
combination is consummated or the date of the liquidation of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 9, 2023, the Company extended the Combination Period from November
9, 2023 to December 9, 2023 by depositing $<span id="xdx_901_eus-gaap--AssetsHeldInTrustCurrent_iI_c20231109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zN2nxdVyd6ye" title="Deposit trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2023-11-09_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,000</ix:nonFraction></span> into the Trust Account on November 3, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 17, 2023, the Company issued an unsecured
promissory note (the &#8220;Eighth Working Capital Note&#8221;) in the amount of $<span id="xdx_90B_eus-gaap--UnsecuredDebt_iI_c20231117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zksO27DF3rud" title="Unsecured promissory note"><ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="AsOf2023-11-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span> to the Sponsor. The Eighth Working Capital Note
does not bear interest, and matures upon the earlier of two days following the date on which the Company&#8217;s initial business combination
is consummated or the date of the liquidation of the Company.</p>

</ix:nonNumeric><p id="xdx_81A_z6UyZbkRGmV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_001"></span>Item
2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
in this quarterly report on Form 10-Q (this &#8220;Quarterly Report&#8221;) to &#8220;we,&#8221; &#8220;us&#8221; or the &#8220;Company&#8221;
refer to Aurora Technology Acquisition Corp. References to our &#8220;management&#8221; or our &#8220;management team&#8221; refer to
our officers and directors, and references to the &#8220;Sponsor&#8221; refer to ATAC Sponsor LLC. The following discussion and analysis
of the Company&#8217;s financial condition and results of operations should be read in conjunction with the financial statements and
the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
Note Regarding Forward-Looking Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Quarterly Report includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as
amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8217;),
that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected
and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation,
statements in this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; regarding
the Company&#8217;s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking
statements. Words such as &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221;
&#8220;seek&#8221; and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but reflect management&#8217;s current beliefs, based on information currently
available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and
results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company&#8217;s
Annual Form 10-K filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company&#8217;s securities filings
can be accessed on the EDGAR section of the SEC&#8217;s website at www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new
information, future events or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 28pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are Cayman Islands exempted company incorporated on August 6, 2021 for the purpose of effecting a merger, share exchange, asset acquisition,
stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses. While we may
pursue an initial business combination target in any business, industry or geographical location, we intend to focus our search on targets
founded by Asian or Asian American entrepreneurs who are building a global enterprise supported by forward thinking vision and innovative
technology in predictable growth businesses with substantial revenue potential in frontier technologies including but not limited to
artificial intelligence, blockchain, quantum computing, and electric vehicles. We intend to effectuate our initial business combination
using cash from the proceeds of the IPO (as defined below) and the private placement of Private Placement Warrants (as defined below),
our capital stock, debt or a combination of cash, stock and debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2022, we consummated our initial public offering (the &#8220;IPO&#8221;) of 20,200,000 of our units (the &#8220;Units&#8221;)
which includes the partial exercise of the underwriters&#8217; over-allotment option. Each Unit consisted of one Class A ordinary share,
one redeemable warrant entitling the holder to purchase one-half of one Class A ordinary share at a purchase price of $11.50 per whole
share (the &#8220;Public Warrants&#8221;), and one right to acquire one-tenth (1/10) of one Class A ordinary share. The Units were sold
at an offering price of $10.00 per Unit, generating gross proceeds of $202,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2022, we announced that the holders of the Units may elect to separately trade the Class A ordinary shares, Public Warrants
and rights included in the Units, commencing on March 21, 2022. Any Units not separated continue to trade on the Nasdaq Stock Market
LLC (&#8220;Nasdaq&#8221;) under the symbol &#8220;ATAKU.&#8221; Any underlying Class A Ordinary Shares, Public Warrants and Rights that
are separated trade on the Nasdaq under the symbols &#8220;ATAK,&#8221; &#8220;ATAKW&#8221; and &#8220;ATAKR,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2023, we had cash of $28,943, prepaids of $26,118, and cash held in a Trust Account of $57,481,369, current liabilities
of $3,650,801, deferred underwriting commission payable of $7,070,000 and $441,300 of warrant liabilities. Further, we expect to continue
to incur significant costs in the pursuit of our acquisition plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have neither engaged in any operations nor generated any revenues to date. Our only activities from August 6, 2021 (inception) through
September 30, 2023 were organizational activities, those necessary to prepare for the IPO, described below, and after the IPO, identifying
a target company for our initial business combination. We do not expect to generate any operating revenues until after the completion
of our initial business combination. We generate non-operating income in the form of interest income on marketable securities held in
the Trust Account (as defined below). We incur expenses as a result of being a public company (for legal, financial reporting, accounting
and auditing compliance), as well as for due diligence expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2023, we had net income of $522,136, which consisted of formation and operating expenses of $479,300,
a loss on the change in fair value of the warrant liabilities of $64,480, offset by a gain on extinguishment of liabilities of $314,248
and $751,668 of dividend income on marketable securities held in the Trust Account. For the three months ended September 30, 2022, we
had net income of $1,154,845, which consists of formation and operating expenses of $219,330, offset by a gain of $471,500 for the change
in fair value of the warrant liability and a gain of $902,675 for dividend income on marketable securities held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2023, we had net income of $311,609, which consists of formation and operating expenses of $2,868,531,
offset by a gain on the change in fair value of the warrant liabilities of $148,120, a gain on extinguishment of liabilities of $314,248,
and $2,717,772 of dividend income on marketable securities held in the Trust Account. For the nine months ended September 30, 2022, we
had net income of $5,451,402, which consists of formation and operating expenses of $1,210,401, offset by a gain of $5,247,547 for the
change in fair value of the warrant liability, a gain of $258,440 on the extinguishment of the over-allotment option liability, and a
gain of $1,155,816 for dividend income on marketable securities held in the Trust Account</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Capital Resources</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2022, we consummated our IPO of 20,200,000 of Units, which includes the partial exercise of the underwriters&#8217; over-allotment
option. Each Unit consists of one Class A ordinary share, one Public Warrant entitling the holder to purchase one-half of one Class A
ordinary share at a purchase price of $11.50 per whole share, and one right to acquire one-tenth (1/10) of one Class A ordinary share.
The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $202,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the IPO, we consummated the private placement (&#8220;Private Placement&#8221;) of 6,470,000 warrants (the &#8220;Private
Placement Warrants&#8221;) at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $6,470,000. The Private Placement
Warrants were sold to the Sponsor. The Private Placement Warrants are identical to the Public Warrants sold in the IPO as part of the
Units, except that the Private Warrants are non-redeemable and may be exercised on a cashless basis, in each case so long as they continue
to be held by the Sponsor or its permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO and the private placement of Private Placement Warrants, an aggregate amount of $204,020,000 has been placed in
the trust account (the &#8220;Trust Account&#8221;) established in connection with the IPO. Transaction costs amounted to $29,192,787
consisting of $2,525,000 of underwriting fees, $7,070,000 of deferred underwriting fees, over-allotment option liability of $258,440,
$3,030,000 for issuance of representative shares, $15,596,420 fair value of rights underlying the Units, and $712,927 of actual offering
costs. In addition, $1,468,333 of cash was held outside of the Trust Account, which is available for the payment of offering costs and
for working capital purposes. As a result of the underwriters&#8217; partial exercise of the over-allotment option, 50,000 Class B ordinary
shares are no longer subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, we had marketable securities held in the Trust Account of $57,481,369 consisting of money market funds which invest
U.S. Treasury securities. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through September 30, 2023,
we have not withdrawn any interest earned on the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2023, net cash used in operating activities was $487,160. Net loss of $311,609 was increased by dividend
income on marketable securities held in Trust Account of $2,717,772, a change in the fair value of our warrant liability of $148,120, and a gain on extinguishment of a liability of $314,248,
a decrease in prepaid assets of $258,479, and an increase in accounts payable and accrued expenses of $2,122,892.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2023, net provided by investing activities was $152,116,305 consisting of $153,196,305 proceeds from
the redemption of marketable securities held in the Trust Account offset by $1,080,000 purchases of marketable securities held in the
Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 30.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2023, net used in financing activities was $151,791,305 as a result of a $153,196,305 payment in
connection with redemptions of Class A ordinary shares. This was offset by proceeds of $1,405,000 under promissory notes with
related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust
Account (less income taxes payable), to complete our initial business combination. To the extent that our capital stock or debt is used,
in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account
will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our
growth strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, we had cash of $28,943 outside the Trust Account. We intend to use the funds held outside the Trust Account primarily
to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices,
plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and complete our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to fund working capital deficiencies or finance transaction costs in connection with initial business combination, the Sponsor,
or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete
initial business combination, we will repay such loaned amounts. In the event that the initial business combination does not close, we
may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account
would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement warrant at a price of $1.00
per private placement warrant, at the option of the lender. The private placement warrants would be identical to the Private Placement
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However,
if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating the initial business
combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior
to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination
or because we become obligated to redeem a significant number of our Public Shares upon consummation of our initial business combination,
in which case we may issue additional securities or incur debt in connection with such initial business combination. Subject to compliance
with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial business combination.
If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced
to cease operations and liquidate the Trust Account. In addition, following our initial business combination, if cash on hand is insufficient,
we may need to obtain additional financing in order to meet our obligations. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
obligations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement
to pay the Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. We began incurring
these fees on February 9, 2022 and will continue to incur these fees monthly until the earlier of the completion of the initial business
combination and our liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter of the IPO is entitled to a deferred discount of $0.35 per Unit, or $7,070,000 in the aggregate. The deferred discount will
become payable to the underwriter from the amounts held in the Trust Account solely in the event that we complete a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2023, the Company issued and drew fully against a promissory note in the amount of $90,000 to fund working capital needs
(the &#8220;First Working Capital Note&#8221;). Additionally, on February 8, 2023, the Company issued a promissory note in the amount
of $135,000 to fund the Company&#8217;s first extension payment (the &#8220;First Extension Note&#8221;), which has not been drawn against.
On March 3, 2023, the Company issued a promissory note in the amount of $810,000 to pay for up to six additional one-month extension
payments (the &#8220;Second Extension Note&#8221;). On each of March 7, 2023, April 6, 2023, May 5, 2023, June 2, 2023, and July 5, 2023,
the Company drew $135,000, $675,000 in the aggregate, against the Second Extension Note to pay for each additional one-month extension.
On April 6, 2023, the Company issued and drew fully against a promissory note in the amount of $100,000 to fund working capital needs
(the &#8220;Second Working Capital Note&#8221;). On May 2, 2023, the Company issued and drew fully against a promissory note in the amount
of $100,000 to fund working capital needs (the &#8220;Third Working Capital Note&#8221;). On June 14, 2023, the Company issued and drew
fully against a promissory note in the amount of $20,000 to fund working capital needs (the &#8220;Fourth Working Capital Note&#8221;).
On July 7, 2023, the Company issued and subsequently on July 10, 2023, drew fully against a promissory note in the amount of $100,000
to fund working capital needs (the &#8220;Fifth Working Capital Note&#8221;). On July 31, 2023, the Company issued a promissory note
in the amount of $810,000 to pay for up to six additional one-month extension payments (the &#8220;Third Extension Note&#8221;). On each
of July 31, 2023, and September 1, 2023, the Company drew $135,000, $270,000 in the aggregate, against the Third Extension Note to pay
for each additional one-month extension. On September 1, 2023, the Company issued and drew fully against a promissory note in the amount
of $50,000 to fund working capital needs (the &#8220;Sixth Working Capital Note&#8221;). On October 24, 2023, the Company issued and drew fully against a promissory
note in the amount of $75,000 to fund working capital needs (the &#8220;Seventh Working Capital Note&#8221;). On November 17, 2023, the
Company issued and drew fully against a promissory note in the amount of $50,000 to fund working capital needs (the &#8220;Eighth Working
Capital Note&#8221; and together with the First Working Capital Note,
the Second Working Capital Note, the Third Working Capital Note, the Fourth Working Capital Note,  the Fifth Working Capital Note, the Sixth Working Capital Note, and the Seventh Working Capital Note,
collectively, the &#8220;Working Capital Notes&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
First Extension Note does not bear interest, and matures (subject to the waiver against trust provisions) upon the earlier of (i)
two (2) days following the date on which the Company&#8217;s initial business combination is consummated or liquidation and (ii)
August 31, 2023. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not draw funds
against the First Extension Note. The Second Extension Note <span style="background-color: white">bears no interest and is repayable
in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#8217;s initial
business combination, or (ii) the date of the Company&#8217;s liquidation. </span>The Third Extension Note <span style="background-color: white">bears
no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the
Company&#8217;s initial business combination, or (ii) the date of the Company&#8217;s liquidation. The Working Capital Notes do not
bear interest, and mature (subject to the waiver against trust provisions) upon the earlier of (i) two (2) days following the date
on which the Company&#8217;s initial business combination is consummated and (ii) the date of the liquidation of the
Company.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, there was $460,000 and $945,000 outstanding ($1,405,000 in the aggregate) under the Working Capital Notes and
Extension Notes, respectively</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
Accounting Policies</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in
the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported.
Actual results could materially differ from those estimates. We have identified the following critical accounting policies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for the warrants underlying the Units and the private placement warrants in accordance with the guidance contained in ASC 815
under which the public warrants and the private placement warrants do not meet the criteria for equity treatment and must be recorded
as liabilities. Under ASC 815-40, the public warrants and the private placement warrants are not indexed to our ordinary shares in the
manner contemplated by ASC 815-40 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on
equity shares. Accordingly, we classify the public warrants and the private placement warrants as liabilities at their fair value and
adjust the public warrants and the private placement warrants to fair value at each reporting period. These liabilities are subject to
re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations.
Subsequent to our initial public offering, the public warrant value is based on the public trading value. The Company utilized the Black
Scholes Merton simulation model to value the private placement warrants as of September 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
A Ordinary Shares Subject to Possible Redemption</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480. Class A ordinary shares subject to mandatory redemption is classified as a liability instrument
and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that
is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s
control) is classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders&#8217; equity.
Our Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject
to occurrence of uncertain future events. Accordingly, at September 30, 2023, Class A ordinary shares subject to possible redemption
is presented at redemption value as temporary equity, outside of the shareholders&#8217; equity section of the Company&#8217;s balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
Income per Ordinary Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during
the period. Ordinary shares subject to possible redemption at September 30, 2023, which are not currently redeemable and are not redeemable
at fair value, have been excluded from the calculation of basic net income per ordinary share since such shares, if redeemed,
only participate in their pro rata share of the trust account earnings. The Company has not considered the effect of the warrants sold
in the initial public offering and the private placement to purchase an aggregate of 6,470,000 private placement warrants in the calculation
of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion
of such warrants would be anti-dilutive. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s statement of operations includes a presentation of net income per ordinary share subject to possible redemption
and allocates the net income into the two classes of shares in calculating net earnings per ordinary share, basic and diluted.
For redeemable Class A ordinary shares, net earnings per ordinary share is calculated by dividing the net loss by the weighted
average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. For non-redeemable Class
A ordinary shares, net income per share is calculated by dividing the net income by the weighted average number of non-redeemable Class
A ordinary shares outstanding for the period. Nonredeemable Class A ordinary shares include the representative shares issued to Maxim
at the closing of the initial public offering. For non-redeemable Class B ordinary shares, net earnings per share is calculated
by dividing the net loss by the weighted average number of nonredeemable Class B ordinary shares outstanding for the period. Non-redeemable
Class B ordinary shares include the founder shares as these shares do not have any redemption features and do not participate in the
income earned on the trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the Financial Accounting Standards Board issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options
(Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible
Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible
instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are
required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation
in certain areas. ASU 2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023 including
interim periods within those fiscal years. We are currently assessing the impact, if any, that ASU 2020-06 would have on our financial
position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions&#8221; (&#8220;ASU 2022-03&#8221;), which amends ASC 820 to clarify that a contractual sales restriction is not considered
in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual
sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities
measured at fair value. The amendments are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods
within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued
or made available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial
position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management does not believe that there are any other recently issued, but not yet effective, accounting standards, if currently adopted,
would have a material effect on our balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_002"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, we were not subject to any market or interest rate risk. Following the consummation of our IPO, the net proceeds
of our IPO, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity
of 180 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments,
we believe there will be no associated material exposure to interest rate risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_003"></span>Item
4. Controls and Procedures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluation
of Disclosure Controls and Procedures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded,
processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is
accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer
or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including our co-principal executive officers and principal financial and
accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d- 15(e) under the Exchange Act) as of the end of the fiscal quarter ended September 30, 2023. Based on this evaluation, our principal
executive officer and principal financial and accounting officer have concluded that during the period covered by this Quarterly Report,
our disclosure controls and procedures were not effective due to material weaknesses in our internal controls over financial reporting,
specifically those surrounding accrued expenses, accounting for complex financial instruments, inappropriate segregation of duties around
the Company&#8217;s financial reporting, and insufficient management review around the Company&#8217;s financial reporting. In light
of the material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared
in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included
in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash
flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remediation
Activities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the determination of the material weakness, we implemented a remediation plan to enhance our processes for identifying and appropriately
applying applicable accounting requirements for complex financial instruments. We plan to continue to enhance our review procedures of
evaluating and implementing the accounting standards that apply to our financial statements, including through additional analyses by
our personnel and third-party professionals with whom we consult regarding complex financial instruments. The elements of our remediation
plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in Internal Controls over Financial Reporting</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as described above, there was no change in our internal control over financial reporting that occurred during the period ended September
30, 2023 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 28.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_004"></span>PART
II&#8212;OTHER INFORMATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_005"></span>Item
1. Legal Proceedings</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 30.3pt; text-align: justify; text-indent: -22.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_006"></span>Item
1A. Risk Factors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Quarterly Report, except as set forth below, there have been no material changes to the risk factors described in
our final prospectus filed with the SEC on February 7, 2022. We may disclose changes to such factors or disclose additional factors from
time to time in our future filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability
to negotiate and complete our initial business combination, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with
certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time
consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those
changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply
with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our
ability to negotiate and complete an initial business combination, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions
involving special purpose acquisition companies (&#8220;SPACs&#8221;) and private operating companies; amending the financial statement
requirements applicable to transactions involving shell companies; effectively eliminating the safe harbor relating to the use of projections
in SEC filings in connection with proposed business combination transactions; increasing the potential liability of certain participants
in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment
Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our ability
to negotiate and complete our initial business combination and may increase the costs and time related thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
failure to meet the continuing listing requirements of Nasdaq could result in a de-listing of our securities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to satisfy the continuing listing requirements of Nasdaq, such as the corporate governance, minimum closing bid price requirements,
or shareholders&#8217; equity or minimum closing bid price requirements, Nasdaq may take steps to delist our securities. Such a delisting
would likely have a negative effect on the price of our securities and would impair our shareholders&#8217; ability to sell or purchase
our securities. In the event of a delisting, we would likely take actions to restore our compliance with Nasdaq&#8217;s listing requirements,
but we can provide no assurance that any such action taken by us would allow our securities to become listed again, stabilize the market
price or improve the liquidity of our securities, prevent our securities from dropping below the Nasdaq minimum bid price requirement
or prevent future non-compliance with Nasdaq&#8217;s listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2023, we received a written notification (the &#8220;Notice Letter&#8221;) from Nasdaq indicating that we were not in compliance
with Nasdaq Listing Rule 5250(c)(1), as a result of our failure to file the Quarterly Report on Form 10-Q for the fiscal quarter ended
March 31, 2023 (the &#8220;Form 10-Q for Q1&#8221;) with the Securities and Exchange Commission (the &#8220;Commission&#8221;). The Notice
Letter stated that, under Nasdaq Listing Rules, we have 60 calendar days from the date of the Notice Letter to submit a plan to regain
compliance and if Nasdaq accepts our plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of this Form 10-Q,
or until November 20, 2023, to regain compliance. We filed the Form 10-Q for Q1 on May 25, 2023 to cure our filing deficiency and regain
compliance with the Nasdaq Listing Rules. See &#8220;<i>Part II. Item 5. Other Information</i>&#8221; of this Quarterly Report on Form
10-Q for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_007"></span>Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_008"></span>Item
3. Defaults Upon Senior Securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_009"></span>Item
4. Mine Safety Disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_010"></span>Item
5. Other Information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2023, we received a written notification (the &#8220;Notice Letter&#8221;) from Nasdaq indicating that we were not in compliance
with Nasdaq Listing Rule 5250(c)(1), as a result of our failure to file the Quarterly Report on Form 10-Q for the fiscal quarter ended
March 31, 2023 (the &#8220;Form 10-Q for Q1&#8221;) with the Securities and Exchange Commission (the &#8220;Commission&#8221;). The Notice
Letter stated that, under Nasdaq Listing Rules, we have 60 calendar days from the date of the Notice Letter to submit a plan to regain
compliance and if Nasdaq accepts our plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of this Form 10-Q,
or until November 20, 2023, to regain compliance. We have filed the Form 10-Q for Q1 on May 25, 2023 to cure our filing deficiency and
regain compliance with the Nasdaq Listing Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_011"></span>Item
6. Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 30.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523051621/d461713dex21.htm" style="-sec-extract: exhibit">Business Combination Agreement, dated as of February 26, 2023, by and among Aurora Technology Acquisition Corp., Aurora Technology Merger Sub Corp., and DIH Holding US, Inc. (filed as Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on February 27, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523025774/d270849dex31.htm" style="-sec-extract: exhibit">Amendment to Amended and Restated Memorandum and Articles of Association (filed as Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on February 6, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223025896/ex3-1.htm" style="-sec-extract: exhibit">Second Amendment to Amended and Restated Memorandum and Articles of Association (filed as Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on July 31, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523025774/d270849dex101.htm" style="-sec-extract: exhibit">Amendment No. 1, dated as of February 3, 2023, to the Investment Management Trust Agreement, dated as of February 7, 2022, between the Company and Continental Stock Transfer &amp; Trust Company, as trustee (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on February 6, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523028600/d391679dex101.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on February 8, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523028600/d391679dex102.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (filed as Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on February 8, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523051621/d461713dex101.htm" style="-sec-extract: exhibit">Sponsor Support Agreement, dated February 26, 2023, by and among Aurora Technology Acquisition Corp., ATAC Sponsor LLC, and certain shareholders (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on February 27, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523051621/d461713dex102.htm" style="-sec-extract: exhibit">Stockholder Support Agreement, dated February 26, 2023, by and among Aurora Technology Acquisition Corp., DIH Holding US, Inc., Aurora Technology Acquisition Corp., and certain stockholders (filed as Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on February 27, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523051621/d461713dex103.htm" style="-sec-extract: exhibit">Form of Amended and Restated Registration Rights Agreement (filed as Exhibit 10.3 to the Current Report on Form 8-K filed with the SEC on February 27, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523065342/d397694dex101.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on March 9, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000119312523094652/d410467dex101.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on April 7, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223015612/ex10-1.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on May 5, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223024039/ex10-1.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on July 7, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223025896/ex10-1.htm" style="-sec-extract: exhibit">Amendment No. 2, dated as of July 27, 2023, to the Investment Management Trust Agreement, dated as of February 7, 2022, between the Company and Continental Stock Transfer &amp; Trust Company, as trustee (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on July 31, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223026525/ex10-1.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (incorporated by reference to Exhibit 10.1 of Aurora Technology Acquisition Corp.&#8217;s Current Report on Form 8-K filed with the SEC on August 3, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.13</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223031668/ex10-1.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (incorporated by reference to Exhibit 10.1 of Aurora Technology Acquisition Corp.&#8217;s Current Report on Form 8-K filed with the SEC on September 5, 2023).</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.14</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223038147/ex10-1.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (incorporated by reference to Exhibit 10.1 of Aurora Technology Acquisition Corp.&#8217;s Current Report on Form 8-K filed with the SEC on October 24, 2023).</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.15</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315223041909/ex10-1.htm" style="-sec-extract: exhibit">Promissory Note to ATAC Sponsor LLC (incorporated by reference to Exhibit 10.1 of Aurora Technology Acquisition Corp.&#8217;s Current Report on Form 8-K filed with the SEC on November 17, 2023).</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certification of Principal Executive Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document&#8212;the instance document does not appear in the Interactive Data File because its XBRL tags are embedded
    within the Inline XBRL document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="ss_012"></span>SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the requirements of the Securities Exchange Act of 1934, as amended, the registrant caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURORA
    TECHNOLOGY ACQUISITION CORP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 20, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Zachary Wang</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    Wang</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 20, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Cathryn Chen</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cathryn
    Chen</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURSUANT
TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Zachary Wang, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this quarterly report on Form 10-Q of Aurora Technology Acquisition Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17.75pt; text-align: justify; text-indent: -9.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during
the period in which this report is being prepared; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
November 20, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zachary Wang </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    Wang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURSUANT
TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Cathryn Chen, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this quarterly report on Form 10-Q of Aurora Technology Acquisition Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17.75pt; text-align: justify; text-indent: -9.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during
the period in which this report is being prepared; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.8pt; text-align: justify; text-indent: -9.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
November 20, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Cathryn Chen</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
U.S.C. SECTION 1350</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Quarterly Report of Aurora Technology Acquisition Corp. (the &ldquo;Company&rdquo;) on Form 10-Q for the quarterly
period ended September 30, 2023, as filed with the Securities and Exchange Commission (the &ldquo;Report&rdquo;), I, Zachary Wang, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. &sect;1350, as added by &sect;906 of the Sarbanes-Oxley Act of 2002,
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 39.9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results
of operations of the Company as of and for the period covered by the Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
November 20, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zachary Wang </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    Wang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
U.S.C. SECTION 1350</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Quarterly Report of Aurora Technology Acquisition Corp. (the &ldquo;Company&rdquo;) on Form 10-Q for the quarterly
period ended September 30, 2023, as filed with the Securities and Exchange Commission (the &ldquo;Report&rdquo;), I, Cathryn Chen, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. &sect;1350, as added by &sect;906 of the Sarbanes-Oxley Act of 2002,
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 39.9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results
of operations of the Company as of and for the period covered by the Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
November 20, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Cathryn Chen</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>atak-20230930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaAibP9z5Z8OekhvWB4bbm6LywvES+FLS6//a4WUaUA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ATAK="http://auroraspac.com/20230930" elementFormDefault="qualified" targetNamespace="http://auroraspac.com/20230930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://auroraspac.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Condensed Statements of Operations (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" id="StatementsOfChangesInShareholdersDeficit">
          <link:definition>00000005 - Statement - Condensed Statements of Changes in Shareholders' Deficit</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" id="OrganizationAndPlansOfBusinessOperations">
          <link:definition>00000007 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/InitialPublicOffering" id="InitialPublicOffering">
          <link:definition>00000009 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/PrivatePlacement" id="PrivatePlacement">
          <link:definition>00000010 - Disclosure - PRIVATE PLACEMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000011 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/ShareholdersDeficit" id="ShareholdersDeficit">
          <link:definition>00000012 - Disclosure - SHAREHOLDERS&#8217; DEFICIT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/Warrants" id="Warrants">
          <link:definition>00000013 - Disclosure - WARRANTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000015 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000016 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" id="OrganizationAndPlansOfBusinessOperationsDetailsNarrative">
          <link:definition>00000020 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" id="SummaryOfTemporaryEquityDetails">
          <link:definition>00000021 - Disclosure - SUMMARY OF TEMPORARY EQUITY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" id="SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails">
          <link:definition>00000022 - Disclosure - SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" id="InitialPublicOfferingDetailsNarrative">
          <link:definition>00000024 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" id="PrivatePlacementDetailsNarrative">
          <link:definition>00000025 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" id="ShareholdersDeficitDetailsNarrative">
          <link:definition>00000027 - Disclosure - SHAREHOLDERS&#8217; DEFICIT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/WarrantsDetailsNarrative" id="WarrantsDetailsNarrative">
          <link:definition>00000028 - Disclosure - WARRANTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" id="SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails">
          <link:definition>00000030 - Disclosure - SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" id="SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails">
          <link:definition>00000031 - Disclosure - SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" id="SummaryOfFairValueInformationAssetsAndLiabilitiesDetails">
          <link:definition>00000032 - Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" id="SummaryOfFairValueMeasurementsInputsDetails">
          <link:definition>00000033 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" id="FairValueMeasurementsDetailsNarrative">
          <link:definition>00000034 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="atak-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atak-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atak-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atak-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="ATAK_NonredeemableCommonStockMember" name="NonredeemableCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" name="OrdinarySharesSubjectToPossibleRedemptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_SponsorMember" name="SponsorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PrivatePlacementWarrantMember" name="PrivatePlacementWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" name="AmendmentNoOneToInvestmentManagementTrustAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" name="IfWeDoNotCompleteOurInitialBusinessCombinationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" name="AbsentOurCompletingAnInitialBusinessCombinationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_CommonClassASubjectToRedemptionMember" name="CommonClassASubjectToRedemptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PublicWarrantsMember" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PrivatePlacementWarrantsMember" name="PrivatePlacementWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RedeemableClassAOrdinarySharesMember" name="RedeemableClassAOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FounderSharesMember" name="FounderSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" name="SharePriceMoreThanOrEqualsToUsdTwelveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FirstWorkingCapitalMember" name="FirstWorkingCapitalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FirstExtensionNoteMember" name="FirstExtensionNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_SecondExtensionNoteMember" name="SecondExtensionNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_SecondWorkingCapitalMember" name="SecondWorkingCapitalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ThirdWorkingCapitalMember" name="ThirdWorkingCapitalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FourthWorkingCapitalMember" name="FourthWorkingCapitalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FifthWorkingCapitalMember" name="FifthWorkingCapitalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ThirdExtensionNoteMember" name="ThirdExtensionNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WorkingCapitalNotesMember" name="WorkingCapitalNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WorkingCapitalAndSecondExtensionNoteMember" name="WorkingCapitalAndSecondExtensionNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WorkingCapitalLoanMember" name="WorkingCapitalLoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" name="OfficeSpaceAdministrativeAndSupportServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_AdministrativeSupportAgreementMember" name="AdministrativeSupportAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RedemptionOfWarrantsMember" name="RedemptionOfWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" name="SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" name="SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_UnderwritingAgreementMember" name="UnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WarrantLiabilityMember" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TrancheOneMember" name="TrancheOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TrancheTwoMember" name="TrancheTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DerivativeWarrantLiabilityMember" name="DerivativeWarrantLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_MeasurementInputProbabilityMember" name="MeasurementInputProbabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_AccruedOfferingCosts" name="AccruedOfferingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DeferredUnderwritingCommissionsNoncurrent" name="DeferredUnderwritingCommissionsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FormationAndOperatingCosts" name="FormationAndOperatingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" name="GainsLossesOnExtinguishmentOfOverAllotmentLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RemeasurementOfRedemptionValue" name="RemeasurementOfRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" name="StockIssuedDuringPeriodRepresentativeSharesIssuedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" name="StockIssuedDuringPeriodRepresentativeSharesIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RightsUnderlyingTheUnitsValue" name="RightsUnderlyingTheUnitsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_Investmentincomedividends" name="Investmentincomedividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" name="AllocationOfDeferredOfferingCostsForWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" name="InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" name="InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DeferredUnderwritingFeePayable" name="DeferredUnderwritingFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" name="RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ForfeitureOfRepresentativeShares" name="ForfeitureOfRepresentativeShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" name="StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" name="DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DisclosureInitialPublicOfferingAbstract" name="DisclosureInitialPublicOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DisclosureOfInitialPublicOfferingTextBlock" name="DisclosureOfInitialPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DisclosurePrivatePlacementAbstract" name="DisclosurePrivatePlacementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DisclosureOfPrivatePlacementTextBlock" name="DisclosureOfPrivatePlacementTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DisclosureWarrantsAbstract" name="DisclosureWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TemporaryEquityPolicyTextBlock" name="TemporaryEquityPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WarrantyLiabilityPolicyTextBlock" name="WarrantyLiabilityPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DisclousreOfTemporaryEquityTextBlock" name="DisclousreOfTemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" name="ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" name="ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TransactionCosts" name="TransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_OverallotmentOptionLiability" name="OverallotmentOptionLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ActualOfferingCosts" name="ActualOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TermOfRestrictedInvestments" name="TermOfRestrictedInvestments" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" name="PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" name="DescriptionOfBusinessCombinationExtendedPeriodTerms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" name="PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" name="BusinessCombinationExtensionOfBusinessCombinationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" name="NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" name="MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_NetWorkingCapitalSurplusDeficit" name="NetWorkingCapitalSurplusDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_FairValueAllocatedToRights" name="FairValueAllocatedToRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PeriodAfterWhichSharesAreRedeemableAxis" name="PeriodAfterWhichSharesAreRedeemableAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="ATAK_PeriodAfterWhichSharesAreRedeemableDomain" name="PeriodAfterWhichSharesAreRedeemableDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" name="PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TriggeringEventAxis" name="TriggeringEventAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="ATAK_TriggeringEventDomain" name="TriggeringEventDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ShareTransferTriggerPricePerShare" name="ShareTransferTriggerPricePerShare" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" name="NumberOfConsecutiveTradingDaysForDeterminingSharePrice" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_NumberOfTradingDaysForDeterminingSharePrice" name="NumberOfTradingDaysForDeterminingSharePrice" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" name="ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_CommonStockThresholdPercentageOnConversionOfShares" name="CommonStockThresholdPercentageOnConversionOfShares" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ShareRedemptionTriggerPriceAxis" name="ShareRedemptionTriggerPriceAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="ATAK_ShareRedemptionTriggerPriceDomain" name="ShareRedemptionTriggerPriceDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" name="WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" name="MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" name="MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ClassOfWarrantsRedemptionPricePerUnit" name="ClassOfWarrantsRedemptionPricePerUnit" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ClassOfWarrantsRedemptionNoticePeriod" name="ClassOfWarrantsRedemptionNoticePeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ShareRedemptionTriggerPrice" name="ShareRedemptionTriggerPrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" name="MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" name="ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" name="ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" name="MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_OverAllotmentOptionPeriod" name="OverAllotmentOptionPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DeferredUnderwritingCommissionPerUnit" name="DeferredUnderwritingCommissionPerUnit" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_TrancheAxis" name="TrancheAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="ATAK_TrancheDomain" name="TrancheDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_UnsecuredPromissoryNote" name="UnsecuredPromissoryNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_DepositsTrustAccount" name="DepositsTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_UnsecuredPromissoryNoteMember" name="UnsecuredPromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RightsToOnetenthOfOneClassOrdinaryShareMember" name="RightsToOnetenthOfOneClassOrdinaryShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember" name="RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATAK_GainOnExtinguishmentOfLiability" name="GainOnExtinguishmentOfLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>atak-20230930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://auroraspac.com/role/Cover" xlink:href="atak-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/BalanceSheets" xlink:href="atak-20230930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/BalanceSheetsParenthetical" xlink:href="atak-20230930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfOperations" xlink:href="atak-20230930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="atak-20230930.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfCashFlows" xlink:href="atak-20230930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" xlink:href="atak-20230930.xsd#OrganizationAndPlansOfBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/InitialPublicOffering" xlink:href="atak-20230930.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/PrivatePlacement" xlink:href="atak-20230930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/RelatedPartyTransactions" xlink:href="atak-20230930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/ShareholdersDeficit" xlink:href="atak-20230930.xsd#ShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/Warrants" xlink:href="atak-20230930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/CommitmentsAndContingencies" xlink:href="atak-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurements" xlink:href="atak-20230930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SubsequentEvents" xlink:href="atak-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurementsTables" xlink:href="atak-20230930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:href="atak-20230930.xsd#OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" xlink:href="atak-20230930.xsd#SummaryOfTemporaryEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:href="atak-20230930.xsd#SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="atak-20230930.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" xlink:href="atak-20230930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="atak-20230930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" xlink:href="atak-20230930.xsd#ShareholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/WarrantsDetailsNarrative" xlink:href="atak-20230930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="atak-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:href="atak-20230930.xsd#SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueMeasurementsInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="atak-20230930.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" xlink:href="atak-20230930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AccruedOfferingCosts" xlink:label="loc_ATAKAccruedOfferingCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ATAKAccruedOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:label="loc_ATAKDeferredUnderwritingCommissionsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_ATAKDeferredUnderwritingCommissionsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FormationAndOperatingCosts" xlink:label="loc_ATAKFormationAndOperatingCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_ATAKFormationAndOperatingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:label="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeDividend" xlink:label="loc_us-gaapInvestmentIncomeDividend" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Statements of Changes in Shareholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_Investmentincomedividends" xlink:label="loc_ATAKInvestmentincomedividends" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ATAKInvestmentincomedividends" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" xlink:label="loc_ATAKAllocationOfDeferredOfferingCostsForWarrantLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ATAKAllocationOfDeferredOfferingCostsForWarrantLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:label="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaapPaymentsToAcquireRestrictedInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireRestrictedInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaapPaymentsToAcquireMarketableSecurities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireMarketableSecurities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" xlink:title="00000007 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/InitialPublicOffering" xlink:title="00000009 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/PrivatePlacement" xlink:title="00000010 - Disclosure - PRIVATE PLACEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/ShareholdersDeficit" xlink:title="00000012 - Disclosure - SHAREHOLDERS&#8217; DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/Warrants" xlink:title="00000013 - Disclosure - WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurements" xlink:title="00000015 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurementsTables" xlink:title="00000019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:title="00000020 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" xlink:title="00000021 - Disclosure - SUMMARY OF TEMPORARY EQUITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:title="00000022 - Disclosure - SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000024 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000025 - Disclosure - PRIVATE PLACEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" xlink:title="00000027 - Disclosure - SHAREHOLDERS&#8217; DEFICIT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/WarrantsDetailsNarrative" xlink:title="00000028 - Disclosure - WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:title="00000030 - Disclosure - SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:title="00000031 - Disclosure - SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:title="00000032 - Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" xlink:title="00000033 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000034 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>atak-20230930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://auroraspac.com/role/Cover" xlink:href="atak-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/BalanceSheets" xlink:href="atak-20230930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/BalanceSheetsParenthetical" xlink:href="atak-20230930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfOperations" xlink:href="atak-20230930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="atak-20230930.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfCashFlows" xlink:href="atak-20230930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" xlink:href="atak-20230930.xsd#OrganizationAndPlansOfBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/InitialPublicOffering" xlink:href="atak-20230930.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/PrivatePlacement" xlink:href="atak-20230930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/RelatedPartyTransactions" xlink:href="atak-20230930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/ShareholdersDeficit" xlink:href="atak-20230930.xsd#ShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/Warrants" xlink:href="atak-20230930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/CommitmentsAndContingencies" xlink:href="atak-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurements" xlink:href="atak-20230930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SubsequentEvents" xlink:href="atak-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurementsTables" xlink:href="atak-20230930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:href="atak-20230930.xsd#OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" xlink:href="atak-20230930.xsd#SummaryOfTemporaryEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:href="atak-20230930.xsd#SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="atak-20230930.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" xlink:href="atak-20230930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="atak-20230930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" xlink:href="atak-20230930.xsd#ShareholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/WarrantsDetailsNarrative" xlink:href="atak-20230930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="atak-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:href="atak-20230930.xsd#SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueMeasurementsInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="atak-20230930.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" xlink:href="atak-20230930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfInvestmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:label="loc_us-gaapScheduleOfInvestmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_us-gaapScheduleOfInvestmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfInvestmentsTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalUnitsMember" xlink:label="loc_us-gaapCapitalUnitsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapCapitalUnitsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightsMember" xlink:label="loc_us-gaapRightsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapRightsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfInvestmentsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentType_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAmendmentFlag_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAmendmentDescription_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentRegistrationStatement_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentAnnualReport_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentQuarterlyReport_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentTransitionReport_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentShellCompanyReport_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentPeriodStartDate_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentPeriodEndDate_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityFileNumber_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityRegistrantName_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityCentralIndexKey_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityPrimarySicNumber_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressAddressLine1_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressAddressLine2_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressAddressLine3_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressCityOrTown_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressCountry_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiCountryRegion_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiCityAreaCode_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiLocalPhoneNumber_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiExtension_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiWrittenCommunications_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSolicitingMaterial_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiPreCommencementTenderOffer_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurity12bTitle_70" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiNoTradingSymbolFlag_70" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiTradingSymbol_70" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurityExchangeName_70" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurity12gTitle_70" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurityReportingObligation_70" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAnnualInformationForm_70" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_70" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_70" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityVoluntaryFilers_70" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_70" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_70" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityFilerCategory_70" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntitySmallBusiness_70" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_70" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityExTransitionPeriod_70" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentAccountingStandard_70" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_70" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityShellCompany_70" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityPublicFloat_70" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_70" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsCurrentAbstract_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapCash_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapPrepaidExpenseCurrent_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAssetsCurrent_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapAssetsNoncurrent_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssets_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccountsPayableCurrent_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AccruedOfferingCosts" xlink:label="loc_ATAKAccruedOfferingCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_ATAKAccruedOfferingCosts_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapNotesPayableCurrent_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrent_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:label="loc_ATAKDeferredUnderwritingCommissionsNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_ATAKDeferredUnderwritingCommissionsNoncurrent_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrent_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilities_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommitmentsAndContingencies_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquityAbstract_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapPreferredStockValue_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommonStockValue_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAdditionalPaidInCapital_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NonredeemableCommonStockMember" xlink:label="loc_ATAKNonredeemableCommonStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKNonredeemableCommonStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FormationAndOperatingCosts" xlink:label="loc_ATAKFormationAndOperatingCosts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKFormationAndOperatingCosts_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:label="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeDividend" xlink:label="loc_us-gaapInvestmentIncomeDividend_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapInvestmentIncomeDividend_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapNonoperatingIncomeExpense_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Statements of Changes in Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" xlink:label="loc_ATAKOrdinarySharesSubjectToPossibleRedemptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ATAKOrdinarySharesSubjectToPossibleRedemptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RemeasurementOfRedemptionValue" xlink:label="loc_ATAKRemeasurementOfRedemptionValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKRemeasurementOfRedemptionValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssued_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="loc_ATAKRightsUnderlyingTheUnitsValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKRightsUnderlyingTheUnitsValue_70" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" xlink:title="00000007 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/InitialPublicOffering" xlink:title="00000009 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/PrivatePlacement" xlink:title="00000010 - Disclosure - PRIVATE PLACEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/ShareholdersDeficit" xlink:title="00000012 - Disclosure - SHAREHOLDERS&#8217; DEFICIT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/Warrants" xlink:title="00000013 - Disclosure - WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurements" xlink:title="00000015 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurementsTables" xlink:title="00000019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:title="00000020 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATAKSponsorMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="loc_ATAKPrivatePlacementWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" xlink:label="loc_ATAKAmendmentNoOneToInvestmentManagementTrustAgreementMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ATAKAmendmentNoOneToInvestmentManagementTrustAgreementMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TransactionCosts" xlink:label="loc_ATAKTransactionCosts_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKTransactionCosts_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_us-gaapOtherUnderwritingExpense_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherUnderwritingExpense_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverallotmentOptionLiability" xlink:label="loc_ATAKOverallotmentOptionLiability_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKOverallotmentOptionLiability_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="loc_ATAKRightsUnderlyingTheUnitsValue_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKRightsUnderlyingTheUnitsValue_200" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ActualOfferingCosts" xlink:label="loc_ATAKActualOfferingCosts_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKActualOfferingCosts_200" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash_200" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaapPaymentsToAcquireRestrictedInvestments_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireRestrictedInvestments_200" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharePrice_200" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="loc_ATAKTermOfRestrictedInvestments_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKTermOfRestrictedInvestments_200" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:label="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_200" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" xlink:label="loc_ATAKDescriptionOfBusinessCombinationExtendedPeriodTerms_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKDescriptionOfBusinessCombinationExtendedPeriodTerms_200" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSubsequentEventDescription_200" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" xlink:label="loc_ATAKPercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKPercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_200" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinimumNetWorthRequiredForCompliance" xlink:label="loc_us-gaapMinimumNetWorthRequiredForCompliance_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMinimumNetWorthRequiredForCompliance_200" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" xlink:label="loc_ATAKBusinessCombinationExtensionOfBusinessCombinationPeriod_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKBusinessCombinationExtensionOfBusinessCombinationPeriod_200" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" xlink:label="loc_ATAKNumberOfDaysWithinWhichPublicSharesShallBeRedeemed_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKNumberOfDaysWithinWhichPublicSharesShallBeRedeemed_200" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" xlink:label="loc_us-gaapLiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_200" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" xlink:label="loc_ATAKMinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKMinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_200" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NetWorkingCapitalSurplusDeficit" xlink:label="loc_ATAKNetWorkingCapitalSurplusDeficit_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKNetWorkingCapitalSurplusDeficit_200" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_200" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_200" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" xlink:title="00000021 - Disclosure - SUMMARY OF TEMPORARY EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_CommonClassASubjectToRedemptionMember" xlink:label="loc_ATAKCommonClassASubjectToRedemptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKCommonClassASubjectToRedemptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepurchaseOfEquity" xlink:label="loc_us-gaapProceedsFromRepurchaseOfEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FairValueAllocatedToRights" xlink:label="loc_ATAKFairValueAllocatedToRights_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKFairValueAllocatedToRights_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_50" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:title="00000022 - Disclosure - SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedeemableClassAOrdinarySharesMember" xlink:label="loc_ATAKRedeemableClassAOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKRedeemableClassAOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NonredeemableCommonStockMember" xlink:label="loc_ATAKNonredeemableCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKNonredeemableCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaapNetIncomeLossAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodAfterWhichSharesAreRedeemableAxis" xlink:label="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodAfterWhichSharesAreRedeemableDomain" xlink:label="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" xlink:to="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodAfterWhichSharesAreRedeemableDomain" xlink:label="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" xlink:to="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" xlink:label="loc_ATAKIfWeDoNotCompleteOurInitialBusinessCombinationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" xlink:to="loc_ATAKIfWeDoNotCompleteOurInitialBusinessCombinationMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" xlink:label="loc_ATAKAbsentOurCompletingAnInitialBusinessCombinationMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" xlink:to="loc_ATAKAbsentOurCompletingAnInitialBusinessCombinationMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="loc_ATAKPrivatePlacementWarrantMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaapPaymentsToAcquireRestrictedInvestments_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireRestrictedInvestments_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="loc_ATAKTermOfRestrictedInvestments_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKTermOfRestrictedInvestments_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" xlink:label="loc_ATAKPercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKPercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:label="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_us-gaapOtherUnderwritingExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherUnderwritingExpense_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverallotmentOptionLiability" xlink:label="loc_ATAKOverallotmentOptionLiability_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKOverallotmentOptionLiability_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="loc_ATAKRightsUnderlyingTheUnitsValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKRightsUnderlyingTheUnitsValue_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ActualOfferingCosts" xlink:label="loc_ATAKActualOfferingCosts_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKActualOfferingCosts_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_150" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_150" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000024 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockConversionBasis" xlink:label="loc_us-gaapCommonStockConversionBasis_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockConversionBasis_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharePrice_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="loc_ATAKTermOfRestrictedInvestments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKTermOfRestrictedInvestments_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000025 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATAKSponsorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="loc_ATAKPrivatePlacementWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FounderSharesMember" xlink:label="loc_ATAKFounderSharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ATAKFounderSharesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TriggeringEventAxis" xlink:label="loc_ATAKTriggeringEventAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_ATAKTriggeringEventAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TriggeringEventDomain" xlink:label="loc_ATAKTriggeringEventDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ATAKTriggeringEventAxis" xlink:to="loc_ATAKTriggeringEventDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TriggeringEventDomain" xlink:label="loc_ATAKTriggeringEventDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ATAKTriggeringEventAxis" xlink:to="loc_ATAKTriggeringEventDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" xlink:label="loc_ATAKSharePriceMoreThanOrEqualsToUsdTwelveMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKTriggeringEventDomain" xlink:to="loc_ATAKSharePriceMoreThanOrEqualsToUsdTwelveMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PromissoryNoteMember" xlink:label="loc_ATAKPromissoryNoteMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKPromissoryNoteMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FirstWorkingCapitalMember" xlink:label="loc_ATAKFirstWorkingCapitalMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFirstWorkingCapitalMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FirstExtensionNoteMember" xlink:label="loc_ATAKFirstExtensionNoteMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFirstExtensionNoteMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SecondExtensionNoteMember" xlink:label="loc_ATAKSecondExtensionNoteMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKSecondExtensionNoteMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SecondWorkingCapitalMember" xlink:label="loc_ATAKSecondWorkingCapitalMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKSecondWorkingCapitalMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThirdWorkingCapitalMember" xlink:label="loc_ATAKThirdWorkingCapitalMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKThirdWorkingCapitalMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FourthWorkingCapitalMember" xlink:label="loc_ATAKFourthWorkingCapitalMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFourthWorkingCapitalMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FifthWorkingCapitalMember" xlink:label="loc_ATAKFifthWorkingCapitalMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFifthWorkingCapitalMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThirdExtensionNoteMember" xlink:label="loc_ATAKThirdExtensionNoteMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKThirdExtensionNoteMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalNotesMember" xlink:label="loc_ATAKWorkingCapitalNotesMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKWorkingCapitalNotesMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalAndSecondExtensionNoteMember" xlink:label="loc_ATAKWorkingCapitalAndSecondExtensionNoteMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKWorkingCapitalAndSecondExtensionNoteMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_us-gaapRelatedPartyMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalLoanMember" xlink:label="loc_ATAKWorkingCapitalLoanMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ATAKWorkingCapitalLoanMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" xlink:label="loc_ATAKOfficeSpaceAdministrativeAndSupportServicesMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ATAKOfficeSpaceAdministrativeAndSupportServicesMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AdministrativeSupportAgreementMember" xlink:label="loc_ATAKAdministrativeSupportAgreementMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ATAKAdministrativeSupportAgreementMember_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_380" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_380" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_380" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_380" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareTransferTriggerPricePerShare" xlink:label="loc_ATAKShareTransferTriggerPricePerShare_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKShareTransferTriggerPricePerShare_380" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice_380" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice_380" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" xlink:label="loc_ATAKThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_380" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_380" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_380" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_380" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayable_380" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_380" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_380" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilities_380" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_380" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_380" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_380" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_380" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_380" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" xlink:title="00000027 - Disclosure - SHAREHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FounderSharesMember" xlink:label="loc_ATAKFounderSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ATAKFounderSharesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_CommonStockThresholdPercentageOnConversionOfShares" xlink:label="loc_ATAKCommonStockThresholdPercentageOnConversionOfShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ATAKCommonStockThresholdPercentageOnConversionOfShares_80" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/WarrantsDetailsNarrative" xlink:title="00000028 - Disclosure - WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedemptionOfWarrantsMember" xlink:label="loc_ATAKRedemptionOfWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKRedemptionOfWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPriceAxis" xlink:label="loc_ATAKShareRedemptionTriggerPriceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_ATAKShareRedemptionTriggerPriceAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPriceDomain" xlink:label="loc_ATAKShareRedemptionTriggerPriceDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ATAKShareRedemptionTriggerPriceAxis" xlink:to="loc_ATAKShareRedemptionTriggerPriceDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPriceDomain" xlink:label="loc_ATAKShareRedemptionTriggerPriceDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ATAKShareRedemptionTriggerPriceAxis" xlink:to="loc_ATAKShareRedemptionTriggerPriceDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" xlink:label="loc_ATAKSharePriceEqualOrExceedsEighteenRupeesPerDollarMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKShareRedemptionTriggerPriceDomain" xlink:to="loc_ATAKSharePriceEqualOrExceedsEighteenRupeesPerDollarMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" xlink:label="loc_ATAKSharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKShareRedemptionTriggerPriceDomain" xlink:to="loc_ATAKSharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" xlink:label="loc_ATAKWarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKWarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" xlink:label="loc_ATAKMinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" xlink:label="loc_ATAKMinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsRedemptionPricePerUnit" xlink:label="loc_ATAKClassOfWarrantsRedemptionPricePerUnit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantsRedemptionPricePerUnit_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsRedemptionNoticePeriod" xlink:label="loc_ATAKClassOfWarrantsRedemptionNoticePeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantsRedemptionNoticePeriod_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharePrice_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPrice" xlink:label="loc_ATAKShareRedemptionTriggerPrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKShareRedemptionTriggerPrice_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" xlink:label="loc_ATAKMinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" xlink:label="loc_ATAKClassOfWarrantOrRightMinimumNoticePeriodForRedemption_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantOrRightMinimumNoticePeriodForRedemption_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" xlink:label="loc_ATAKClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" xlink:label="loc_ATAKMinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_120" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnderwritingAgreementMember" xlink:label="loc_ATAKUnderwritingAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ATAKUnderwritingAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATAKSponsorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverAllotmentOptionPeriod" xlink:label="loc_ATAKOverAllotmentOptionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKOverAllotmentOptionPeriod_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionPerUnit" xlink:label="loc_ATAKDeferredUnderwritingCommissionPerUnit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKDeferredUnderwritingCommissionPerUnit_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:label="loc_ATAKDeferredUnderwritingCommissionsNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKDeferredUnderwritingCommissionsNoncurrent_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:title="00000030 - Disclosure - SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantLiabilityMember" xlink:label="loc_ATAKWarrantLiabilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKWarrantLiabilityMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheAxis" xlink:label="loc_ATAKTrancheAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_ATAKTrancheAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheDomain" xlink:label="loc_ATAKTrancheDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ATAKTrancheAxis" xlink:to="loc_ATAKTrancheDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheDomain" xlink:label="loc_ATAKTrancheDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ATAKTrancheAxis" xlink:to="loc_ATAKTrancheDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheOneMember" xlink:label="loc_ATAKTrancheOneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKTrancheDomain" xlink:to="loc_ATAKTrancheOneMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheTwoMember" xlink:label="loc_ATAKTrancheTwoMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ATAKTrancheDomain" xlink:to="loc_ATAKTrancheTwoMember_270" xlink:type="arc" order="273" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_520" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_520" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_520" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_520" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:title="00000031 - Disclosure - SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapMoneyMarketFundsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_190" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:title="00000032 - Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DerivativeWarrantLiabilityMember" xlink:label="loc_ATAKDerivativeWarrantLiabilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKDerivativeWarrantLiabilityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_520" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_520" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_520" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" xlink:title="00000033 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MeasurementInputProbabilityMember" xlink:label="loc_ATAKMeasurementInputProbabilityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_ATAKMeasurementInputProbabilityMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_220" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000034 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATAKSponsorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustCurrent" xlink:label="loc_us-gaapAssetsHeldInTrustCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustCurrent_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnsecuredPromissoryNote" xlink:label="loc_ATAKUnsecuredPromissoryNote_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATAKUnsecuredPromissoryNote_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebt" xlink:label="loc_us-gaapUnsecuredDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapUnsecuredDebt_50" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>atak-20230930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalUnitsMember" xlink:label="us-gaap_CapitalUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitsMember" xlink:to="us-gaap_CapitalUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalUnitsMember_lbl" xml:lang="en-US">Capital Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightsMember" xlink:label="us-gaap_RightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightsMember" xlink:to="us-gaap_RightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightsMember_lbl" xml:lang="en-US">Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NonredeemableCommonStockMember" xlink:label="ATAK_NonredeemableCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NonredeemableCommonStockMember" xlink:to="ATAK_NonredeemableCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_NonredeemableCommonStockMember_lbl" xml:lang="en-US">Nonredeemable Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" xlink:label="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" xlink:to="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember_lbl" xml:lang="en-US">Ordinary Shares Subject To Possible Redemption [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="ATAK_SponsorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SponsorMember" xlink:to="ATAK_SponsorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="ATAK_PrivatePlacementWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PrivatePlacementWarrantMember" xlink:to="ATAK_PrivatePlacementWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PrivatePlacementWarrantMember_lbl" xml:lang="en-US">Private Placement Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" xlink:label="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" xlink:to="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember_lbl" xml:lang="en-US">Amendment No One To Investment Management Trust Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodAfterWhichSharesAreRedeemableAxis" xlink:label="ATAK_PeriodAfterWhichSharesAreRedeemableAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PeriodAfterWhichSharesAreRedeemableAxis" xlink:to="ATAK_PeriodAfterWhichSharesAreRedeemableAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PeriodAfterWhichSharesAreRedeemableAxis_lbl" xml:lang="en-US">Period After Which Shares Are Redeemable [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" xlink:label="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" xlink:to="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember_lbl" xml:lang="en-US">If We Do Not Complete Our Initial Business Combination [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" xlink:label="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" xlink:to="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember_lbl" xml:lang="en-US">Absent Our Completing An Initial Business Combination [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_CommonClassASubjectToRedemptionMember" xlink:label="ATAK_CommonClassASubjectToRedemptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_CommonClassASubjectToRedemptionMember" xlink:to="ATAK_CommonClassASubjectToRedemptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_CommonClassASubjectToRedemptionMember_lbl" xml:lang="en-US">Common Class A Subject To Redemption [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="ATAK_PublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PublicWarrantsMember" xlink:to="ATAK_PublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="ATAK_PrivatePlacementWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PrivatePlacementWarrantsMember" xlink:to="ATAK_PrivatePlacementWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedeemableClassAOrdinarySharesMember" xlink:label="ATAK_RedeemableClassAOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RedeemableClassAOrdinarySharesMember" xlink:to="ATAK_RedeemableClassAOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_RedeemableClassAOrdinarySharesMember_lbl" xml:lang="en-US">Redeemable Class A Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FounderSharesMember" xlink:label="ATAK_FounderSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FounderSharesMember" xlink:to="ATAK_FounderSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FounderSharesMember_lbl" xml:lang="en-US">Founder Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TriggeringEventAxis" xlink:label="ATAK_TriggeringEventAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TriggeringEventAxis" xlink:to="ATAK_TriggeringEventAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TriggeringEventAxis_lbl" xml:lang="en-US">Triggering Event [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" xlink:label="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" xlink:to="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember_lbl" xml:lang="en-US">Share Price More Than Or Equals To Used Twelve [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PromissoryNoteMember" xlink:label="ATAK_PromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PromissoryNoteMember" xlink:to="ATAK_PromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FirstWorkingCapitalMember" xlink:label="ATAK_FirstWorkingCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FirstWorkingCapitalMember" xlink:to="ATAK_FirstWorkingCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FirstWorkingCapitalMember_lbl" xml:lang="en-US">First Working Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FirstExtensionNoteMember" xlink:label="ATAK_FirstExtensionNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FirstExtensionNoteMember" xlink:to="ATAK_FirstExtensionNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FirstExtensionNoteMember_lbl" xml:lang="en-US">First Extension Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SecondExtensionNoteMember" xlink:label="ATAK_SecondExtensionNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SecondExtensionNoteMember" xlink:to="ATAK_SecondExtensionNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_SecondExtensionNoteMember_lbl" xml:lang="en-US">Second Extension Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SecondWorkingCapitalMember" xlink:label="ATAK_SecondWorkingCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SecondWorkingCapitalMember" xlink:to="ATAK_SecondWorkingCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_SecondWorkingCapitalMember_lbl" xml:lang="en-US">Second Working Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThirdWorkingCapitalMember" xlink:label="ATAK_ThirdWorkingCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ThirdWorkingCapitalMember" xlink:to="ATAK_ThirdWorkingCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ThirdWorkingCapitalMember_lbl" xml:lang="en-US">Third Working Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FourthWorkingCapitalMember" xlink:label="ATAK_FourthWorkingCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FourthWorkingCapitalMember" xlink:to="ATAK_FourthWorkingCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FourthWorkingCapitalMember_lbl" xml:lang="en-US">Fourth Working Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FifthWorkingCapitalMember" xlink:label="ATAK_FifthWorkingCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FifthWorkingCapitalMember" xlink:to="ATAK_FifthWorkingCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FifthWorkingCapitalMember_lbl" xml:lang="en-US">Fifth Working Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThirdExtensionNoteMember" xlink:label="ATAK_ThirdExtensionNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ThirdExtensionNoteMember" xlink:to="ATAK_ThirdExtensionNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ThirdExtensionNoteMember_lbl" xml:lang="en-US">Third Extension Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalNotesMember" xlink:label="ATAK_WorkingCapitalNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WorkingCapitalNotesMember" xlink:to="ATAK_WorkingCapitalNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WorkingCapitalNotesMember_lbl" xml:lang="en-US">Working Capital Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalAndSecondExtensionNoteMember" xlink:label="ATAK_WorkingCapitalAndSecondExtensionNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WorkingCapitalAndSecondExtensionNoteMember" xlink:to="ATAK_WorkingCapitalAndSecondExtensionNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WorkingCapitalAndSecondExtensionNoteMember_lbl" xml:lang="en-US">Working Capital And Second Extension Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalLoanMember" xlink:label="ATAK_WorkingCapitalLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WorkingCapitalLoanMember" xlink:to="ATAK_WorkingCapitalLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WorkingCapitalLoanMember_lbl" xml:lang="en-US">Working Capital Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" xlink:label="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" xlink:to="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember_lbl" xml:lang="en-US">Office Space Administrative And Support Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AdministrativeSupportAgreementMember" xlink:label="ATAK_AdministrativeSupportAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AdministrativeSupportAgreementMember" xlink:to="ATAK_AdministrativeSupportAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_AdministrativeSupportAgreementMember_lbl" xml:lang="en-US">Administrative Support Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedemptionOfWarrantsMember" xlink:label="ATAK_RedemptionOfWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RedemptionOfWarrantsMember" xlink:to="ATAK_RedemptionOfWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_RedemptionOfWarrantsMember_lbl" xml:lang="en-US">Redemption Of Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPriceAxis" xlink:label="ATAK_ShareRedemptionTriggerPriceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ShareRedemptionTriggerPriceAxis" xlink:to="ATAK_ShareRedemptionTriggerPriceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ShareRedemptionTriggerPriceAxis_lbl" xml:lang="en-US">Share Redemption Trigger Price [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" xlink:label="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" xlink:to="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_lbl" xml:lang="en-US">Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" xlink:label="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" xlink:to="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_lbl" xml:lang="en-US">Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnderwritingAgreementMember" xlink:label="ATAK_UnderwritingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_UnderwritingAgreementMember" xlink:to="ATAK_UnderwritingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_UnderwritingAgreementMember_lbl" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantLiabilityMember" xlink:label="ATAK_WarrantLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantLiabilityMember" xlink:to="ATAK_WarrantLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WarrantLiabilityMember_lbl" xml:lang="en-US">Warrant Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheAxis" xlink:label="ATAK_TrancheAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TrancheAxis" xlink:to="ATAK_TrancheAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TrancheAxis_lbl" xml:lang="en-US">Tranche [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheOneMember" xlink:label="ATAK_TrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TrancheOneMember" xlink:to="ATAK_TrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TrancheOneMember_lbl" xml:lang="en-US">Tranche One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheTwoMember" xlink:label="ATAK_TrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TrancheTwoMember" xlink:to="ATAK_TrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TrancheTwoMember_lbl" xml:lang="en-US">Tranche Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DerivativeWarrantLiabilityMember" xlink:label="ATAK_DerivativeWarrantLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DerivativeWarrantLiabilityMember" xlink:to="ATAK_DerivativeWarrantLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DerivativeWarrantLiabilityMember_lbl" xml:lang="en-US">Derivative Warrant Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MeasurementInputProbabilityMember" xlink:label="ATAK_MeasurementInputProbabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MeasurementInputProbabilityMember" xlink:to="ATAK_MeasurementInputProbabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_MeasurementInputProbabilityMember_lbl" xml:lang="en-US">Measurement Input Probability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_ScheduleOfInvestmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsTable_lbl" xml:lang="en-US">Schedule of Investments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Marketable securities held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AccruedOfferingCosts" xlink:label="ATAK_AccruedOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AccruedOfferingCosts" xlink:to="ATAK_AccruedOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_AccruedOfferingCosts_lbl" xml:lang="en-US">Accrued offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non-current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:label="ATAK_DeferredUnderwritingCommissionsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:to="ATAK_DeferredUnderwritingCommissionsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DeferredUnderwritingCommissionsNoncurrent_lbl" xml:lang="en-US">Deferred underwriting commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 8)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, 5,307,292 and 20,200,000 shares subject to redemption issued and outstanding, at redemption value of $10.83 and $10.24 per share, as of September 30, 2023 and December 31, 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Deficit:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Temporary equity, par or stated value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Temporary equity, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Temporary equity, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Temporary equity, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Temporary equity, redemption price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par or stated value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par or stated value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FormationAndOperatingCosts" xlink:label="ATAK_FormationAndOperatingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FormationAndOperatingCosts" xlink:to="ATAK_FormationAndOperatingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FormationAndOperatingCosts_lbl" xml:lang="en-US">Formation and Operating expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (loss):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:label="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:to="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability_lbl" xml:lang="en-US">Gain on extinguishment of over-allotment liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on extinguishment of liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeDividend" xlink:label="us-gaap_InvestmentIncomeDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeDividend" xlink:to="us-gaap_InvestmentIncomeDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeDividend_lbl" xml:lang="en-US">Dividend income on marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic weighted average shares outstanding, non-redeemable ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted weighted average shares outstanding, non-redeemable ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net (loss) income per share, Class A ordinary shares subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net (loss) income per share, Class A ordinary shares subject to redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Redemption of Class A ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Redemption of Class A ordinary shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RemeasurementOfRedemptionValue" xlink:label="ATAK_RemeasurementOfRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RemeasurementOfRedemptionValue" xlink:to="ATAK_RemeasurementOfRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_RemeasurementOfRedemptionValue_lbl" xml:lang="en-US">Remeasurement of Class A ordinary shares to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Class A ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Class A ordianry shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xml:lang="en-US">Forfeiture of Class B shares issued to Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Forfeiture of Class B shares issued to Sponsor, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue_lbl" xml:lang="en-US">Issuance of Representative Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued_lbl" xml:lang="en-US">Issuance of Representative Shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="ATAK_RightsUnderlyingTheUnitsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RightsUnderlyingTheUnitsValue" xlink:to="ATAK_RightsUnderlyingTheUnitsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_RightsUnderlyingTheUnitsValue_lbl" xml:lang="en-US">Rights underlying the Units</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_Investmentincomedividends" xlink:label="ATAK_Investmentincomedividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_Investmentincomedividends" xlink:to="ATAK_Investmentincomedividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ATAK_Investmentincomedividends_lbl" xml:lang="en-US">Dividend income on marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" xlink:label="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" xlink:to="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability_lbl" xml:lang="en-US">Allocation of deferred offering costs for warrant liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:to="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability_2_lbl" xml:lang="en-US">Gain on extinguishment of over-allotment liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain on extinguishment of liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in current assets and current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="us-gaap_PaymentsToAcquireRestrictedInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:to="us-gaap_PaymentsToAcquireRestrictedInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireRestrictedInvestments_lbl" xml:lang="en-US">Investment of cash in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US">Purchase of marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US">Redemption of marketable securities held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided (used) in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of Class A ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from sale Private Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of underwriting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Payment of promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Payment of deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Payment of redemption on Class A ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash (used) provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net Change in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash &#8211; Beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash &#8211; End of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-cash Investing Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" xlink:label="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" xlink:to="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Initial measurement of Class A ordinary shares subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" xlink:label="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" xlink:to="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants_lbl" xml:lang="en-US">Initial measurement of public warrants and private placement warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingFeePayable" xlink:label="ATAK_DeferredUnderwritingFeePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredUnderwritingFeePayable" xlink:to="ATAK_DeferredUnderwritingFeePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DeferredUnderwritingFeePayable_lbl" xml:lang="en-US">Deferred underwriting fee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" xlink:label="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" xlink:to="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Remeasurement of Class A ordinary shares subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ForfeitureOfRepresentativeShares" xlink:label="ATAK_ForfeitureOfRepresentativeShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ForfeitureOfRepresentativeShares" xlink:to="ATAK_ForfeitureOfRepresentativeShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ForfeitureOfRepresentativeShares_lbl" xml:lang="en-US">Forfeiture of Representative Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_lbl" xml:lang="en-US">Issuance of Representative Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" xlink:label="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" xlink:to="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs included in accrued offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureInitialPublicOfferingAbstract" xlink:label="ATAK_DisclosureInitialPublicOfferingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosureInitialPublicOfferingAbstract" xlink:to="ATAK_DisclosureInitialPublicOfferingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DisclosureInitialPublicOfferingAbstract_lbl" xml:lang="en-US">Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureOfInitialPublicOfferingTextBlock" xlink:label="ATAK_DisclosureOfInitialPublicOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosureOfInitialPublicOfferingTextBlock" xlink:to="ATAK_DisclosureOfInitialPublicOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DisclosureOfInitialPublicOfferingTextBlock_lbl" xml:lang="en-US">INITIAL PUBLIC OFFERING</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosurePrivatePlacementAbstract" xlink:label="ATAK_DisclosurePrivatePlacementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosurePrivatePlacementAbstract" xlink:to="ATAK_DisclosurePrivatePlacementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DisclosurePrivatePlacementAbstract_lbl" xml:lang="en-US">Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureOfPrivatePlacementTextBlock" xlink:label="ATAK_DisclosureOfPrivatePlacementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosureOfPrivatePlacementTextBlock" xlink:to="ATAK_DisclosureOfPrivatePlacementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DisclosureOfPrivatePlacementTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureWarrantsAbstract" xlink:label="ATAK_DisclosureWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosureWarrantsAbstract" xlink:to="ATAK_DisclosureWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DisclosureWarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantsDisclosureTextBlock" xlink:label="ATAK_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantsDisclosureTextBlock" xlink:to="ATAK_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_EmergingGrowthCompanyPolicyTextBlock" xlink:label="ATAK_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_EmergingGrowthCompanyPolicyTextBlock" xlink:to="ATAK_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Marketable Securities Held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Offering Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TemporaryEquityPolicyTextBlock" xlink:label="ATAK_TemporaryEquityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TemporaryEquityPolicyTextBlock" xlink:to="ATAK_TemporaryEquityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TemporaryEquityPolicyTextBlock_lbl" xml:lang="en-US">Class A Ordinary shares Subject to Possible Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net income per Ordinary Share</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RelatedPartiesPolicyTextBlock" xlink:label="ATAK_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RelatedPartiesPolicyTextBlock" xlink:to="ATAK_RelatedPartiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_RelatedPartiesPolicyTextBlock_lbl" xml:lang="en-US">Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantyLiabilityPolicyTextBlock" xlink:label="ATAK_WarrantyLiabilityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantyLiabilityPolicyTextBlock" xlink:to="ATAK_WarrantyLiabilityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WarrantyLiabilityPolicyTextBlock_lbl" xml:lang="en-US">Warranty Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclousreOfTemporaryEquityTextBlock" xlink:label="ATAK_DisclousreOfTemporaryEquityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclousreOfTemporaryEquityTextBlock" xlink:to="ATAK_DisclousreOfTemporaryEquityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DisclousreOfTemporaryEquityTextBlock_lbl" xml:lang="en-US">SUMMARY OF TEMPORARY EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock issued during period, shares, new issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock, price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from issuance initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:to="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_lbl" xml:lang="en-US">Class of warrants or rights warrants issued during the period units</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:to="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_lbl" xml:lang="en-US">Class of warrants or rights warrants issued issue price per warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds from issuance of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TransactionCosts" xlink:label="ATAK_TransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TransactionCosts" xlink:to="ATAK_TransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TransactionCosts_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="us-gaap_OtherUnderwritingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherUnderwritingExpense" xlink:to="us-gaap_OtherUnderwritingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherUnderwritingExpense_lbl" xml:lang="en-US">Underwriting discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xml:lang="en-US">Deferred underwriting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverallotmentOptionLiability" xlink:label="ATAK_OverallotmentOptionLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OverallotmentOptionLiability" xlink:to="ATAK_OverallotmentOptionLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_OverallotmentOptionLiability_lbl" xml:lang="en-US">Over-allotment option liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue_2_lbl" xml:lang="en-US">Issuance of representative shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ActualOfferingCosts" xlink:label="ATAK_ActualOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ActualOfferingCosts" xlink:to="ATAK_ActualOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ActualOfferingCosts_lbl" xml:lang="en-US">Actual offering costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Operating cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:to="us-gaap_PaymentsToAcquireRestrictedInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireRestrictedInvestments_2_lbl" xml:lang="en-US">Net proceeds amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="ATAK_TermOfRestrictedInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TermOfRestrictedInvestments" xlink:to="ATAK_TermOfRestrictedInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_TermOfRestrictedInvestments_lbl" xml:lang="en-US">Term of restricted investments</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:label="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:to="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_lbl" xml:lang="en-US">Period within which business combination shall be consummated from the consummation of initial public offer</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" xlink:label="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" xlink:to="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms_lbl" xml:lang="en-US">Description of business combination extended period terms</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventDescription" xlink:label="us-gaap_SubsequentEventDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventDescription_lbl" xml:lang="en-US">Subsequent event, description</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" xlink:label="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" xlink:to="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_lbl" xml:lang="en-US">Percentage of fair market value of target business to asset held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinimumNetWorthRequiredForCompliance" xlink:label="us-gaap_MinimumNetWorthRequiredForCompliance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumNetWorthRequiredForCompliance" xlink:to="us-gaap_MinimumNetWorthRequiredForCompliance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumNetWorthRequiredForCompliance_lbl" xml:lang="en-US">Banking regulation, mortgage banking, net worth, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" xlink:label="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" xlink:to="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod_lbl" xml:lang="en-US">Business combination extension of business combination period</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" xlink:label="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" xlink:to="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_lbl" xml:lang="en-US">Number of days within which public shares shall be redeemed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" xlink:label="us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" xlink:to="us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_lbl" xml:lang="en-US">Expenses payable on dissolution</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" xlink:label="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" xlink:to="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_lbl" xml:lang="en-US">Minimum Public Share price due to reductions in the value of the trust assets less taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NetWorkingCapitalSurplusDeficit" xlink:label="ATAK_NetWorkingCapitalSurplusDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NetWorkingCapitalSurplusDeficit" xlink:to="ATAK_NetWorkingCapitalSurplusDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_NetWorkingCapitalSurplusDeficit_lbl" xml:lang="en-US">Working capital (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock shares issued during the period for services shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Gross proceeds from initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepurchaseOfEquity" xlink:label="us-gaap_ProceedsFromRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="us-gaap_ProceedsFromRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepurchaseOfEquity_lbl" xml:lang="en-US">Proceeds allocated to private warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Offering costs allocated to Class A ordinary shares subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FairValueAllocatedToRights" xlink:label="ATAK_FairValueAllocatedToRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FairValueAllocatedToRights" xlink:to="ATAK_FairValueAllocatedToRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_FairValueAllocatedToRights_lbl" xml:lang="en-US">Fair value allocated to rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xml:lang="en-US">Re-measurement of Class A ordinary shares subject to possible redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xml:lang="en-US">Class A ordinary shares subject to possible redemption, September 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xml:lang="en-US">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income attributable to non-redeemable Class A and Class B ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Diluted weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic net income per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted net income per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" xlink:label="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" xlink:to="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_lbl" xml:lang="en-US">Percentage of public shares to be redeemed in case business combination is not consummated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl" xml:lang="en-US">Offering costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherUnderwritingExpense" xlink:to="us-gaap_OtherUnderwritingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherUnderwritingExpense_2_lbl" xml:lang="en-US">Underwriting fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OverallotmentOptionLiability" xlink:to="ATAK_OverallotmentOptionLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATAK_OverallotmentOptionLiability_2_lbl" xml:lang="en-US">Overallotment option liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_2_lbl" xml:lang="en-US">Adjustments to additional paid in capital, warrant issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_2_lbl" xml:lang="en-US">Redemption of Class A ordinary shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Federal depository insurance coverage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockConversionBasis" xlink:label="us-gaap_CommonStockConversionBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConversionBasis" xlink:to="us-gaap_CommonStockConversionBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockConversionBasis_lbl" xml:lang="en-US">Common stock, conversion basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:to="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_2_lbl" xml:lang="en-US">Class of warrants or rights warrants issued price per warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Class of warrant or right, number of securities called by each warrant or right</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of warrant or right, exercise price of warrants or rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock issued during period, shares, issued for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Stock issued during period, shares, issued for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2_lbl" xml:lang="en-US">Shares issued, shares, share based payment arrangement, forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_2_lbl" xml:lang="en-US">Temporary equity shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareTransferTriggerPricePerShare" xlink:label="ATAK_ShareTransferTriggerPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ShareTransferTriggerPricePerShare" xlink:to="ATAK_ShareTransferTriggerPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ShareTransferTriggerPricePerShare_lbl" xml:lang="en-US">Share transfer, trigger price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:label="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:to="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice_lbl" xml:lang="en-US">Number of consecutive trading days for determining share price</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:label="ATAK_NumberOfTradingDaysForDeterminingSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:to="ATAK_NumberOfTradingDaysForDeterminingSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_NumberOfTradingDaysForDeterminingSharePrice_lbl" xml:lang="en-US">Number of trading days for determining share price</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" xlink:label="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" xlink:to="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_lbl" xml:lang="en-US">Threshold number of trading days for determining share price from date of business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrument, face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt instrument interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt instrument, maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Aggregate debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Outstanding value under the note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xml:lang="en-US">Debt instrument convertible into warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Debt instrument conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Due to related parties current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Related party payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Administrative support agreement expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common stock shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common stock shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Common stock shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xml:lang="en-US">Temporary equity shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_CommonStockThresholdPercentageOnConversionOfShares" xlink:label="ATAK_CommonStockThresholdPercentageOnConversionOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_CommonStockThresholdPercentageOnConversionOfShares" xlink:to="ATAK_CommonStockThresholdPercentageOnConversionOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_CommonStockThresholdPercentageOnConversionOfShares_lbl" xml:lang="en-US">Common stock, threshold percentage on conversion of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Number of warrants or rights outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" xlink:label="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" xlink:to="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_lbl" xml:lang="en-US">Warrants exercisable term from the date of completion of business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" xlink:label="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" xlink:to="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_lbl" xml:lang="en-US">Minimum lock in period for SEC registration from date of business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" xlink:label="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" xlink:to="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_lbl" xml:lang="en-US">Minimum lock in period to become effective after the closing of the initial business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsRedemptionPricePerUnit" xlink:label="ATAK_ClassOfWarrantsRedemptionPricePerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsRedemptionPricePerUnit" xlink:to="ATAK_ClassOfWarrantsRedemptionPricePerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ClassOfWarrantsRedemptionPricePerUnit_lbl" xml:lang="en-US">Class of warrants redemption price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsRedemptionNoticePeriod" xlink:label="ATAK_ClassOfWarrantsRedemptionNoticePeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsRedemptionNoticePeriod" xlink:to="ATAK_ClassOfWarrantsRedemptionNoticePeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ClassOfWarrantsRedemptionNoticePeriod_lbl" xml:lang="en-US">Class of warrants, redemption notice period</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPrice" xlink:label="ATAK_ShareRedemptionTriggerPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ShareRedemptionTriggerPrice" xlink:to="ATAK_ShareRedemptionTriggerPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ShareRedemptionTriggerPrice_lbl" xml:lang="en-US">Share redemption trigger price</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" xlink:label="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" xlink:to="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_lbl" xml:lang="en-US">Minimum percentage gross proceeds required from issuance of equity</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" xlink:label="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" xlink:to="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_lbl" xml:lang="en-US">Class of warrant right minimum notice period for redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" xlink:label="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" xlink:to="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_lbl" xml:lang="en-US">Class of warrant or right exercise price adjustment percentage higher of market value</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" xlink:label="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" xlink:to="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_lbl" xml:lang="en-US">Minimum lock In period for transfer, assign or sell warrants after completion of IPO</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverAllotmentOptionPeriod" xlink:label="ATAK_OverAllotmentOptionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OverAllotmentOptionPeriod" xlink:to="ATAK_OverAllotmentOptionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_OverAllotmentOptionPeriod_lbl" xml:lang="en-US">Over allotment option period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Maxim IPO shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_3_lbl" xml:lang="en-US">Shares issued, shares, share-based payment arrangement, forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionPerUnit" xlink:label="ATAK_DeferredUnderwritingCommissionPerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredUnderwritingCommissionPerUnit" xlink:to="ATAK_DeferredUnderwritingCommissionPerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_DeferredUnderwritingCommissionPerUnit_lbl" xml:lang="en-US">Deferred underwriting commission per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Derivative warrant liabilities, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US">Initial fair value at issuance public and private placement warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xml:lang="en-US">Transfer of private placement warrants to level 2 measurement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Derivative warrant liabilities, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xml:lang="en-US">Cash and marketable securities held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Private Placement Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_2_lbl" xml:lang="en-US">Initial fair value at issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustCurrent" xlink:label="us-gaap_AssetsHeldInTrustCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl" xml:lang="en-US">Deposit trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnsecuredPromissoryNote" xlink:label="ATAK_UnsecuredPromissoryNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_UnsecuredPromissoryNote" xlink:to="ATAK_UnsecuredPromissoryNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_UnsecuredPromissoryNote_lbl" xml:lang="en-US">Unsecured promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebt" xlink:label="us-gaap_UnsecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnsecuredDebt_lbl" xml:lang="en-US">Unsecured promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AccruedOfferingCosts" xlink:to="ATAK_AccruedOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_AccruedOfferingCosts_doc" xml:lang="en-US">Accrued offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:to="ATAK_DeferredUnderwritingCommissionsNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DeferredUnderwritingCommissionsNoncurrent_doc" xml:lang="en-US">Deferred underwriting commissions noncurrent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosureOfInitialPublicOfferingTextBlock" xlink:to="ATAK_DisclosureOfInitialPublicOfferingTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DisclosureOfInitialPublicOfferingTextBlock_doc" xml:lang="en-US">Disclosure Of Initial Public Offering [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FormationAndOperatingCosts" xlink:to="ATAK_FormationAndOperatingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FormationAndOperatingCosts_doc" xml:lang="en-US">Formation and operating costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TermOfRestrictedInvestments" xlink:to="ATAK_TermOfRestrictedInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_TermOfRestrictedInvestments_doc" xml:lang="en-US">Term of restricted investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclosureOfPrivatePlacementTextBlock" xlink:to="ATAK_DisclosureOfPrivatePlacementTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DisclosureOfPrivatePlacementTextBlock_doc" xml:lang="en-US">Disclosure Of Private Placement [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:to="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_doc" xml:lang="en-US">Class of warrants or rights warrants issued during the period units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SponsorMember" xlink:to="ATAK_SponsorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_SponsorMember_doc" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PrivatePlacementWarrantMember" xlink:to="ATAK_PrivatePlacementWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PrivatePlacementWarrantMember_doc" xml:lang="en-US">Private Placement Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:to="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_doc" xml:lang="en-US">Class of warrants or rights warrants issued price per warrant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FounderSharesMember" xlink:to="ATAK_FounderSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FounderSharesMember_doc" xml:lang="en-US">Founder Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ShareTransferTriggerPricePerShare" xlink:to="ATAK_ShareTransferTriggerPricePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ShareTransferTriggerPricePerShare_doc" xml:lang="en-US">Share transfer trigger price per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:to="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice_doc" xml:lang="en-US">Number of consecutive trading days for determining share price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TriggeringEventAxis" xlink:to="ATAK_TriggeringEventAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_TriggeringEventAxis_doc" xml:lang="en-US">Triggering Event [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" xlink:to="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember_doc" xml:lang="en-US">Share Price More Than Or Equals To Used Twelve [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:to="ATAK_NumberOfTradingDaysForDeterminingSharePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_NumberOfTradingDaysForDeterminingSharePrice_doc" xml:lang="en-US">Number of trading days for determining share price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" xlink:to="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_doc" xml:lang="en-US">Threshold number of trading days for determining share price from date of business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PromissoryNoteMember" xlink:to="ATAK_PromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PromissoryNoteMember_doc" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FirstWorkingCapitalMember" xlink:to="ATAK_FirstWorkingCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FirstWorkingCapitalMember_doc" xml:lang="en-US">First Working Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FirstExtensionNoteMember" xlink:to="ATAK_FirstExtensionNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FirstExtensionNoteMember_doc" xml:lang="en-US">First Extension Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SecondExtensionNoteMember" xlink:to="ATAK_SecondExtensionNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_SecondExtensionNoteMember_doc" xml:lang="en-US">Second Extension Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NonredeemableCommonStockMember" xlink:to="ATAK_NonredeemableCommonStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_NonredeemableCommonStockMember_doc" xml:lang="en-US">Nonredeemable Common Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SecondWorkingCapitalMember" xlink:to="ATAK_SecondWorkingCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_SecondWorkingCapitalMember_doc" xml:lang="en-US">Second Working Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ThirdWorkingCapitalMember" xlink:to="ATAK_ThirdWorkingCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ThirdWorkingCapitalMember_doc" xml:lang="en-US">Third Working Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FourthWorkingCapitalMember" xlink:to="ATAK_FourthWorkingCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FourthWorkingCapitalMember_doc" xml:lang="en-US">Fourth Working Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" xlink:to="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_OrdinarySharesSubjectToPossibleRedemptionMember_doc" xml:lang="en-US">Ordinary Shares Subject To Possible Redemption [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WorkingCapitalNotesMember" xlink:to="ATAK_WorkingCapitalNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WorkingCapitalNotesMember_doc" xml:lang="en-US">Working Capital Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WorkingCapitalAndSecondExtensionNoteMember" xlink:to="ATAK_WorkingCapitalAndSecondExtensionNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WorkingCapitalAndSecondExtensionNoteMember_doc" xml:lang="en-US">Working Capital And Second Extension Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WorkingCapitalLoanMember" xlink:to="ATAK_WorkingCapitalLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WorkingCapitalLoanMember_doc" xml:lang="en-US">Working Capital Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" xlink:to="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_OfficeSpaceAdministrativeAndSupportServicesMember_doc" xml:lang="en-US">Office Space Administrative And Support Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AdministrativeSupportAgreementMember" xlink:to="ATAK_AdministrativeSupportAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_AdministrativeSupportAgreementMember_doc" xml:lang="en-US">Administrative Support Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RemeasurementOfRedemptionValue" xlink:to="ATAK_RemeasurementOfRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RemeasurementOfRedemptionValue_doc" xml:lang="en-US">Remeasurement of redemption value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_CommonStockThresholdPercentageOnConversionOfShares" xlink:to="ATAK_CommonStockThresholdPercentageOnConversionOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_CommonStockThresholdPercentageOnConversionOfShares_doc" xml:lang="en-US">Common stock threshold percentage on conversion of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantsDisclosureTextBlock" xlink:to="ATAK_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PublicWarrantsMember" xlink:to="ATAK_PublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PublicWarrantsMember_doc" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PrivatePlacementWarrantsMember" xlink:to="ATAK_PrivatePlacementWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PrivatePlacementWarrantsMember_doc" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" xlink:to="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_doc" xml:lang="en-US">Warrants exercisable term from the date of completion of business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" xlink:to="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_doc" xml:lang="en-US">Minimum lock in period for sec registration from date of business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" xlink:to="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_doc" xml:lang="en-US">Minimum lock in period to become effective after the closing of the initial business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsRedemptionPricePerUnit" xlink:to="ATAK_ClassOfWarrantsRedemptionPricePerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ClassOfWarrantsRedemptionPricePerUnit_doc" xml:lang="en-US">Class of warrants redemption price per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RedemptionOfWarrantsMember" xlink:to="ATAK_RedemptionOfWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RedemptionOfWarrantsMember_doc" xml:lang="en-US">Redemption Of Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ShareRedemptionTriggerPriceAxis" xlink:to="ATAK_ShareRedemptionTriggerPriceAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ShareRedemptionTriggerPriceAxis_doc" xml:lang="en-US">Share Redemption Trigger Price [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" xlink:to="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_doc" xml:lang="en-US">Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantsRedemptionNoticePeriod" xlink:to="ATAK_ClassOfWarrantsRedemptionNoticePeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ClassOfWarrantsRedemptionNoticePeriod_doc" xml:lang="en-US">Class of warrants redemption notice period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ShareRedemptionTriggerPrice" xlink:to="ATAK_ShareRedemptionTriggerPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ShareRedemptionTriggerPrice_doc" xml:lang="en-US">Share redemption trigger price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" xlink:to="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_doc" xml:lang="en-US">Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" xlink:to="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_doc" xml:lang="en-US">Minimum percentage gross proceeds required from issuance of equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" xlink:to="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_doc" xml:lang="en-US">Class of warrant or right minimum notice period for redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" xlink:to="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_doc" xml:lang="en-US">Class of warrant or right exercise price adjustment percentage higher of market value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" xlink:to="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_doc" xml:lang="en-US">Minimum lock in period for transfer assign or sell warrants after completion of ipo.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OverAllotmentOptionPeriod" xlink:to="ATAK_OverAllotmentOptionPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_OverAllotmentOptionPeriod_doc" xml:lang="en-US">Over allotment option period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_UnderwritingAgreementMember" xlink:to="ATAK_UnderwritingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_UnderwritingAgreementMember_doc" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredUnderwritingCommissionPerUnit" xlink:to="ATAK_DeferredUnderwritingCommissionPerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DeferredUnderwritingCommissionPerUnit_doc" xml:lang="en-US">Deferred underwriting commission per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue_doc" xml:lang="en-US">Stock issued during period representative shares issued value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RightsUnderlyingTheUnitsValue" xlink:to="ATAK_RightsUnderlyingTheUnitsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RightsUnderlyingTheUnitsValue_doc" xml:lang="en-US">Rights underlying the units value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TrancheAxis" xlink:to="ATAK_TrancheAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_TrancheAxis_doc" xml:lang="en-US">Tranche [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TrancheOneMember" xlink:to="ATAK_TrancheOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_TrancheOneMember_doc" xml:lang="en-US">Tranche One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_Investmentincomedividends" xlink:to="ATAK_Investmentincomedividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_Investmentincomedividends_doc" xml:lang="en-US">Amount of dividend income on nonoperating securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" xlink:to="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability_doc" xml:lang="en-US">Allocation of deferred offering costs for warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TrancheTwoMember" xlink:to="ATAK_TrancheTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_TrancheTwoMember_doc" xml:lang="en-US">Tranche Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" xlink:to="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption_doc" xml:lang="en-US">Initial measurement of Class&amp;#160;A ordinary shares subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" xlink:to="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants_doc" xml:lang="en-US">Initial measurement of public warrants and private placement warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredUnderwritingFeePayable" xlink:to="ATAK_DeferredUnderwritingFeePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DeferredUnderwritingFeePayable_doc" xml:lang="en-US">Deferred underwriting fee payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" xlink:to="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption_doc" xml:lang="en-US">Re-measurement of Class A ordinary shares subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ForfeitureOfRepresentativeShares" xlink:to="ATAK_ForfeitureOfRepresentativeShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ForfeitureOfRepresentativeShares_doc" xml:lang="en-US">Forfeiture of representative shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_doc" xml:lang="en-US">Stock issued during period representative shares issued value class A.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" xlink:to="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts_doc" xml:lang="en-US">Deferred offering costs incurred included in accrued offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantLiabilityMember" xlink:to="ATAK_WarrantLiabilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WarrantLiabilityMember_doc" xml:lang="en-US">Warrant Liability [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_TransactionCosts" xlink:to="ATAK_TransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_TransactionCosts_doc" xml:lang="en-US">Transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_OverallotmentOptionLiability" xlink:to="ATAK_OverallotmentOptionLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_OverallotmentOptionLiability_doc" xml:lang="en-US">Overallotment option liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" xlink:to="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms_doc" xml:lang="en-US">Description of business combination extended period terms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" xlink:to="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember_doc" xml:lang="en-US">Amendment No One To Investment Management Trust Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" xlink:to="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_doc" xml:lang="en-US">Number of days with in which public shares shall be redeemed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" xlink:to="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod_doc" xml:lang="en-US">Business combination extension of business combination period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" xlink:to="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_doc" xml:lang="en-US">Minimum public share price due to reductions in the value of the trust assets less taxes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_NetWorkingCapitalSurplusDeficit" xlink:to="ATAK_NetWorkingCapitalSurplusDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_NetWorkingCapitalSurplusDeficit_doc" xml:lang="en-US">Net working capital surplus deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:to="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_doc" xml:lang="en-US">Period with in which business combination shall be consummated from the consummation of initial public offer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PeriodAfterWhichSharesAreRedeemableAxis" xlink:to="ATAK_PeriodAfterWhichSharesAreRedeemableAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PeriodAfterWhichSharesAreRedeemableAxis_doc" xml:lang="en-US">Period After Which Shares Are Redeemable [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" xlink:to="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember_doc" xml:lang="en-US">If We Do Not Complete Our Initial Business Combination [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" xlink:to="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_doc" xml:lang="en-US">Percentage of public shares to be redeemed in case business combination is not consummated.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" xlink:to="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember_doc" xml:lang="en-US">Absent Our Completing An Initial Business Combination [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ActualOfferingCosts" xlink:to="ATAK_ActualOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ActualOfferingCosts_doc" xml:lang="en-US">Actual offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DisclousreOfTemporaryEquityTextBlock" xlink:to="ATAK_DisclousreOfTemporaryEquityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DisclousreOfTemporaryEquityTextBlock_doc" xml:lang="en-US">Disclousre Of Temporary Equity [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_CommonClassASubjectToRedemptionMember" xlink:to="ATAK_CommonClassASubjectToRedemptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_CommonClassASubjectToRedemptionMember_doc" xml:lang="en-US">Common Class A Subject To Redemption [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FairValueAllocatedToRights" xlink:to="ATAK_FairValueAllocatedToRights_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FairValueAllocatedToRights_doc" xml:lang="en-US">Fair value allocated to rights.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RedeemableClassAOrdinarySharesMember" xlink:to="ATAK_RedeemableClassAOrdinarySharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RedeemableClassAOrdinarySharesMember_doc" xml:lang="en-US">Redeemable Class A Ordinary Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DerivativeWarrantLiabilityMember" xlink:to="ATAK_DerivativeWarrantLiabilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DerivativeWarrantLiabilityMember_doc" xml:lang="en-US">Derivative Warrant Liability [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_MeasurementInputProbabilityMember" xlink:to="ATAK_MeasurementInputProbabilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_MeasurementInputProbabilityMember_doc" xml:lang="en-US">Measurement Input Probability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DepositsTrustAccount" xlink:label="ATAK_DepositsTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_DepositsTrustAccount" xlink:to="ATAK_DepositsTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_DepositsTrustAccount_doc" xml:lang="en-US">Deposits trust account.</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnsecuredPromissoryNoteMember" xlink:label="ATAK_UnsecuredPromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_UnsecuredPromissoryNoteMember" xlink:to="ATAK_UnsecuredPromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_UnsecuredPromissoryNoteMember_doc" xml:lang="en-US">Unsecured Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsToOnetenthOfOneClassOrdinaryShareMember" xlink:label="ATAK_RightsToOnetenthOfOneClassOrdinaryShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RightsToOnetenthOfOneClassOrdinaryShareMember" xlink:to="ATAK_RightsToOnetenthOfOneClassOrdinaryShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RightsToOnetenthOfOneClassOrdinaryShareMember_doc" xml:lang="en-US">Rights To Onetenth Of One Class Ordinary Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember" xlink:label="ATAK_RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember" xlink:to="ATAK_RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RedeemableWarrantsExercisableForClassOrdinarySharesAtExercisePriceOf11.50PerShareMember_doc" xml:lang="en-US">Redeemable Warrants Exercisable For Class Ordinary Shares At Exercise Price Of 11.50 Per Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainOnExtinguishmentOfLiability" xlink:label="ATAK_GainOnExtinguishmentOfLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_GainOnExtinguishmentOfLiability" xlink:to="ATAK_GainOnExtinguishmentOfLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_GainOnExtinguishmentOfLiability_doc" xml:lang="en-US">Gain on extinguishment of liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_FifthWorkingCapitalMember" xlink:to="ATAK_FifthWorkingCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_FifthWorkingCapitalMember_doc" xml:lang="en-US">Fifth Working Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_ThirdExtensionNoteMember" xlink:to="ATAK_ThirdExtensionNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_ThirdExtensionNoteMember_doc" xml:lang="en-US">Third Extension Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_EmergingGrowthCompanyPolicyTextBlock" xlink:to="ATAK_EmergingGrowthCompanyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_EmergingGrowthCompanyPolicyTextBlock_doc" xml:lang="en-US">Emerging growth company [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_RelatedPartiesPolicyTextBlock" xlink:to="ATAK_RelatedPartiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_RelatedPartiesPolicyTextBlock_doc" xml:lang="en-US">Related parties [policy text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_WarrantyLiabilityPolicyTextBlock" xlink:to="ATAK_WarrantyLiabilityPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_WarrantyLiabilityPolicyTextBlock_doc" xml:lang="en-US">Warranty liability [policy text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued_doc" xml:lang="en-US">Stock issued during period representative shares issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" xlink:to="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_doc" xml:lang="en-US">Percentage of fair market value of target business to asset held in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_Investmentincomedividends" xlink:to="ATAK_Investmentincomedividends_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_Investmentincomedividends_3_lbl" xml:lang="en-US">InvestmentIncomeDividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_2_lbl" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_2_lbl" xml:lang="en-US">Payments of Financing Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" xlink:to="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA_3_lbl" xml:lang="en-US">Stock issued during period representative shares issued value class A</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_3_lbl" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebt_2_lbl" xml:lang="en-US">Unsecured Debt</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>atak-20230930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://auroraspac.com/role/Cover" xlink:href="atak-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/BalanceSheets" xlink:href="atak-20230930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/BalanceSheetsParenthetical" xlink:href="atak-20230930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfOperations" xlink:href="atak-20230930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="atak-20230930.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/StatementsOfCashFlows" xlink:href="atak-20230930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" xlink:href="atak-20230930.xsd#OrganizationAndPlansOfBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/InitialPublicOffering" xlink:href="atak-20230930.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/PrivatePlacement" xlink:href="atak-20230930.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/RelatedPartyTransactions" xlink:href="atak-20230930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/ShareholdersDeficit" xlink:href="atak-20230930.xsd#ShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/Warrants" xlink:href="atak-20230930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/CommitmentsAndContingencies" xlink:href="atak-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurements" xlink:href="atak-20230930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SubsequentEvents" xlink:href="atak-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurementsTables" xlink:href="atak-20230930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:href="atak-20230930.xsd#OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" xlink:href="atak-20230930.xsd#SummaryOfTemporaryEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:href="atak-20230930.xsd#SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="atak-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="atak-20230930.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" xlink:href="atak-20230930.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="atak-20230930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" xlink:href="atak-20230930.xsd#ShareholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/WarrantsDetailsNarrative" xlink:href="atak-20230930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="atak-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:href="atak-20230930.xsd#SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" xlink:href="atak-20230930.xsd#SummaryOfFairValueMeasurementsInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="atak-20230930.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" xlink:href="atak-20230930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:label="loc_us-gaapScheduleOfInvestmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapScheduleOfInvestmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfInvestmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsTable" xlink:to="loc_us-gaapScheduleOfInvestmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalUnitsMember" xlink:label="loc_us-gaapCapitalUnitsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapCapitalUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightsMember" xlink:label="loc_us-gaapRightsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AccruedOfferingCosts" xlink:label="loc_ATAKAccruedOfferingCosts" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ATAKAccruedOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:label="loc_ATAKDeferredUnderwritingCommissionsNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_ATAKDeferredUnderwritingCommissionsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NonredeemableCommonStockMember" xlink:label="loc_ATAKNonredeemableCommonStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKNonredeemableCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FormationAndOperatingCosts" xlink:label="loc_ATAKFormationAndOperatingCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKFormationAndOperatingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:label="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeDividend" xlink:label="loc_us-gaapInvestmentIncomeDividend" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Statements of Changes in Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OrdinarySharesSubjectToPossibleRedemptionMember" xlink:label="loc_ATAKOrdinarySharesSubjectToPossibleRedemptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_ATAKOrdinarySharesSubjectToPossibleRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RemeasurementOfRedemptionValue" xlink:label="loc_ATAKRemeasurementOfRedemptionValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKRemeasurementOfRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssued" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="loc_ATAKRightsUnderlyingTheUnitsValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKRightsUnderlyingTheUnitsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_Investmentincomedividends" xlink:label="loc_ATAKInvestmentincomedividends" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ATAKInvestmentincomedividends" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability" xlink:label="loc_ATAKAllocationOfDeferredOfferingCostsForWarrantLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ATAKAllocationOfDeferredOfferingCostsForWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:label="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ATAKGainsLossesOnExtinguishmentOfOverAllotmentLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaapPaymentsToAcquireRestrictedInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireRestrictedInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaapPaymentsToAcquireMarketableSecurities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireMarketableSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_ATAKInitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKInitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" xlink:label="loc_ATAKInitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKInitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingFeePayable" xlink:label="loc_ATAKDeferredUnderwritingFeePayable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKDeferredUnderwritingFeePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" xlink:label="loc_ATAKRemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKRemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ForfeitureOfRepresentativeShares" xlink:label="loc_ATAKForfeitureOfRepresentativeShares" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKForfeitureOfRepresentativeShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" xlink:label="loc_ATAKDeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ATAKDeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations" xlink:title="00000007 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/InitialPublicOffering" xlink:title="00000009 - Disclosure - INITIAL PUBLIC OFFERING">
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_ATAKDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureOfInitialPublicOfferingTextBlock" xlink:label="loc_ATAKDisclosureOfInitialPublicOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKDisclosureInitialPublicOfferingAbstract" xlink:to="loc_ATAKDisclosureOfInitialPublicOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/PrivatePlacement" xlink:title="00000010 - Disclosure - PRIVATE PLACEMENT">
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosurePrivatePlacementAbstract" xlink:label="loc_ATAKDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureOfPrivatePlacementTextBlock" xlink:label="loc_ATAKDisclosureOfPrivatePlacementTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKDisclosurePrivatePlacementAbstract" xlink:to="loc_ATAKDisclosureOfPrivatePlacementTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/ShareholdersDeficit" xlink:title="00000012 - Disclosure - SHAREHOLDERS&#8217; DEFICIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/Warrants" xlink:title="00000013 - Disclosure - WARRANTS">
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureWarrantsAbstract" xlink:label="loc_ATAKDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantsDisclosureTextBlock" xlink:label="loc_ATAKWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKDisclosureWarrantsAbstract" xlink:to="loc_ATAKWarrantsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurements" xlink:title="00000015 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_ATAKEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATAKEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="loc_us-gaapDeferredChargesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredChargesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TemporaryEquityPolicyTextBlock" xlink:label="loc_ATAKTemporaryEquityPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATAKTemporaryEquityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RelatedPartiesPolicyTextBlock" xlink:label="loc_ATAKRelatedPartiesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATAKRelatedPartiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantyLiabilityPolicyTextBlock" xlink:label="loc_ATAKWarrantyLiabilityPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATAKWarrantyLiabilityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclousreOfTemporaryEquityTextBlock" xlink:label="loc_ATAKDisclousreOfTemporaryEquityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATAKDisclousreOfTemporaryEquityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurementsTables" xlink:title="00000019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative" xlink:title="00000020 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATAKSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="loc_ATAKPrivatePlacementWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember" xlink:label="loc_ATAKAmendmentNoOneToInvestmentManagementTrustAgreementMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ATAKAmendmentNoOneToInvestmentManagementTrustAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TransactionCosts" xlink:label="loc_ATAKTransactionCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_us-gaapOtherUnderwritingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOtherUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverallotmentOptionLiability" xlink:label="loc_ATAKOverallotmentOptionLiability" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKOverallotmentOptionLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="loc_ATAKRightsUnderlyingTheUnitsValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKRightsUnderlyingTheUnitsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ActualOfferingCosts" xlink:label="loc_ATAKActualOfferingCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKActualOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaapPaymentsToAcquireRestrictedInvestments" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireRestrictedInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="loc_ATAKTermOfRestrictedInvestments" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKTermOfRestrictedInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:label="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms" xlink:label="loc_ATAKDescriptionOfBusinessCombinationExtendedPeriodTerms" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKDescriptionOfBusinessCombinationExtendedPeriodTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSubsequentEventDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" xlink:label="loc_ATAKPercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKPercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinimumNetWorthRequiredForCompliance" xlink:label="loc_us-gaapMinimumNetWorthRequiredForCompliance" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMinimumNetWorthRequiredForCompliance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod" xlink:label="loc_ATAKBusinessCombinationExtensionOfBusinessCombinationPeriod" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKBusinessCombinationExtensionOfBusinessCombinationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed" xlink:label="loc_ATAKNumberOfDaysWithinWhichPublicSharesShallBeRedeemed" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKNumberOfDaysWithinWhichPublicSharesShallBeRedeemed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" xlink:label="loc_us-gaapLiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" xlink:label="loc_ATAKMinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKMinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NetWorkingCapitalSurplusDeficit" xlink:label="loc_ATAKNetWorkingCapitalSurplusDeficit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ATAKNetWorkingCapitalSurplusDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfTemporaryEquityDetails" xlink:title="00000021 - Disclosure - SUMMARY OF TEMPORARY EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_CommonClassASubjectToRedemptionMember" xlink:label="loc_ATAKCommonClassASubjectToRedemptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKCommonClassASubjectToRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepurchaseOfEquity" xlink:label="loc_us-gaapProceedsFromRepurchaseOfEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FairValueAllocatedToRights" xlink:label="loc_ATAKFairValueAllocatedToRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKFairValueAllocatedToRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails" xlink:title="00000022 - Disclosure - SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedeemableClassAOrdinarySharesMember" xlink:label="loc_ATAKRedeemableClassAOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKRedeemableClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NonredeemableCommonStockMember" xlink:label="loc_ATAKNonredeemableCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATAKNonredeemableCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaapNetIncomeLossAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodAfterWhichSharesAreRedeemableAxis" xlink:label="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodAfterWhichSharesAreRedeemableDomain" xlink:label="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableAxis" xlink:to="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember" xlink:label="loc_ATAKIfWeDoNotCompleteOurInitialBusinessCombinationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" xlink:to="loc_ATAKIfWeDoNotCompleteOurInitialBusinessCombinationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember" xlink:label="loc_ATAKAbsentOurCompletingAnInitialBusinessCombinationMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKPeriodAfterWhichSharesAreRedeemableDomain" xlink:to="loc_ATAKAbsentOurCompletingAnInitialBusinessCombinationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="loc_ATAKPrivatePlacementWarrantMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaapPaymentsToAcquireRestrictedInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireRestrictedInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="loc_ATAKTermOfRestrictedInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKTermOfRestrictedInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" xlink:label="loc_ATAKPercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKPercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:label="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKPeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_us-gaapOtherUnderwritingExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherUnderwritingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverallotmentOptionLiability" xlink:label="loc_ATAKOverallotmentOptionLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKOverallotmentOptionLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:label="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKStockIssuedDuringPeriodRepresentativeSharesIssuedValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RightsUnderlyingTheUnitsValue" xlink:label="loc_ATAKRightsUnderlyingTheUnitsValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKRightsUnderlyingTheUnitsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ActualOfferingCosts" xlink:label="loc_ATAKActualOfferingCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKActualOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000024 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_ATAKDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKDisclosureInitialPublicOfferingAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockConversionBasis" xlink:label="loc_us-gaapCommonStockConversionBasis" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockConversionBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TermOfRestrictedInvestments" xlink:label="loc_ATAKTermOfRestrictedInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKTermOfRestrictedInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000025 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosurePrivatePlacementAbstract" xlink:label="loc_ATAKDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKDisclosurePrivatePlacementAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATAKSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantMember" xlink:label="loc_ATAKPrivatePlacementWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:label="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_ATAKClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FounderSharesMember" xlink:label="loc_ATAKFounderSharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ATAKFounderSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TriggeringEventAxis" xlink:label="loc_ATAKTriggeringEventAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_ATAKTriggeringEventAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TriggeringEventDomain" xlink:label="loc_ATAKTriggeringEventDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKTriggeringEventAxis" xlink:to="loc_ATAKTriggeringEventDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember" xlink:label="loc_ATAKSharePriceMoreThanOrEqualsToUsdTwelveMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKTriggeringEventDomain" xlink:to="loc_ATAKSharePriceMoreThanOrEqualsToUsdTwelveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PromissoryNoteMember" xlink:label="loc_ATAKPromissoryNoteMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FirstWorkingCapitalMember" xlink:label="loc_ATAKFirstWorkingCapitalMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFirstWorkingCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FirstExtensionNoteMember" xlink:label="loc_ATAKFirstExtensionNoteMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFirstExtensionNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SecondExtensionNoteMember" xlink:label="loc_ATAKSecondExtensionNoteMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKSecondExtensionNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SecondWorkingCapitalMember" xlink:label="loc_ATAKSecondWorkingCapitalMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKSecondWorkingCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThirdWorkingCapitalMember" xlink:label="loc_ATAKThirdWorkingCapitalMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKThirdWorkingCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FourthWorkingCapitalMember" xlink:label="loc_ATAKFourthWorkingCapitalMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFourthWorkingCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FifthWorkingCapitalMember" xlink:label="loc_ATAKFifthWorkingCapitalMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKFifthWorkingCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThirdExtensionNoteMember" xlink:label="loc_ATAKThirdExtensionNoteMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKThirdExtensionNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalNotesMember" xlink:label="loc_ATAKWorkingCapitalNotesMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKWorkingCapitalNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalAndSecondExtensionNoteMember" xlink:label="loc_ATAKWorkingCapitalAndSecondExtensionNoteMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATAKWorkingCapitalAndSecondExtensionNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WorkingCapitalLoanMember" xlink:label="loc_ATAKWorkingCapitalLoanMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ATAKWorkingCapitalLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OfficeSpaceAdministrativeAndSupportServicesMember" xlink:label="loc_ATAKOfficeSpaceAdministrativeAndSupportServicesMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ATAKOfficeSpaceAdministrativeAndSupportServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_AdministrativeSupportAgreementMember" xlink:label="loc_ATAKAdministrativeSupportAgreementMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ATAKAdministrativeSupportAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareTransferTriggerPricePerShare" xlink:label="loc_ATAKShareTransferTriggerPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKShareTransferTriggerPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" xlink:label="loc_ATAKThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATAKThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative" xlink:title="00000027 - Disclosure - SHAREHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_FounderSharesMember" xlink:label="loc_ATAKFounderSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ATAKFounderSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_CommonStockThresholdPercentageOnConversionOfShares" xlink:label="loc_ATAKCommonStockThresholdPercentageOnConversionOfShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ATAKCommonStockThresholdPercentageOnConversionOfShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/WarrantsDetailsNarrative" xlink:title="00000028 - Disclosure - WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DisclosureWarrantsAbstract" xlink:label="loc_ATAKDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKDisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_RedemptionOfWarrantsMember" xlink:label="loc_ATAKRedemptionOfWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKRedemptionOfWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPriceAxis" xlink:label="loc_ATAKShareRedemptionTriggerPriceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_ATAKShareRedemptionTriggerPriceAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPriceDomain" xlink:label="loc_ATAKShareRedemptionTriggerPriceDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKShareRedemptionTriggerPriceAxis" xlink:to="loc_ATAKShareRedemptionTriggerPriceDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember" xlink:label="loc_ATAKSharePriceEqualOrExceedsEighteenRupeesPerDollarMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKShareRedemptionTriggerPriceDomain" xlink:to="loc_ATAKSharePriceEqualOrExceedsEighteenRupeesPerDollarMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" xlink:label="loc_ATAKSharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKShareRedemptionTriggerPriceDomain" xlink:to="loc_ATAKSharePriceEqualOrLessNinePointTwoRupeesPerDollarMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" xlink:label="loc_ATAKWarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKWarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" xlink:label="loc_ATAKMinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" xlink:label="loc_ATAKMinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsRedemptionPricePerUnit" xlink:label="loc_ATAKClassOfWarrantsRedemptionPricePerUnit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantsRedemptionPricePerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantsRedemptionNoticePeriod" xlink:label="loc_ATAKClassOfWarrantsRedemptionNoticePeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantsRedemptionNoticePeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKNumberOfConsecutiveTradingDaysForDeterminingSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_NumberOfTradingDaysForDeterminingSharePrice" xlink:label="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKNumberOfTradingDaysForDeterminingSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ShareRedemptionTriggerPrice" xlink:label="loc_ATAKShareRedemptionTriggerPrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKShareRedemptionTriggerPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" xlink:label="loc_ATAKMinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption" xlink:label="loc_ATAKClassOfWarrantOrRightMinimumNoticePeriodForRedemption" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantOrRightMinimumNoticePeriodForRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" xlink:label="loc_ATAKClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" xlink:label="loc_ATAKMinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_ATAKMinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnderwritingAgreementMember" xlink:label="loc_ATAKUnderwritingAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ATAKUnderwritingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATAKSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_OverAllotmentOptionPeriod" xlink:label="loc_ATAKOverAllotmentOptionPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKOverAllotmentOptionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionPerUnit" xlink:label="loc_ATAKDeferredUnderwritingCommissionPerUnit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKDeferredUnderwritingCommissionPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DeferredUnderwritingCommissionsNoncurrent" xlink:label="loc_ATAKDeferredUnderwritingCommissionsNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_ATAKDeferredUnderwritingCommissionsNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails" xlink:title="00000030 - Disclosure - SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_WarrantLiabilityMember" xlink:label="loc_ATAKWarrantLiabilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheAxis" xlink:label="loc_ATAKTrancheAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_ATAKTrancheAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheDomain" xlink:label="loc_ATAKTrancheDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKTrancheAxis" xlink:to="loc_ATAKTrancheDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheOneMember" xlink:label="loc_ATAKTrancheOneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKTrancheDomain" xlink:to="loc_ATAKTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_TrancheTwoMember" xlink:label="loc_ATAKTrancheTwoMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATAKTrancheDomain" xlink:to="loc_ATAKTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails" xlink:title="00000031 - Disclosure - SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapMoneyMarketFundsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails" xlink:title="00000032 - Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_DerivativeWarrantLiabilityMember" xlink:label="loc_ATAKDerivativeWarrantLiabilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKDerivativeWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails" xlink:title="00000033 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_MeasurementInputProbabilityMember" xlink:label="loc_ATAKMeasurementInputProbabilityMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_ATAKMeasurementInputProbabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PrivatePlacementWarrantsMember" xlink:label="loc_ATAKPrivatePlacementWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_PublicWarrantsMember" xlink:label="loc_ATAKPublicWarrantsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ATAKPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000034 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://auroraspac.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_SponsorMember" xlink:label="loc_ATAKSponsorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATAKSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrustCurrent" xlink:label="loc_us-gaapAssetsHeldInTrustCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atak-20230930.xsd#ATAK_UnsecuredPromissoryNote" xlink:label="loc_ATAKUnsecuredPromissoryNote" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATAKUnsecuredPromissoryNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebt" xlink:label="loc_us-gaapUnsecuredDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapUnsecuredDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099058099232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Nov. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AURORA
TECHNOLOGY ACQUISITION CORP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001883788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1624542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4
Embarcadero Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
1449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-0458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class
    A Ordinary Share, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATAK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,610,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CapitalUnitsMember', window );">Capital Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units,
    each consisting of one Class A Ordinary Share, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATAKU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable
    Warrants, exercisable for Class A Ordinary Shares at an exercise price of $11.50 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATAKW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RightsMember', window );">Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Rights
    to one-tenth of one Class A Ordinary Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATAKR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CapitalUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CapitalUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099048539648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 28,943<span></span>
</td>
<td class="nump">$ 191,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">26,118<span></span>
</td>
<td class="nump">284,597<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">55,061<span></span>
</td>
<td class="nump">475,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Marketable securities held in trust account</a></td>
<td class="nump">57,481,369<span></span>
</td>
<td class="nump">206,879,903<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">57,481,369<span></span>
</td>
<td class="nump">206,879,903<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">57,536,430<span></span>
</td>
<td class="nump">207,355,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,980,439<span></span>
</td>
<td class="nump">30,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">215,362<span></span>
</td>
<td class="nump">357,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_AccruedOfferingCosts', window );">Accrued offering costs</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,650,801<span></span>
</td>
<td class="nump">437,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liabilities</a></td>
<td class="nump">441,300<span></span>
</td>
<td class="nump">589,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DeferredUnderwritingCommissionsNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="nump">7,070,000<span></span>
</td>
<td class="nump">7,070,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">7,511,300<span></span>
</td>
<td class="nump">7,659,420<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">11,162,101<span></span>
</td>
<td class="nump">8,096,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, 5,307,292 and 20,200,000 shares subject to redemption issued and outstanding, at redemption value of $10.83 and $10.24 per share, as of September 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">57,481,369<span></span>
</td>
<td class="nump">206,879,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(11,107,575)<span></span>
</td>
<td class="num">(7,621,413)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Deficit</a></td>
<td class="num">(11,107,040)<span></span>
</td>
<td class="num">(7,620,878)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</a></td>
<td class="nump">57,536,430<span></span>
</td>
<td class="nump">207,355,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Promissory note &#8211; related party</a></td>
<td class="nump">$ 1,405,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_AccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_AccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DeferredUnderwritingCommissionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commissions noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DeferredUnderwritingCommissionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099048411040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share</a></td>
<td class="nump">$ 10.83<span></span>
</td>
<td class="nump">$ 10.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued</a></td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued</a></td>
<td class="nump">5,050,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">5,050,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099056151328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_FormationAndOperatingCosts', window );">Formation and Operating expense</a></td>
<td class="nump">$ 479,300<span></span>
</td>
<td class="nump">$ 219,330<span></span>
</td>
<td class="nump">$ 2,868,531<span></span>
</td>
<td class="nump">$ 1,210,401<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(479,300)<span></span>
</td>
<td class="num">(219,330)<span></span>
</td>
<td class="num">(2,868,531)<span></span>
</td>
<td class="num">(1,210,401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="num">(64,480)<span></span>
</td>
<td class="nump">471,500<span></span>
</td>
<td class="nump">148,120<span></span>
</td>
<td class="nump">5,247,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability', window );">Gain on extinguishment of over-allotment liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">258,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of liability</a></td>
<td class="nump">314,248<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">314,248<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeDividend', window );">Dividend income on marketable securities held in Trust Account</a></td>
<td class="nump">751,668<span></span>
</td>
<td class="nump">902,675<span></span>
</td>
<td class="nump">2,717,772<span></span>
</td>
<td class="nump">1,155,816<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">1,001,436<span></span>
</td>
<td class="nump">1,374,175<span></span>
</td>
<td class="nump">3,180,140<span></span>
</td>
<td class="nump">6,661,803<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 522,136<span></span>
</td>
<td class="nump">$ 1,154,845<span></span>
</td>
<td class="nump">$ 311,609<span></span>
</td>
<td class="nump">$ 5,451,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">5,413,775<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">7,659,431<span></span>
</td>
<td class="nump">17,314,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">5,413,775<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">7,659,431<span></span>
</td>
<td class="nump">17,314,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share, Class A ordinary shares subject to redemption</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per share, Class A ordinary shares subject to redemption</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATAK_NonredeemableCommonStockMember', window );">Nonredeemable Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,302,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding, non-redeemable ordinary shares</a></td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,302,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share, Class A ordinary shares subject to redemption</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per share, Class A ordinary shares subject to redemption</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_FormationAndOperatingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Formation and operating costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_FormationAndOperatingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATAK_NonredeemableCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATAK_NonredeemableCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099053218960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Changes in Shareholders' Deficit - USD ($)<br></strong></div></th>
<th class="th">
<div>Ordinary Shares Subject To Possible Redemption [Member] </div>
<div>Common Class A [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Common Class A [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Common Class B [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 24,425<span></span>
</td>
<td class="num">$ (9,963)<span></span>
</td>
<td class="nump">$ 15,037<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfRedemptionValue', window );">Remeasurement of Class A ordinary shares to redemption value</a></td>
<td class="nump">$ 30,006,587<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,650,885)<span></span>
</td>
<td class="num">(11,355,702)<span></span>
</td>
<td class="num">(30,006,587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,097,637<span></span>
</td>
<td class="nump">3,097,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class A ordinary shares</a></td>
<td class="nump">$ 174,013,413<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class A ordianry shares, shares</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of Class B shares issued to Sponsor</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of Class B shares issued to Sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue', window );">Issuance of Representative Shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,029,970<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,030,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued', window );">Issuance of Representative Shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RightsUnderlyingTheUnitsValue', window );">Rights underlying the Units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,596,420<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,596,420<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 204,020,000<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,268,028)<span></span>
</td>
<td class="num">(8,267,493)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">24,425<span></span>
</td>
<td class="num">(9,963)<span></span>
</td>
<td class="nump">15,037<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,451,402<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 205,175,816<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,070,079)<span></span>
</td>
<td class="num">(7,069,544)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">$ 204,020,000<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,268,028)<span></span>
</td>
<td class="num">(8,267,493)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfRedemptionValue', window );">Remeasurement of Class A ordinary shares to redemption value</a></td>
<td class="nump">$ 253,141<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(253,141)<span></span>
</td>
<td class="num">(253,141)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,198,920<span></span>
</td>
<td class="nump">1,198,920<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 204,273,141<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,322,249)<span></span>
</td>
<td class="num">(7,321,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfRedemptionValue', window );">Remeasurement of Class A ordinary shares to redemption value</a></td>
<td class="nump">$ 902,675<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(902,675)<span></span>
</td>
<td class="num">(902,675)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,154,845<span></span>
</td>
<td class="nump">1,154,845<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 205,175,816<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,070,079)<span></span>
</td>
<td class="num">(7,069,544)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 206,879,903<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,621,413)<span></span>
</td>
<td class="num">(7,620,878)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption of Class A ordinary shares</a></td>
<td class="num">$ (149,322,133)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption of Class A ordinary shares, shares</a></td>
<td class="num">(14,529,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfRedemptionValue', window );">Remeasurement of Class A ordinary shares to redemption value</a></td>
<td class="nump">$ 1,538,885<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,538,885)<span></span>
</td>
<td class="num">(1,538,885)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(361,371)<span></span>
</td>
<td class="num">(361,371)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 59,096,655<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,521,669)<span></span>
</td>
<td class="num">(9,521,134)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2023</a></td>
<td class="nump">5,670,123<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 206,879,903<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,621,413)<span></span>
</td>
<td class="num">(7,620,878)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2022</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,609<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">$ 57,481,369<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,107,575)<span></span>
</td>
<td class="num">(11,107,040)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2023</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">$ 59,096,655<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,521,669)<span></span>
</td>
<td class="num">(9,521,134)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2023</a></td>
<td class="nump">5,670,123<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfRedemptionValue', window );">Remeasurement of Class A ordinary shares to redemption value</a></td>
<td class="nump">$ 1,102,219<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,102,219)<span></span>
</td>
<td class="num">(1,102,219)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">150,844<span></span>
</td>
<td class="nump">150,844<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 60,198,874<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,473,044)<span></span>
</td>
<td class="num">(10,472,509)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2023</a></td>
<td class="nump">5,670,123<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption of Class A ordinary shares</a></td>
<td class="num">$ (3,874,172)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption of Class A ordinary shares, shares</a></td>
<td class="num">(362,831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfRedemptionValue', window );">Remeasurement of Class A ordinary shares to redemption value</a></td>
<td class="nump">$ 1,156,667<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,156,667)<span></span>
</td>
<td class="num">(1,156,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">522,136<span></span>
</td>
<td class="nump">522,136<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">$ 57,481,369<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (11,107,575)<span></span>
</td>
<td class="num">$ (11,107,040)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2023</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_RemeasurementOfRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement of redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_RemeasurementOfRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_RightsUnderlyingTheUnitsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rights underlying the units value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_RightsUnderlyingTheUnitsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period representative shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period representative shares issued value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099059338576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 311,609<span></span>
</td>
<td class="nump">$ 5,451,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_Investmentincomedividends', window );">Dividend income on marketable securities held in Trust Account</a></td>
<td class="num">(2,717,772)<span></span>
</td>
<td class="num">(1,155,816)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability', window );">Allocation of deferred offering costs for warrant liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">516,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(148,120)<span></span>
</td>
<td class="num">(5,247,547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability', window );">Gain on extinguishment of over-allotment liability</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(258,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of liability</a></td>
<td class="num">(314,248)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in current assets and current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expense</a></td>
<td class="nump">258,479<span></span>
</td>
<td class="num">(432,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,122,892<span></span>
</td>
<td class="nump">81,275<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(487,160)<span></span>
</td>
<td class="num">(1,044,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Investment of cash in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(204,020,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities held in Trust Account</a></td>
<td class="num">(1,080,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Redemption of marketable securities held in Trust Account</a></td>
<td class="nump">153,196,305<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided (used) in investing activities</a></td>
<td class="nump">152,116,305<span></span>
</td>
<td class="num">(204,020,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of Class A ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">202,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from sale Private Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,470,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of underwriting fee</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,525,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note &#8211; related party</a></td>
<td class="nump">1,405,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payment of promissory note &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(242,801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of deferred offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(446,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payment of redemption on Class A ordinary shares</a></td>
<td class="num">(153,196,305)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used) provided by financing activities</a></td>
<td class="num">(151,791,305)<span></span>
</td>
<td class="nump">205,256,197<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="num">(162,160)<span></span>
</td>
<td class="nump">191,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning of the period</a></td>
<td class="nump">191,103<span></span>
</td>
<td class="nump">65,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; End of the period</a></td>
<td class="nump">28,943<span></span>
</td>
<td class="nump">257,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash Investing Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption', window );">Initial measurement of Class A ordinary shares subject to possible redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">174,013,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants', window );">Initial measurement of public warrants and private placement warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,780,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DeferredUnderwritingFeePayable', window );">Deferred underwriting fee payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,070,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption', window );">Remeasurement of Class A ordinary shares subject to possible redemption</a></td>
<td class="nump">3,797,771<span></span>
</td>
<td class="nump">31,162,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ForfeitureOfRepresentativeShares', window );">Forfeiture of Representative Shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA', window );">Issuance of Representative Shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts', window );">Deferred offering costs included in accrued offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 64,512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocation of deferred offering costs for warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs incurred included in accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting fee payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ForfeitureOfRepresentativeShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forfeiture of representative shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ForfeitureOfRepresentativeShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial measurement of Class&amp;#160;A ordinary shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial measurement of public warrants and private placement warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_Investmentincomedividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_Investmentincomedividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Re-measurement of Class A ordinary shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period representative shares issued value class A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062029712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND PLANS OF BUSINESS OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</a></td>
<td class="text"><p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zD94sDycK0Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
1. <span id="xdx_820_zeRplP3cU0xh">ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
and General</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aurora
Technology Acquisition Corporation (the &#8220;Company&#8221;) was incorporated as a Cayman Islands exempted company on August 6, 2021.
The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization, recapitalization or similar business combination with one or more businesses (a &#8220;Business Combination&#8221;).
The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor
and Initial Financing</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company&#8217;s
formation, the initial public offering (the &#8220;Initial Public Offering&#8221; or &#8220;IPO&#8221;), which is described below, and
identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its
initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Initial Public Offering was declared effective on February 7, 2022. On February 9, 2022, the Company consummated
the Initial Public Offering of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zdCSM9XRn5R2" title="Stock issued during period, shares, new issues">20,200,000</span> units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in
the Units sold, the &#8220;Public Shares&#8221;), which includes the exercise by the underwriter of its over-allotment option in the
amount of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXM6yznwqmXe" title="Stock issued during period, shares, new issues">200,000</span> Units, at $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuDeOHcTeEDl" title="Sale of stock, price per share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOBkgWAcScR9" title="Proceeds from issuance initial public offering">202,000,000</span>, which is described in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zguyyM1M9iT8" title="Class of warrants or rights warrants issued during the period units">6,470,000</span> warrants (each, a &#8220;Private Placement
Warrant&#8221; and, collectively, the &#8220;Private Placement Warrants&#8221;) at a price of $<span id="xdx_900_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_z09YtLjJjS2i" title="Class of warrants or rights warrants issued issue price per warrant">1.00</span> per Private Placement Warrant in
a private placement to ATAC Sponsor LLC (the &#8220;Sponsor&#8221;), generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zuBNKU2ixrVh" title="Proceeds from issuance of warrants">6,470,000</span>, which is described in Note
4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs related to the consummation of the IPO on February 9, 2022, amounted to $<span id="xdx_90A_ecustom--TransactionCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxxSiWwQvMtd" title="Transaction costs">29,192,787</span>, consisting of $<span id="xdx_90C_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTosweShAQ8" title="Underwriting discount">2,525,000</span> of underwriting discount,
$<span id="xdx_905_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWMOSOO2o2Rf" title="Deferred underwriting fees">7,070,000</span> of deferred underwriting fees, over-allotment option liability of $<span id="xdx_904_ecustom--OverallotmentOptionLiability_c20220209__20220209_zen3ggiPemR2" title="Over-allotment option liability">258,440</span>, $<span id="xdx_90B_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zS7yJMYeyja" title="Issuance of representative shares">3,030,000</span> for issuance of representative shares,
$<span id="xdx_90B_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zak6DtBwWPn8" title="Rights underlying the Units">15,596,420</span> fair value of rights underlying the Units, and $<span id="xdx_90E_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEIjCexT5do5" title="Actual offering costs">712,927</span> of actual offering costs. In addition, on February 9, 2022, cash
of $<span id="xdx_909_eus-gaap--Cash_iI_c20220209_z5VCIgCy3Hh5" title="Cash">1,468,333</span> was held outside of the Trust Account (as defined below) and was available for the payment of offering costs and for working
capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust Account</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 9, 2022 (&#8220;IPO Closing Date&#8221;), an amount of $<span id="xdx_90A_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDV5d72fIcec" title="Net proceeds amount">204,020,000</span> ($<span id="xdx_909_eus-gaap--SharePrice_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuQvc8w5Bthi" title="Share price">10.10</span> per
Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was
placed in a trust account (the &#8220;Trust Account&#8221;). The funds in the Trust Account is invested only in U.S. government treasury
bills with a maturity of <span id="xdx_903_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrqgJSTHhH55" title="Term of restricted investments">185</span> days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions
under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal
or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account
will not otherwise be released from the trust account until the earliest of: (i) the Company&#8217;s completion of a Business Combination;
(ii) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s Amendment
No. 1 to the Amended and Restated Memorandum of Association, and (iii) the redemption of the Company&#8217;s Public Shares if the Company
is unable to complete the initial Business Combination within <span id="xdx_907_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MinimumMember_zf3RK8G4coW6" title="Period within which business combination shall be consummated from the consummation of initial public offer">12</span> months (or up to <span id="xdx_905_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MaximumMember_zgxHZscZMJ93" title="Period within which business combination shall be consummated from the consummation of initial public offer">24</span> months, if applicable) from the IPO Closing Date
(the &#8220;Combination Period&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023 in connection with its Extraordinary General Meeting held on February 3, 2023 (the &#8220;February Extraordinary General
Meeting&#8221;), the Company and Continental Stock Transfer &amp; Trust Company (the &#8220;Trustee&#8221;) entered into Amendment No.
1 to the Investment Management Trust Agreement dated February 7, 2022 to allow the <span id="xdx_904_ecustom--DescriptionOfBusinessCombinationExtendedPeriodTerms_c20230203__20230203__us-gaap--TypeOfArrangementAxis__custom--AmendmentNoOneToInvestmentManagementTrustAgreementMember_zztFMc7vxu3j" title="Description of business combination extended period terms">Company to extend the date by which it has to consummate
a business combination six times for an additional one month each time from February 9, 2023 to August 9, 2023, extending the Combination
period up to 24 months, if applicable, by depositing into the Trust Account for each one-month extension the lesser of $135,000 or $0.045
per share multiplied by the number of public shares then outstanding</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2023, <span id="xdx_904_eus-gaap--SubsequentEventDescription_c20230727__20230727_zZJ2wWKUpwd8" title="Subsequent event, description">the Company held an extraordinary general meeting of shareholders (the &#8220;July Extraordinary General Meeting&#8221;),
to, among other things, approve (i) a special resolution to amend the amended and restated articles of association of the Company (the
&#8220;Articles&#8221;) giving the Company the right to further extend the Business Combination Period six (6) times for an additional
one (1) month each time, from August 9, 2023 to February 7, 2024 (the &#8220;Second Extension Amendment&#8221;) and (ii) the proposal
to approve the Second Trust Amendment (as defined below). All proposals at the July Extraordinary General Meeting were approved by the
shareholders of the Company. As such, the Company and Transfer Agent entered into Amendment No. 2 to the Investment Management Trust
Agreement, to allow ATAK to extend the Business Combination Period six (6) times for an additional one (1) month each time from August
9, 2023 to February 9, 2024 by depositing into the Trust Account for each one-month extension the lesser of: (x) $135,000 or (y) $0.045
per share multiplied by the number of public shares then outstanding (the &#8220;Second Trust Amendment&#8221;). In addition, on July
27, 2023, the Company adopted the Second Extension Amendment, amending the Company&#8217;s Articles. As of September 30, 2023, the Company
exercised eight of the one-month extensions, depositing a total of $1,080,000 into the Trust Account to fund the extensions</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Combination</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds from the Initial Public
Offering, although substantially all of the net proceeds from the Initial Public Offering are intended to be generally applied toward
consummating a Business Combination with (or acquisition of) a Target Business. As used herein, &#8220;Target Business&#8221; means one
or more target businesses that together have an aggregate fair market value equal to at least <span id="xdx_909_ecustom--PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_iI_pid_dp_uPure_c20230930_zkPXN1U2MIlf" title="Percentage of fair market value of target business to asset held in trust account">80</span>% of the value of the assets held in
the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at
the time of the signing of a definitive agreement in connection with a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
there is no assurance that the Company will be able to successfully effect a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination, either (i) in connection with a shareholder meeting called to approve such Business Combination or (ii) by
means of a tender offer. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in
the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount
to be distributed to the public shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the
Company will pay to the underwriter in connection with the IPO (as discussed in Note 6). There will be no redemption rights upon the
completion of a Business Combination with respect to the Company&#8217;s warrants. As a result, shares are recorded at their redemption
amount and classified as temporary equity, in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting
Standards Codification (&#8220;ASC&#8221;) 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decision as to whether the Company will seek shareholder approval of a Business Combination or will allow shareholders to sell their
shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing
of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a
vote is required by law or stock exchange listing requirements. If the Company seeks shareholder approval, it will complete its Business
Combination only if a majority of the Company&#8217;s ordinary shares entitled to vote thereon are voted in favor of such Business Combination.
However, in no event will the Company redeem its Public Shares in an amount that would cause the Company&#8217;s net tangible assets
to be less than $<span id="xdx_903_eus-gaap--MinimumNetWorthRequiredForCompliance_iI_c20230930_z2kftrzYbf7b" title="Banking regulation, mortgage banking, net worth, minimum">5,000,001</span> upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption
of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has until February 9, 2024, to complete its initial Business Combination, if we exercise out right to extend as approved in
the Extraordinary General Meeting held on July 27, 2023; provided the Company, by resolution of the board of directors if requested
by the Sponsor, <span id="xdx_90F_ecustom--BusinessCombinationExtensionOfBusinessCombinationPeriod_c20230101__20230930_zugRDHTIsT9j" title="Business combination extension of business combination period">extends
the period of time to consummate the initial Business Combination up to six times, each by an additional one month (for a total of
up to 24 months from the date of the Initial Public Offering to complete the Business Combination)</span>, subject to the Sponsor
depositing additional funds into the Trust Account (each one month period individually, an &#8220;Extension Period&#8221;) pursuant
to the Company&#8217;s Amendment No. 1 to the Amended and Restated Memorandum of Association. If the Company does not complete a
Business Combination by such date (or such longer period as described above), the Company shall (i) cease all operations except for
the purposes of winding up; (ii) as promptly as reasonably possible but not more than <span id="xdx_903_ecustom--NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_dtD_c20230101__20230930_zdOjOTw5ggb3" title="Number of days within which public shares shall be redeemed">10</span>
business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account, including interest (less up to $<span id="xdx_90F_eus-gaap--LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_iI_c20230930_zumsHR8pvfg2" title="Expenses payable on dissolution">50,000</span>
of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and
outstanding Public Shares, which redemption will completely extinguish public shareholders&#8217; rights as shareholders (including
the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#8217;s remaining shareholders and its board of directors, liquidate and
dissolve, subject in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors and
the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the
Company&#8217;s warrants, which will expire worthless if the Company fails to complete its initial Business Combination by February
9, 2024, or within any applicable Extension Period. The Company&#8217;s &#8220;initial shareholders&#8221; (as defined below) have
entered into a letter agreement with the Company, pursuant to which the initial shareholders have waived their rights to liquidating
distributions from the Trust Account with respect to their Founder Shares (as defined in Note 5) if the Company fails to complete
its initial Business Combination by February 9, 2024, or within any applicable Extension Period. However, if any initial
shareholders acquire Public Shares, such initial shareholders will be entitled to liquidating distributions from the Trust Account
with respect to such Public Shares if the Company fails to complete its initial Business Combination by February 9, 2024, or within
any applicable Extension Period. As used herein, the term &#8220;initial shareholders&#8221; refers to the holders of Founder Shares
prior to the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company&#8217;s
independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company
has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $<span id="xdx_900_ecustom--MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_iI_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zgxBM8LRjpwl" title="Minimum Public Share price due to reductions in the value of the trust assets less taxes payable">10.10</span> per Public Share
or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions
in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the
Company&#8217;s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not
be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including,
but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target
businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest
or claims of any kind in or to any monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2023 (the &#8220;Signing Date&#8221;), Aurora Technology Acquisition Corp., a Cayman Islands exempted company (which shall
migrate to and domesticate as a Delaware corporation prior to the Closing, as defined below) (&#8220;ATAK&#8221;), entered into a Business
Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the &#8220;Business
Combination Agreement&#8221;), among ATAK, Aurora Technology Merger Sub Corp., a Nevada corporation and a direct, wholly-owned subsidiary
of ATAK (&#8220;Merger Sub&#8221;), and DIH Holding US, Inc., a Nevada corporation (&#8220;DIH&#8221;). ATAK and DIH are each individually
referred to herein as a &#8220;Party&#8221; and, collectively, the &#8220;Parties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement has been approved by the board of directors of each of ATAK and Merger Sub and DIH, respectively. The
transactions contemplated by the Business Combination Agreement are referred to as the &#8220;Business Combination.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the time of the closing of the Business Combination (the &#8220;Closing,&#8221; and the date on which the Closing occurs, the &#8220;Closing
Date&#8221;), the combined company will be organized as a Delaware corporation, in which substantially all of the assets and the business
of the combined company will be held by DIH. The combined company&#8217;s business will continue to operate through DIH and its subsidiaries.
In connection with the Closing, ATAK will change its name to &#8220;DIH Holding US, Inc.&#8221; (such company after the Closing, &#8220;New
DIH&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Going Concern</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, the Company had $<span id="xdx_905_eus-gaap--Cash_iI_c20230930_zaSmhoIONvP2" title="Operating cash">28,943</span> and $<span id="xdx_90C_eus-gaap--Cash_iI_c20221231_za52WYHshWy1" title="Operating cash">191,103</span> in operating cash, respectively, and working capital
(deficit) of $<span id="xdx_901_ecustom--NetWorkingCapitalSurplusDeficit_iI_c20230930_zkTX3tqGrMni" title="Working capital (deficit)">(3,595,740)</span> and $<span id="xdx_90A_ecustom--NetWorkingCapitalSurplusDeficit_iI_c20221231_zUHgSaU9Wxz6" title="Working capital (deficit)">38,542</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s liquidity needs up to September 30, 2023 had been satisfied through a payment from the Sponsor of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZnJ2slI5uNh" title="Stock shares issued during the period for services shares">25,000</span> for Class B
ordinary shares, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zW5T3OYnHGZ2" title="Common stock, par or stated value per share">0.0001</span> per share (see Note 5), and proceeds from the Initial Public Offering and the issuance of the Private
Placement Warrants. Additionally, the Company drew on unsecured promissory notes to pay certain offering costs and extension payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company
may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or
third parties. The Company&#8217;s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to
time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company&#8217;s working capital needs.
Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may
be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
and Uncertainties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of operations and the Company&#8217;s ability to complete an Initial Business Combination may be adversely affected by various factors
that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could
be impacted by, among other things, downturns in the financial markets or in economic conditions, inflation, increases in interest rates,
adverse developments affecting the financial services industry, and geopolitical instability, such as the military conflict in the Ukraine.
The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent
to which they may negatively impact our business and our ability to complete an Initial Business Combination. The unaudited condensed
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation
Reduction Act</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic
(i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the
repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1%
of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of
stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury
(the &#8220;Treasury&#8221;) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or
avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination may be subject to the excise
tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination would depend
on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination,
extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any &#8220;PIPE&#8221; or other
equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued
within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In
addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#8217;s ability to complete a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will continue to monitor for updates to the Company&#8217;s business along with guidance issued with respect to the IR Act to
determine whether any adjustments are needed to the Company&#8217;s tax provision in future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062156624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zO2S0twikXdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
2. <span id="xdx_829_zK33lbDmrij6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5c7ZQjccLqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zQx4h1dnoTW1">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements should be read in conjunction with the Annual Report on Form 10-K for the year
ended December 31, 2022 as filed with the SEC on April 19, 2023, which contains the audited financial statements and notes thereto. The
financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company&#8217;s Annual
Report on Form 10-K. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the
results to be expected for the year ending December 31, 2023 or for any future interim periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zob0Lry84z67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zlQrHyqu40K3">Emerging
Growth Company</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are
not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new
or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard
at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements
with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--UseOfEstimates_z2eKLJz4ABVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zGi4D2n12B3l">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject
to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziHEdcElBAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_z3HLudZMAYg4">Cash
and Cash Equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did <span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230930_zGqSKr38mMO4" title="Cash equivalents"><span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zIy2dmr9Ltxd" title="Cash equivalents">no</span></span>t have any cash equivalents as of September 30, 2023 and December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_848_eus-gaap--MarketableSecuritiesPolicy_zgSim9l0fWV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zM7u8FDrjVRe">Marketable
Securities Held in Trust Account</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 9, 2022, an amount of $<span id="xdx_903_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEh1TfD0NkMd" title="Net proceeds amount">204,020,000</span> from the net proceeds of the sale of the Units
in the Initial Public Offering and the sale of the Private Placement Warrants were placed in the Trust Account and is invested only in
U.S. government securities with a maturity of <span id="xdx_904_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRtH5s5xBKf5" title="Term of restricted investments">185</span> days or less or in money market funds meeting certain conditions under Rule 2a-7 under
the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding
place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any
public shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s Amended and Restated Memorandum of
Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have
their shares redeemed in connection with our initial business combination or to redeem <span id="xdx_908_ecustom--PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_iI_pid_dp_uPure_c20230930_z5CkJ6FaHeZ3" title="Percentage of public shares to be redeemed in case business combination is not consummated">100</span>% of our public shares if we do not complete
our initial business combination within <span id="xdx_902_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--IfWeDoNotCompleteOurInitialBusinessCombinationMember_zNTRLhQvUsWh" title="Period within which business combination shall be consummated from the consummation of initial public offer">24</span> months from the closing of the IPO (with exercise of six one-month extensions) or (B) with
respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an initial
business combination within <span id="xdx_90D_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--AbsentOurCompletingAnInitialBusinessCombinationMember_z1VIgxwm0mwb" title="Period within which business combination shall be consummated from the consummation of initial public offer">24</span> months from the closing of our initial public offering (with exercise of six one-month extensions), our
return of the funds held in the trust account to our public shareholders as part of our redemption of the Public Shares. As of September
30, 2023, substantially all of the assets held in the Trust Account were held in money market funds which invest in United States Treasury
securities. All of the investments held in the Trust Account are classified as trading securities. Trading securities are presented on
the balance sheet at fair value at the end of each reporting period. The estimated fair values of investments held in Trust Account are
determined using available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zUuvblWO2gIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zkwmhAaGaN53">Offering
Costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A&#8212;&#8221;Expenses
of Offering&#8221;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the IPO. Offering costs are charged to shareholders&#8217; deficit or the statement of operations based on the relative
value of the Public Warrants and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the
IPO. Accordingly, on February 9, 2022, offering costs totaling $<span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zewwkQpvfngi" title="Offering costs">29,192,787</span> (consisting of $<span id="xdx_904_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJeIEabnl2Gd" title="Underwriting fees">2,525,000</span> of underwriting fees, $<span id="xdx_909_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zolMxtUxdHze" title="Deferred underwriting fees">7,070,000</span>
of deferred underwriting fees, over-allotment option liability of $<span id="xdx_905_ecustom--OverallotmentOptionLiability_c20220209__20220209_zPA2zHE7oZpj" title="Overallotment option liability">258,440</span>, $<span id="xdx_909_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zsOkxRHx08ef" title="Issuance of representative shares">3,030,000</span> for issuance of representative shares, $<span id="xdx_902_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zJ0MIuZXt5Nh" title="Rights underlying the Units">15,596,420</span>
fair value of rights underlying the Units, and $<span id="xdx_907_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvVYeyWQ04Cl" title="Actual offering costs">712,927</span> of actual offering costs), with $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzJjDfu5bgU9" title="Accumulated deficit">265,808</span> included in accumulated deficit as an
allocation for the Public Warrants, and $<span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDrOv6Q1wwqb" title="Adjustments to additional paid in capital, warrant issued">10,300,559</span> included as a reduction to proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--TemporaryEquityPolicyTextBlock_zYEWZ5qlFjle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zDS8A7r8180i">Class
A Ordinary shares Subject to Possible Redemption</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Conditionally redeemable ordinary shares
(including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times,
ordinary shares is classified as shareholders&#8217; equity. The Company&#8217;s Class A ordinary shares features certain redemption
rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. On February
9, 2023, certain investors redeemed <span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230209__20230209_z3aSo4Uxbfma" title="Redemption of Class A ordinary shares, shares">14,529,877</span> shares of Class A ordinary shares for $<span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230209__20230209_zk0KFCtSx2S" title="Redemption of Class A ordinary shares, value">149,322,133</span>, resulting in a reduction to shares
of Class A ordinary shares outstanding to <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230201__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9ciN1oB9pAe" title="Shares outstanding">5,670,123</span>. On July 28, 2023, certain investors redeemed <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230728__20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuUpwzym4ULj" title="Redemption of Class A ordinary shares, shares">362,831</span> shares of Class A ordinary
shares for $<span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230728__20230728_zsjVqqQdtzH" title="Redemption of Class A ordinary shares">3,874,172</span>, resulting in a reduction to shares of Class A ordinary shares outstanding to <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVXXzYx9gEX" title="Temporary equity, shares outstanding">5,307,292</span>. Accordingly, at September
30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary
equity, outside of the shareholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the
absence of additional capital, in accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zHcf6nR58UCi" style="display: none">SUMMARY OF TEMPORARY EQUITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 79%; text-align: left">Gross proceeds from initial public offering</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" style="padding: 0pt; width: 18%; text-align: right" title="Gross proceeds from initial public offering">202,000,000</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Less:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to public warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" style="padding: 0pt; text-align: right" title="Proceeds allocated to public warrants">(3,521,870</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Offering costs allocated to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" style="padding: 0pt; text-align: right" title="Offering costs allocated to Class A ordinary shares subject to possible redemption">(13,079,620</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Fair value allocated to rights</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" style="padding: 0pt; text-align: right" title="Fair value allocated to rights">(15,596,420</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Plus:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to private warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" style="padding: 0pt; text-align: right" title="Proceeds allocated to private warrants">4,211,323</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Redemption of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" style="padding: 0pt; text-align: right" title="Redemption of Class A ordinary shares">(153,196,305</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Re-measurement of Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Re-measurement of Class A ordinary shares subject to possible redemption">36,664,261</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Class A ordinary shares subject to possible redemption, September 30, 2023</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">$</td><td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Class A ordinary shares subject to possible redemption, September 30, 2023">57,481,369</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table><div style="clear: both"></div>

<p id="xdx_8A5_zoCVqASZ9NG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zN6ihQlobsm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zsXoHBhnjAK1">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;).
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30,
2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be subject to potential examination by U.S. federal, U.S. state or foreign taxing authorities in the area of income taxes.
These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions
and compliance with U.S. federal, U.S. state and foreign tax laws. There is currently no taxation imposed on income by the Government
of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently,
deferred tax assets and income taxes are not reflected in the Company&#8217;s financial statements. The Company&#8217;s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zlDhTOoQNTf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zMEqkd0zGo82">Net
income per Ordinary Share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding
during the period. Ordinary shares subject to possible redemption at September 30, 2023, which are not currently redeemable and are not
redeemable at fair value, have been excluded from the calculation of basic net income per ordinary share since such shares, if
redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of the warrants
sold in the Initial Public Offering and the private placement to purchase an aggregate of <span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zH8O5cB0wZM7" title="Class of warrants or rights warrants issued during the period units">6,470,000</span> Private Placement Warrants in the
calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events and the
inclusion of such warrants would be anti-dilutive. As a result, diluted net income (loss) per ordinary share is the same as basic net
income per ordinary share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s statement of operations includes a presentation of net income per ordinary share subject to possible redemption
and allocates the net income into the two classes of stock in calculating net earnings per ordinary share, basic and diluted.
For redeemable Class A ordinary shares, net income per ordinary share is calculated by dividing the net income by the weighted
average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. For non-redeemable Class
A ordinary shares, net income per share is calculated by dividing the net income by the weighted average number of non-redeemable
Class A ordinary shares outstanding for the period. Non-redeemable Class A ordinary shares include the representative shares issued to
Maxim at the closing of the initial public offering. For non-redeemable Class B ordinary shares, net income per share is calculated
by dividing the net income by the weighted average number of non-redeemable Class B ordinary shares outstanding for the period.
Non-redeemable Class B ordinary shares include the founder shares as these shares do not have any redemption features and do not participate
in the income earned on the Trust Account. As of September 30, 2023, the Company did not have any dilutive securities or other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
net income per ordinary share is the same as basic net income per ordinary share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none">SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Three Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">262,542</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">912,921</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj">5,413,775</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd">20,200,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">259,594</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">241,924</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Nine Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">183,421</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">4,173,309</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">7,659,431</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">17,314,286</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption">0.02</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption">0.24</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">128,188</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">1,278,093</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding">5,302,571</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share">0.02</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share">0.24</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zD9STglapad3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zn6txi3e7Jra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zbNK8Mc6pn8a">Related
Parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z0rL5e341nuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zu9h4xeAzRWj">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zUsDGM9cFSA7" title="Federal depository insurance coverage">250,000</span>. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbRiclSaBLi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_ztH9AGXbx30c">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value Measurement&#8221;
(&#8220;ASC 820&#8221;), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to
their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z0mtbpTsBPQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_ziYGfXBKh0la">Fair
Value Measurements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--WarrantyLiabilityPolicyTextBlock_ziGdbr12fuBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zGlNU7vkEWq9">Warranty
Liability</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the <span id="xdx_907_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDtZFfYhB441" title="Class of warrants or rights warrants issued during the period units">26,670,000</span> warrants issued in connection with the Initial Public Offering and the Private Placement Warrants
(collectively, the &#8220;Warrants&#8221;) as either equity-classified or liability-classified instruments based on an assessment of
the Warrant&#8217;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, &#8220;Derivatives and Hedging&#8221;
(&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the company&#8217;s own ordinary shares, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as
a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon
the closing of the Initial Public Offering. Accordingly, the Company will classify each warrant as a liability at its fair value and
the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This liability is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with
the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each
balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the
date of the event that causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmVqWsEk1uzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zp1njrD6GmUg">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in
an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020- 06&#8221;), which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results
of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions&#8221; (&#8220;ASU 2022-03&#8221;), which amends ASC 820 to clarify that a contractual sales restriction is not considered
in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual
sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities
measured at fair value. The amendments are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods
within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued
or made available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial
position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s condensed financial statements.</span></p>
<p id="xdx_856_zZPQaKExVd55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062178192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DisclosureInitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DisclosureOfInitialPublicOfferingTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p id="xdx_80A_ecustom--DisclosureOfInitialPublicOfferingTextBlock_zjdp5Jc8pFwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
3. <span id="xdx_824_zMzbHbOg1Ooj">INITIAL PUBLIC OFFERING</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2022, pursuant to the Initial Public Offering, the Company sold <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPbYym7mU6a" title="Stock issued during period, shares, new issues">20,200,000</span> Units, which includes the partial exercise by
the underwriter of its over-allotment option in the amount of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zh5AD6Nt1L6a" title="Stock issued during period, shares, new issues">200,000</span> Units, at a price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrmRWzmQUlL2" title="Sale of stock, price per share">10.00</span> per Unit. <span id="xdx_90A_eus-gaap--CommonStockConversionBasis_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zu7F6RRFHpp4" title="Common stock, conversion basis">Each Unit consists of one
Class A ordinary share, one redeemable warrant (each whole warrant, a &#8220;Public Warrant&#8221;), and one right to receive one-tenth
of one Class A ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Each two Public Warrants entitle
the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aggregate of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVUCN9zPjfef" title="Share price">10.10</span> per Unit sold in the IPO was held in the Trust Account and invested in U.S. government securities, within the meaning
set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of <span id="xdx_90E_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaFI22ntpuzd" title="Term of restricted investments">185</span> days or less or in any open-ended investment company
that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DisclosureInitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DisclosureInitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DisclosureOfInitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Initial Public Offering [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DisclosureOfInitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099057949312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DisclosurePrivatePlacementAbstract', window );"><strong>Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DisclosureOfPrivatePlacementTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p id="xdx_80E_ecustom--DisclosureOfPrivatePlacementTextBlock_zacKhridVzTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
4. <span id="xdx_823_zVGa5FoW5c4l">PRIVATE PLACEMENT</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of <span id="xdx_902_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zxgjobz3yxVf" title="Class of warrants or rights warrants issued during the period units">6,470,000</span> Private Placement Warrants at a price
of $<span id="xdx_908_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zJaPvnW6kerh" title="Class of warrants or rights warrants issued price per warrant">1.00</span> per warrant ($<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zjKAX5VZXL4k" title="Proceeds from issuance of warrants">6,470,000</span> in the aggregate) in a private placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
two private placement warrants (the &#8220;Private Placement Warrants&#8221;) are exercisable for <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_dc_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zO5cda13vAVh" title="Class of warrant or right, number of securities called by each warrant or right">one</span> whole Class A ordinary share at
a price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zh8YzzQTryyf" title="Class of warrant or right, exercise price of warrants or rights">11.50</span> per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial
Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period,
the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public
Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DisclosureOfPrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Private Placement [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DisclosureOfPrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DisclosurePrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DisclosurePrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099152636784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zHmrxzUsi456" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
5. <span id="xdx_82D_zHVu4KGAWXF">RELATED PARTY TRANSACTIONS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder
shares</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2021, the Sponsor was issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zg9TpWN6Jph9" title="Stock issued during period, shares, issued for services">5,750,000</span> of the Company&#8217;s Class B ordinary shares (the &#8220;Founder Shares&#8221;) for
an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zaytSPsSwQj5" title="Stock issued during period, shares, issued for services">25,00</span>0. Due to the underwriters&#8217; partial exercise of the over-allotment option, the Sponsor forfeited
<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zBYbyTLNHo1k" title="Shares issued, shares, share based payment arrangement, forfeited">700,000</span> Founder Shares back to the Company. As a result, the Sponsor currently has <span id="xdx_90A_eus-gaap--TemporaryEquitySharesIssued_iI_c20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zUZKmB3eRoth" title="Temporary equity shares issued">5,050,000</span> Founder Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier
of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported
sale price of the Class A ordinary shares equals or exceeds $<span id="xdx_902_ecustom--ShareTransferTriggerPricePerShare_iI_c20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQWEKqyr12M4" title="Share transfer, trigger price per share">12.00</span> per share (as adjusted for share sub-divisions, share reorganizations,
recapitalizations and the like) for any <span id="xdx_907_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zpr8BtdXaPg6" title="Number of consecutive trading days for determining share price">20</span> trading days within any <span id="xdx_907_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zU1cHOnyQUT" title="Number of trading days for determining share price">30</span>-trading day period commencing at least <span id="xdx_903_ecustom--ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zvG3vG7Ngt7l" title="Threshold number of trading days for determining share price from date of business combination">150</span> days after a Business
Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction
that results in all of the Company&#8217;s shareholders having the right to exchange their Class A ordinary shares for cash, securities
or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
notes &#8211; related party</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2021, the Company issued an unsecured promissory note to the Sponsor (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDkxqAr7TwFb" title="Debt instrument, face amount">300,000</span>. The Promissory Note was <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_do_c20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zLO5BkKYYNI5" title="Debt instrument interest rate">no</span>n-interest bearing and payable on the
earlier of <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20210807__20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zkObZI5rf114" title="Debt instrument, maturity date">March 31, 2022</span>, or the completion of the IPO. At the time of repayment, there was $<span id="xdx_903_eus-gaap--NotesPayable_iI_c20220209__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zBqY1O5GB598" title="Aggregate debt">242,801</span> outstanding under the Promissory
Note. On February 9, 2022, the Company repaid the Sponsor for amounts outstanding under the Promissory Note. As of September 30, 2023
and December 31, 2022, there were <span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_do_c20230930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDN8qx6k29Q3" title="Long-term debt"><span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_do_c20221231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zdNNQlJYLV85" title="Long-term debt">no</span></span> amounts outstanding under the Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2023, the Company issued and drew fully against a promissory note in the amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230208__us-gaap--DebtInstrumentAxis__custom--FirstWorkingCapitalMember_zDSdRIr3YZag">90,000</span> to fund working capital needs
(the &#8220;First Working Capital Note&#8221;). Additionally, on February 8, 2023, the Company issued a promissory note in the amount
of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230208__us-gaap--DebtInstrumentAxis__custom--FirstExtensionNoteMember_zVVYSFJ4UIC5">135,000</span> to fund the Company&#8217;s first extension payment (the &#8220;First Extension Note&#8221;), which has not been drawn against.
On March 3, 2023, the Company issued a promissory note in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230303__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z8OplOF2dAlc">810,000</span> to pay for up to six additional one-month extension
payments (the &#8220;Second Extension Note&#8221;). On each of March 7, 2023, April 6, 2023, May 5, 2023, June 2, 2023, and July 5, 2023,
the Company drew $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20230307__20230307__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_ztYlaXEonttf"><span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20230406__20230406__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zWY7nl8EIxEi"><span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_c20230505__20230505__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zRNuq3xMakYg"><span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20230602__20230602__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zZv8A9haGfVa"><span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20230705__20230705__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zcH4jFNcb13k">135,000</span></span></span></span></span>, $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfDebt_c20230101__20230930__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zgTDU1IOCS64">675,000</span> in the aggregate, against the Second Extension Note to pay for each additional one-month extension.
On April 6, 2023, the Company issued and drew fully against a promissory note in the amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230406__us-gaap--DebtInstrumentAxis__custom--SecondWorkingCapitalMember_zXKnu1p4b6A3">100,000</span> to fund working capital needs
(the &#8220;Second Working Capital Note&#8221;). On May 2, 2023, the Company issued and drew fully against a promissory note in the amount
of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230502__us-gaap--DebtInstrumentAxis__custom--ThirdWorkingCapitalMember_zCG4yRjUbWW">100,000</span> to fund working capital needs (the &#8220;Third Working Capital Note&#8221;). On June 14, 2023, the Company issued and drew
fully against a promissory note in the amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230614__us-gaap--DebtInstrumentAxis__custom--FourthWorkingCapitalMember_zSzU34Wlraa6">20,000</span> to fund working capital needs (the &#8220;Fourth Working Capital Note&#8221;).
On July 7, 2023, the Company issued and subsequently on July 10, 2023, drew fully against a promissory note in the amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20230710__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_zxyAbe9VWS45">100,000</span>
to fund working capital needs (the &#8220;Fifth Working Capital Note&#8221;). On July 31, 2023, the Company issued a promissory note
in the amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230731__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_zY7esLkv7ubk">810,000</span> to pay for up to six additional one-month extension payments (the &#8220;Third Extension Note&#8221;). On each
of July 31, 2023, and September 1, 2023, the Company drew $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20230731__20230731__us-gaap--DebtInstrumentAxis__custom--ThirdExtensionNoteMember_zSYoxcxFoiA2">135,000</span>, $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfDebt_c20230901__20230901__us-gaap--DebtInstrumentAxis__custom--ThirdExtensionNoteMember_zNCoE5nB7iMf">270,000</span> in the aggregate, against the Third Extension Note to pay
for each additional one-month extension. On September 1, 2023, the Company issued and drew fully against a promissory note in the amount
of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20230901__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_z9ejbSx2bdA4" title="Debt instrument, face amount">50,000</span> to fund working capital needs (the &#8220;Sixth Working Capital Note&#8221; and together with the First Working Capital Note,
the Second Working Capital Note, the Third Working Capital Note, the Fourth Working Capital Note, and the Fifth Working Capital Note
collectively, the &#8220;Working Capital Notes&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
First Extension Note does not bear interest, and matures (subject to the waiver against trust provisions) upon the earlier of (i)
two (2) days following the date on which the Company&#8217;s initial business combination is consummated or liquidation and (ii)
August 31, 2023. The Company did not draw funds against the First Extension Note. The Second Extension Note bears no interest and is
repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#8217;s
initial business combination, or (ii) the date of the Company&#8217;s liquidation. The Third Extension Note bears no interest and is
repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#8217;s
initial business combination, or (ii) the date of the Company&#8217;s liquidation. The Working Capital Notes do not bear interest,
and mature (subject to the waiver against trust provisions) upon the earlier of (i) two (2) days following the date on which the
Company&#8217;s initial business combination is consummated and (ii) the date of the liquidation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, there was $<span id="xdx_903_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalNotesMember_zAI4x6b2eOye" title="Outstanding value under the note">460,000</span> and $<span id="xdx_900_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_z5fTc5BRuuIi" title="Outstanding value under the note">945,000</span> outstanding ($<span id="xdx_905_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalAndSecondExtensionNoteMember_zEY7LcPwBN93" title="Outstanding value under the note">1,405,000</span> in the aggregate) under the Working Capital Notes and
Extension Notes, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
Capital Loans</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor, certain of the Company&#8217;s officers, directors
or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;).
If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital
Loans would either be repaid upon completion of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to
$<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_iI_c20230930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember_zdC0B3VBw5Zh" title="Debt instrument convertible into warrants">1,500,000</span> of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember_zokEJpwibXNh" title="Debt instrument conversion price">1.00</span>
per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2023 and December 31, 2022, <span id="xdx_908_eus-gaap--OtherLiabilitiesCurrent_iI_do_c20230930__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zYuVkhxvtqd" title="Due to related parties current"><span id="xdx_90E_eus-gaap--OtherLiabilitiesCurrent_iI_do_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zxONTowyS17e" title="Due to related parties current">no</span></span> Working
Capital Loans were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administrative
support agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on February 9, 2022, the Company agreed to pay the Sponsor a total of $<span id="xdx_90F_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220209__20220209__us-gaap--RelatedPartyTransactionAxis__custom--OfficeSpaceAdministrativeAndSupportServicesMember_zvs6CnLtAKke" title="Related party payments">10,000</span> per month for office space, secretarial and administrative
services provided to the Company. Upon completion of the initial Business Combination or the Company&#8217;s liquidation, the Company
will cease paying these monthly fees. The Company has incurred and paid $<span id="xdx_905_eus-gaap--OperatingCostsAndExpenses_c20230701__20230930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zXu4ZRto1x4k" title="Administrative support agreement expenses">30,000</span> and $<span id="xdx_907_eus-gaap--OperatingCostsAndExpenses_c20230101__20230930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zBFPSbsn84q7" title="Administrative support agreement expenses">90,000 </span>in administrative support agreement expenses
for the three and nine months ended September 30, 2023. The Company has incurred and paid $<span id="xdx_908_eus-gaap--OperatingCostsAndExpenses_c20220701__20220930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zh1fpnF9i0Bl" title="Administrative support agreement expenses">30,000</span> and $<span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_c20220101__20220930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zOWpqOKAhyVl" title="Administrative support agreement expenses">80,000</span> in administrative support
agreement expenses for the three and nine months ended September 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliate
investment in potential target</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was in discussions with a number of potential target companies. Through introductions by the Company, an affiliate of one of
the Company&#8217;s directors invested in one potential target&#8217;s latest private fundraising round. The result of which benefited
the Company through deeper discussions of a potential transaction. However, the Company did not enter into a business combination agreement
with the aforementioned potential target.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099160878960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS&#8217; DEFICIT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; DEFICIT</a></td>
<td class="text"><p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zs3sBPKp5erj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
6. <span id="xdx_82E_zMwbKLSNPAIl">SHAREHOLDERS&#8217; DEFICIT</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preference
shares-The Company is authorized to issue up to <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930_z7CGsX9PRedd" title="Preferred stock, shares authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zXCnH47jsw06" title="Preferred stock, shares authorized">5,000,000</span></span> preference shares with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230930_zl5KwixPfN73" title="Preferred stock, par or stated value per share"><span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_z4VZjfQlljz2" title="Preferred stock, par or stated value per share">0.0001</span></span> per share with such designation,
rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At September 30, 2023 and December
31, 2022, there were <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_do_c20230930_zz7t2rGETm" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zxGrpLslRMH4" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20230930_zy3w6SDHrhX3" title="Preferred stock, shares outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zzIG9iZN4dd6" title="Preferred stock, shares outstanding">no</span></span></span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
A ordinary shares- The Company is authorized to issue up to <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zag3slqfd6Yb" title="Common stock shares authorized"><span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRhI1JJlK2yk" title="Common stock shares authorized">500,000,000</span></span> Class A ordinary shares with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zODbl7b0BFPd" title="Common stock par value per share"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCFUHmHZPUu2" title="Common stock par value per share">0.0001</span></span> per share.
Holders of the Company&#8217;s Class A ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31,
2022, there were <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjKaNmolG7t8" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGnkAVIAdEdc" title="Common stock shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zO0ECWyHTZzl" title="Common stock shares outstanding"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zgSCs5d1zQMc" title="Common stock shares outstanding">303,000</span></span></span></span> Class A Ordinary Shares issued or outstanding, excluding <span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z28P1MY1PgXd" title="Temporary equity shares outstanding"><span id="xdx_902_eus-gaap--TemporaryEquitySharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWBwkdnG7KKi" title="Temporary equity shares issued">5,307,292</span></span> and <span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGtqq33G8Br4" title="Temporary equity shares outstanding"><span id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8447AoSn7qd" title="Temporary equity shares issued">20,200,000</span></span> shares subject to possible
redemption as presented in temporary equity as of September 30, 2023 and December 31, 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
B ordinary shares- The Company is authorized to issue up to <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zf4eWPkDIOR3" title="Common stock shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeoORmZmwFy2" title="Common stock shares authorized">50,000,000</span></span> Class B ordinary shares with a par value of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zVD3y9mndx4k" title="Common stock par value per share"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zNnwh3yDYCn" title="Common stock par value per share">0.0001 </span></span>per share.
At September 30, 2023 and December 31, 2022, there were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHQwMnotGCqd" title="Common stock shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjiDbNK1f2Yf" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpP0l5WQodj5" title="Common stock shares outstanding"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z1w589LFjhc" title="Common stock shares outstanding">5,050,000</span></span></span></span> Class B ordinary shares issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and holders of Class
A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the
shareholders except as required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
so long as any Class B ordinary shares remain outstanding, we may not, without the prior vote or written consent of the holders of a
majority of the Class B ordinary shares then outstanding, voting separately as a single class, amend, alter or repeal any provision of
our memorandum and articles of association, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would
alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B ordinary shares.
Any action required or permitted to be taken at any meeting of the holders of Class B ordinary shares may be taken without a general
meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed
by the holders of the outstanding Class B ordinary shares having not less than the minimum number of votes that would be necessary to
authorize or take such action at a general meeting at which all Class B ordinary shares were present and voted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Class B ordinary shares will convert into Class A ordinary shares automatically at the time of a Business Combination, or at an earlier date at the option of the holder, on a
one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are
issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of a Business Combination, the ratio
at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of
the outstanding Class B ordinary shares to waive such adjustment with respect to any such issuance or deemed issuance) so that the
number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an
as-converted basis, <span id="xdx_901_ecustom--CommonStockThresholdPercentageOnConversionOfShares_iI_dp_c20230930__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zsntYgtuPLG1" title="Common stock, threshold percentage on conversion of shares">20</span>%
of the sum of the total number of all ordinary shares outstanding upon the completion of the IPO plus all Class A ordinary shares
and equity-linked securities issued or deemed issued by the Company in connection with or in relation to the completion of the
initial Business Combination, any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A
ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any private placement warrants issued
to the Sponsor upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary
shares at a rate of less than one to one.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights-
Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive
one-tenth (1/10) of one Class A ordinary share upon consummation of a Business Combination, even if the holder of a right redeemed all
shares held by him, her or it in connection with a Business Combination or an amendment to the Company&#8217;s Amended and Restated Memorandum
of Association with respect to its pre-business combination activities. In the event that the Company will not be the surviving company
upon completion of a Business Combination, each holder of a right will be required to affirmatively exchange his, her or its rights in
order to receive the one-tenth (1/10) of a share underlying each right upon consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the
nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders
of the rights must hold rights in multiples of 10 in order to receive shares for all of the holders&#8217; rights upon closing of a Business
Combination. If the Company is unable to complete an initial Business Combination within the Combination Period and the Company redeems
the Public Shares for the funds held in the Trust Account, holders of rights will not receive any of such funds for their rights and
the rights will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099057949312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_WarrantsDisclosureTextBlock', window );">WARRANTS</a></td>
<td class="text"><p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zUdDtwnj54Kd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
7. <span id="xdx_826_zO3usRGWeXha">WARRANTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930_zvhl8PcTU1rh" title="Number of warrants or rights outstanding">26,670,000</span> warrants that were issued in the IPO (representing <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMDTVyzCh1Vk" title="Number of warrants or rights outstanding">20,200,000</span> Public Warrants and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHrChTdYI8f1" title="Number of warrants or rights outstanding">6,470,000</span> Private
Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not
meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify
each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such
re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#8217;s
statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
&#8212; Public Warrants may only be exercised for a whole number of Class A ordinary shares. No fractional warrants have been or will
be issued upon separation of the Units and only whole warrants will trade. Accordingly, unless holders purchase at least two Units, they
will not be able to receive or trade a whole warrant. The Public Warrants will become exercisable <span id="xdx_90C_ecustom--WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z3jvh60RdGEf" title="Warrants exercisable term from the date of completion of business combination">30</span> days after the completion of a Business
Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any Class A Ordinary Shares pursuant to the exercise of a Public Warrant and will have no obligation
to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary
Shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company
satisfying its obligations with respect to registration, or a valid exemption from registration is available. No Public Warrant will
be exercisable, and the Company will not be obligated to issue any Class A Ordinary Shares upon exercise of a Public Warrant unless the
Class A Ordinary Share issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities
laws of the state of residence of the registered holder of the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed that as soon as practicable, but in no event later than <span id="xdx_901_ecustom--MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z8sdNreSzCVa" title="Minimum lock in period for SEC registration from date of business combination">20</span> business days after the closing of a Business Combination,
it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which
this prospectus forms a part or a new registration statement covering the registration under the Securities Act of the Class A Ordinary
Shares issuable upon exercise of the Public Warrants, and the Company will use its commercially reasonable efforts to cause the same
to become effective within <span id="xdx_907_ecustom--MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zdCx8PPjteAj" title="Minimum lock in period to become effective after the closing of the initial business combination">60</span> business days after the closing of a Business Combination, and to maintain the effectiveness of such registration
statement and a current prospectus relating to those Class A Ordinary Shares until the Public Warrants expire or are redeemed, as specified
in the warrant agreement; provided that if the Class A Ordinary Shares is at the time of any exercise of a Public Warrant not listed
on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of
the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless
basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be
required to file or maintain in effect a registration statement, but it will use its commercially reasonably efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class
A Ordinary Shares issuable upon exercise of the Public Warrants is not effective by the 60th day after the closing of a Business Combination,
Public Warrant holders may, until such time as there is an effective registration statement and during any period when the Company will
have failed to maintain an effective registration statement, exercise Public Warrants on a &#8220;cashless basis&#8221; in accordance
with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonably efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
of warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the warrant become exercisable, the Company may redeem the outstanding warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    whole and not in part;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    a price of $<span id="xdx_904_ecustom--ClassOfWarrantsRedemptionPricePerUnit_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJ44vU4heVk" title="Class of warrants redemption price per unit">0.01</span> per warrant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than <span id="xdx_908_ecustom--ClassOfWarrantsRedemptionNoticePeriod_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPF6wiANdyr9" title="Class of warrants, redemption notice period">30</span> days&#8217; prior written notice of redemption to each warrant holder; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the last sale price of our ordinary shares equals or exceeds $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHTWRmQveZFi" title="Share price">18.00</span> per share (as adjusted for share sub-divisions,
    share dividends, reorganizations, recapitalizations and the like) for any <span id="xdx_904_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWiSLcfc7wEb" title="Number of consecutive trading days for determining share price">20</span> trading days within a <span id="xdx_90B_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zp0g45qXbhVe" title="Number of trading days for determining share price">30</span>-trading day period ending on
    the third trading day prior to the date on which we send the notice of redemption to the warrant holder.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 57.2pt; text-align: justify; text-indent: -21.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection
with the closing of a Business Combination at an issue price or effective issue price of less than $<span id="xdx_90F_ecustom--ShareRedemptionTriggerPrice_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zLEPK7fjdJH8" title="Share redemption trigger price">9.20</span> per Class A Ordinary Share (with
such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of
any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent
more than <span id="xdx_906_ecustom--MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_iI_pid_dp_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zzrdqJgGB63b" title="Minimum percentage gross proceeds required from issuance of equity">60</span>% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of
the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary
shares during the <span id="xdx_902_ecustom--ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_dtD_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zMTc7WOpep6" title="Class of warrant right minimum notice period for redemption">20</span> trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination
(such price, the &#8220;Market Value&#8221;) is below $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zZaaNwnlFSH6" title="Class of warrant or right, exercise price of warrants or rights">9.20</span> per share, then the exercise price of the warrants will be adjusted (to the
nearest cent) to be equal to <span id="xdx_90F_ecustom--ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_iI_pid_dp_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zth1LSnxGk29" title="Class of warrant or right exercise price adjustment percentage higher of market value">115</span>% of the higher of the Market Value and the Newly Issued Price, the $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zbRC6ir0bWsg" title="Class of warrant or right, exercise price of warrants or rights">18.00</span> per share redemption trigger
price described above (to the nearest cent) to be equal to <span id="xdx_904_ecustom--ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_iI_pid_dp_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_z83t3IroCtji" title="Class of warrant or right exercise price adjustment percentage higher of market value">180</span>% of the higher of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private
Placement Warrants and the Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants will not be transferable,
assignable or saleable until <span id="xdx_90C_ecustom--MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_dtD_c20230101__20230930_zowVYBtcXPP8" title="Minimum lock In period for transfer, assign or sell warrants after completion of IPO">30</span> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally,
the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder&#8217;s option, and be non-redeemable
so long as they are held by the initial purchasers or their permitted transferees (except for a number of Class A Ordinary Shares as
described above under Redemption of warrants for Class A Ordinary Shares). If the Private Placement Warrants are held by someone other
than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption
scenarios and exercisable by such holders on the same basis as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062084704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsDisclosureTextBlock_z41seqf91WRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
8. <span id="xdx_827_zY8C7MwxeNn">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
right and Shareholder Rights</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Warrants, warrants that may be issued upon conversion of Working Capital Loans (and
any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion
of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration
rights agreement that was signed on the effective date of the IPO, requiring the Company to register such securities for resale. The
holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule
415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a <span id="xdx_900_ecustom--OverAllotmentOptionPeriod_dtD_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zXaZ7EgDntOa" title="Over allotment option period">45</span>-day option from the date of the IPO to purchase up to <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_ziSDkUgLazZd" title="Stock issued during period, shares, new issues">3,000,000</span> additional Units to cover over-allotments
at the IPO price less the underwriting discount. The underwriters partially exercised the over-allotment option, generating an additional
$<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zvrc9dspmfOk" title="Proceeds from issuance of common stock">2,000,000</span> in gross proceeds. As a result of the over-allotment being exercised in part, the Sponsor forfeited <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230101__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zNfXNwpxp3O4" title="Shares issued, shares, share-based payment arrangement, forfeited">700,000</span> Founder Shares
back to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were paid a cash underwriting discount of $<span id="xdx_90D_eus-gaap--PaymentsForUnderwritingExpense_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zU7PbOgvdQF4" title="Deferred underwriting fees">2,525,000</span> in the aggregate at the closing of the IPO. In addition, $<span id="xdx_905_ecustom--DeferredUnderwritingCommissionPerUnit_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z31Vosa8wMP7" title="Deferred underwriting commission per unit">0.35 </span>per
Unit, or $<span id="xdx_907_ecustom--DeferredUnderwritingCommissionsNoncurrent_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z0nVCBKhx3Ni" title="Deferred underwriting commissions">7,070,000</span> in the aggregate is payable to the underwriters for deferred underwriting commissions. The deferred fee is payable
to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a contingent fee arrangement with their legal counsel, in which the deferred fee is payable to the Company&#8217;s legal
counsel solely in the event that the Company completes a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
of First Refusal</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain conditions, the Company granted Maxim, for a period beginning on the closing of the IPO, and ending on the earlier of 18 months
after the date of the consummation of the Business Combination and February 7, 2025, the three year anniversary of the effective date
of the registration statement filed in connection with the IPO (the &#8220;S-1 Effective Date&#8221;), a right of first refusal to act
as book-running managing underwriter or placement agent for any and all future public and private equity, convertible and debt offerings
for us or any of our successors or subsidiaries. In accordance with FINRA Rule 5110(g)(6), such right of first refusal shall not have
a duration of more than three years from the commencement of sales of securities in the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative&#8217;s
Ordinary Shares</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued to Maxim and/or its designees, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyKt45ksxOR9" title="Maxim IPO shares issued">303,000</span> Class A ordinary shares upon the consummation of the IPO. Maxim has agreed not
to transfer, assign or sell any such shares until the completion of the Company&#8217;s initial Business Combination. In addition, Maxim
has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company&#8217;s initial
business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if
the Company fails to complete its initial business combination within 12 months (or up to 18 months if we extend the period of time to
consummate a business combination by the full amount of time) from the closing of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the
S-1 Effective Date. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative,
put or call transaction nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following
the commencement of sales of securities in the IPO, except to any underwriter and selected dealer participating in the offering and their
officers or partners, associated persons or affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062191440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_z5ZkIR5Pk3vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
9. <span id="xdx_82D_zbNoGHWbrnaf">FAIR VALUE MEASUREMENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2023 and December 31, 2022, the Company&#8217;s warrant liability was valued at $<span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_c20230930_zx1ws3UGbRX6" title="Warrant liability">441,300</span> and $<span id="xdx_90B_eus-gaap--DerivativeLiabilities_iI_c20221231_zMLFMXd6RrZb" title="Warrant liability">589,420</span>, respectively. Under
the guidance in ASC 815-40, the Public Warrants and the Private Placement Warrants do not meet the criteria for equity treatment. As
such, the Public Warrants and the Private Placement Warrants must be recorded on the balance sheet at fair value. This valuation is subject
to re-measurement at each balance sheet date. With each re-measurement, the valuations will be adjusted to fair value, with the change
in fair value recognized in the Company&#8217;s statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fair value information as of September 30, 2023 and December 31, 2022, of the Company&#8217;s financial assets
and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques
the Company utilized to determine such fair value. The Company&#8217;s warrant liability is based on a valuation model utilizing management
judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets.
Significant deviations from these estimates and inputs could result in a material change in fair value The Company transferred the fair
value of Public Warrants and Private Placement Warrants from a Level 3 measurement to a Level 1 and Level 2 measurement, respectively,
in 2022. The measurement of the Public Warrants as of September 30, 2023 is classified as Level 1 due to the use of an observable market
quote in an active market under the ticker ATAKW. The measurement of the Private Placement Warrants as of September 30, 2023 is classified
as Level 2 as its value is derived from the directly observable quoted prices of the Public Warrants in active markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-CPH_zD5cUhCEa5G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zTQjK1biSbR9">SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Private</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Public</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Placement</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Warrant</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Liability</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Derivative warrant liabilities at December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAAW9yvaFCI5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBJzhpVJpDW6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zjkR2Mp5EXyi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1203">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Initial fair value at issuance of public and private placement warrants</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcautWchdM11" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants">3,521,870</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPUaYY8buI58" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants">2,258,677</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwi5VWCHxiK7" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants">5,780,547</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zJ6ACioAM5C5" style="text-align: right" title="Change in fair value">(1,905,870</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zYWePiQpVVgf" style="text-align: right" title="Change in fair value">(1,730,725</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zaQWyTYRhrh" style="text-align: right" title="Change in fair value">(3,636,595</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Transfer of public warrants to Level 1 measurement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zR4yEiDOuKkg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement">(1,616,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_z9W2JM0r1QC9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"><span style="-sec-ix-hidden: xdx2ixbrl1219">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zIplz2uZgEY6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement">(1,616,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk35ZPQJCoX7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1223">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuiqX6BjD9A5" style="text-align: right" title="Derivative warrant liabilities, beginning balance">527,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z2vE14XdjkQl" style="text-align: right" title="Derivative warrant liabilities, beginning balance">527,952</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0lzc9YO1OB4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1229">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVSK2fdxPwu2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(280,952</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zaBexgiz6SD4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(280,952</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmJTHnEftI1j" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1235">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlGdKKEfZs3i" style="text-align: right" title="Derivative warrant liabilities, beginning balance">247,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_ztHgU0al2dre" style="text-align: right" title="Derivative warrant liabilities, beginning balance">247,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zvbpohzSkmE5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1241">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbit6K09oeg6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(118,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zxtkvJDzYeZa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(118,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of September 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNfqDo9nRbVf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1247">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z62F0CUYCOo3" style="text-align: right" title="Derivative warrant liabilities, beginning balance">129,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zeY4B19DBa66" style="text-align: right" title="Derivative warrant liabilities, beginning balance">129,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMXPPrCSeCHj" style="text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1253">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVJzQGYcYjxc" style="text-align: right" title="Change in fair value">14,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zsutCbF2VPb5" style="text-align: right" title="Change in fair value">14,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Transfer of Private Placement Warrants to Level 2 measurement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_z4EZ1dRZY6oa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"><span style="-sec-ix-hidden: xdx2ixbrl1259">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_zsoZT2Mvnmdi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement">(143,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__custom--TrancheAxis__custom--TrancheTwoMember_zfINuQwZ7j99" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement">(143,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5rkpQNhkq3" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1265">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZS2C3AJDrkf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1267">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zrjaYmZ89xzc" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1269">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTqEyRStrWk3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z2rlvsLI1no1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1273">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zOFg2Kn1tMC8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1275">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of March 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5s8rddgc5h" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1277">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zItxLcHXcHa7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1279">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zTF7FfZOHWub" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1281">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zLxLA71OMLLj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1283">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUypW4OnZY1g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1285">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zCiEM6DJpA22" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1287">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzHseD5ond3g" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIpO0PQXXyK" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1291">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z1ahTQKItRh6" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1293">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zEQyCr1lmi27" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1295">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zIcy9iXVC5ff" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zoW9aiFeNFM" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1299">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Level 3 derivative warrant liabilities as of September 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGMd85PfYbol" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1301">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zA84LOaPHYB8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1303">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zo8I0YtjQoUj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1305">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zOl6j2TvERhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxL5juBT1i5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that were accounted for
at fair value on a recurring basis at September 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zjDZeVmZNQj8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY
OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Cash and marketable securities held in trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4gawblzyND5" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account">57,481,369</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjL6ihv07bGi" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1311">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKfKmzxa0mKj" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1313">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUpVGrwowabe" style="text-align: right" title="Public Warrants">333,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z2UzQA5ORCXk" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1317">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zmX9FjgKRCIf" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1319">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5rPXzSJlan7" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1321">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zlq4icCL71K5" style="text-align: right" title="Private Placement Warrants">108,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUeBNa89tspk" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1325">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that were accounted for
at fair value on a recurring basis at December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Cash and marketable securities held in trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKO5NLuAMp7k" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account">206,879,903</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgIGL1Zf3wId" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1329">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqnmllIx2U" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1331">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziIb67mCZpRe" style="text-align: right" title="Public Warrants">446,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAp98Oyxi5E3" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1335">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zC3EnF8U5du7" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1337">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxyU81j4Q092" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1339">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDbWrxtK1Era" style="text-align: right" title="Private Placement Warrants">143,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUhcMt9t0x7d" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zEsOHpHNFfgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the fair value of derivative warrant liabilities as of September 30, 2023 and December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C05_gL3FVLMORBUIR-CPH_zNkZBCkxBfA9"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<div id="xdx_C0E_gL3FVLMORBUIR-CPH_zoQfsLwwIdX5"><table cellpadding="0" cellspacing="0" id="xdx_300_134_zXvobzVu7bj4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Public Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Private Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total Derivative Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Fair value at August 6, 2021 (inception)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoHDbRua9gO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"><span style="-sec-ix-hidden: xdx2ixbrl1345">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zaDW6fPMSV3j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"><span style="-sec-ix-hidden: xdx2ixbrl1347">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zEtGHsMFZuE8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"><span style="-sec-ix-hidden: xdx2ixbrl1349">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zfGLRHvw1C53" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zCpInILvqkAb" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1353">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z2TLeaOuA2P1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Derivative warrant liabilities as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaPoTc5OGa72" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1357">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zvTJB4eFFOrj" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1359">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z5NGqrpyZjq6" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1361">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Initial fair value at issuance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zusAqYCMyzJe" style="width: 14%; text-align: right" title="Initial fair value at issuance">3,521,870</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z1DwZtMuWkli" style="width: 14%; text-align: right" title="Initial fair value at issuance">2,258,677</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zlWxhKHlVtD2" style="width: 14%; text-align: right" title="Initial fair value at issuance">5,780,547</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zxwm5JtkoSxi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(1,905,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxKYSGFygD4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(1,730,725</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z3MTrlLBzOrb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(3,636,595</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMjpHJPMYFCh" style="text-align: right" title="Beginning balance">1,616,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5RX6lbVUhqk" style="text-align: right" title="Beginning balance">527,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zsnrp3pkvSui" style="text-align: right" title="Beginning balance">2,143,952</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcqo6J3Iufd3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(858,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbus30l94wfd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(280,952</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zPZIPMXD5OSg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(1,139,452</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgAtIztGvnJa" style="text-align: right" title="Beginning balance">757,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zAinMA6aMoLk" style="text-align: right" title="Beginning balance">247,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zoi4DoxsH0g" style="text-align: right" title="Beginning balance">1,004,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7iD7sBnVLB1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(353,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zg5ZLeIj6He3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(118,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zihHLQZOYDZd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(471,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of September 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z22mlIrpvDzi" style="text-align: right" title="Beginning balance">404,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zMTyxZ0la7Mb" style="text-align: right" title="Beginning balance">129,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zvkWjznTQL6k" style="text-align: right" title="Beginning balance">533,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zm0OF5ZcsLgg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">42,420</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ztq2KfsXNqi1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">14,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zU8nnSUYWGU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">56,420</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuNRYsE2pMv9" style="text-align: right" title="Beginning balance">446,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zOnBX3nNM0f7" style="text-align: right" title="Beginning balance">143,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zAjBDQ3RdICk" style="text-align: right" title="Beginning balance">589,420</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zhlIcHSpkWoe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">58,580</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zgXpwvXdwbS8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">20,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z8CfLV9zo6Da" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">78,580</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of March 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z747OAysoByl" style="text-align: right" title="Beginning balance">505,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zPvSDxXFfYVi" style="text-align: right" title="Beginning balance">163,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zG5ctc2KhBwf" style="text-align: right" title="Beginning balance">668,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zsCjyvl8T6o7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(220,180</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zJ5V073Zrfk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(71,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zMWBTSKhBbbg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(291,180</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUavEazgfMoi" style="text-align: right" title="Beginning balance">284,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zsdGhl7zi4je" style="text-align: right" title="Beginning balance">92,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zIz0ZrdIElo7" style="text-align: right" title="Beginning balance">376,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSuc8wJCxUj8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">48,480</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z70Dx1pLPZzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">16,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z0nBpgYbN8hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">64,480</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Derivative warrant liabilities as of September 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7XGXEv1FLrd" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">333,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDSizcf5br8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">108,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zkIkdqCM81Yb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">441,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C05_gL3FVLMORBUIR-CPH_zZKsCxvjiaNk"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Measurement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company established the initial fair value for the warrants on February 9, 2022, the date of the completion of the Company&#8217;s IPO.
The Company used a Black Scholes Merton model to value the warrants. The Company allocated the proceeds received from (i) the sale of
Units (which is inclusive of one Class A Ordinary Share, one Public Warrant and one right to receive one-tenth of a Class A ordinary
share upon consummation of an initial business combination), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class
B Ordinary Shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds
allocated to Class A Ordinary Shares subject to possible redemption (temporary equity), Class A Ordinary Shares (permanent equity) and
Class B Ordinary Shares (permanent equity) based on their relative fair values at the initial measurement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-TZRS_zQShlPTDOnU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key inputs into the Black Scholes Merton model formula were as follows at February 9, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zt5f0kGmw2Z6" style="display: none">SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Private Placement</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Ordinary Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zuktzM4J1VX1" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input">9.08</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zp0zHjqqyWq4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate of interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ziRclMY3UQvk" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">1.80</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHj8xkDcreh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">9.43</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zENdeyDcOmib" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">5.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant to buy one share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zBPRmOTVN4j2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.35</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zSrI2W5Ump7h" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8AE_zLHFwktJOZLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
Measurement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values the Private Placement Warrants relative to the market prices of ordinary share and the Public Warrants, which are both actively
traded on a public market. The valuation model for the Private Placement Warrants is a risk-neutral Monte Carlo simulation. As of September
30, 2023, the measurement of the Public Warrants was valued using an observable market quote in an active market under the ticker ATAKW.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key inputs into the Monte Carlo simulation model were as follows at September 30, 2023 and December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C07_gL3FVAALMORAN-TZRS_zcX8P1iueOb6"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<div id="xdx_C0C_gL3FVAALMORAN-TZRS_zdmMpGs5GbJf"><table cellpadding="0" cellspacing="0" id="xdx_306_134_zq0JWE1vTZ6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">September 30,</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">December 31,</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Ordinary Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMdUV0T19Iif" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input">10.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk02Y9p3unUl" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input">10.23</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ztp1y6L9hRP4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcajHRr5ONx5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate of interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpnBjcQSIfM8" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">4.55</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zDLfN9CWdDdh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">3.94</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z1LF6V0RVsAf" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zXoC6C2Pss8g" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zw7FkrY1Uw1d" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">5.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTX7fIxpqkA5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">5.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant to buy one share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zow9dOFzrUe" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIGyt4fTbSN2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.02</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziOxtRzZN6Ai" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSQiBRQBJN4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td></tr>
  </table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C0F_gL3FVAALMORAN-TZRS_zrGVFZkIFN74"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
risk-free interest rate assumption was based on the linearly interpolated Treasury Constant Maturity Rate Curve between five and seven
year rates, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) six years after the
completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in
isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099056511456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zzDMwwIEYqG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE
10. <span id="xdx_82B_zqeghYTWnHpc">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or
disclosure in the condensed financial statements, other than the below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On October 9, 2023, the Company extended the Combination
Period from October 9, 2023 to November 9, 2023 by depositing $<span id="xdx_90C_eus-gaap--AssetsHeldInTrustCurrent_iI_c20231009__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztsZl6Kuh6Pe" title="Trust account">135,000</span> into the Trust Account on October 2, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On October 24, 2023, the Company issued an unsecured
promissory note (the &#8220;Seventh Working Capital Note&#8221;) in the amount of $<span id="xdx_901_ecustom--UnsecuredPromissoryNote_c20231023__20231024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zea3ezA55Tt3" title="Unsecured promissory note">75,000</span> to the Sponsor. The Seventh Working Capital
Note does not bear interest, and matures upon the earlier of two days following the date on which the Company&#8217;s initial business
combination is consummated or the date of the liquidation of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 9, 2023, the Company extended the Combination Period from November
9, 2023 to December 9, 2023 by depositing $<span id="xdx_901_eus-gaap--AssetsHeldInTrustCurrent_iI_c20231109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zN2nxdVyd6ye" title="Deposit trust account">135,000</span> into the Trust Account on November 3, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 17, 2023, the Company issued an unsecured
promissory note (the &#8220;Eighth Working Capital Note&#8221;) in the amount of $<span id="xdx_90B_eus-gaap--UnsecuredDebt_iI_c20231117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zksO27DF3rud" title="Unsecured promissory note">50,000</span> to the Sponsor. The Eighth Working Capital Note
does not bear interest, and matures upon the earlier of two days following the date on which the Company&#8217;s initial business combination
is consummated or the date of the liquidation of the Company.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099059386672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5c7ZQjccLqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zQx4h1dnoTW1">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed financial statements should be read in conjunction with the Annual Report on Form 10-K for the year
ended December 31, 2022 as filed with the SEC on April 19, 2023, which contains the audited financial statements and notes thereto. The
financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company&#8217;s Annual
Report on Form 10-K. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the
results to be expected for the year ending December 31, 2023 or for any future interim periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zob0Lry84z67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zlQrHyqu40K3">Emerging
Growth Company</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are
not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new
or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard
at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements
with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--UseOfEstimates_z2eKLJz4ABVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zGi4D2n12B3l">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject
to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziHEdcElBAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_z3HLudZMAYg4">Cash
and Cash Equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did <span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230930_zGqSKr38mMO4" title="Cash equivalents"><span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zIy2dmr9Ltxd" title="Cash equivalents">no</span></span>t have any cash equivalents as of September 30, 2023 and December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities Held in Trust Account</a></td>
<td class="text"><p id="xdx_848_eus-gaap--MarketableSecuritiesPolicy_zgSim9l0fWV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zM7u8FDrjVRe">Marketable
Securities Held in Trust Account</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on February 9, 2022, an amount of $<span id="xdx_903_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEh1TfD0NkMd" title="Net proceeds amount">204,020,000</span> from the net proceeds of the sale of the Units
in the Initial Public Offering and the sale of the Private Placement Warrants were placed in the Trust Account and is invested only in
U.S. government securities with a maturity of <span id="xdx_904_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRtH5s5xBKf5" title="Term of restricted investments">185</span> days or less or in money market funds meeting certain conditions under Rule 2a-7 under
the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding
place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any
public shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s Amended and Restated Memorandum of
Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have
their shares redeemed in connection with our initial business combination or to redeem <span id="xdx_908_ecustom--PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_iI_pid_dp_uPure_c20230930_z5CkJ6FaHeZ3" title="Percentage of public shares to be redeemed in case business combination is not consummated">100</span>% of our public shares if we do not complete
our initial business combination within <span id="xdx_902_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--IfWeDoNotCompleteOurInitialBusinessCombinationMember_zNTRLhQvUsWh" title="Period within which business combination shall be consummated from the consummation of initial public offer">24</span> months from the closing of the IPO (with exercise of six one-month extensions) or (B) with
respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an initial
business combination within <span id="xdx_90D_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--AbsentOurCompletingAnInitialBusinessCombinationMember_z1VIgxwm0mwb" title="Period within which business combination shall be consummated from the consummation of initial public offer">24</span> months from the closing of our initial public offering (with exercise of six one-month extensions), our
return of the funds held in the trust account to our public shareholders as part of our redemption of the Public Shares. As of September
30, 2023, substantially all of the assets held in the Trust Account were held in money market funds which invest in United States Treasury
securities. All of the investments held in the Trust Account are classified as trading securities. Trading securities are presented on
the balance sheet at fair value at the end of each reporting period. The estimated fair values of investments held in Trust Account are
determined using available market information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Offering Costs</a></td>
<td class="text"><p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zUuvblWO2gIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zkwmhAaGaN53">Offering
Costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A&#8212;&#8221;Expenses
of Offering&#8221;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the IPO. Offering costs are charged to shareholders&#8217; deficit or the statement of operations based on the relative
value of the Public Warrants and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the
IPO. Accordingly, on February 9, 2022, offering costs totaling $<span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zewwkQpvfngi" title="Offering costs">29,192,787</span> (consisting of $<span id="xdx_904_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJeIEabnl2Gd" title="Underwriting fees">2,525,000</span> of underwriting fees, $<span id="xdx_909_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zolMxtUxdHze" title="Deferred underwriting fees">7,070,000</span>
of deferred underwriting fees, over-allotment option liability of $<span id="xdx_905_ecustom--OverallotmentOptionLiability_c20220209__20220209_zPA2zHE7oZpj" title="Overallotment option liability">258,440</span>, $<span id="xdx_909_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zsOkxRHx08ef" title="Issuance of representative shares">3,030,000</span> for issuance of representative shares, $<span id="xdx_902_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zJ0MIuZXt5Nh" title="Rights underlying the Units">15,596,420</span>
fair value of rights underlying the Units, and $<span id="xdx_907_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvVYeyWQ04Cl" title="Actual offering costs">712,927</span> of actual offering costs), with $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzJjDfu5bgU9" title="Accumulated deficit">265,808</span> included in accumulated deficit as an
allocation for the Public Warrants, and $<span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDrOv6Q1wwqb" title="Adjustments to additional paid in capital, warrant issued">10,300,559</span> included as a reduction to proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_TemporaryEquityPolicyTextBlock', window );">Class A Ordinary shares Subject to Possible Redemption</a></td>
<td class="text"><p id="xdx_846_ecustom--TemporaryEquityPolicyTextBlock_zYEWZ5qlFjle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zDS8A7r8180i">Class
A Ordinary shares Subject to Possible Redemption</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Conditionally redeemable ordinary shares
(including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times,
ordinary shares is classified as shareholders&#8217; equity. The Company&#8217;s Class A ordinary shares features certain redemption
rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. On February
9, 2023, certain investors redeemed <span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230209__20230209_z3aSo4Uxbfma" title="Redemption of Class A ordinary shares, shares">14,529,877</span> shares of Class A ordinary shares for $<span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230209__20230209_zk0KFCtSx2S" title="Redemption of Class A ordinary shares, value">149,322,133</span>, resulting in a reduction to shares
of Class A ordinary shares outstanding to <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230201__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9ciN1oB9pAe" title="Shares outstanding">5,670,123</span>. On July 28, 2023, certain investors redeemed <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230728__20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuUpwzym4ULj" title="Redemption of Class A ordinary shares, shares">362,831</span> shares of Class A ordinary
shares for $<span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230728__20230728_zsjVqqQdtzH" title="Redemption of Class A ordinary shares">3,874,172</span>, resulting in a reduction to shares of Class A ordinary shares outstanding to <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVXXzYx9gEX" title="Temporary equity, shares outstanding">5,307,292</span>. Accordingly, at September
30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary
equity, outside of the shareholders&#8217; equity section of the Company&#8217;s balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the
absence of additional capital, in accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zHcf6nR58UCi" style="display: none">SUMMARY OF TEMPORARY EQUITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 79%; text-align: left">Gross proceeds from initial public offering</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" style="padding: 0pt; width: 18%; text-align: right" title="Gross proceeds from initial public offering">202,000,000</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Less:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to public warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" style="padding: 0pt; text-align: right" title="Proceeds allocated to public warrants">(3,521,870</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Offering costs allocated to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" style="padding: 0pt; text-align: right" title="Offering costs allocated to Class A ordinary shares subject to possible redemption">(13,079,620</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Fair value allocated to rights</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" style="padding: 0pt; text-align: right" title="Fair value allocated to rights">(15,596,420</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Plus:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to private warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" style="padding: 0pt; text-align: right" title="Proceeds allocated to private warrants">4,211,323</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Redemption of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" style="padding: 0pt; text-align: right" title="Redemption of Class A ordinary shares">(153,196,305</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Re-measurement of Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Re-measurement of Class A ordinary shares subject to possible redemption">36,664,261</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Class A ordinary shares subject to possible redemption, September 30, 2023</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">$</td><td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Class A ordinary shares subject to possible redemption, September 30, 2023">57,481,369</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table><div style="clear: both"></div>

<p id="xdx_8A5_zoCVqASZ9NG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zN6ihQlobsm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zsXoHBhnjAK1">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;).
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30,
2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be subject to potential examination by U.S. federal, U.S. state or foreign taxing authorities in the area of income taxes.
These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions
and compliance with U.S. federal, U.S. state and foreign tax laws. There is currently no taxation imposed on income by the Government
of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently,
deferred tax assets and income taxes are not reflected in the Company&#8217;s financial statements. The Company&#8217;s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income per Ordinary Share</a></td>
<td class="text"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zlDhTOoQNTf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zMEqkd0zGo82">Net
income per Ordinary Share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding
during the period. Ordinary shares subject to possible redemption at September 30, 2023, which are not currently redeemable and are not
redeemable at fair value, have been excluded from the calculation of basic net income per ordinary share since such shares, if
redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of the warrants
sold in the Initial Public Offering and the private placement to purchase an aggregate of <span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zH8O5cB0wZM7" title="Class of warrants or rights warrants issued during the period units">6,470,000</span> Private Placement Warrants in the
calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events and the
inclusion of such warrants would be anti-dilutive. As a result, diluted net income (loss) per ordinary share is the same as basic net
income per ordinary share for the period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s statement of operations includes a presentation of net income per ordinary share subject to possible redemption
and allocates the net income into the two classes of stock in calculating net earnings per ordinary share, basic and diluted.
For redeemable Class A ordinary shares, net income per ordinary share is calculated by dividing the net income by the weighted
average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. For non-redeemable Class
A ordinary shares, net income per share is calculated by dividing the net income by the weighted average number of non-redeemable
Class A ordinary shares outstanding for the period. Non-redeemable Class A ordinary shares include the representative shares issued to
Maxim at the closing of the initial public offering. For non-redeemable Class B ordinary shares, net income per share is calculated
by dividing the net income by the weighted average number of non-redeemable Class B ordinary shares outstanding for the period.
Non-redeemable Class B ordinary shares include the founder shares as these shares do not have any redemption features and do not participate
in the income earned on the Trust Account. As of September 30, 2023, the Company did not have any dilutive securities or other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
net income per ordinary share is the same as basic net income per ordinary share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none">SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Three Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">262,542</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">912,921</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj">5,413,775</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd">20,200,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">259,594</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">241,924</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Nine Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">183,421</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">4,173,309</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">7,659,431</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">17,314,286</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption">0.02</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption">0.24</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">128,188</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">1,278,093</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding">5,302,571</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share">0.02</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share">0.24</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zD9STglapad3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RelatedPartiesPolicyTextBlock', window );">Related Parties</a></td>
<td class="text"><p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zn6txi3e7Jra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zbNK8Mc6pn8a">Related
Parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z0rL5e341nuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zu9h4xeAzRWj">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zUsDGM9cFSA7" title="Federal depository insurance coverage">250,000</span>. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbRiclSaBLi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_ztH9AGXbx30c">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;Fair Value Measurement&#8221;
(&#8220;ASC 820&#8221;), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to
their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z0mtbpTsBPQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_ziYGfXBKh0la">Fair
Value Measurements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_WarrantyLiabilityPolicyTextBlock', window );">Warranty Liability</a></td>
<td class="text"><p id="xdx_847_ecustom--WarrantyLiabilityPolicyTextBlock_ziGdbr12fuBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zGlNU7vkEWq9">Warranty
Liability</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the <span id="xdx_907_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDtZFfYhB441" title="Class of warrants or rights warrants issued during the period units">26,670,000</span> warrants issued in connection with the Initial Public Offering and the Private Placement Warrants
(collectively, the &#8220;Warrants&#8221;) as either equity-classified or liability-classified instruments based on an assessment of
the Warrant&#8217;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, &#8220;Derivatives and Hedging&#8221;
(&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the company&#8217;s own ordinary shares, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as
a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon
the closing of the Initial Public Offering. Accordingly, the Company will classify each warrant as a liability at its fair value and
the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This liability is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with
the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the classification at each
balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the
date of the event that causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmVqWsEk1uzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zp1njrD6GmUg">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in
an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020- 06&#8221;), which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results
of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions&#8221; (&#8220;ASU 2022-03&#8221;), which amends ASC 820 to clarify that a contractual sales restriction is not considered
in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual
sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities
measured at fair value. The amendments are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods
within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued
or made available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial
position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s condensed financial statements.</span></p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging growth company [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_RelatedPartiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related parties [policy text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_RelatedPartiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TemporaryEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TemporaryEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_WarrantyLiabilityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warranty liability [policy text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_WarrantyLiabilityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062027616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DisclousreOfTemporaryEquityTextBlock', window );">SUMMARY OF TEMPORARY EQUITY</a></td>
<td class="text"><p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zHcf6nR58UCi" style="display: none">SUMMARY OF TEMPORARY EQUITY</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 79%; text-align: left">Gross proceeds from initial public offering</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" style="padding: 0pt; width: 18%; text-align: right" title="Gross proceeds from initial public offering">202,000,000</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Less:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to public warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" style="padding: 0pt; text-align: right" title="Proceeds allocated to public warrants">(3,521,870</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Offering costs allocated to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" style="padding: 0pt; text-align: right" title="Offering costs allocated to Class A ordinary shares subject to possible redemption">(13,079,620</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Fair value allocated to rights</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" style="padding: 0pt; text-align: right" title="Fair value allocated to rights">(15,596,420</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt">Plus:</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Proceeds allocated to private warrants</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" style="padding: 0pt; text-align: right" title="Proceeds allocated to private warrants">4,211,323</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Redemption of Class A ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" style="padding: 0pt; text-align: right" title="Redemption of Class A ordinary shares">(153,196,305</td><td style="padding: 0pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Re-measurement of Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Re-measurement of Class A ordinary shares subject to possible redemption">36,664,261</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Class A ordinary shares subject to possible redemption, September 30, 2023</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left">$</td><td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Class A ordinary shares subject to possible redemption, September 30, 2023">57,481,369</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table><div style="clear: both"></div>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none">SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Three Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">262,542</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">912,921</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj">5,413,775</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd">20,200,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">259,594</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">241,924</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption">0.05</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">Nine Months Ended September 30,</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2023</td><td style="padding: 0pt">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center">2022</td><td style="padding: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic; text-align: left">Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 68%; text-align: left">Net income attributable to Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">183,421</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right">4,173,309</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">7,659,431</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption">17,314,286</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption">0.02</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption">0.24</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-style: italic">Non-redeemable ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Net income attributable to non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">128,188</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right">1,278,093</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Denominator: weighted average non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right">&#160;</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-align: left">Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding">5,353,000</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding">5,302,571</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; text-align: left">Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share">0.02</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: left">$</td><td style="padding: 0pt; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share">0.24</span></span></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DisclousreOfTemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclousre Of Temporary Equity [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DisclousreOfTemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099057949536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-CPH_zD5cUhCEa5G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zTQjK1biSbR9">SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Private</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Public</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Placement</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Warrant</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Liability</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Derivative warrant liabilities at December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAAW9yvaFCI5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBJzhpVJpDW6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zjkR2Mp5EXyi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1203">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Initial fair value at issuance of public and private placement warrants</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcautWchdM11" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants">3,521,870</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPUaYY8buI58" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants">2,258,677</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwi5VWCHxiK7" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants">5,780,547</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zJ6ACioAM5C5" style="text-align: right" title="Change in fair value">(1,905,870</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zYWePiQpVVgf" style="text-align: right" title="Change in fair value">(1,730,725</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zaQWyTYRhrh" style="text-align: right" title="Change in fair value">(3,636,595</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Transfer of public warrants to Level 1 measurement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zR4yEiDOuKkg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement">(1,616,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_z9W2JM0r1QC9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"><span style="-sec-ix-hidden: xdx2ixbrl1219">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zIplz2uZgEY6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement">(1,616,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk35ZPQJCoX7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1223">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuiqX6BjD9A5" style="text-align: right" title="Derivative warrant liabilities, beginning balance">527,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z2vE14XdjkQl" style="text-align: right" title="Derivative warrant liabilities, beginning balance">527,952</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0lzc9YO1OB4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1229">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVSK2fdxPwu2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(280,952</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zaBexgiz6SD4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(280,952</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmJTHnEftI1j" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1235">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlGdKKEfZs3i" style="text-align: right" title="Derivative warrant liabilities, beginning balance">247,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_ztHgU0al2dre" style="text-align: right" title="Derivative warrant liabilities, beginning balance">247,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zvbpohzSkmE5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1241">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbit6K09oeg6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(118,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zxtkvJDzYeZa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(118,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Level 3 derivative warrant liabilities as of September 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNfqDo9nRbVf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1247">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z62F0CUYCOo3" style="text-align: right" title="Derivative warrant liabilities, beginning balance">129,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zeY4B19DBa66" style="text-align: right" title="Derivative warrant liabilities, beginning balance">129,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMXPPrCSeCHj" style="text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1253">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVJzQGYcYjxc" style="text-align: right" title="Change in fair value">14,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zsutCbF2VPb5" style="text-align: right" title="Change in fair value">14,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Transfer of Private Placement Warrants to Level 2 measurement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_z4EZ1dRZY6oa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"><span style="-sec-ix-hidden: xdx2ixbrl1259">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_zsoZT2Mvnmdi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement">(143,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__custom--TrancheAxis__custom--TrancheTwoMember_zfINuQwZ7j99" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement">(143,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5rkpQNhkq3" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1265">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZS2C3AJDrkf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1267">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zrjaYmZ89xzc" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1269">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTqEyRStrWk3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z2rlvsLI1no1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1273">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zOFg2Kn1tMC8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1275">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of March 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5s8rddgc5h" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1277">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zItxLcHXcHa7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1279">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zTF7FfZOHWub" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1281">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zLxLA71OMLLj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1283">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUypW4OnZY1g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1285">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zCiEM6DJpA22" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1287">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Level 3 derivative warrant liabilities as of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzHseD5ond3g" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIpO0PQXXyK" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1291">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z1ahTQKItRh6" style="text-align: right" title="Derivative warrant liabilities, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1293">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zEQyCr1lmi27" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1295">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zIcy9iXVC5ff" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1297">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zoW9aiFeNFM" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1299">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Level 3 derivative warrant liabilities as of September 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGMd85PfYbol" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1301">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zA84LOaPHYB8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1303">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zo8I0YtjQoUj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1305">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><table cellpadding="0" cellspacing="0" id="xdx_300_134_zXvobzVu7bj4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Public Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Private Placement <br/> Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total Derivative Warrant <br/> Liability</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Fair value at August 6, 2021 (inception)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoHDbRua9gO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"><span style="-sec-ix-hidden: xdx2ixbrl1345">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zaDW6fPMSV3j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"><span style="-sec-ix-hidden: xdx2ixbrl1347">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zEtGHsMFZuE8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"><span style="-sec-ix-hidden: xdx2ixbrl1349">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zfGLRHvw1C53" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zCpInILvqkAb" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1353">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z2TLeaOuA2P1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Derivative warrant liabilities as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaPoTc5OGa72" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1357">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zvTJB4eFFOrj" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1359">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z5NGqrpyZjq6" style="text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1361">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Initial fair value at issuance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zusAqYCMyzJe" style="width: 14%; text-align: right" title="Initial fair value at issuance">3,521,870</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z1DwZtMuWkli" style="width: 14%; text-align: right" title="Initial fair value at issuance">2,258,677</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zlWxhKHlVtD2" style="width: 14%; text-align: right" title="Initial fair value at issuance">5,780,547</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zxwm5JtkoSxi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(1,905,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxKYSGFygD4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(1,730,725</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z3MTrlLBzOrb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(3,636,595</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMjpHJPMYFCh" style="text-align: right" title="Beginning balance">1,616,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5RX6lbVUhqk" style="text-align: right" title="Beginning balance">527,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zsnrp3pkvSui" style="text-align: right" title="Beginning balance">2,143,952</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcqo6J3Iufd3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(858,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbus30l94wfd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(280,952</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zPZIPMXD5OSg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(1,139,452</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgAtIztGvnJa" style="text-align: right" title="Beginning balance">757,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zAinMA6aMoLk" style="text-align: right" title="Beginning balance">247,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zoi4DoxsH0g" style="text-align: right" title="Beginning balance">1,004,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7iD7sBnVLB1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(353,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zg5ZLeIj6He3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(118,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zihHLQZOYDZd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(471,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of September 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z22mlIrpvDzi" style="text-align: right" title="Beginning balance">404,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zMTyxZ0la7Mb" style="text-align: right" title="Beginning balance">129,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zvkWjznTQL6k" style="text-align: right" title="Beginning balance">533,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zm0OF5ZcsLgg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">42,420</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ztq2KfsXNqi1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">14,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zU8nnSUYWGU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">56,420</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuNRYsE2pMv9" style="text-align: right" title="Beginning balance">446,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zOnBX3nNM0f7" style="text-align: right" title="Beginning balance">143,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zAjBDQ3RdICk" style="text-align: right" title="Beginning balance">589,420</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zhlIcHSpkWoe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">58,580</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zgXpwvXdwbS8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">20,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z8CfLV9zo6Da" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">78,580</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of March 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z747OAysoByl" style="text-align: right" title="Beginning balance">505,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zPvSDxXFfYVi" style="text-align: right" title="Beginning balance">163,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zG5ctc2KhBwf" style="text-align: right" title="Beginning balance">668,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zsCjyvl8T6o7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(220,180</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zJ5V073Zrfk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(71,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zMWBTSKhBbbg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(291,180</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Derivative warrant liabilities as of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUavEazgfMoi" style="text-align: right" title="Beginning balance">284,820</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zsdGhl7zi4je" style="text-align: right" title="Beginning balance">92,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zIz0ZrdIElo7" style="text-align: right" title="Beginning balance">376,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSuc8wJCxUj8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">48,480</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z70Dx1pLPZzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">16,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z0nBpgYbN8hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">64,480</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Derivative warrant liabilities as of September 30, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7XGXEv1FLrd" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">333,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDSizcf5br8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">108,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zkIkdqCM81Yb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">441,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxL5juBT1i5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that were accounted for
at fair value on a recurring basis at September 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zjDZeVmZNQj8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY
OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Cash and marketable securities held in trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4gawblzyND5" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account">57,481,369</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjL6ihv07bGi" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1311">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKfKmzxa0mKj" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1313">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUpVGrwowabe" style="text-align: right" title="Public Warrants">333,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z2UzQA5ORCXk" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1317">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zmX9FjgKRCIf" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1319">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5rPXzSJlan7" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1321">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zlq4icCL71K5" style="text-align: right" title="Private Placement Warrants">108,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUeBNa89tspk" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1325">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that were accounted for
at fair value on a recurring basis at December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Cash and marketable securities held in trust account</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKO5NLuAMp7k" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account">206,879,903</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgIGL1Zf3wId" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1329">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqnmllIx2U" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"><span style="-sec-ix-hidden: xdx2ixbrl1331">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziIb67mCZpRe" style="text-align: right" title="Public Warrants">446,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAp98Oyxi5E3" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1335">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zC3EnF8U5du7" style="text-align: right" title="Public Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1337">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxyU81j4Q092" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1339">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDbWrxtK1Era" style="text-align: right" title="Private Placement Warrants">143,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUhcMt9t0x7d" style="text-align: right" title="Private Placement Warrants"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS</a></td>
<td class="text"><p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-TZRS_zQShlPTDOnU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key inputs into the Black Scholes Merton model formula were as follows at February 9, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zt5f0kGmw2Z6" style="display: none">SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Private Placement</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Ordinary Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zuktzM4J1VX1" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input">9.08</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zp0zHjqqyWq4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate of interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ziRclMY3UQvk" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">1.80</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHj8xkDcreh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">9.43</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zENdeyDcOmib" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">5.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant to buy one share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zBPRmOTVN4j2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.35</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zSrI2W5Ump7h" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td></tr>
  </table>

<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><table cellpadding="0" cellspacing="0" id="xdx_306_134_zq0JWE1vTZ6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">September 30,</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">December 31,</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Ordinary Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMdUV0T19Iif" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input">10.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk02Y9p3unUl" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input">10.23</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ztp1y6L9hRP4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcajHRr5ONx5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate of interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpnBjcQSIfM8" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">4.55</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zDLfN9CWdDdh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">3.94</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z1LF6V0RVsAf" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zXoC6C2Pss8g" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zw7FkrY1Uw1d" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">5.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTX7fIxpqkA5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">5.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant to buy one share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zow9dOFzrUe" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIGyt4fTbSN2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.02</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziOxtRzZN6Ai" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSQiBRQBJN4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input">0.00</td><td style="text-align: left">%</td></tr>
  </table>

<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099047704912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 27, 2023</div></th>
<th class="th"><div>Feb. 03, 2023</div></th>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_OverallotmentOptionLiability', window );">Over-allotment option liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 258,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue', window );">Issuance of representative shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,030,000<span></span>
</td>
<td class="nump">$ 3,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RightsUnderlyingTheUnitsValue', window );">Rights underlying the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,596,420<span></span>
</td>
<td class="nump">$ 15,596,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Operating cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,468,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Net proceeds amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 204,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent event, description</a></td>
<td class="text">the Company held an extraordinary general meeting of shareholders (the &#8220;July Extraordinary General Meeting&#8221;),
to, among other things, approve (i) a special resolution to amend the amended and restated articles of association of the Company (the
&#8220;Articles&#8221;) giving the Company the right to further extend the Business Combination Period six (6) times for an additional
one (1) month each time, from August 9, 2023 to February 7, 2024 (the &#8220;Second Extension Amendment&#8221;) and (ii) the proposal
to approve the Second Trust Amendment (as defined below). All proposals at the July Extraordinary General Meeting were approved by the
shareholders of the Company. As such, the Company and Transfer Agent entered into Amendment No. 2 to the Investment Management Trust
Agreement, to allow ATAK to extend the Business Combination Period six (6) times for an additional one (1) month each time from August
9, 2023 to February 9, 2024 by depositing into the Trust Account for each one-month extension the lesser of: (x) $135,000 or (y) $0.045
per share multiplied by the number of public shares then outstanding (the &#8220;Second Trust Amendment&#8221;). In addition, on July
27, 2023, the Company adopted the Second Extension Amendment, amending the Company&#8217;s Articles. As of September 30, 2023, the Company
exercised eight of the one-month extensions, depositing a total of $1,080,000 into the Trust Account to fund the extensions<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount', window );">Percentage of fair market value of target business to asset held in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinimumNetWorthRequiredForCompliance', window );">Banking regulation, mortgage banking, net worth, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod', window );">Business combination extension of business combination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">extends
the period of time to consummate the initial Business Combination up to six times, each by an additional one month (for a total of
up to 24 months from the date of the Initial Public Offering to complete the Business Combination)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed', window );">Number of days within which public shares shall be redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities', window );">Expenses payable on dissolution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_NetWorkingCapitalSurplusDeficit', window );">Working capital (deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,595,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember', window );">Amendment No One To Investment Management Trust Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms', window );">Description of business combination extended period terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Company to extend the date by which it has to consummate
a business combination six times for an additional one month each time from February 9, 2023 to August 9, 2023, extending the Combination
period up to 24 months, if applicable, by depositing into the Trust Account for each one-month extension the lesser of $135,000 or $0.045
per share multiplied by the number of public shares then outstanding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable', window );">Minimum Public Share price due to reductions in the value of the trust assets less taxes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember', window );">Sponsor [Member] | Private Placement Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits', window );">Class of warrants or rights warrants issued during the period units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant', window );">Class of warrants or rights warrants issued issue price per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock shares issued during the period for services shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,192,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherUnderwritingExpense', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ActualOfferingCosts', window );">Actual offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Net proceeds amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_TermOfRestrictedInvestments', window );">Term of restricted investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">185 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer', window );">Period within which business combination shall be consummated from the consummation of initial public offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer', window );">Period within which business combination shall be consummated from the consummation of initial public offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Private Placement Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits', window );">Class of warrants or rights warrants issued during the period units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ActualOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actual offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ActualOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination extension of business combination period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights warrants issued during the period units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights warrants issued price per warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of business combination extended period terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum public share price due to reductions in the value of the trust assets less taxes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_NetWorkingCapitalSurplusDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net working capital surplus deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_NetWorkingCapitalSurplusDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of days with in which public shares shall be redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_OverallotmentOptionLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Overallotment option liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_OverallotmentOptionLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair market value of target business to asset held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period with in which business combination shall be consummated from the consummation of initial public offer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_RightsUnderlyingTheUnitsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rights underlying the units value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_RightsUnderlyingTheUnitsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period representative shares issued value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TermOfRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of restricted investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TermOfRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480034/205-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinimumNetWorthRequiredForCompliance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum net worth required for mortgage banking as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 948<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481586/948-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 948<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481586/948-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 948<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481586/948-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 948<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481586/948-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinimumNetWorthRequiredForCompliance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 720<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479448/944-720-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099047489280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF TEMPORARY EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 28, 2023</div></th>
<th class="th"><div>Feb. 09, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption of Class A ordinary shares</a></td>
<td class="nump">$ 3,874,172<span></span>
</td>
<td class="nump">$ 149,322,133<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares subject to possible redemption, September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,481,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,481,369<span></span>
</td>
<td class="nump">$ 206,879,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATAK_CommonClassASubjectToRedemptionMember', window );">Common Class A Subject To Redemption [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds from initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Offering costs allocated to Class A ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,079,620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_FairValueAllocatedToRights', window );">Fair value allocated to rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,596,420)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption of Class A ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(153,196,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Re-measurement of Class A ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,664,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares subject to possible redemption, September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,481,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,481,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATAK_CommonClassASubjectToRedemptionMember', window );">Common Class A Subject To Redemption [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Proceeds allocated to private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,521,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATAK_CommonClassASubjectToRedemptionMember', window );">Common Class A Subject To Redemption [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Proceeds allocated to private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,211,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_FairValueAllocatedToRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value allocated to rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_FairValueAllocatedToRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATAK_CommonClassASubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATAK_CommonClassASubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099053043344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATAK_RedeemableClassAOrdinarySharesMember', window );">Redeemable Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to non-redeemable Class A and Class B ordinary shares</a></td>
<td class="nump">$ 262,542<span></span>
</td>
<td class="nump">$ 912,921<span></span>
</td>
<td class="nump">$ 183,421<span></span>
</td>
<td class="nump">$ 4,173,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Denominator: weighted average non-redeemable Class A and Class B ordinary shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding</a></td>
<td class="nump">5,413,775<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">7,659,431<span></span>
</td>
<td class="nump">17,314,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding</a></td>
<td class="nump">5,413,775<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="nump">7,659,431<span></span>
</td>
<td class="nump">17,314,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATAK_NonredeemableCommonStockMember', window );">Nonredeemable Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator: income attributable to non-redeemable Class A and Class B ordinary shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to non-redeemable Class A and Class B ordinary shares</a></td>
<td class="nump">$ 259,594<span></span>
</td>
<td class="nump">$ 241,924<span></span>
</td>
<td class="nump">$ 128,188<span></span>
</td>
<td class="nump">$ 1,278,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Denominator: weighted average non-redeemable Class A and Class B ordinary shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding</a></td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,302,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding</a></td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,353,000<span></span>
</td>
<td class="nump">5,302,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATAK_RedeemableClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATAK_RedeemableClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATAK_NonredeemableCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATAK_NonredeemableCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099046941952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 28, 2023</div></th>
<th class="th"><div>Feb. 09, 2023</div></th>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Net proceeds amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 204,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated', window );">Percentage of public shares to be redeemed in case business combination is not consummated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_OverallotmentOptionLiability', window );">Overallotment option liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 258,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue', window );">Issuance of representative shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_RightsUnderlyingTheUnitsValue', window );">Rights underlying the Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,596,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,596,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,107,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,107,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,621,413)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption of Class A ordinary shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,529,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption of Class A ordinary shares</a></td>
<td class="nump">$ 3,874,172<span></span>
</td>
<td class="nump">$ 149,322,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federal depository insurance coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits', window );">Class of warrants or rights warrants issued during the period units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption of Class A ordinary shares, shares</a></td>
<td class="nump">362,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,307,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,307,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,670,123<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PeriodAfterWhichSharesAreRedeemableAxis=ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember', window );">If We Do Not Complete Our Initial Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer', window );">Period within which business combination shall be consummated from the consummation of initial public offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PeriodAfterWhichSharesAreRedeemableAxis=ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember', window );">Absent Our Completing An Initial Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer', window );">Period within which business combination shall be consummated from the consummation of initial public offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Net proceeds amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_TermOfRestrictedInvestments', window );">Term of restricted investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">185 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,192,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherUnderwritingExpense', window );">Underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ActualOfferingCosts', window );">Actual offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid in capital, warrant issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Private Placement Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits', window );">Class of warrants or rights warrants issued during the period units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ActualOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actual offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ActualOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights warrants issued during the period units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_OverallotmentOptionLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Overallotment option liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_OverallotmentOptionLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares to be redeemed in case business combination is not consummated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period with in which business combination shall be consummated from the consummation of initial public offer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_RightsUnderlyingTheUnitsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rights underlying the units value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_RightsUnderlyingTheUnitsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period representative shares issued value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TermOfRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of restricted investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TermOfRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction cost incurred as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 720<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479448/944-720-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_PeriodAfterWhichSharesAreRedeemableAxis=ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_PeriodAfterWhichSharesAreRedeemableAxis=ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_PeriodAfterWhichSharesAreRedeemableAxis=ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_PeriodAfterWhichSharesAreRedeemableAxis=ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099052950832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_TermOfRestrictedInvestments', window );">Term of restricted investments</a></td>
<td class="text">185 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="nump">20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockConversionBasis', window );">Common stock, conversion basis</a></td>
<td class="text">Each Unit consists of one
Class A ordinary share, one redeemable warrant (each whole warrant, a &#8220;Public Warrant&#8221;), and one right to receive one-tenth
of one Class A ordinary share upon the consummation of the Company&#8217;s initial Business Combination. Each two Public Warrants entitle
the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TermOfRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of restricted investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TermOfRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of basis for conversion of convertible common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099048452432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PRIVATE PLACEMENT (Details Narrative) - Private Placement Warrant [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrant or right, number of securities called by each warrant or right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits', window );">Class of warrants or rights warrants issued during the period units</a></td>
<td class="nump">6,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant', window );">Class of warrants or rights warrants issued price per warrant</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">$ 6,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights warrants issued during the period units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights warrants issued price per warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099051933696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 01, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 05, 2023</div></th>
<th class="th"><div>Jun. 02, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
<th class="th"><div>Apr. 06, 2023</div></th>
<th class="th"><div>Mar. 07, 2023</div></th>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Aug. 07, 2021</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jul. 10, 2023</div></th>
<th class="th"><div>Jun. 14, 2023</div></th>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>Mar. 03, 2023</div></th>
<th class="th"><div>Feb. 08, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related parties current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ATAK_WorkingCapitalLoanMember', window );">Working Capital Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt instrument convertible into warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt instrument conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ATAK_OfficeSpaceAdministrativeAndSupportServicesMember', window );">Office Space Administrative And Support Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ATAK_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Administrative support agreement expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_PromissoryNoteMember', window );">Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 810,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_PromissoryNoteMember', window );">Promissory Note [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Aggregate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_FirstWorkingCapitalMember', window );">First Working Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_FirstExtensionNoteMember', window );">First Extension Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_SecondExtensionNoteMember', window );">Second Extension Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Outstanding value under the note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_SecondWorkingCapitalMember', window );">Second Working Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_ThirdWorkingCapitalMember', window );">Third Working Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_FourthWorkingCapitalMember', window );">Fourth Working Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_FifthWorkingCapitalMember', window );">Fifth Working Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 810,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_ThirdExtensionNoteMember', window );">Third Extension Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">$ 270,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_WorkingCapitalNotesMember', window );">Working Capital Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Outstanding value under the note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATAK_WorkingCapitalAndSecondExtensionNoteMember', window );">Working Capital And Second Extension Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Outstanding value under the note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member] | Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares issued, shares, share based payment arrangement, forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,307,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,307,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ShareTransferTriggerPricePerShare', window );">Share transfer, trigger price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Share Price More Than Or Equals To Used Twelve [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice', window );">Number of consecutive trading days for determining share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_NumberOfTradingDaysForDeterminingSharePrice', window );">Number of trading days for determining share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination', window );">Threshold number of trading days for determining share price from date of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days for determining share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_NumberOfTradingDaysForDeterminingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of trading days for determining share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_NumberOfTradingDaysForDeterminingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ShareTransferTriggerPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share transfer trigger price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ShareTransferTriggerPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of trading days for determining share price from date of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ATAK_WorkingCapitalLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ATAK_WorkingCapitalLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ATAK_OfficeSpaceAdministrativeAndSupportServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ATAK_OfficeSpaceAdministrativeAndSupportServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ATAK_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ATAK_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_FirstWorkingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_FirstWorkingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_FirstExtensionNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_FirstExtensionNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_SecondExtensionNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_SecondExtensionNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_SecondWorkingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_SecondWorkingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_ThirdWorkingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_ThirdWorkingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_FourthWorkingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_FourthWorkingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_FifthWorkingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_FifthWorkingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_ThirdExtensionNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_ThirdExtensionNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_WorkingCapitalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_WorkingCapitalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATAK_WorkingCapitalAndSecondExtensionNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATAK_WorkingCapitalAndSecondExtensionNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ATAK_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ATAK_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TriggeringEventAxis=ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TriggeringEventAxis=ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099056825456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SHAREHOLDERS&#8217; DEFICIT (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jul. 28, 2023</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 07, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity shares outstanding</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="nump">5,307,292<span></span>
</td>
<td class="nump">5,670,123<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity shares issued</a></td>
<td class="nump">5,307,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_CommonStockThresholdPercentageOnConversionOfShares', window );">Common stock, threshold percentage on conversion of shares</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member] | Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,050,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_CommonStockThresholdPercentageOnConversionOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock threshold percentage on conversion of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_CommonStockThresholdPercentageOnConversionOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ATAK_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ATAK_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099048402240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants or rights outstanding | shares</a></td>
<td class="nump">26,670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo', window );">Minimum lock In period for transfer, assign or sell warrants after completion of IPO</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember', window );">Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights</a></td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue', window );">Class of warrant or right exercise price adjustment percentage higher of market value</a></td>
<td class="nump">180.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember', window );">Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights</a></td>
<td class="nump">$ 9.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue', window );">Class of warrant or right exercise price adjustment percentage higher of market value</a></td>
<td class="nump">115.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember', window );">Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ShareRedemptionTriggerPrice', window );">Share redemption trigger price</a></td>
<td class="nump">$ 9.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity', window );">Minimum percentage gross proceeds required from issuance of equity</a></td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption', window );">Class of warrant right minimum notice period for redemption</a></td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants or rights outstanding | shares</a></td>
<td class="nump">20,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination', window );">Warrants exercisable term from the date of completion of business combination</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination', window );">Minimum lock in period for SEC registration from date of business combination</a></td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination', window );">Minimum lock in period to become effective after the closing of the initial business combination</a></td>
<td class="text">60 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants or rights outstanding | shares</a></td>
<td class="nump">6,470,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_RedemptionOfWarrantsMember', window );">Redemption Of Warrants [Member] | Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsRedemptionPricePerUnit', window );">Class of warrants redemption price per unit</a></td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_ClassOfWarrantsRedemptionNoticePeriod', window );">Class of warrants, redemption notice period</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice', window );">Number of consecutive trading days for determining share price</a></td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_NumberOfTradingDaysForDeterminingSharePrice', window );">Number of trading days for determining share price</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right exercise price adjustment percentage higher of market value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right minimum notice period for redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsRedemptionNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants redemption notice period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsRedemptionNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ClassOfWarrantsRedemptionPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants redemption price per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ClassOfWarrantsRedemptionPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum lock in period for transfer assign or sell warrants after completion of ipo.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum lock in period to become effective after the closing of the initial business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum lock in period for sec registration from date of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage gross proceeds required from issuance of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days for determining share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_NumberOfTradingDaysForDeterminingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of trading days for determining share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_NumberOfTradingDaysForDeterminingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ShareRedemptionTriggerPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share redemption trigger price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ShareRedemptionTriggerPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable term from the date of completion of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_ShareRedemptionTriggerPriceAxis=ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_RedemptionOfWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_RedemptionOfWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099046833424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 202,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DeferredUnderwritingCommissionsNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,070,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ATAK_UnderwritingAgreementMember', window );">Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DeferredUnderwritingCommissionPerUnit', window );">Deferred underwriting commission per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_DeferredUnderwritingCommissionsNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ATAK_UnderwritingAgreementMember', window );">Underwriting Agreement [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares issued, shares, share-based payment arrangement, forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_OverAllotmentOptionPeriod', window );">Over allotment option period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Maxim IPO shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Maxim IPO shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting fees</a></td>
<td class="nump">$ 7,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DeferredUnderwritingCommissionPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commission per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DeferredUnderwritingCommissionPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_DeferredUnderwritingCommissionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commissions noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_DeferredUnderwritingCommissionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_OverAllotmentOptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over allotment option period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_OverAllotmentOptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ATAK_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ATAK_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATAK_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099053291200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance public and private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,521,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">$ 48,480<span></span>
</td>
<td class="num">$ (220,180)<span></span>
</td>
<td class="nump">$ 58,580<span></span>
</td>
<td class="nump">$ 42,420<span></span>
</td>
<td class="num">$ (353,500)<span></span>
</td>
<td class="num">$ (858,500)<span></span>
</td>
<td class="num">(1,905,870)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember', window );">Public Warrants [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities, beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance public and private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,521,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember', window );">Public Warrants [Member] | Fair Value, Inputs, Level 3 [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,905,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfer of private placement warrants to level 2 measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,616,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember', window );">Public Warrants [Member] | Fair Value, Inputs, Level 3 [Member] | Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfer of private placement warrants to level 2 measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance public and private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,258,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="num">(71,000)<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
<td class="num">(280,952)<span></span>
</td>
<td class="num">(1,730,725)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities, beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
<td class="nump">527,952<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance public and private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,258,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
<td class="num">(280,952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
<td class="nump">527,952<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Fair Value, Inputs, Level 3 [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,730,725)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfer of private placement warrants to level 2 measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Fair Value, Inputs, Level 3 [Member] | Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfer of private placement warrants to level 2 measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_WarrantLiabilityMember', window );">Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities, beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
<td class="nump">527,952<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance public and private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,780,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
<td class="num">(280,952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 129,000<span></span>
</td>
<td class="nump">$ 247,000<span></span>
</td>
<td class="nump">527,952<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_WarrantLiabilityMember', window );">Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,636,595)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfer of private placement warrants to level 2 measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,616,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_WarrantLiabilityMember', window );">Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfer of private placement warrants to level 2 measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (143,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TrancheAxis=ATAK_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TrancheAxis=ATAK_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_TrancheAxis=ATAK_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_TrancheAxis=ATAK_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099056332304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in trust account</a></td>
<td class="nump">$ 57,481,369<span></span>
</td>
<td class="nump">$ 206,879,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Private Placement Warrants</a></td>
<td class="nump">333,300<span></span>
</td>
<td class="nump">446,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Private Placement Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Private Placement Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Private Placement Warrants</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Private Placement Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Private Placement Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in trust account</a></td>
<td class="nump">57,481,369<span></span>
</td>
<td class="nump">206,879,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in trust account</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in trust account</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099052914048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Beginning balance</a></td>
<td class="nump">$ 284,820<span></span>
</td>
<td class="nump">$ 505,000<span></span>
</td>
<td class="nump">$ 446,420<span></span>
</td>
<td class="nump">$ 404,000<span></span>
</td>
<td class="nump">$ 757,500<span></span>
</td>
<td class="nump">$ 1,616,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">48,480<span></span>
</td>
<td class="num">(220,180)<span></span>
</td>
<td class="nump">58,580<span></span>
</td>
<td class="nump">42,420<span></span>
</td>
<td class="num">(353,500)<span></span>
</td>
<td class="num">(858,500)<span></span>
</td>
<td class="num">(1,905,870)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,521,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Ending balance</a></td>
<td class="nump">333,300<span></span>
</td>
<td class="nump">284,820<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">446,420<span></span>
</td>
<td class="nump">404,000<span></span>
</td>
<td class="nump">757,500<span></span>
</td>
<td class="nump">1,616,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Beginning balance</a></td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">163,000<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
<td class="nump">527,952<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="num">(71,000)<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
<td class="num">(280,952)<span></span>
</td>
<td class="num">(1,730,725)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,258,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Ending balance</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">163,000<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
<td class="nump">527,952<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_DerivativeWarrantLiabilityMember', window );">Derivative Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Beginning balance</a></td>
<td class="nump">376,820<span></span>
</td>
<td class="nump">668,000<span></span>
</td>
<td class="nump">589,420<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
<td class="nump">1,004,500<span></span>
</td>
<td class="nump">2,143,952<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">64,480<span></span>
</td>
<td class="num">(291,180)<span></span>
</td>
<td class="nump">78,580<span></span>
</td>
<td class="nump">56,420<span></span>
</td>
<td class="num">(471,500)<span></span>
</td>
<td class="num">(1,139,452)<span></span>
</td>
<td class="num">(3,636,595)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial fair value at issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,780,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Ending balance</a></td>
<td class="nump">$ 441,300<span></span>
</td>
<td class="nump">$ 376,820<span></span>
</td>
<td class="nump">$ 668,000<span></span>
</td>
<td class="nump">$ 589,420<span></span>
</td>
<td class="nump">$ 533,000<span></span>
</td>
<td class="nump">$ 1,004,500<span></span>
</td>
<td class="nump">$ 2,143,952<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_DerivativeWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_DerivativeWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099053025376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 09, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">10.85<span></span>
</td>
<td class="nump">10.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">4.55<span></span>
</td>
<td class="nump">3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">5.25<span></span>
</td>
<td class="nump">5.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=ATAK_MeasurementInputProbabilityMember', window );">Measurement Input Probability [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=ATAK_MeasurementInputProbabilityMember', window );">Measurement Input Probability [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">0.02<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ATAK_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ATAK_MeasurementInputProbabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ATAK_MeasurementInputProbabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099062029712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liability</a></td>
<td class="nump">$ 441,300<span></span>
</td>
<td class="nump">$ 589,420<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140099048515744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 24, 2023</div></th>
<th class="th"><div>Nov. 17, 2023</div></th>
<th class="th"><div>Nov. 09, 2023</div></th>
<th class="th"><div>Oct. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Deposit trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATAK_UnsecuredPromissoryNote', window );">Unsecured promissory note</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATAK_UnsecuredPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATAK_UnsecuredPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATAK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ATAK_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ATAK_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>form10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ATAK="http://auroraspac.com/20230930"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="atak-20230930.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CapitalUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_RightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-20_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="AsOf2023-11-20_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:NonredeemableCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2022-02-092022-02-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2022-02-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2023-02-032023-02-03_custom_AmendmentNoOneToInvestmentManagementTrustAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:AmendmentNoOneToInvestmentManagementTrustAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-03</startDate>
            <endDate>2023-02-03</endDate>
        </period>
    </context>
    <context id="From2023-07-272023-07-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-07-27</startDate>
            <endDate>2023-07-27</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_IfWeDoNotCompleteOurInitialBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:PeriodAfterWhichSharesAreRedeemableAxis">ATAK:IfWeDoNotCompleteOurInitialBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_AbsentOurCompletingAnInitialBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:PeriodAfterWhichSharesAreRedeemableAxis">ATAK:AbsentOurCompletingAnInitialBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-02-092023-02-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-02-09</startDate>
            <endDate>2023-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-01_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="From2023-07-282023-07-28_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-28</startDate>
            <endDate>2023-07-28</endDate>
        </period>
    </context>
    <context id="From2023-07-282023-07-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
        </entity>
        <period>
            <startDate>2023-07-28</startDate>
            <endDate>2023-07-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-28_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-28</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_IPOMember_custom_PrivatePlacementWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_WarrantMember68552781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_CommonClassASubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:CommonClassASubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATAK:RedeemableClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-07</startDate>
            <endDate>2021-08-07</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-07</instant>
        </period>
    </context>
    <context id="AsOf2021-08-07_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-07</instant>
        </period>
    </context>
    <context id="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TriggeringEventAxis">ATAK:SharePriceMoreThanOrEqualsToUsdTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-07</startDate>
            <endDate>2021-08-07</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-07_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-07</instant>
        </period>
    </context>
    <context id="From2021-08-072021-08-07_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-07</startDate>
            <endDate>2021-08-07</endDate>
        </period>
    </context>
    <context id="AsOf2022-02-09_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-02-08_custom_FirstWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FirstWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-08</instant>
        </period>
    </context>
    <context id="AsOf2023-02-08_custom_FirstExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FirstExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-08</instant>
        </period>
    </context>
    <context id="AsOf2023-03-03_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-03</instant>
        </period>
    </context>
    <context id="From2023-03-072023-03-07_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <context id="From2023-04-062023-04-06_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-06</startDate>
            <endDate>2023-04-06</endDate>
        </period>
    </context>
    <context id="From2023-05-052023-05-05_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <context id="From2023-06-022023-06-02_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-02</endDate>
        </period>
    </context>
    <context id="From2023-07-052023-07-05_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-05</startDate>
            <endDate>2023-07-05</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-06_custom_SecondWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-06</instant>
        </period>
    </context>
    <context id="AsOf2023-05-02_custom_ThirdWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:ThirdWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="AsOf2023-06-14_custom_FourthWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FourthWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-14</instant>
        </period>
    </context>
    <context id="AsOf2023-07-10_custom_FifthWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FifthWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-10</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_FifthWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FifthWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-07-312023-07-31_custom_ThirdExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:ThirdExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-01_custom_ThirdExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:ThirdExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-01_custom_FifthWorkingCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:FifthWorkingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WorkingCapitalNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:WorkingCapitalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_SecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:SecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WorkingCapitalAndSecondExtensionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATAK:WorkingCapitalAndSecondExtensionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WorkingCapitalLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:WorkingCapitalLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RelatedPartyMember68554234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RelatedPartyMember68554250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-02-092022-02-09_custom_OfficeSpaceAdministrativeAndSupportServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:OfficeSpaceAdministrativeAndSupportServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-09</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_AdministrativeSupportAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_AdministrativeSupportAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_AdministrativeSupportAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_custom_AdministrativeSupportAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ATAK:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_FounderSharesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ATAK:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:RedemptionOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:RedemptionOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:ShareRedemptionTriggerPriceAxis">ATAK:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SponsorMember_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATAK:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_UnderwritingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ATAK:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember_custom_TrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember_custom_TrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember_custom_TrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ATAK:TrancheAxis">ATAK:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-08-05_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="AsOf2021-08-05_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="AsOf2021-08-05_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="From2021-08-062021-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-08-062021-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-08-062021-12-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_DerivativeWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:DerivativeWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_MeasurementInputSharePriceMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_MeasurementInputExercisePriceMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_MeasurementInputPriceVolatilityMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_MeasurementInputExpectedTermMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_custom_MeasurementInputProbabilityMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ATAK:MeasurementInputProbabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2022-02-09_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ATAK:MeasurementInputProbabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ATAK:MeasurementInputProbabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ATAK:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-10-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-09</instant>
        </period>
    </context>
    <context id="From2023-10-232023-10-24_us-gaap_SubsequentEventMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ATAK:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-23</startDate>
            <endDate>2023-10-24</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-09</instant>
        </period>
    </context>
    <context id="AsOf2023-11-17_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001883788</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-17</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-09-30">0001883788</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-09-30"
      id="xdx2ixbrl0113"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-09-30"
      id="xdx2ixbrl0142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0143"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-09-30"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0238"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability
      contextRef="From2022-07-012022-09-30"
      id="xdx2ixbrl0239"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-07-012022-09-30"
      id="xdx2ixbrl0244"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0342"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-03-31"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0359"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-04-012023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-04-012023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0446"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0448"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0486"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0530"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0555"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0556"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:AllocationOfDeferredOfferingCostsForWarrantLiability
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0653"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0659"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl0666"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0686"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:DeferredUnderwritingFeePayable
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0689"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:ForfeitureOfRepresentativeShares
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0695"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0698"
      unitRef="USD"
      xsi:nil="true"/>
    <ATAK:DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl0701"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1199"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember"
      id="xdx2ixbrl1219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1235"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember_custom_TrancheTwoMember"
      id="xdx2ixbrl1259"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1277"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1279"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1285"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-04-012023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-06-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-07-012023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1305"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-30_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PublicWarrantsMember"
      id="xdx2ixbrl1335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-08-05_custom_PublicWarrantsMember"
      id="xdx2ixbrl1345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-08-05_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-08-05_custom_DerivativeWarrantLiabilityMember"
      id="xdx2ixbrl1349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-08-062021-12-31_custom_PublicWarrantsMember"
      id="xdx2ixbrl1351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-08-062021-12-31_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-08-062021-12-31_custom_DerivativeWarrantLiabilityMember"
      id="xdx2ixbrl1355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-12-31_custom_PublicWarrantsMember"
      id="xdx2ixbrl1357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1359"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-12-31_custom_DerivativeWarrantLiabilityMember"
      id="xdx2ixbrl1361"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-01-01to2023-09-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2023-01-01to2023-09-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-09-30">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-09-30">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2023-01-01to2023-09-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2023-01-01to2023-09-30">001-41250</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-09-30">AURORA TECHNOLOGY ACQUISITION CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-09-30">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-01to2023-09-30">98-1624542</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-09-30">4 Embarcadero Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-09-30">Suite 1449</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-09-30">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-01to2023-09-30">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-09-30">94105</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-01to2023-09-30">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-01to2023-09-30">550-0458</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember">Units,     each consisting of one Class A Ordinary Share, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember">ATAKU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-012023-09-30_us-gaap_CapitalUnitsMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-01to2023-09-30">Class     A Ordinary Share, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-01to2023-09-30">ATAK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-01to2023-09-30">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember">Redeemable     Warrants, exercisable for Class A Ordinary Shares at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember">ATAKW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-012023-09-30_us-gaap_RightsMember">Rights     to one-tenth of one Class A Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-012023-09-30_us-gaap_RightsMember">ATAKR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-012023-09-30_us-gaap_RightsMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-09-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-01-01to2023-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-01-01to2023-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-09-30">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-01-01to2023-09-30">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="From2023-01-01to2023-09-30">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-11-20_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5610292</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-11-20_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">28943</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">191103</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">26118</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">284597</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">55061</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">475700</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">57481369</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">206879903</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">57481369</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">206879903</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">57536430</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">207355603</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">1980439</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">30132</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">215362</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">357026</us-gaap:AccruedLiabilitiesCurrent>
    <ATAK:AccruedOfferingCosts contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">50000</ATAK:AccruedOfferingCosts>
    <ATAK:AccruedOfferingCosts contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">50000</ATAK:AccruedOfferingCosts>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-09-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1405000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">3650801</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">437158</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">441300</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">589420</us-gaap:DerivativeLiabilitiesNoncurrent>
    <ATAK:DeferredUnderwritingCommissionsNoncurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">7070000</ATAK:DeferredUnderwritingCommissionsNoncurrent>
    <ATAK:DeferredUnderwritingCommissionsNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">7070000</ATAK:DeferredUnderwritingCommissionsNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">7511300</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">7659420</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">11162101</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">8096578</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">500000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">500000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2023-09-30"
      decimals="INF"
      unitRef="USDPShares">10.83</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">10.24</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">57481369</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">206879903</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">30</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">30</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">505</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">505</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">505</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">505</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">-11107575</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-7621413</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">-11107040</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-7620878</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">57536430</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">207355603</us-gaap:LiabilitiesAndStockholdersEquity>
    <ATAK:FormationAndOperatingCosts
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">479300</ATAK:FormationAndOperatingCosts>
    <ATAK:FormationAndOperatingCosts
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">219330</ATAK:FormationAndOperatingCosts>
    <ATAK:FormationAndOperatingCosts
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">2868531</ATAK:FormationAndOperatingCosts>
    <ATAK:FormationAndOperatingCosts
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">1210401</ATAK:FormationAndOperatingCosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">-479300</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">-219330</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-2868531</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-1210401</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">64480</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">-471500</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-148120</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-5247547</us-gaap:FairValueAdjustmentOfWarrants>
    <ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">258440</ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">314248</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">314248</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InvestmentIncomeDividend
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">751668</us-gaap:InvestmentIncomeDividend>
    <us-gaap:InvestmentIncomeDividend
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">902675</us-gaap:InvestmentIncomeDividend>
    <us-gaap:InvestmentIncomeDividend
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">2717772</us-gaap:InvestmentIncomeDividend>
    <us-gaap:InvestmentIncomeDividend
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">1155816</us-gaap:InvestmentIncomeDividend>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">1001436</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">1374175</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">3180140</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">6661803</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">522136</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">1154845</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">311609</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">5451402</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5413775</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5413775</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">7659431</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">7659431</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">17314286</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">17314286</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5302571</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5302571</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">206879903</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-7621413</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-7620878</us-gaap:StockholdersEquity>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">14529877</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">-149322133</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-01-012023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">1538885</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1538885</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      unitRef="USD">-1538885</ATAK:RemeasurementOfRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-361371</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      unitRef="USD">-361371</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5670123</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">59096655</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9521669</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31" decimals="0" unitRef="USD">-9521134</us-gaap:StockholdersEquity>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-04-012023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">1102219</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1102219</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      unitRef="USD">-1102219</ATAK:RemeasurementOfRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">150844</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      unitRef="USD">150844</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5670123</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">60198874</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-10473044</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">-10472509</us-gaap:StockholdersEquity>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">362831</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">-3874172</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-07-012023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">1156667</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1156667</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">-1156667</ATAK:RemeasurementOfRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">522136</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      unitRef="USD">522136</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">57481369</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-11107575</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">-11107040</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5750000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">575</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">24425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9963</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15037</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">174013413</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">30006587</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-18650885</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-11355702</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">-30006587</ATAK:RemeasurementOfRedemptionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">-70</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">70</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssued
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssued>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">3029970</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">3030000</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">15596420</ATAK:RightsUnderlyingTheUnitsValue>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">15596420</ATAK:RightsUnderlyingTheUnitsValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">3097637</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">3097637</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">204020000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-8268028</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">-8267493</us-gaap:StockholdersEquity>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-04-012022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">253141</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-253141</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-253141</ATAK:RemeasurementOfRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">1198920</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">1198920</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">204273141</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-7322249</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-7321714</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">204273141</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-7322249</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-7321714</us-gaap:StockholdersEquity>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-07-012022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">902675</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-902675</ATAK:RemeasurementOfRedemptionValue>
    <ATAK:RemeasurementOfRedemptionValue
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">-902675</ATAK:RemeasurementOfRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">1154845</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      unitRef="USD">1154845</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">205175816</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-7070079</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-09-30" decimals="0" unitRef="USD">-7069544</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">205175816</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_CommonClassAMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-7070079</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-09-30" decimals="0" unitRef="USD">-7069544</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">311609</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">5451402</us-gaap:NetIncomeLoss>
    <ATAK:Investmentincomedividends
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">2717772</ATAK:Investmentincomedividends>
    <ATAK:Investmentincomedividends
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">1155816</ATAK:Investmentincomedividends>
    <ATAK:AllocationOfDeferredOfferingCostsForWarrantLiability
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">516746</ATAK:AllocationOfDeferredOfferingCostsForWarrantLiability>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-148120</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-5247547</us-gaap:FairValueAdjustmentOfWarrants>
    <ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">258440</ATAK:GainsLossesOnExtinguishmentOfOverAllotmentLiability>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">314248</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-258479</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">432070</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">2122892</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">81275</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-487160</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-1044450</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">204020000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">1080000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">153196305</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">152116305</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-204020000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">202000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">6470000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">2525000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">1405000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">242801</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">446002</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">153196305</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-151791305</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">205256197</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">-162160</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">191747</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">191103</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">65373</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">28943</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-09-30" decimals="0" unitRef="USD">257120</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <ATAK:InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">174013413</ATAK:InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption>
    <ATAK:InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">5780547</ATAK:InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants>
    <ATAK:DeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">7070000</ATAK:DeferredUnderwritingFeePayable>
    <ATAK:RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      unitRef="USD">3797771</ATAK:RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption>
    <ATAK:RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">31162403</ATAK:RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption>
    <ATAK:ForfeitureOfRepresentativeShares
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-70</ATAK:ForfeitureOfRepresentativeShares>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">30</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA>
    <ATAK:DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">64512</ATAK:DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zD94sDycK0Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
1. &lt;span id="xdx_820_zeRplP3cU0xh"&gt;ORGANIZATION AND PLANS OF BUSINESS OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Organization
and General&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aurora
Technology Acquisition Corporation (the &#x201c;Company&#x201d;) was incorporated as a Cayman Islands exempted company on August 6, 2021.
The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization, recapitalization or similar business combination with one or more businesses (a &#x201c;Business Combination&#x201d;).
The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sponsor
and Initial Financing&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company&#x2019;s
formation, the initial public offering (the &#x201c;Initial Public Offering&#x201d; or &#x201c;IPO&#x201d;), which is described below, and
identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its
initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Initial Public Offering was declared effective on February 7, 2022. On February 9, 2022, the Company consummated
the Initial Public Offering of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zdCSM9XRn5R2" title="Stock issued during period, shares, new issues"&gt;20,200,000&lt;/span&gt; units (the &#x201c;Units&#x201d; and, with respect to the Class A ordinary shares included in
the Units sold, the &#x201c;Public Shares&#x201d;), which includes the exercise by the underwriter of its over-allotment option in the
amount of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXM6yznwqmXe" title="Stock issued during period, shares, new issues"&gt;200,000&lt;/span&gt; Units, at $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuDeOHcTeEDl" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOBkgWAcScR9" title="Proceeds from issuance initial public offering"&gt;202,000,000&lt;/span&gt;, which is described in Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of &lt;span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zguyyM1M9iT8" title="Class of warrants or rights warrants issued during the period units"&gt;6,470,000&lt;/span&gt; warrants (each, a &#x201c;Private Placement
Warrant&#x201d; and, collectively, the &#x201c;Private Placement Warrants&#x201d;) at a price of $&lt;span id="xdx_900_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_z09YtLjJjS2i" title="Class of warrants or rights warrants issued issue price per warrant"&gt;1.00&lt;/span&gt; per Private Placement Warrant in
a private placement to ATAC Sponsor LLC (the &#x201c;Sponsor&#x201d;), generating gross proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zuBNKU2ixrVh" title="Proceeds from issuance of warrants"&gt;6,470,000&lt;/span&gt;, which is described in Note
4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs related to the consummation of the IPO on February 9, 2022, amounted to $&lt;span id="xdx_90A_ecustom--TransactionCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxxSiWwQvMtd" title="Transaction costs"&gt;29,192,787&lt;/span&gt;, consisting of $&lt;span id="xdx_90C_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTosweShAQ8" title="Underwriting discount"&gt;2,525,000&lt;/span&gt; of underwriting discount,
$&lt;span id="xdx_905_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWMOSOO2o2Rf" title="Deferred underwriting fees"&gt;7,070,000&lt;/span&gt; of deferred underwriting fees, over-allotment option liability of $&lt;span id="xdx_904_ecustom--OverallotmentOptionLiability_c20220209__20220209_zen3ggiPemR2" title="Over-allotment option liability"&gt;258,440&lt;/span&gt;, $&lt;span id="xdx_90B_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zS7yJMYeyja" title="Issuance of representative shares"&gt;3,030,000&lt;/span&gt; for issuance of representative shares,
$&lt;span id="xdx_90B_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zak6DtBwWPn8" title="Rights underlying the Units"&gt;15,596,420&lt;/span&gt; fair value of rights underlying the Units, and $&lt;span id="xdx_90E_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEIjCexT5do5" title="Actual offering costs"&gt;712,927&lt;/span&gt; of actual offering costs. In addition, on February 9, 2022, cash
of $&lt;span id="xdx_909_eus-gaap--Cash_iI_c20220209_z5VCIgCy3Hh5" title="Cash"&gt;1,468,333&lt;/span&gt; was held outside of the Trust Account (as defined below) and was available for the payment of offering costs and for working
capital purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust Account&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on February 9, 2022 (&#x201c;IPO Closing Date&#x201d;), an amount of $&lt;span id="xdx_90A_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDV5d72fIcec" title="Net proceeds amount"&gt;204,020,000&lt;/span&gt; ($&lt;span id="xdx_909_eus-gaap--SharePrice_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuQvc8w5Bthi" title="Share price"&gt;10.10&lt;/span&gt; per
Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was
placed in a trust account (the &#x201c;Trust Account&#x201d;). The funds in the Trust Account is invested only in U.S. government treasury
bills with a maturity of &lt;span id="xdx_903_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrqgJSTHhH55" title="Term of restricted investments"&gt;185&lt;/span&gt; days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions
under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal
or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account
will not otherwise be released from the trust account until the earliest of: (i) the Company&#x2019;s completion of a Business Combination;
(ii) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s Amendment
No. 1 to the Amended and Restated Memorandum of Association, and (iii) the redemption of the Company&#x2019;s Public Shares if the Company
is unable to complete the initial Business Combination within &lt;span id="xdx_907_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MinimumMember_zf3RK8G4coW6" title="Period within which business combination shall be consummated from the consummation of initial public offer"&gt;12&lt;/span&gt; months (or up to &lt;span id="xdx_905_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MaximumMember_zgxHZscZMJ93" title="Period within which business combination shall be consummated from the consummation of initial public offer"&gt;24&lt;/span&gt; months, if applicable) from the IPO Closing Date
(the &#x201c;Combination Period&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 3, 2023 in connection with its Extraordinary General Meeting held on February 3, 2023 (the &#x201c;February Extraordinary General
Meeting&#x201d;), the Company and Continental Stock Transfer &amp;amp; Trust Company (the &#x201c;Trustee&#x201d;) entered into Amendment No.
1 to the Investment Management Trust Agreement dated February 7, 2022 to allow the &lt;span id="xdx_904_ecustom--DescriptionOfBusinessCombinationExtendedPeriodTerms_c20230203__20230203__us-gaap--TypeOfArrangementAxis__custom--AmendmentNoOneToInvestmentManagementTrustAgreementMember_zztFMc7vxu3j" title="Description of business combination extended period terms"&gt;Company to extend the date by which it has to consummate
a business combination six times for an additional one month each time from February 9, 2023 to August 9, 2023, extending the Combination
period up to 24 months, if applicable, by depositing into the Trust Account for each one-month extension the lesser of $135,000 or $0.045
per share multiplied by the number of public shares then outstanding&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 27, 2023, &lt;span id="xdx_904_eus-gaap--SubsequentEventDescription_c20230727__20230727_zZJ2wWKUpwd8" title="Subsequent event, description"&gt;the Company held an extraordinary general meeting of shareholders (the &#x201c;July Extraordinary General Meeting&#x201d;),
to, among other things, approve (i) a special resolution to amend the amended and restated articles of association of the Company (the
&#x201c;Articles&#x201d;) giving the Company the right to further extend the Business Combination Period six (6) times for an additional
one (1) month each time, from August 9, 2023 to February 7, 2024 (the &#x201c;Second Extension Amendment&#x201d;) and (ii) the proposal
to approve the Second Trust Amendment (as defined below). All proposals at the July Extraordinary General Meeting were approved by the
shareholders of the Company. As such, the Company and Transfer Agent entered into Amendment No. 2 to the Investment Management Trust
Agreement, to allow ATAK to extend the Business Combination Period six (6) times for an additional one (1) month each time from August
9, 2023 to February 9, 2024 by depositing into the Trust Account for each one-month extension the lesser of: (x) $135,000 or (y) $0.045
per share multiplied by the number of public shares then outstanding (the &#x201c;Second Trust Amendment&#x201d;). In addition, on July
27, 2023, the Company adopted the Second Extension Amendment, amending the Company&#x2019;s Articles. As of September 30, 2023, the Company
exercised eight of the one-month extensions, depositing a total of $1,080,000 into the Trust Account to fund the extensions&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.95pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Business
Combination&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds from the Initial Public
Offering, although substantially all of the net proceeds from the Initial Public Offering are intended to be generally applied toward
consummating a Business Combination with (or acquisition of) a Target Business. As used herein, &#x201c;Target Business&#x201d; means one
or more target businesses that together have an aggregate fair market value equal to at least &lt;span id="xdx_909_ecustom--PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount_iI_pid_dp_uPure_c20230930_zkPXN1U2MIlf" title="Percentage of fair market value of target business to asset held in trust account"&gt;80&lt;/span&gt;% of the value of the assets held in
the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at
the time of the signing of a definitive agreement in connection with a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furthermore,
there is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide its public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination, either (i) in connection with a shareholder meeting called to approve such Business Combination or (ii) by
means of a tender offer. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in
the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount
to be distributed to the public shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the
Company will pay to the underwriter in connection with the IPO (as discussed in Note 6). There will be no redemption rights upon the
completion of a Business Combination with respect to the Company&#x2019;s warrants. As a result, shares are recorded at their redemption
amount and classified as temporary equity, in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting
Standards Codification (&#x201c;ASC&#x201d;) 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
decision as to whether the Company will seek shareholder approval of a Business Combination or will allow shareholders to sell their
shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing
of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a
vote is required by law or stock exchange listing requirements. If the Company seeks shareholder approval, it will complete its Business
Combination only if a majority of the Company&#x2019;s ordinary shares entitled to vote thereon are voted in favor of such Business Combination.
However, in no event will the Company redeem its Public Shares in an amount that would cause the Company&#x2019;s net tangible assets
to be less than $&lt;span id="xdx_903_eus-gaap--MinimumNetWorthRequiredForCompliance_iI_c20230930_z2kftrzYbf7b" title="Banking regulation, mortgage banking, net worth, minimum"&gt;5,000,001&lt;/span&gt; upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption
of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has until February 9, 2024, to complete its initial Business Combination, if we exercise out right to extend as approved in
the Extraordinary General Meeting held on July 27, 2023; provided the Company, by resolution of the board of directors if requested
by the Sponsor, &lt;span id="xdx_90F_ecustom--BusinessCombinationExtensionOfBusinessCombinationPeriod_c20230101__20230930_zugRDHTIsT9j" title="Business combination extension of business combination period"&gt;extends
the period of time to consummate the initial Business Combination up to six times, each by an additional one month (for a total of
up to 24 months from the date of the Initial Public Offering to complete the Business Combination)&lt;/span&gt;, subject to the Sponsor
depositing additional funds into the Trust Account (each one month period individually, an &#x201c;Extension Period&#x201d;) pursuant
to the Company&#x2019;s Amendment No. 1 to the Amended and Restated Memorandum of Association. If the Company does not complete a
Business Combination by such date (or such longer period as described above), the Company shall (i) cease all operations except for
the purposes of winding up; (ii) as promptly as reasonably possible but not more than &lt;span id="xdx_903_ecustom--NumberOfDaysWithinWhichPublicSharesShallBeRedeemed_dtD_c20230101__20230930_zdOjOTw5ggb3" title="Number of days within which public shares shall be redeemed"&gt;10&lt;/span&gt;
business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account, including interest (less up to $&lt;span id="xdx_90F_eus-gaap--LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities_iI_c20230930_zumsHR8pvfg2" title="Expenses payable on dissolution"&gt;50,000&lt;/span&gt;
of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and
outstanding Public Shares, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including
the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#x2019;s remaining shareholders and its board of directors, liquidate and
dissolve, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and
the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the
Company&#x2019;s warrants, which will expire worthless if the Company fails to complete its initial Business Combination by February
9, 2024, or within any applicable Extension Period. The Company&#x2019;s &#x201c;initial shareholders&#x201d; (as defined below) have
entered into a letter agreement with the Company, pursuant to which the initial shareholders have waived their rights to liquidating
distributions from the Trust Account with respect to their Founder Shares (as defined in Note 5) if the Company fails to complete
its initial Business Combination by February 9, 2024, or within any applicable Extension Period. However, if any initial
shareholders acquire Public Shares, such initial shareholders will be entitled to liquidating distributions from the Trust Account
with respect to such Public Shares if the Company fails to complete its initial Business Combination by February 9, 2024, or within
any applicable Extension Period. As used herein, the term &#x201c;initial shareholders&#x201d; refers to the holders of Founder Shares
prior to the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company&#x2019;s
independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company
has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $&lt;span id="xdx_900_ecustom--MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable_iI_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zgxBM8LRjpwl" title="Minimum Public Share price due to reductions in the value of the trust assets less taxes payable"&gt;10.10&lt;/span&gt; per Public Share
or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions
in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims
by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the
Company&#x2019;s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not
be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including,
but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target
businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest
or claims of any kind in or to any monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 26, 2023 (the &#x201c;Signing Date&#x201d;), Aurora Technology Acquisition Corp., a Cayman Islands exempted company (which shall
migrate to and domesticate as a Delaware corporation prior to the Closing, as defined below) (&#x201c;ATAK&#x201d;), entered into a Business
Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the &#x201c;Business
Combination Agreement&#x201d;), among ATAK, Aurora Technology Merger Sub Corp., a Nevada corporation and a direct, wholly-owned subsidiary
of ATAK (&#x201c;Merger Sub&#x201d;), and DIH Holding US, Inc., a Nevada corporation (&#x201c;DIH&#x201d;). ATAK and DIH are each individually
referred to herein as a &#x201c;Party&#x201d; and, collectively, the &#x201c;Parties.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Business Combination Agreement has been approved by the board of directors of each of ATAK and Merger Sub and DIH, respectively. The
transactions contemplated by the Business Combination Agreement are referred to as the &#x201c;Business Combination.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the time of the closing of the Business Combination (the &#x201c;Closing,&#x201d; and the date on which the Closing occurs, the &#x201c;Closing
Date&#x201d;), the combined company will be organized as a Delaware corporation, in which substantially all of the assets and the business
of the combined company will be held by DIH. The combined company&#x2019;s business will continue to operate through DIH and its subsidiaries.
In connection with the Closing, ATAK will change its name to &#x201c;DIH Holding US, Inc.&#x201d; (such company after the Closing, &#x201c;New
DIH&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liquidity
and Going Concern&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023 and December 31, 2022, the Company had $&lt;span id="xdx_905_eus-gaap--Cash_iI_c20230930_zaSmhoIONvP2" title="Operating cash"&gt;28,943&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--Cash_iI_c20221231_za52WYHshWy1" title="Operating cash"&gt;191,103&lt;/span&gt; in operating cash, respectively, and working capital
(deficit) of $&lt;span id="xdx_901_ecustom--NetWorkingCapitalSurplusDeficit_iI_c20230930_zkTX3tqGrMni" title="Working capital (deficit)"&gt;(3,595,740)&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--NetWorkingCapitalSurplusDeficit_iI_c20221231_zUHgSaU9Wxz6" title="Working capital (deficit)"&gt;38,542&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s liquidity needs up to September 30, 2023 had been satisfied through a payment from the Sponsor of $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZnJ2slI5uNh" title="Stock shares issued during the period for services shares"&gt;25,000&lt;/span&gt; for Class B
ordinary shares, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zW5T3OYnHGZ2" title="Common stock, par or stated value per share"&gt;0.0001&lt;/span&gt; per share (see Note 5), and proceeds from the Initial Public Offering and the issuance of the Private
Placement Warrants. Additionally, the Company drew on unsecured promissory notes to pay certain offering costs and extension payments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company
may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or
third parties. The Company&#x2019;s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to
time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company&#x2019;s working capital needs.
Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may
be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risks
and Uncertainties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Results
of operations and the Company&#x2019;s ability to complete an Initial Business Combination may be adversely affected by various factors
that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could
be impacted by, among other things, downturns in the financial markets or in economic conditions, inflation, increases in interest rates,
adverse developments affecting the financial services industry, and geopolitical instability, such as the military conflict in the Ukraine.
The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent
to which they may negatively impact our business and our ability to complete an Initial Business Combination. The unaudited condensed
financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inflation
Reduction Act&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic
(i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the
repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1%
of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of
stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury
(the &#x201c;Treasury&#x201d;) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or
avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination may be subject to the excise
tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination would depend
on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination,
extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any &#x201c;PIPE&#x201d; or other
equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued
within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In
addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#x2019;s ability to complete a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will continue to monitor for updates to the Company&#x2019;s business along with guidance issued with respect to the IR Act to
determine whether any adjustments are needed to the Company&#x2019;s tax provision in future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-02-092022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-02-09_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-02-092022-02-09_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">202000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits
      contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="Shares">6470000</ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits>
    <ATAK:ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant
      contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="USDPShares">1.00</ATAK:ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember"
      decimals="0"
      unitRef="USD">6470000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <ATAK:TransactionCosts
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">29192787</ATAK:TransactionCosts>
    <us-gaap:OtherUnderwritingExpense
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">2525000</us-gaap:OtherUnderwritingExpense>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">7070000</us-gaap:PaymentsForUnderwritingExpense>
    <ATAK:OverallotmentOptionLiability
      contextRef="From2022-02-092022-02-09"
      decimals="0"
      unitRef="USD">258440</ATAK:OverallotmentOptionLiability>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-02-092022-02-09"
      decimals="0"
      unitRef="USD">3030000</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-02-092022-02-09"
      decimals="0"
      unitRef="USD">15596420</ATAK:RightsUnderlyingTheUnitsValue>
    <ATAK:ActualOfferingCosts
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">712927</ATAK:ActualOfferingCosts>
    <us-gaap:Cash contextRef="AsOf2022-02-09" decimals="0" unitRef="USD">1468333</us-gaap:Cash>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">204020000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:SharePrice
      contextRef="AsOf2022-02-09_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharePrice>
    <ATAK:TermOfRestrictedInvestments contextRef="From2022-02-092022-02-09_us-gaap_IPOMember">P185D</ATAK:TermOfRestrictedInvestments>
    <ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MinimumMember">P12M</ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer>
    <ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_srt_MaximumMember">P24M</ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer>
    <ATAK:DescriptionOfBusinessCombinationExtendedPeriodTerms contextRef="From2023-02-032023-02-03_custom_AmendmentNoOneToInvestmentManagementTrustAgreementMember">Company to extend the date by which it has to consummate
a business combination six times for an additional one month each time from February 9, 2023 to August 9, 2023, extending the Combination
period up to 24 months, if applicable, by depositing into the Trust Account for each one-month extension the lesser of $135,000 or $0.045
per share multiplied by the number of public shares then outstanding</ATAK:DescriptionOfBusinessCombinationExtendedPeriodTerms>
    <us-gaap:SubsequentEventDescription contextRef="From2023-07-272023-07-27">the Company held an extraordinary general meeting of shareholders (the &#x201c;July Extraordinary General Meeting&#x201d;),
to, among other things, approve (i) a special resolution to amend the amended and restated articles of association of the Company (the
&#x201c;Articles&#x201d;) giving the Company the right to further extend the Business Combination Period six (6) times for an additional
one (1) month each time, from August 9, 2023 to February 7, 2024 (the &#x201c;Second Extension Amendment&#x201d;) and (ii) the proposal
to approve the Second Trust Amendment (as defined below). All proposals at the July Extraordinary General Meeting were approved by the
shareholders of the Company. As such, the Company and Transfer Agent entered into Amendment No. 2 to the Investment Management Trust
Agreement, to allow ATAK to extend the Business Combination Period six (6) times for an additional one (1) month each time from August
9, 2023 to February 9, 2024 by depositing into the Trust Account for each one-month extension the lesser of: (x) $135,000 or (y) $0.045
per share multiplied by the number of public shares then outstanding (the &#x201c;Second Trust Amendment&#x201d;). In addition, on July
27, 2023, the Company adopted the Second Extension Amendment, amending the Company&#x2019;s Articles. As of September 30, 2023, the Company
exercised eight of the one-month extensions, depositing a total of $1,080,000 into the Trust Account to fund the extensions</us-gaap:SubsequentEventDescription>
    <ATAK:PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount contextRef="AsOf2023-09-30" decimals="INF" unitRef="Pure">0.80</ATAK:PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount>
    <us-gaap:MinimumNetWorthRequiredForCompliance contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">5000001</us-gaap:MinimumNetWorthRequiredForCompliance>
    <ATAK:BusinessCombinationExtensionOfBusinessCombinationPeriod contextRef="From2023-01-01to2023-09-30">extends
the period of time to consummate the initial Business Combination up to six times, each by an additional one month (for a total of
up to 24 months from the date of the Initial Public Offering to complete the Business Combination)</ATAK:BusinessCombinationExtensionOfBusinessCombinationPeriod>
    <ATAK:NumberOfDaysWithinWhichPublicSharesShallBeRedeemed contextRef="From2023-01-01to2023-09-30">P10D</ATAK:NumberOfDaysWithinWhichPublicSharesShallBeRedeemed>
    <us-gaap:LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">50000</us-gaap:LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities>
    <ATAK:MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable
      contextRef="AsOf2023-09-30_custom_SponsorMember"
      decimals="INF"
      unitRef="USDPShares">10.10</ATAK:MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable>
    <us-gaap:Cash contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">28943</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">191103</us-gaap:Cash>
    <ATAK:NetWorkingCapitalSurplusDeficit contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">-3595740</ATAK:NetWorkingCapitalSurplusDeficit>
    <ATAK:NetWorkingCapitalSurplusDeficit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">38542</ATAK:NetWorkingCapitalSurplusDeficit>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember_custom_SponsorMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zO2S0twikXdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
2. &lt;span id="xdx_829_zK33lbDmrij6"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5c7ZQjccLqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zQx4h1dnoTW1"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements should be read in conjunction with the Annual Report on Form 10-K for the year
ended December 31, 2022 as filed with the SEC on April 19, 2023, which contains the audited financial statements and notes thereto. The
financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company&#x2019;s Annual
Report on Form 10-K. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the
results to be expected for the year ending December 31, 2023 or for any future interim periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zob0Lry84z67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_zlQrHyqu40K3"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are
not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new
or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard
at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements
with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_z2eKLJz4ABVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_zGi4D2n12B3l"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject
to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziHEdcElBAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_z3HLudZMAYg4"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did &lt;span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230930_zGqSKr38mMO4" title="Cash equivalents"&gt;&lt;span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zIy2dmr9Ltxd" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt;t have any cash equivalents as of September 30, 2023 and December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--MarketableSecuritiesPolicy_zgSim9l0fWV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_zM7u8FDrjVRe"&gt;Marketable
Securities Held in Trust Account&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on February 9, 2022, an amount of $&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEh1TfD0NkMd" title="Net proceeds amount"&gt;204,020,000&lt;/span&gt; from the net proceeds of the sale of the Units
in the Initial Public Offering and the sale of the Private Placement Warrants were placed in the Trust Account and is invested only in
U.S. government securities with a maturity of &lt;span id="xdx_904_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRtH5s5xBKf5" title="Term of restricted investments"&gt;185&lt;/span&gt; days or less or in money market funds meeting certain conditions under Rule 2a-7 under
the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding
place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any
public shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s Amended and Restated Memorandum of
Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have
their shares redeemed in connection with our initial business combination or to redeem &lt;span id="xdx_908_ecustom--PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_iI_pid_dp_uPure_c20230930_z5CkJ6FaHeZ3" title="Percentage of public shares to be redeemed in case business combination is not consummated"&gt;100&lt;/span&gt;% of our public shares if we do not complete
our initial business combination within &lt;span id="xdx_902_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--IfWeDoNotCompleteOurInitialBusinessCombinationMember_zNTRLhQvUsWh" title="Period within which business combination shall be consummated from the consummation of initial public offer"&gt;24&lt;/span&gt; months from the closing of the IPO (with exercise of six one-month extensions) or (B) with
respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an initial
business combination within &lt;span id="xdx_90D_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--AbsentOurCompletingAnInitialBusinessCombinationMember_z1VIgxwm0mwb" title="Period within which business combination shall be consummated from the consummation of initial public offer"&gt;24&lt;/span&gt; months from the closing of our initial public offering (with exercise of six one-month extensions), our
return of the funds held in the trust account to our public shareholders as part of our redemption of the Public Shares. As of September
30, 2023, substantially all of the assets held in the Trust Account were held in money market funds which invest in United States Treasury
securities. All of the investments held in the Trust Account are classified as trading securities. Trading securities are presented on
the balance sheet at fair value at the end of each reporting period. The estimated fair values of investments held in Trust Account are
determined using available market information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zUuvblWO2gIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_zkwmhAaGaN53"&gt;Offering
Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A&#x2014;&#x201d;Expenses
of Offering&#x201d;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the IPO. Offering costs are charged to shareholders&#x2019; deficit or the statement of operations based on the relative
value of the Public Warrants and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the
IPO. Accordingly, on February 9, 2022, offering costs totaling $&lt;span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zewwkQpvfngi" title="Offering costs"&gt;29,192,787&lt;/span&gt; (consisting of $&lt;span id="xdx_904_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJeIEabnl2Gd" title="Underwriting fees"&gt;2,525,000&lt;/span&gt; of underwriting fees, $&lt;span id="xdx_909_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zolMxtUxdHze" title="Deferred underwriting fees"&gt;7,070,000&lt;/span&gt;
of deferred underwriting fees, over-allotment option liability of $&lt;span id="xdx_905_ecustom--OverallotmentOptionLiability_c20220209__20220209_zPA2zHE7oZpj" title="Overallotment option liability"&gt;258,440&lt;/span&gt;, $&lt;span id="xdx_909_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zsOkxRHx08ef" title="Issuance of representative shares"&gt;3,030,000&lt;/span&gt; for issuance of representative shares, $&lt;span id="xdx_902_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zJ0MIuZXt5Nh" title="Rights underlying the Units"&gt;15,596,420&lt;/span&gt;
fair value of rights underlying the Units, and $&lt;span id="xdx_907_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvVYeyWQ04Cl" title="Actual offering costs"&gt;712,927&lt;/span&gt; of actual offering costs), with $&lt;span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzJjDfu5bgU9" title="Accumulated deficit"&gt;265,808&lt;/span&gt; included in accumulated deficit as an
allocation for the Public Warrants, and $&lt;span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDrOv6Q1wwqb" title="Adjustments to additional paid in capital, warrant issued"&gt;10,300,559&lt;/span&gt; included as a reduction to proceeds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--TemporaryEquityPolicyTextBlock_zYEWZ5qlFjle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zDS8A7r8180i"&gt;Class
A Ordinary shares Subject to Possible Redemption&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Conditionally redeemable ordinary shares
(including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times,
ordinary shares is classified as shareholders&#x2019; equity. The Company&#x2019;s Class A ordinary shares features certain redemption
rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. On February
9, 2023, certain investors redeemed &lt;span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230209__20230209_z3aSo4Uxbfma" title="Redemption of Class A ordinary shares, shares"&gt;14,529,877&lt;/span&gt; shares of Class A ordinary shares for $&lt;span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230209__20230209_zk0KFCtSx2S" title="Redemption of Class A ordinary shares, value"&gt;149,322,133&lt;/span&gt;, resulting in a reduction to shares
of Class A ordinary shares outstanding to &lt;span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230201__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9ciN1oB9pAe" title="Shares outstanding"&gt;5,670,123&lt;/span&gt;. On July 28, 2023, certain investors redeemed &lt;span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230728__20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuUpwzym4ULj" title="Redemption of Class A ordinary shares, shares"&gt;362,831&lt;/span&gt; shares of Class A ordinary
shares for $&lt;span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230728__20230728_zsjVqqQdtzH" title="Redemption of Class A ordinary shares"&gt;3,874,172&lt;/span&gt;, resulting in a reduction to shares of Class A ordinary shares outstanding to &lt;span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVXXzYx9gEX" title="Temporary equity, shares outstanding"&gt;5,307,292&lt;/span&gt;. Accordingly, at September
30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary
equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the
absence of additional capital, in accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zHcf6nR58UCi" style="display: none"&gt;SUMMARY OF TEMPORARY EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 79%; text-align: left"&gt;Gross proceeds from initial public offering&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" style="padding: 0pt; width: 18%; text-align: right" title="Gross proceeds from initial public offering"&gt;202,000,000&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt"&gt;Less:&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Proceeds allocated to public warrants&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" style="padding: 0pt; text-align: right" title="Proceeds allocated to public warrants"&gt;(3,521,870&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Offering costs allocated to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" style="padding: 0pt; text-align: right" title="Offering costs allocated to Class A ordinary shares subject to possible redemption"&gt;(13,079,620&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Fair value allocated to rights&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" style="padding: 0pt; text-align: right" title="Fair value allocated to rights"&gt;(15,596,420&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt"&gt;Plus:&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Proceeds allocated to private warrants&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" style="padding: 0pt; text-align: right" title="Proceeds allocated to private warrants"&gt;4,211,323&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Redemption of Class A ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" style="padding: 0pt; text-align: right" title="Redemption of Class A ordinary shares"&gt;(153,196,305&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Re-measurement of Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Re-measurement of Class A ordinary shares subject to possible redemption"&gt;36,664,261&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Class A ordinary shares subject to possible redemption, September 30, 2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Class A ordinary shares subject to possible redemption, September 30, 2023"&gt;57,481,369&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;div style="clear: both"&gt;&lt;/div&gt;

&lt;p id="xdx_8A5_zoCVqASZ9NG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zN6ihQlobsm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zsXoHBhnjAK1"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;).
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30,
2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may be subject to potential examination by U.S. federal, U.S. state or foreign taxing authorities in the area of income taxes.
These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions
and compliance with U.S. federal, U.S. state and foreign tax laws. There is currently no taxation imposed on income by the Government
of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently,
deferred tax assets and income taxes are not reflected in the Company&#x2019;s financial statements. The Company&#x2019;s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zlDhTOoQNTf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zMEqkd0zGo82"&gt;Net
income per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding
during the period. Ordinary shares subject to possible redemption at September 30, 2023, which are not currently redeemable and are not
redeemable at fair value, have been excluded from the calculation of basic net income per ordinary share since such shares, if
redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of the warrants
sold in the Initial Public Offering and the private placement to purchase an aggregate of &lt;span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zH8O5cB0wZM7" title="Class of warrants or rights warrants issued during the period units"&gt;6,470,000&lt;/span&gt; Private Placement Warrants in the
calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events and the
inclusion of such warrants would be anti-dilutive. As a result, diluted net income (loss) per ordinary share is the same as basic net
income per ordinary share for the period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s statement of operations includes a presentation of net income per ordinary share subject to possible redemption
and allocates the net income into the two classes of stock in calculating net earnings per ordinary share, basic and diluted.
For redeemable Class A ordinary shares, net income per ordinary share is calculated by dividing the net income by the weighted
average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. For non-redeemable Class
A ordinary shares, net income per share is calculated by dividing the net income by the weighted average number of non-redeemable
Class A ordinary shares outstanding for the period. Non-redeemable Class A ordinary shares include the representative shares issued to
Maxim at the closing of the initial public offering. For non-redeemable Class B ordinary shares, net income per share is calculated
by dividing the net income by the weighted average number of non-redeemable Class B ordinary shares outstanding for the period.
Non-redeemable Class B ordinary shares include the founder shares as these shares do not have any redemption features and do not participate
in the income earned on the Trust Account. As of September 30, 2023, the Company did not have any dilutive securities or other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
net income per ordinary share is the same as basic net income per ordinary share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none"&gt;SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;Three Months Ended September 30,&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic; text-align: left"&gt;Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 68%; text-align: left"&gt;Net income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;262,542&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;912,921&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj"&gt;5,413,775&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd"&gt;20,200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic"&gt;Non-redeemable ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Net income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;259,594&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;241,924&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;Nine Months Ended September 30,&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic; text-align: left"&gt;Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 68%; text-align: left"&gt;Net income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;183,421&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;4,173,309&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;7,659,431&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;17,314,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic"&gt;Non-redeemable ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Net income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;128,188&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;1,278,093&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding"&gt;5,302,571&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zD9STglapad3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zn6txi3e7Jra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_zbNK8Mc6pn8a"&gt;Related
Parties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z0rL5e341nuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86C_zu9h4xeAzRWj"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zUsDGM9cFSA7" title="Federal depository insurance coverage"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbRiclSaBLi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_ztH9AGXbx30c"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;Fair Value Measurement&#x201d;
(&#x201c;ASC 820&#x201d;), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to
their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z0mtbpTsBPQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_ziYGfXBKh0la"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--WarrantyLiabilityPolicyTextBlock_ziGdbr12fuBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_zGlNU7vkEWq9"&gt;Warranty
Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the &lt;span id="xdx_907_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDtZFfYhB441" title="Class of warrants or rights warrants issued during the period units"&gt;26,670,000&lt;/span&gt; warrants issued in connection with the Initial Public Offering and the Private Placement Warrants
(collectively, the &#x201c;Warrants&#x201d;) as either equity-classified or liability-classified instruments based on an assessment of
the Warrant&#x2019;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, &#x201c;Derivatives and Hedging&#x201d;
(&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the company&#x2019;s own ordinary shares, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Such
guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as
a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon
the closing of the Initial Public Offering. Accordingly, the Company will classify each warrant as a liability at its fair value and
the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This liability is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with
the change in fair value recognized in the Company&#x2019;s statement of operations. The Company will reassess the classification at each
balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the
date of the event that causes the reclassification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmVqWsEk1uzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zp1njrD6GmUg"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in
an Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020- 06&#x201d;), which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results
of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#x201c;Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions&#x201d; (&#x201c;ASU 2022-03&#x201d;), which amends ASC 820 to clarify that a contractual sales restriction is not considered
in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual
sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities
measured at fair value. The amendments are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods
within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued
or made available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial
position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s condensed financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p id="xdx_856_zZPQaKExVd55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5c7ZQjccLqk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zQx4h1dnoTW1"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed financial statements should be read in conjunction with the Annual Report on Form 10-K for the year
ended December 31, 2022 as filed with the SEC on April 19, 2023, which contains the audited financial statements and notes thereto. The
financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company&#x2019;s Annual
Report on Form 10-K. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the
results to be expected for the year ending December 31, 2023 or for any future interim periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <ATAK:EmergingGrowthCompanyPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zob0Lry84z67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_zlQrHyqu40K3"&gt;Emerging
Growth Company&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and
it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are
not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new
or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period
and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard
at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements
with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATAK:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_z2eKLJz4ABVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_zGi4D2n12B3l"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject
to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ziHEdcElBAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_z3HLudZMAYg4"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did &lt;span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230930_zGqSKr38mMO4" title="Cash equivalents"&gt;&lt;span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zIy2dmr9Ltxd" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt;t have any cash equivalents as of September 30, 2023 and December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_848_eus-gaap--MarketableSecuritiesPolicy_zgSim9l0fWV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_zM7u8FDrjVRe"&gt;Marketable
Securities Held in Trust Account&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on February 9, 2022, an amount of $&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireRestrictedInvestments_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEh1TfD0NkMd" title="Net proceeds amount"&gt;204,020,000&lt;/span&gt; from the net proceeds of the sale of the Units
in the Initial Public Offering and the sale of the Private Placement Warrants were placed in the Trust Account and is invested only in
U.S. government securities with a maturity of &lt;span id="xdx_904_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRtH5s5xBKf5" title="Term of restricted investments"&gt;185&lt;/span&gt; days or less or in money market funds meeting certain conditions under Rule 2a-7 under
the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding
place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any
public shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s Amended and Restated Memorandum of
Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have
their shares redeemed in connection with our initial business combination or to redeem &lt;span id="xdx_908_ecustom--PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated_iI_pid_dp_uPure_c20230930_z5CkJ6FaHeZ3" title="Percentage of public shares to be redeemed in case business combination is not consummated"&gt;100&lt;/span&gt;% of our public shares if we do not complete
our initial business combination within &lt;span id="xdx_902_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--IfWeDoNotCompleteOurInitialBusinessCombinationMember_zNTRLhQvUsWh" title="Period within which business combination shall be consummated from the consummation of initial public offer"&gt;24&lt;/span&gt; months from the closing of the IPO (with exercise of six one-month extensions) or (B) with
respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an initial
business combination within &lt;span id="xdx_90D_ecustom--PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer_dtM_c20230101__20230930__custom--PeriodAfterWhichSharesAreRedeemableAxis__custom--AbsentOurCompletingAnInitialBusinessCombinationMember_z1VIgxwm0mwb" title="Period within which business combination shall be consummated from the consummation of initial public offer"&gt;24&lt;/span&gt; months from the closing of our initial public offering (with exercise of six one-month extensions), our
return of the funds held in the trust account to our public shareholders as part of our redemption of the Public Shares. As of September
30, 2023, substantially all of the assets held in the Trust Account were held in money market funds which invest in United States Treasury
securities. All of the investments held in the Trust Account are classified as trading securities. Trading securities are presented on
the balance sheet at fair value at the end of each reporting period. The estimated fair values of investments held in Trust Account are
determined using available market information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">204020000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <ATAK:TermOfRestrictedInvestments contextRef="From2022-02-092022-02-09_us-gaap_IPOMember">P185D</ATAK:TermOfRestrictedInvestments>
    <ATAK:PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated contextRef="AsOf2023-09-30" decimals="INF" unitRef="Pure">1</ATAK:PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated>
    <ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer contextRef="From2023-01-012023-09-30_custom_IfWeDoNotCompleteOurInitialBusinessCombinationMember">P24M</ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer>
    <ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer contextRef="From2023-01-012023-09-30_custom_AbsentOurCompletingAnInitialBusinessCombinationMember">P24M</ATAK:PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zUuvblWO2gIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_zkwmhAaGaN53"&gt;Offering
Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A&#x2014;&#x201d;Expenses
of Offering&#x201d;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the IPO. Offering costs are charged to shareholders&#x2019; deficit or the statement of operations based on the relative
value of the Public Warrants and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the
IPO. Accordingly, on February 9, 2022, offering costs totaling $&lt;span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zewwkQpvfngi" title="Offering costs"&gt;29,192,787&lt;/span&gt; (consisting of $&lt;span id="xdx_904_eus-gaap--OtherUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJeIEabnl2Gd" title="Underwriting fees"&gt;2,525,000&lt;/span&gt; of underwriting fees, $&lt;span id="xdx_909_eus-gaap--PaymentsForUnderwritingExpense_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zolMxtUxdHze" title="Deferred underwriting fees"&gt;7,070,000&lt;/span&gt;
of deferred underwriting fees, over-allotment option liability of $&lt;span id="xdx_905_ecustom--OverallotmentOptionLiability_c20220209__20220209_zPA2zHE7oZpj" title="Overallotment option liability"&gt;258,440&lt;/span&gt;, $&lt;span id="xdx_909_ecustom--StockIssuedDuringPeriodRepresentativeSharesIssuedValue_c20220209__20220209_zsOkxRHx08ef" title="Issuance of representative shares"&gt;3,030,000&lt;/span&gt; for issuance of representative shares, $&lt;span id="xdx_902_ecustom--RightsUnderlyingTheUnitsValue_c20220209__20220209_zJ0MIuZXt5Nh" title="Rights underlying the Units"&gt;15,596,420&lt;/span&gt;
fair value of rights underlying the Units, and $&lt;span id="xdx_907_ecustom--ActualOfferingCosts_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvVYeyWQ04Cl" title="Actual offering costs"&gt;712,927&lt;/span&gt; of actual offering costs), with $&lt;span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzJjDfu5bgU9" title="Accumulated deficit"&gt;265,808&lt;/span&gt; included in accumulated deficit as an
allocation for the Public Warrants, and $&lt;span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDrOv6Q1wwqb" title="Adjustments to additional paid in capital, warrant issued"&gt;10,300,559&lt;/span&gt; included as a reduction to proceeds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">29192787</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <us-gaap:OtherUnderwritingExpense
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">2525000</us-gaap:OtherUnderwritingExpense>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">7070000</us-gaap:PaymentsForUnderwritingExpense>
    <ATAK:OverallotmentOptionLiability
      contextRef="From2022-02-092022-02-09"
      decimals="0"
      unitRef="USD">258440</ATAK:OverallotmentOptionLiability>
    <ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue
      contextRef="From2022-02-092022-02-09"
      decimals="0"
      unitRef="USD">3030000</ATAK:StockIssuedDuringPeriodRepresentativeSharesIssuedValue>
    <ATAK:RightsUnderlyingTheUnitsValue
      contextRef="From2022-02-092022-02-09"
      decimals="0"
      unitRef="USD">15596420</ATAK:RightsUnderlyingTheUnitsValue>
    <ATAK:ActualOfferingCosts
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">712927</ATAK:ActualOfferingCosts>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">265808</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">10300559</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <ATAK:TemporaryEquityPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_846_ecustom--TemporaryEquityPolicyTextBlock_zYEWZ5qlFjle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zDS8A7r8180i"&gt;Class
A Ordinary shares Subject to Possible Redemption&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Conditionally redeemable ordinary shares
(including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times,
ordinary shares is classified as shareholders&#x2019; equity. The Company&#x2019;s Class A ordinary shares features certain redemption
rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. On February
9, 2023, certain investors redeemed &lt;span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230209__20230209_z3aSo4Uxbfma" title="Redemption of Class A ordinary shares, shares"&gt;14,529,877&lt;/span&gt; shares of Class A ordinary shares for $&lt;span id="xdx_90B_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230209__20230209_zk0KFCtSx2S" title="Redemption of Class A ordinary shares, value"&gt;149,322,133&lt;/span&gt;, resulting in a reduction to shares
of Class A ordinary shares outstanding to &lt;span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230201__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9ciN1oB9pAe" title="Shares outstanding"&gt;5,670,123&lt;/span&gt;. On July 28, 2023, certain investors redeemed &lt;span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20230728__20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuUpwzym4ULj" title="Redemption of Class A ordinary shares, shares"&gt;362,831&lt;/span&gt; shares of Class A ordinary
shares for $&lt;span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230728__20230728_zsjVqqQdtzH" title="Redemption of Class A ordinary shares"&gt;3,874,172&lt;/span&gt;, resulting in a reduction to shares of Class A ordinary shares outstanding to &lt;span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230728__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVXXzYx9gEX" title="Temporary equity, shares outstanding"&gt;5,307,292&lt;/span&gt;. Accordingly, at September
30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary
equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the
absence of additional capital, in accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zHcf6nR58UCi" style="display: none"&gt;SUMMARY OF TEMPORARY EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 79%; text-align: left"&gt;Gross proceeds from initial public offering&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" style="padding: 0pt; width: 18%; text-align: right" title="Gross proceeds from initial public offering"&gt;202,000,000&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt"&gt;Less:&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Proceeds allocated to public warrants&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" style="padding: 0pt; text-align: right" title="Proceeds allocated to public warrants"&gt;(3,521,870&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Offering costs allocated to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" style="padding: 0pt; text-align: right" title="Offering costs allocated to Class A ordinary shares subject to possible redemption"&gt;(13,079,620&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Fair value allocated to rights&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" style="padding: 0pt; text-align: right" title="Fair value allocated to rights"&gt;(15,596,420&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt"&gt;Plus:&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Proceeds allocated to private warrants&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" style="padding: 0pt; text-align: right" title="Proceeds allocated to private warrants"&gt;4,211,323&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Redemption of Class A ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" style="padding: 0pt; text-align: right" title="Redemption of Class A ordinary shares"&gt;(153,196,305&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Re-measurement of Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Re-measurement of Class A ordinary shares subject to possible redemption"&gt;36,664,261&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Class A ordinary shares subject to possible redemption, September 30, 2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Class A ordinary shares subject to possible redemption, September 30, 2023"&gt;57,481,369&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;div style="clear: both"&gt;&lt;/div&gt;

&lt;p id="xdx_8A5_zoCVqASZ9NG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATAK:TemporaryEquityPolicyTextBlock>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2023-02-092023-02-09"
      decimals="INF"
      unitRef="Shares">14529877</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-02-092023-02-09"
      decimals="0"
      unitRef="USD">149322133</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-02-01_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5670123</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2023-07-282023-07-28_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">362831</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-282023-07-28"
      decimals="0"
      unitRef="USD">3874172</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-07-28_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:TemporaryEquitySharesOutstanding>
    <ATAK:DisclousreOfTemporaryEquityTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_892_ecustom--DisclousreOfTemporaryEquityTextBlock_zsnMvWnUfDke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023, the Class A ordinary shares, classified as temporary equity in the balance sheet, are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zHcf6nR58UCi" style="display: none"&gt;SUMMARY OF TEMPORARY EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 79%; text-align: left"&gt;Gross proceeds from initial public offering&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkfnIIVRw4" style="padding: 0pt; width: 18%; text-align: right" title="Gross proceeds from initial public offering"&gt;202,000,000&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt"&gt;Less:&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Proceeds allocated to public warrants&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSwkjut46Wli" style="padding: 0pt; text-align: right" title="Proceeds allocated to public warrants"&gt;(3,521,870&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Offering costs allocated to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iN_di_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zhIkjqIH8ROe" style="padding: 0pt; text-align: right" title="Offering costs allocated to Class A ordinary shares subject to possible redemption"&gt;(13,079,620&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Fair value allocated to rights&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FairValueAllocatedToRights_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zTkxFmm8Ktsg" style="padding: 0pt; text-align: right" title="Fair value allocated to rights"&gt;(15,596,420&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt"&gt;Plus:&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Proceeds allocated to private warrants&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zkU3Tf9tXFKl" style="padding: 0pt; text-align: right" title="Proceeds allocated to private warrants"&gt;4,211,323&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Redemption of Class A ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zHByOFdIZMN6" style="padding: 0pt; text-align: right" title="Redemption of Class A ordinary shares"&gt;(153,196,305&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Re-measurement of Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zJgNWv9Vd1z4" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Re-measurement of Class A ordinary shares subject to possible redemption"&gt;36,664,261&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Class A ordinary shares subject to possible redemption, September 30, 2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonClassASubjectToRedemptionMember_zlC0HTOiYjFa" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: right" title="Class A ordinary shares subject to possible redemption, September 30, 2023"&gt;57,481,369&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;div style="clear: both"&gt;&lt;/div&gt;

</ATAK:DisclousreOfTemporaryEquityTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">202000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">-3521870</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">13079620</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <ATAK:FairValueAllocatedToRights
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">-15596420</ATAK:FairValueAllocatedToRights>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">4211323</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">-153196305</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">36664261</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-09-30_custom_CommonClassASubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">57481369</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zN6ihQlobsm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zsXoHBhnjAK1"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;).
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the
financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30,
2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may be subject to potential examination by U.S. federal, U.S. state or foreign taxing authorities in the area of income taxes.
These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions
and compliance with U.S. federal, U.S. state and foreign tax laws. There is currently no taxation imposed on income by the Government
of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently,
deferred tax assets and income taxes are not reflected in the Company&#x2019;s financial statements. The Company&#x2019;s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zlDhTOoQNTf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zMEqkd0zGo82"&gt;Net
income per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding
during the period. Ordinary shares subject to possible redemption at September 30, 2023, which are not currently redeemable and are not
redeemable at fair value, have been excluded from the calculation of basic net income per ordinary share since such shares, if
redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of the warrants
sold in the Initial Public Offering and the private placement to purchase an aggregate of &lt;span id="xdx_901_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zH8O5cB0wZM7" title="Class of warrants or rights warrants issued during the period units"&gt;6,470,000&lt;/span&gt; Private Placement Warrants in the
calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events and the
inclusion of such warrants would be anti-dilutive. As a result, diluted net income (loss) per ordinary share is the same as basic net
income per ordinary share for the period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s statement of operations includes a presentation of net income per ordinary share subject to possible redemption
and allocates the net income into the two classes of stock in calculating net earnings per ordinary share, basic and diluted.
For redeemable Class A ordinary shares, net income per ordinary share is calculated by dividing the net income by the weighted
average number of Class A ordinary shares subject to possible redemption outstanding since original issuance. For non-redeemable Class
A ordinary shares, net income per share is calculated by dividing the net income by the weighted average number of non-redeemable
Class A ordinary shares outstanding for the period. Non-redeemable Class A ordinary shares include the representative shares issued to
Maxim at the closing of the initial public offering. For non-redeemable Class B ordinary shares, net income per share is calculated
by dividing the net income by the weighted average number of non-redeemable Class B ordinary shares outstanding for the period.
Non-redeemable Class B ordinary shares include the founder shares as these shares do not have any redemption features and do not participate
in the income earned on the Trust Account. As of September 30, 2023, the Company did not have any dilutive securities or other contracts
that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted
net income per ordinary share is the same as basic net income per ordinary share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none"&gt;SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;Three Months Ended September 30,&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic; text-align: left"&gt;Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 68%; text-align: left"&gt;Net income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;262,542&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;912,921&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj"&gt;5,413,775&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd"&gt;20,200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic"&gt;Non-redeemable ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Net income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;259,594&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;241,924&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;Nine Months Ended September 30,&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic; text-align: left"&gt;Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 68%; text-align: left"&gt;Net income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;183,421&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;4,173,309&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;7,659,431&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;17,314,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic"&gt;Non-redeemable ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Net income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;128,188&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;1,278,093&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding"&gt;5,302,571&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zD9STglapad3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits
      contextRef="From2023-01-012023-09-30_us-gaap_IPOMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="Shares">6470000</ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhDhewOE4fDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8B3_zSWSw5l7b0Hk" style="display: none"&gt;SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230701__20230930_z7HmlIaAW9o" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220701__20220930_zE8Oojupr3dl" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;Three Months Ended September 30,&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic; text-align: left"&gt;Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zT8U4VxnRrYj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zQA8xwtu2Q5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 68%; text-align: left"&gt;Net income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;262,542&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;912,921&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_z5JXVuJq8mwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zc6LTnlAwR2c" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zolvkOHwbeuj"&gt;5,413,775&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd"&gt;20,200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_pdd" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic"&gt;Non-redeemable ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zJxVbBwoEXR4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zsRH6v1Cx0Zk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Net income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;259,594&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;241,924&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zHu63H2b6ez3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zDhQLj189RF"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zCsVcUCTp8Od" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_pdd" title="Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zTZQiiYMeLG6" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zOFm4I526mye" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zYfqmbEi5K55" title="Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zfupiCtcDDt7" title="Basic and diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20230930_zkPfwwgcuv74" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220930_z6kK8KpZOFJ7" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;Nine Months Ended September 30,&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic; text-align: left"&gt;Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAbstract_iB_zRZkUviQBeA7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zcCHTWIAk3m2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 68%; text-align: left"&gt;Net income attributable to Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;183,421&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; width: 12%; text-align: right"&gt;4,173,309&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zBdsMn5VI6g3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zWwXUdeYilO5" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zMTT8rBJyueh" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;7,659,431&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zuhYDpgoRGJl" title="Basic weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zOskECcKTRE6" title="Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption"&gt;17,314,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, Class A ordinary shares subject to possible redemption&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zejAGzlTAy9c"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zfGJqVneTFmi" title="Diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zguKDT1TuyNf" title="Basic net income per share, non-redeemable Class A and Class B ordinary shares"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--RedeemableClassAOrdinarySharesMember_zYUvu1T9ax2l" title="Diluted net income per share, Class A ordinary shares subject to possible redemption"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-style: italic"&gt;Non-redeemable ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLossAbstract_iB_zxQrU5pwjCRb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Numerator: income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_hus-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z0D1UrgU8zH4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Net income attributable to non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;128,188&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; padding: 0pt; text-align: right"&gt;1,278,093&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EarningsPerShareBasicAbstract_iB_zxDRnJGDIckl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Denominator: weighted average non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zUnPBtAhfEHc" title="Basic weighted average shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zysyIIw27KTi" title="Diluted weighted average shares outstanding"&gt;5,353,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zFvrfSTmumv5" title="Basic weighted average shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zavVXjuiYLkj" title="Diluted weighted average shares outstanding"&gt;5,302,571&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z59Szim2Utk7" title="Basic net income per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zipRTnMunlC6" title="Diluted net income per share"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding: 0pt; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyOXyXaPNjDl" title="Basic net income per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQkFTSUMgQU5EIERJTFVURUQgTkVUIElOQ09NRSBQRVIgT1JESU5BUlkgU0hBUkUgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20220101__20220930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zahquNFBrlxg" title="Diluted net income per share"&gt;0.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="0"
      unitRef="USD">262542</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="0"
      unitRef="USD">912921</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">5413775</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">5413775</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="0"
      unitRef="USD">259594</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="0"
      unitRef="USD">241924</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="0"
      unitRef="USD">183421</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="0"
      unitRef="USD">4173309</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">7659431</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">7659431</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">17314286</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">17314286</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-09-30_custom_RedeemableClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="0"
      unitRef="USD">128188</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="0"
      unitRef="USD">1278093</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5353000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5302571</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="Shares">5302571</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-09-30_custom_NonredeemableCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.24</us-gaap:EarningsPerShareDiluted>
    <ATAK:RelatedPartiesPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zn6txi3e7Jra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_zbNK8Mc6pn8a"&gt;Related
Parties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATAK:RelatedPartiesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z0rL5e341nuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86C_zu9h4xeAzRWj"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zUsDGM9cFSA7" title="Federal depository insurance coverage"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbRiclSaBLi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_ztH9AGXbx30c"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;Fair Value Measurement&#x201d;
(&#x201c;ASC 820&#x201d;), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to
their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z0mtbpTsBPQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_ziYGfXBKh0la"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
    prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
    and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
    such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <ATAK:WarrantyLiabilityPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_847_ecustom--WarrantyLiabilityPolicyTextBlock_ziGdbr12fuBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_zGlNU7vkEWq9"&gt;Warranty
Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the &lt;span id="xdx_907_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDtZFfYhB441" title="Class of warrants or rights warrants issued during the period units"&gt;26,670,000&lt;/span&gt; warrants issued in connection with the Initial Public Offering and the Private Placement Warrants
(collectively, the &#x201c;Warrants&#x201d;) as either equity-classified or liability-classified instruments based on an assessment of
the Warrant&#x2019;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, &#x201c;Derivatives and Hedging&#x201d;
(&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the company&#x2019;s own ordinary shares, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Such
guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as
a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon
the closing of the Initial Public Offering. Accordingly, the Company will classify each warrant as a liability at its fair value and
the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This liability is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with
the change in fair value recognized in the Company&#x2019;s statement of operations. The Company will reassess the classification at each
balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the
date of the event that causes the reclassification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATAK:WarrantyLiabilityPolicyTextBlock>
    <ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember68552781"
      decimals="INF"
      unitRef="Shares">26670000</ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmVqWsEk1uzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zp1njrD6GmUg"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, &#x201c;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in
an Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020- 06&#x201d;), which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results
of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#x201c;Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions&#x201d; (&#x201c;ASU 2022-03&#x201d;), which amends ASC 820 to clarify that a contractual sales restriction is not considered
in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual
sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities
measured at fair value. The amendments are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods
within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued
or made available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial
position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s condensed financial statements.&lt;/span&gt;&lt;/p&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ATAK:DisclosureOfInitialPublicOfferingTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_80A_ecustom--DisclosureOfInitialPublicOfferingTextBlock_zjdp5Jc8pFwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
3. &lt;span id="xdx_824_zMzbHbOg1Ooj"&gt;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 9, 2022, pursuant to the Initial Public Offering, the Company sold &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPbYym7mU6a" title="Stock issued during period, shares, new issues"&gt;20,200,000&lt;/span&gt; Units, which includes the partial exercise by
the underwriter of its over-allotment option in the amount of &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zh5AD6Nt1L6a" title="Stock issued during period, shares, new issues"&gt;200,000&lt;/span&gt; Units, at a price of $&lt;span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrmRWzmQUlL2" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Unit. &lt;span id="xdx_90A_eus-gaap--CommonStockConversionBasis_c20220209__20220209__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zu7F6RRFHpp4" title="Common stock, conversion basis"&gt;Each Unit consists of one
Class A ordinary share, one redeemable warrant (each whole warrant, a &#x201c;Public Warrant&#x201d;), and one right to receive one-tenth
of one Class A ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. Each two Public Warrants entitle
the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8)&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
aggregate of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_c20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVUCN9zPjfef" title="Share price"&gt;10.10&lt;/span&gt; per Unit sold in the IPO was held in the Trust Account and invested in U.S. government securities, within the meaning
set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of &lt;span id="xdx_90E_ecustom--TermOfRestrictedInvestments_dtD_c20220209__20220209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zaFI22ntpuzd" title="Term of restricted investments"&gt;185&lt;/span&gt; days or less or in any open-ended investment company
that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the
Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATAK:DisclosureOfInitialPublicOfferingTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-02-092022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-02-09_us-gaap_CommonClassAMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockConversionBasis contextRef="From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember">Each Unit consists of one
Class A ordinary share, one redeemable warrant (each whole warrant, a &#x201c;Public Warrant&#x201d;), and one right to receive one-tenth
of one Class A ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. Each two Public Warrants entitle
the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8)</us-gaap:CommonStockConversionBasis>
    <us-gaap:SharePrice
      contextRef="AsOf2022-02-09_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharePrice>
    <ATAK:TermOfRestrictedInvestments contextRef="From2022-02-092022-02-09_us-gaap_IPOMember">P185D</ATAK:TermOfRestrictedInvestments>
    <ATAK:DisclosureOfPrivatePlacementTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_80E_ecustom--DisclosureOfPrivatePlacementTextBlock_zacKhridVzTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
4. &lt;span id="xdx_823_zVGa5FoW5c4l"&gt;PRIVATE PLACEMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of &lt;span id="xdx_902_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zxgjobz3yxVf" title="Class of warrants or rights warrants issued during the period units"&gt;6,470,000&lt;/span&gt; Private Placement Warrants at a price
of $&lt;span id="xdx_908_ecustom--ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zJaPvnW6kerh" title="Class of warrants or rights warrants issued price per warrant"&gt;1.00&lt;/span&gt; per warrant ($&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220209__20220209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zjKAX5VZXL4k" title="Proceeds from issuance of warrants"&gt;6,470,000&lt;/span&gt; in the aggregate) in a private placement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
two private placement warrants (the &#x201c;Private Placement Warrants&#x201d;) are exercisable for &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_dc_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zO5cda13vAVh" title="Class of warrant or right, number of securities called by each warrant or right"&gt;one&lt;/span&gt; whole Class A ordinary share at
a price of $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_zh8YzzQTryyf" title="Class of warrant or right, exercise price of warrants or rights"&gt;11.50&lt;/span&gt; per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial
Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period,
the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public
Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ATAK:DisclosureOfPrivatePlacementTextBlock>
    <ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits
      contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="Shares">6470000</ATAK:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits>
    <ATAK:ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant
      contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="USDPShares">1.00</ATAK:ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2022-02-092022-02-09_custom_SponsorMember_custom_PrivatePlacementWarrantMember"
      decimals="0"
      unitRef="USD">6470000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zHmrxzUsi456" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
5. &lt;span id="xdx_82D_zHVu4KGAWXF"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Founder
shares&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 7, 2021, the Sponsor was issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zg9TpWN6Jph9" title="Stock issued during period, shares, issued for services"&gt;5,750,000&lt;/span&gt; of the Company&#x2019;s Class B ordinary shares (the &#x201c;Founder Shares&#x201d;) for
an aggregate purchase price of $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zaytSPsSwQj5" title="Stock issued during period, shares, issued for services"&gt;25,00&lt;/span&gt;0. Due to the underwriters&#x2019; partial exercise of the over-allotment option, the Sponsor forfeited
&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zBYbyTLNHo1k" title="Shares issued, shares, share based payment arrangement, forfeited"&gt;700,000&lt;/span&gt; Founder Shares back to the Company. As a result, the Sponsor currently has &lt;span id="xdx_90A_eus-gaap--TemporaryEquitySharesIssued_iI_c20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zUZKmB3eRoth" title="Temporary equity shares issued"&gt;5,050,000&lt;/span&gt; Founder Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier
of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported
sale price of the Class A ordinary shares equals or exceeds $&lt;span id="xdx_902_ecustom--ShareTransferTriggerPricePerShare_iI_c20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQWEKqyr12M4" title="Share transfer, trigger price per share"&gt;12.00&lt;/span&gt; per share (as adjusted for share sub-divisions, share reorganizations,
recapitalizations and the like) for any &lt;span id="xdx_907_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zpr8BtdXaPg6" title="Number of consecutive trading days for determining share price"&gt;20&lt;/span&gt; trading days within any &lt;span id="xdx_907_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zU1cHOnyQUT" title="Number of trading days for determining share price"&gt;30&lt;/span&gt;-trading day period commencing at least &lt;span id="xdx_903_ecustom--ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination_dtD_c20210807__20210807__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--TriggeringEventAxis__custom--SharePriceMoreThanOrEqualsToUsdTwelveMember_zvG3vG7Ngt7l" title="Threshold number of trading days for determining share price from date of business combination"&gt;150&lt;/span&gt; days after a Business
Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction
that results in all of the Company&#x2019;s shareholders having the right to exchange their Class A ordinary shares for cash, securities
or other property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
notes &#x2013; related party&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 7, 2021, the Company issued an unsecured promissory note to the Sponsor (the &#x201c;Promissory Note&#x201d;), pursuant to which
the Company may borrow up to an aggregate principal amount of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDkxqAr7TwFb" title="Debt instrument, face amount"&gt;300,000&lt;/span&gt;. The Promissory Note was &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_do_c20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zLO5BkKYYNI5" title="Debt instrument interest rate"&gt;no&lt;/span&gt;n-interest bearing and payable on the
earlier of &lt;span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20210807__20210807__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zkObZI5rf114" title="Debt instrument, maturity date"&gt;March 31, 2022&lt;/span&gt;, or the completion of the IPO. At the time of repayment, there was $&lt;span id="xdx_903_eus-gaap--NotesPayable_iI_c20220209__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zBqY1O5GB598" title="Aggregate debt"&gt;242,801&lt;/span&gt; outstanding under the Promissory
Note. On February 9, 2022, the Company repaid the Sponsor for amounts outstanding under the Promissory Note. As of September 30, 2023
and December 31, 2022, there were &lt;span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_do_c20230930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDN8qx6k29Q3" title="Long-term debt"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_do_c20221231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zdNNQlJYLV85" title="Long-term debt"&gt;no&lt;/span&gt;&lt;/span&gt; amounts outstanding under the Promissory Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 8, 2023, the Company issued and drew fully against a promissory note in the amount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230208__us-gaap--DebtInstrumentAxis__custom--FirstWorkingCapitalMember_zDSdRIr3YZag"&gt;90,000&lt;/span&gt; to fund working capital needs
(the &#x201c;First Working Capital Note&#x201d;). Additionally, on February 8, 2023, the Company issued a promissory note in the amount
of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230208__us-gaap--DebtInstrumentAxis__custom--FirstExtensionNoteMember_zVVYSFJ4UIC5"&gt;135,000&lt;/span&gt; to fund the Company&#x2019;s first extension payment (the &#x201c;First Extension Note&#x201d;), which has not been drawn against.
On March 3, 2023, the Company issued a promissory note in the amount of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230303__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z8OplOF2dAlc"&gt;810,000&lt;/span&gt; to pay for up to six additional one-month extension
payments (the &#x201c;Second Extension Note&#x201d;). On each of March 7, 2023, April 6, 2023, May 5, 2023, June 2, 2023, and July 5, 2023,
the Company drew $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20230307__20230307__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_ztYlaXEonttf"&gt;&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20230406__20230406__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zWY7nl8EIxEi"&gt;&lt;span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_c20230505__20230505__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zRNuq3xMakYg"&gt;&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_c20230602__20230602__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zZv8A9haGfVa"&gt;&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20230705__20230705__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zcH4jFNcb13k"&gt;135,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfDebt_c20230101__20230930__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_zgTDU1IOCS64"&gt;675,000&lt;/span&gt; in the aggregate, against the Second Extension Note to pay for each additional one-month extension.
On April 6, 2023, the Company issued and drew fully against a promissory note in the amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230406__us-gaap--DebtInstrumentAxis__custom--SecondWorkingCapitalMember_zXKnu1p4b6A3"&gt;100,000&lt;/span&gt; to fund working capital needs
(the &#x201c;Second Working Capital Note&#x201d;). On May 2, 2023, the Company issued and drew fully against a promissory note in the amount
of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230502__us-gaap--DebtInstrumentAxis__custom--ThirdWorkingCapitalMember_zCG4yRjUbWW"&gt;100,000&lt;/span&gt; to fund working capital needs (the &#x201c;Third Working Capital Note&#x201d;). On June 14, 2023, the Company issued and drew
fully against a promissory note in the amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230614__us-gaap--DebtInstrumentAxis__custom--FourthWorkingCapitalMember_zSzU34Wlraa6"&gt;20,000&lt;/span&gt; to fund working capital needs (the &#x201c;Fourth Working Capital Note&#x201d;).
On July 7, 2023, the Company issued and subsequently on July 10, 2023, drew fully against a promissory note in the amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20230710__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_zxyAbe9VWS45"&gt;100,000&lt;/span&gt;
to fund working capital needs (the &#x201c;Fifth Working Capital Note&#x201d;). On July 31, 2023, the Company issued a promissory note
in the amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230731__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_zY7esLkv7ubk"&gt;810,000&lt;/span&gt; to pay for up to six additional one-month extension payments (the &#x201c;Third Extension Note&#x201d;). On each
of July 31, 2023, and September 1, 2023, the Company drew $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20230731__20230731__us-gaap--DebtInstrumentAxis__custom--ThirdExtensionNoteMember_zSYoxcxFoiA2"&gt;135,000&lt;/span&gt;, $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfDebt_c20230901__20230901__us-gaap--DebtInstrumentAxis__custom--ThirdExtensionNoteMember_zNCoE5nB7iMf"&gt;270,000&lt;/span&gt; in the aggregate, against the Third Extension Note to pay
for each additional one-month extension. On September 1, 2023, the Company issued and drew fully against a promissory note in the amount
of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20230901__us-gaap--DebtInstrumentAxis__custom--FifthWorkingCapitalMember_z9ejbSx2bdA4" title="Debt instrument, face amount"&gt;50,000&lt;/span&gt; to fund working capital needs (the &#x201c;Sixth Working Capital Note&#x201d; and together with the First Working Capital Note,
the Second Working Capital Note, the Third Working Capital Note, the Fourth Working Capital Note, and the Fifth Working Capital Note
collectively, the &#x201c;Working Capital Notes&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
First Extension Note does not bear interest, and matures (subject to the waiver against trust provisions) upon the earlier of (i)
two (2) days following the date on which the Company&#x2019;s initial business combination is consummated or liquidation and (ii)
August 31, 2023. The Company did not draw funds against the First Extension Note. The Second Extension Note bears no interest and is
repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#x2019;s
initial business combination, or (ii) the date of the Company&#x2019;s liquidation. The Third Extension Note bears no interest and is
repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company&#x2019;s
initial business combination, or (ii) the date of the Company&#x2019;s liquidation. The Working Capital Notes do not bear interest,
and mature (subject to the waiver against trust provisions) upon the earlier of (i) two (2) days following the date on which the
Company&#x2019;s initial business combination is consummated and (ii) the date of the liquidation of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023, there was $&lt;span id="xdx_903_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalNotesMember_zAI4x6b2eOye" title="Outstanding value under the note"&gt;460,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--SecondExtensionNoteMember_z5fTc5BRuuIi" title="Outstanding value under the note"&gt;945,000&lt;/span&gt; outstanding ($&lt;span id="xdx_905_eus-gaap--OtherLiabilities_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalAndSecondExtensionNoteMember_zEY7LcPwBN93" title="Outstanding value under the note"&gt;1,405,000&lt;/span&gt; in the aggregate) under the Working Capital Notes and
Extension Notes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Working
Capital Loans&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with a Business Combination, the Sponsor, certain of the Company&#x2019;s officers, directors
or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;).
If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital
Loans would either be repaid upon completion of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to
$&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_iI_c20230930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember_zdC0B3VBw5Zh" title="Debt instrument convertible into warrants"&gt;1,500,000&lt;/span&gt; of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember_zokEJpwibXNh" title="Debt instrument conversion price"&gt;1.00&lt;/span&gt;
per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2023 and December 31, 2022, &lt;span id="xdx_908_eus-gaap--OtherLiabilitiesCurrent_iI_do_c20230930__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zYuVkhxvtqd" title="Due to related parties current"&gt;&lt;span id="xdx_90E_eus-gaap--OtherLiabilitiesCurrent_iI_do_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zxONTowyS17e" title="Due to related parties current"&gt;no&lt;/span&gt;&lt;/span&gt; Working
Capital Loans were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Administrative
support agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on February 9, 2022, the Company agreed to pay the Sponsor a total of $&lt;span id="xdx_90F_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20220209__20220209__us-gaap--RelatedPartyTransactionAxis__custom--OfficeSpaceAdministrativeAndSupportServicesMember_zvs6CnLtAKke" title="Related party payments"&gt;10,000&lt;/span&gt; per month for office space, secretarial and administrative
services provided to the Company. Upon completion of the initial Business Combination or the Company&#x2019;s liquidation, the Company
will cease paying these monthly fees. The Company has incurred and paid $&lt;span id="xdx_905_eus-gaap--OperatingCostsAndExpenses_c20230701__20230930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zXu4ZRto1x4k" title="Administrative support agreement expenses"&gt;30,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--OperatingCostsAndExpenses_c20230101__20230930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zBFPSbsn84q7" title="Administrative support agreement expenses"&gt;90,000 &lt;/span&gt;in administrative support agreement expenses
for the three and nine months ended September 30, 2023. The Company has incurred and paid $&lt;span id="xdx_908_eus-gaap--OperatingCostsAndExpenses_c20220701__20220930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zh1fpnF9i0Bl" title="Administrative support agreement expenses"&gt;30,000&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--OperatingCostsAndExpenses_c20220101__20220930__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportAgreementMember_zOWpqOKAhyVl" title="Administrative support agreement expenses"&gt;80,000&lt;/span&gt; in administrative support
agreement expenses for the three and nine months ended September 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Affiliate
investment in potential target&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company was in discussions with a number of potential target companies. Through introductions by the Company, an affiliate of one of
the Company&#x2019;s directors invested in one potential target&#x2019;s latest private fundraising round. The result of which benefited
the Company through deeper discussions of a potential transaction. However, the Company did not enter into a business combination agreement
with the aforementioned potential target.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember"
      decimals="INF"
      unitRef="Shares">5750000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember"
      decimals="0"
      unitRef="USD">25.00</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2021-08-072021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember"
      decimals="INF"
      unitRef="Shares">700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2021-08-07_us-gaap_CommonClassBMember_custom_FounderSharesMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:TemporaryEquitySharesIssued>
    <ATAK:ShareTransferTriggerPricePerShare
      contextRef="AsOf2021-08-07_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">12.00</ATAK:ShareTransferTriggerPricePerShare>
    <ATAK:NumberOfConsecutiveTradingDaysForDeterminingSharePrice contextRef="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember">P20D</ATAK:NumberOfConsecutiveTradingDaysForDeterminingSharePrice>
    <ATAK:NumberOfTradingDaysForDeterminingSharePrice contextRef="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember">P30D</ATAK:NumberOfTradingDaysForDeterminingSharePrice>
    <ATAK:ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination contextRef="From2021-08-072021-08-07_us-gaap_CommonClassAMember_custom_SharePriceMoreThanOrEqualsToUsdTwelveMember">P150D</ATAK:ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-08-07_custom_PromissoryNoteMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-08-07_custom_PromissoryNoteMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-08-072021-08-07_custom_PromissoryNoteMember">2022-03-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-02-09_custom_PromissoryNoteMember_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">242801</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-09-30_custom_PromissoryNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31_custom_PromissoryNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-02-08_custom_FirstWorkingCapitalMember"
      decimals="0"
      unitRef="USD">90000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-02-08_custom_FirstExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-03-03_custom_PromissoryNoteMember"
      decimals="0"
      unitRef="USD">810000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-03-072023-03-07_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-04-062023-04-06_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-05-052023-05-05_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-06-022023-06-02_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-07-052023-07-05_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-01-012023-09-30_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">675000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-04-06_custom_SecondWorkingCapitalMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-05-02_custom_ThirdWorkingCapitalMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-06-14_custom_FourthWorkingCapitalMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-07-10_custom_FifthWorkingCapitalMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-07-31_custom_FifthWorkingCapitalMember"
      decimals="0"
      unitRef="USD">810000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-07-312023-07-31_custom_ThirdExtensionNoteMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-09-012023-09-01_custom_ThirdExtensionNoteMember"
      decimals="0"
      unitRef="USD">270000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-09-01_custom_FifthWorkingCapitalMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-09-30_custom_WorkingCapitalNotesMember"
      decimals="0"
      unitRef="USD">460000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-09-30_custom_SecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">945000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-09-30_custom_WorkingCapitalAndSecondExtensionNoteMember"
      decimals="0"
      unitRef="USD">1405000</us-gaap:OtherLiabilities>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="AsOf2023-09-30_custom_WorkingCapitalLoanMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-09-30_custom_WorkingCapitalLoanMember"
      decimals="INF"
      unitRef="USDPShares">1.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-09-30_us-gaap_RelatedPartyMember68554234"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember68554250"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="From2022-02-092022-02-09_custom_OfficeSpaceAdministrativeAndSupportServicesMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-07-012023-09-30_custom_AdministrativeSupportAgreementMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2023-01-012023-09-30_custom_AdministrativeSupportAgreementMember"
      decimals="0"
      unitRef="USD">90000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2022-07-012022-09-30_custom_AdministrativeSupportAgreementMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2022-01-012022-09-30_custom_AdministrativeSupportAgreementMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zs3sBPKp5erj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
6. &lt;span id="xdx_82E_zMwbKLSNPAIl"&gt;SHAREHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preference
shares-The Company is authorized to issue up to &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930_z7CGsX9PRedd" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zXCnH47jsw06" title="Preferred stock, shares authorized"&gt;5,000,000&lt;/span&gt;&lt;/span&gt; preference shares with a par value of $&lt;span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230930_zl5KwixPfN73" title="Preferred stock, par or stated value per share"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_z4VZjfQlljz2" title="Preferred stock, par or stated value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share with such designation,
rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. At September 30, 2023 and December
31, 2022, there were &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_do_c20230930_zz7t2rGETm" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zxGrpLslRMH4" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20230930_zy3w6SDHrhX3" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zzIG9iZN4dd6" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preferred shares issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Class
A ordinary shares- The Company is authorized to issue up to &lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zag3slqfd6Yb" title="Common stock shares authorized"&gt;&lt;span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRhI1JJlK2yk" title="Common stock shares authorized"&gt;500,000,000&lt;/span&gt;&lt;/span&gt; Class A ordinary shares with a par value of $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zODbl7b0BFPd" title="Common stock par value per share"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCFUHmHZPUu2" title="Common stock par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share.
Holders of the Company&#x2019;s Class A ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31,
2022, there were &lt;span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjKaNmolG7t8" title="Common stock shares issued"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGnkAVIAdEdc" title="Common stock shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zO0ECWyHTZzl" title="Common stock shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zgSCs5d1zQMc" title="Common stock shares outstanding"&gt;303,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; Class A Ordinary Shares issued or outstanding, excluding &lt;span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z28P1MY1PgXd" title="Temporary equity shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--TemporaryEquitySharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWBwkdnG7KKi" title="Temporary equity shares issued"&gt;5,307,292&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGtqq33G8Br4" title="Temporary equity shares outstanding"&gt;&lt;span id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8447AoSn7qd" title="Temporary equity shares issued"&gt;20,200,000&lt;/span&gt;&lt;/span&gt; shares subject to possible
redemption as presented in temporary equity as of September 30, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Class
B ordinary shares- The Company is authorized to issue up to &lt;span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zf4eWPkDIOR3" title="Common stock shares authorized"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeoORmZmwFy2" title="Common stock shares authorized"&gt;50,000,000&lt;/span&gt;&lt;/span&gt; Class B ordinary shares with a par value of $&lt;span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zVD3y9mndx4k" title="Common stock par value per share"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zNnwh3yDYCn" title="Common stock par value per share"&gt;0.0001 &lt;/span&gt;&lt;/span&gt;per share.
At September 30, 2023 and December 31, 2022, there were &lt;span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHQwMnotGCqd" title="Common stock shares issued"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjiDbNK1f2Yf" title="Common stock shares issued"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpP0l5WQodj5" title="Common stock shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z1w589LFjhc" title="Common stock shares outstanding"&gt;5,050,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; Class B ordinary shares issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary
shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and holders of Class
A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the
shareholders except as required by law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
so long as any Class B ordinary shares remain outstanding, we may not, without the prior vote or written consent of the holders of a
majority of the Class B ordinary shares then outstanding, voting separately as a single class, amend, alter or repeal any provision of
our memorandum and articles of association, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would
alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B ordinary shares.
Any action required or permitted to be taken at any meeting of the holders of Class B ordinary shares may be taken without a general
meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed
by the holders of the outstanding Class B ordinary shares having not less than the minimum number of votes that would be necessary to
authorize or take such action at a general meeting at which all Class B ordinary shares were present and voted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Class B ordinary shares will convert into Class A ordinary shares automatically at the time of a Business Combination, or at an earlier date at the option of the holder, on a
one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are
issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of a Business Combination, the ratio
at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of
the outstanding Class B ordinary shares to waive such adjustment with respect to any such issuance or deemed issuance) so that the
number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an
as-converted basis, &lt;span id="xdx_901_ecustom--CommonStockThresholdPercentageOnConversionOfShares_iI_dp_c20230930__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zsntYgtuPLG1" title="Common stock, threshold percentage on conversion of shares"&gt;20&lt;/span&gt;%
of the sum of the total number of all ordinary shares outstanding upon the completion of the IPO plus all Class A ordinary shares
and equity-linked securities issued or deemed issued by the Company in connection with or in relation to the completion of the
initial Business Combination, any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A
ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any private placement warrants issued
to the Sponsor upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary
shares at a rate of less than one to one.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rights-
Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive
one-tenth (1/10) of one Class A ordinary share upon consummation of a Business Combination, even if the holder of a right redeemed all
shares held by him, her or it in connection with a Business Combination or an amendment to the Company&#x2019;s Amended and Restated Memorandum
of Association with respect to its pre-business combination activities. In the event that the Company will not be the surviving company
upon completion of a Business Combination, each holder of a right will be required to affirmatively exchange his, her or its rights in
order to receive the one-tenth (1/10) of a share underlying each right upon consummation of the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the
nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders
of the rights must hold rights in multiples of 10 in order to receive shares for all of the holders&#x2019; rights upon closing of a Business
Combination. If the Company is unable to complete an initial Business Combination within the Combination Period and the Company redeems
the Public Shares for the funds held in the Trust Account, holders of rights will not receive any of such funds for their rights and
the rights will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">5307292</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5050000</us-gaap:CommonStockSharesOutstanding>
    <ATAK:CommonStockThresholdPercentageOnConversionOfShares
      contextRef="AsOf2023-09-30_custom_FounderSharesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Pure">0.20</ATAK:CommonStockThresholdPercentageOnConversionOfShares>
    <ATAK:WarrantsDisclosureTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zUdDtwnj54Kd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
7. &lt;span id="xdx_826_zO3usRGWeXha"&gt;WARRANTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for the &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930_zvhl8PcTU1rh" title="Number of warrants or rights outstanding"&gt;26,670,000&lt;/span&gt; warrants that were issued in the IPO (representing &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMDTVyzCh1Vk" title="Number of warrants or rights outstanding"&gt;20,200,000&lt;/span&gt; Public Warrants and &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHrChTdYI8f1" title="Number of warrants or rights outstanding"&gt;6,470,000&lt;/span&gt; Private
Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not
meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify
each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such
re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company&#x2019;s
statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants
&#x2014; Public Warrants may only be exercised for a whole number of Class A ordinary shares. No fractional warrants have been or will
be issued upon separation of the Units and only whole warrants will trade. Accordingly, unless holders purchase at least two Units, they
will not be able to receive or trade a whole warrant. The Public Warrants will become exercisable &lt;span id="xdx_90C_ecustom--WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z3jvh60RdGEf" title="Warrants exercisable term from the date of completion of business combination"&gt;30&lt;/span&gt; days after the completion of a Business
Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any Class A Ordinary Shares pursuant to the exercise of a Public Warrant and will have no obligation
to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary
Shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company
satisfying its obligations with respect to registration, or a valid exemption from registration is available. No Public Warrant will
be exercisable, and the Company will not be obligated to issue any Class A Ordinary Shares upon exercise of a Public Warrant unless the
Class A Ordinary Share issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities
laws of the state of residence of the registered holder of the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has agreed that as soon as practicable, but in no event later than &lt;span id="xdx_901_ecustom--MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z8sdNreSzCVa" title="Minimum lock in period for SEC registration from date of business combination"&gt;20&lt;/span&gt; business days after the closing of a Business Combination,
it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which
this prospectus forms a part or a new registration statement covering the registration under the Securities Act of the Class A Ordinary
Shares issuable upon exercise of the Public Warrants, and the Company will use its commercially reasonable efforts to cause the same
to become effective within &lt;span id="xdx_907_ecustom--MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zdCx8PPjteAj" title="Minimum lock in period to become effective after the closing of the initial business combination"&gt;60&lt;/span&gt; business days after the closing of a Business Combination, and to maintain the effectiveness of such registration
statement and a current prospectus relating to those Class A Ordinary Shares until the Public Warrants expire or are redeemed, as specified
in the warrant agreement; provided that if the Class A Ordinary Shares is at the time of any exercise of a Public Warrant not listed
on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of
the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless
basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be
required to file or maintain in effect a registration statement, but it will use its commercially reasonably efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class
A Ordinary Shares issuable upon exercise of the Public Warrants is not effective by the 60th day after the closing of a Business Combination,
Public Warrant holders may, until such time as there is an effective registration statement and during any period when the Company will
have failed to maintain an effective registration statement, exercise Public Warrants on a &#x201c;cashless basis&#x201d; in accordance
with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonably efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redemption
of warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the warrant become exercisable, the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
    whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
    a price of $&lt;span id="xdx_904_ecustom--ClassOfWarrantsRedemptionPricePerUnit_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJ44vU4heVk" title="Class of warrants redemption price per unit"&gt;0.01&lt;/span&gt; per warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
    not less than &lt;span id="xdx_908_ecustom--ClassOfWarrantsRedemptionNoticePeriod_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPF6wiANdyr9" title="Class of warrants, redemption notice period"&gt;30&lt;/span&gt; days&#x2019; prior written notice of redemption to each warrant holder; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
    and only if, the last sale price of our ordinary shares equals or exceeds $&lt;span id="xdx_90D_eus-gaap--SharePrice_iI_c20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHTWRmQveZFi" title="Share price"&gt;18.00&lt;/span&gt; per share (as adjusted for share sub-divisions,
    share dividends, reorganizations, recapitalizations and the like) for any &lt;span id="xdx_904_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWiSLcfc7wEb" title="Number of consecutive trading days for determining share price"&gt;20&lt;/span&gt; trading days within a &lt;span id="xdx_90B_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20230101__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zp0g45qXbhVe" title="Number of trading days for determining share price"&gt;30&lt;/span&gt;-trading day period ending on
    the third trading day prior to the date on which we send the notice of redemption to the warrant holder.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 57.2pt; text-align: justify; text-indent: -21.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection
with the closing of a Business Combination at an issue price or effective issue price of less than $&lt;span id="xdx_90F_ecustom--ShareRedemptionTriggerPrice_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zLEPK7fjdJH8" title="Share redemption trigger price"&gt;9.20&lt;/span&gt; per Class A Ordinary Share (with
such issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of
any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent
more than &lt;span id="xdx_906_ecustom--MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity_iI_pid_dp_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zzrdqJgGB63b" title="Minimum percentage gross proceeds required from issuance of equity"&gt;60&lt;/span&gt;% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of
the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary
shares during the &lt;span id="xdx_902_ecustom--ClassOfWarrantOrRightMinimumNoticePeriodForRedemption_dtD_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zMTc7WOpep6" title="Class of warrant right minimum notice period for redemption"&gt;20&lt;/span&gt; trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination
(such price, the &#x201c;Market Value&#x201d;) is below $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zZaaNwnlFSH6" title="Class of warrant or right, exercise price of warrants or rights"&gt;9.20&lt;/span&gt; per share, then the exercise price of the warrants will be adjusted (to the
nearest cent) to be equal to &lt;span id="xdx_90F_ecustom--ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_iI_pid_dp_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember_zth1LSnxGk29" title="Class of warrant or right exercise price adjustment percentage higher of market value"&gt;115&lt;/span&gt;% of the higher of the Market Value and the Newly Issued Price, the $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zbRC6ir0bWsg" title="Class of warrant or right, exercise price of warrants or rights"&gt;18.00&lt;/span&gt; per share redemption trigger
price described above (to the nearest cent) to be equal to &lt;span id="xdx_904_ecustom--ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue_iI_pid_dp_c20230930__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_z83t3IroCtji" title="Class of warrant or right exercise price adjustment percentage higher of market value"&gt;180&lt;/span&gt;% of the higher of the Market Value and the Newly Issued Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private
Placement Warrants and the Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants will not be transferable,
assignable or saleable until &lt;span id="xdx_90C_ecustom--MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo_dtD_c20230101__20230930_zowVYBtcXPP8" title="Minimum lock In period for transfer, assign or sell warrants after completion of IPO"&gt;30&lt;/span&gt; days after the completion of a Business Combination, subject to certain limited exceptions. Additionally,
the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder&#x2019;s option, and be non-redeemable
so long as they are held by the initial purchasers or their permitted transferees (except for a number of Class A Ordinary Shares as
described above under Redemption of warrants for Class A Ordinary Shares). If the Private Placement Warrants are held by someone other
than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption
scenarios and exercisable by such holders on the same basis as the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATAK:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2023-09-30" decimals="INF" unitRef="Shares">26670000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Shares">20200000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Shares">6470000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ATAK:WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination contextRef="From2023-01-012023-09-30_custom_PublicWarrantsMember">P30D</ATAK:WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination>
    <ATAK:MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination contextRef="From2023-01-012023-09-30_custom_PublicWarrantsMember">P20D</ATAK:MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination>
    <ATAK:MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination contextRef="From2023-01-012023-09-30_custom_PublicWarrantsMember">P60D</ATAK:MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination>
    <ATAK:ClassOfWarrantsRedemptionPricePerUnit
      contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.01</ATAK:ClassOfWarrantsRedemptionPricePerUnit>
    <ATAK:ClassOfWarrantsRedemptionNoticePeriod contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">P30D</ATAK:ClassOfWarrantsRedemptionNoticePeriod>
    <us-gaap:SharePrice
      contextRef="AsOf2023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">18.00</us-gaap:SharePrice>
    <ATAK:NumberOfConsecutiveTradingDaysForDeterminingSharePrice contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">P20D</ATAK:NumberOfConsecutiveTradingDaysForDeterminingSharePrice>
    <ATAK:NumberOfTradingDaysForDeterminingSharePrice contextRef="From2023-01-012023-09-30_custom_RedemptionOfWarrantsMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_us-gaap_CommonClassAMember">P30D</ATAK:NumberOfTradingDaysForDeterminingSharePrice>
    <ATAK:ShareRedemptionTriggerPrice
      contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember"
      decimals="INF"
      unitRef="USDPShares">9.20</ATAK:ShareRedemptionTriggerPrice>
    <ATAK:MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember"
      decimals="INF"
      unitRef="Pure">0.60</ATAK:MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity>
    <ATAK:ClassOfWarrantOrRightMinimumNoticePeriodForRedemption contextRef="From2023-01-012023-09-30_us-gaap_CommonClassAMember_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember">P20D</ATAK:ClassOfWarrantOrRightMinimumNoticePeriodForRedemption>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember"
      decimals="INF"
      unitRef="USDPShares">9.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ATAK:ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue
      contextRef="AsOf2023-09-30_custom_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember"
      decimals="INF"
      unitRef="Pure">1.15</ATAK:ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
      decimals="INF"
      unitRef="USDPShares">18.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ATAK:ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue
      contextRef="AsOf2023-09-30_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
      decimals="INF"
      unitRef="Pure">1.80</ATAK:ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue>
    <ATAK:MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo contextRef="From2023-01-01to2023-09-30">P30D</ATAK:MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_805_eus-gaap--CommitmentsDisclosureTextBlock_z41seqf91WRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
8. &lt;span id="xdx_827_zY8C7MwxeNn"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Registration
right and Shareholder Rights&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares, Private Placement Warrants, warrants that may be issued upon conversion of Working Capital Loans (and
any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion
of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration
rights agreement that was signed on the effective date of the IPO, requiring the Company to register such securities for resale. The
holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule
415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Underwriting
agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company granted the underwriters a &lt;span id="xdx_900_ecustom--OverAllotmentOptionPeriod_dtD_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zXaZ7EgDntOa" title="Over allotment option period"&gt;45&lt;/span&gt;-day option from the date of the IPO to purchase up to &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_ziSDkUgLazZd" title="Stock issued during period, shares, new issues"&gt;3,000,000&lt;/span&gt; additional Units to cover over-allotments
at the IPO price less the underwriting discount. The underwriters partially exercised the over-allotment option, generating an additional
$&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zvrc9dspmfOk" title="Proceeds from issuance of common stock"&gt;2,000,000&lt;/span&gt; in gross proceeds. As a result of the over-allotment being exercised in part, the Sponsor forfeited &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230101__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zNfXNwpxp3O4" title="Shares issued, shares, share-based payment arrangement, forfeited"&gt;700,000&lt;/span&gt; Founder Shares
back to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were paid a cash underwriting discount of $&lt;span id="xdx_90D_eus-gaap--PaymentsForUnderwritingExpense_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zU7PbOgvdQF4" title="Deferred underwriting fees"&gt;2,525,000&lt;/span&gt; in the aggregate at the closing of the IPO. In addition, $&lt;span id="xdx_905_ecustom--DeferredUnderwritingCommissionPerUnit_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z31Vosa8wMP7" title="Deferred underwriting commission per unit"&gt;0.35 &lt;/span&gt;per
Unit, or $&lt;span id="xdx_907_ecustom--DeferredUnderwritingCommissionsNoncurrent_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z0nVCBKhx3Ni" title="Deferred underwriting commissions"&gt;7,070,000&lt;/span&gt; in the aggregate is payable to the underwriters for deferred underwriting commissions. The deferred fee is payable
to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination,
subject to the terms of the underwriting agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Legal
Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a contingent fee arrangement with their legal counsel, in which the deferred fee is payable to the Company&#x2019;s legal
counsel solely in the event that the Company completes a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right
of First Refusal&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to certain conditions, the Company granted Maxim, for a period beginning on the closing of the IPO, and ending on the earlier of 18 months
after the date of the consummation of the Business Combination and February 7, 2025, the three year anniversary of the effective date
of the registration statement filed in connection with the IPO (the &#x201c;S-1 Effective Date&#x201d;), a right of first refusal to act
as book-running managing underwriter or placement agent for any and all future public and private equity, convertible and debt offerings
for us or any of our successors or subsidiaries. In accordance with FINRA Rule 5110(g)(6), such right of first refusal shall not have
a duration of more than three years from the commencement of sales of securities in the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Representative&#x2019;s
Ordinary Shares&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued to Maxim and/or its designees, &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyKt45ksxOR9" title="Maxim IPO shares issued"&gt;303,000&lt;/span&gt; Class A ordinary shares upon the consummation of the IPO. Maxim has agreed not
to transfer, assign or sell any such shares until the completion of the Company&#x2019;s initial Business Combination. In addition, Maxim
has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company&#x2019;s initial
business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if
the Company fails to complete its initial business combination within 12 months (or up to 18 months if we extend the period of time to
consummate a business combination by the full amount of time) from the closing of the IPO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the
S-1 Effective Date. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative,
put or call transaction nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following
the commencement of sales of securities in the IPO, except to any underwriter and selected dealer participating in the offering and their
officers or partners, associated persons or affiliates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsDisclosureTextBlock>
    <ATAK:OverAllotmentOptionPeriod contextRef="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember">P45D</ATAK:OverAllotmentOptionPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember"
      decimals="INF"
      unitRef="Shares">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-012023-09-30_us-gaap_OverAllotmentOptionMember_custom_UnderwritingAgreementMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-01-012023-09-30_custom_SponsorMember_custom_UnderwritingAgreementMember"
      decimals="INF"
      unitRef="Shares">700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-01-012023-09-30_custom_UnderwritingAgreementMember"
      decimals="0"
      unitRef="USD">2525000</us-gaap:PaymentsForUnderwritingExpense>
    <ATAK:DeferredUnderwritingCommissionPerUnit
      contextRef="From2023-01-012023-09-30_custom_UnderwritingAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.35</ATAK:DeferredUnderwritingCommissionPerUnit>
    <ATAK:DeferredUnderwritingCommissionsNoncurrent
      contextRef="AsOf2023-09-30_custom_UnderwritingAgreementMember"
      decimals="0"
      unitRef="USD">7070000</ATAK:DeferredUnderwritingCommissionsNoncurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_IPOMember"
      decimals="INF"
      unitRef="Shares">303000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_806_eus-gaap--FairValueDisclosuresTextBlock_z5ZkIR5Pk3vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
9. &lt;span id="xdx_82D_zbNoGHWbrnaf"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2023 and December 31, 2022, the Company&#x2019;s warrant liability was valued at $&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_c20230930_zx1ws3UGbRX6" title="Warrant liability"&gt;441,300&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--DerivativeLiabilities_iI_c20221231_zMLFMXd6RrZb" title="Warrant liability"&gt;589,420&lt;/span&gt;, respectively. Under
the guidance in ASC 815-40, the Public Warrants and the Private Placement Warrants do not meet the criteria for equity treatment. As
such, the Public Warrants and the Private Placement Warrants must be recorded on the balance sheet at fair value. This valuation is subject
to re-measurement at each balance sheet date. With each re-measurement, the valuations will be adjusted to fair value, with the change
in fair value recognized in the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents fair value information as of September 30, 2023 and December 31, 2022, of the Company&#x2019;s financial assets
and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques
the Company utilized to determine such fair value. The Company&#x2019;s warrant liability is based on a valuation model utilizing management
judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets.
Significant deviations from these estimates and inputs could result in a material change in fair value The Company transferred the fair
value of Public Warrants and Private Placement Warrants from a Level 3 measurement to a Level 1 and Level 2 measurement, respectively,
in 2022. The measurement of the Public Warrants as of September 30, 2023 is classified as Level 1 due to the use of an observable market
quote in an active market under the ticker ATAKW. The measurement of the Private Placement Warrants as of September 30, 2023 is classified
as Level 2 as its value is derived from the directly observable quoted prices of the Public Warrants in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-CPH_zD5cUhCEa5G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zTQjK1biSbR9"&gt;SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Private&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Public&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Warrant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Derivative warrant liabilities at December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAAW9yvaFCI5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBJzhpVJpDW6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zjkR2Mp5EXyi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1203"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 1.5pt"&gt;Initial fair value at issuance of public and private placement warrants&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcautWchdM11" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants"&gt;3,521,870&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPUaYY8buI58" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants"&gt;2,258,677&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwi5VWCHxiK7" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants"&gt;5,780,547&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zJ6ACioAM5C5" style="text-align: right" title="Change in fair value"&gt;(1,905,870&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zYWePiQpVVgf" style="text-align: right" title="Change in fair value"&gt;(1,730,725&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zaQWyTYRhrh" style="text-align: right" title="Change in fair value"&gt;(3,636,595&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Transfer of public warrants to Level 1 measurement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zR4yEiDOuKkg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"&gt;(1,616,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_z9W2JM0r1QC9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zIplz2uZgEY6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"&gt;(1,616,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk35ZPQJCoX7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1223"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuiqX6BjD9A5" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;527,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z2vE14XdjkQl" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;527,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0lzc9YO1OB4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1229"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVSK2fdxPwu2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(280,952&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zaBexgiz6SD4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(280,952&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmJTHnEftI1j" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1235"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlGdKKEfZs3i" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;247,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_ztHgU0al2dre" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;247,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zvbpohzSkmE5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbit6K09oeg6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(118,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zxtkvJDzYeZa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(118,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of September 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNfqDo9nRbVf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z62F0CUYCOo3" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;129,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zeY4B19DBa66" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;129,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMXPPrCSeCHj" style="text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1253"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVJzQGYcYjxc" style="text-align: right" title="Change in fair value"&gt;14,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zsutCbF2VPb5" style="text-align: right" title="Change in fair value"&gt;14,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Transfer of Private Placement Warrants to Level 2 measurement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_z4EZ1dRZY6oa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1259"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_zsoZT2Mvnmdi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"&gt;(143,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__custom--TrancheAxis__custom--TrancheTwoMember_zfINuQwZ7j99" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"&gt;(143,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5rkpQNhkq3" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1265"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZS2C3AJDrkf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1267"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zrjaYmZ89xzc" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1269"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTqEyRStrWk3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z2rlvsLI1no1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1273"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zOFg2Kn1tMC8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1275"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5s8rddgc5h" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1277"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zItxLcHXcHa7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1279"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zTF7FfZOHWub" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zLxLA71OMLLj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUypW4OnZY1g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1285"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zCiEM6DJpA22" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1287"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzHseD5ond3g" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1289"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIpO0PQXXyK" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z1ahTQKItRh6" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1293"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zEQyCr1lmi27" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1295"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zIcy9iXVC5ff" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1297"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zoW9aiFeNFM" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1299"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Level 3 derivative warrant liabilities as of September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGMd85PfYbol" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1301"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zA84LOaPHYB8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1303"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zo8I0YtjQoUj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1305"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zOl6j2TvERhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxL5juBT1i5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth by level within the fair value hierarchy the Company&#x2019;s assets and liabilities that were accounted for
at fair value on a recurring basis at September 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zjDZeVmZNQj8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SUMMARY
OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Cash and marketable securities held in trust account&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4gawblzyND5" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;57,481,369&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjL6ihv07bGi" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKfKmzxa0mKj" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1313"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUpVGrwowabe" style="text-align: right" title="Public Warrants"&gt;333,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z2UzQA5ORCXk" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1317"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zmX9FjgKRCIf" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1319"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5rPXzSJlan7" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1321"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zlq4icCL71K5" style="text-align: right" title="Private Placement Warrants"&gt;108,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUeBNa89tspk" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1325"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth by level within the fair value hierarchy the Company&#x2019;s assets and liabilities that were accounted for
at fair value on a recurring basis at December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Cash and marketable securities held in trust account&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKO5NLuAMp7k" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;206,879,903&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgIGL1Zf3wId" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1329"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqnmllIx2U" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1331"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziIb67mCZpRe" style="text-align: right" title="Public Warrants"&gt;446,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAp98Oyxi5E3" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1335"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zC3EnF8U5du7" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1337"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxyU81j4Q092" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1339"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDbWrxtK1Era" style="text-align: right" title="Private Placement Warrants"&gt;143,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUhcMt9t0x7d" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1343"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zEsOHpHNFfgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the changes in the fair value of derivative warrant liabilities as of September 30, 2023 and December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_C05_gL3FVLMORBUIR-CPH_zNkZBCkxBfA9"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C0E_gL3FVLMORBUIR-CPH_zoQfsLwwIdX5"&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_300_134_zXvobzVu7bj4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Public Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Private Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total Derivative Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Fair value at August 6, 2021 (inception)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoHDbRua9gO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1345"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zaDW6fPMSV3j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1347"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zEtGHsMFZuE8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zfGLRHvw1C53" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1351"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zCpInILvqkAb" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1353"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z2TLeaOuA2P1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1355"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Derivative warrant liabilities as of December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaPoTc5OGa72" style="text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1357"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zvTJB4eFFOrj" style="text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1359"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z5NGqrpyZjq6" style="text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1361"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Initial fair value at issuance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zusAqYCMyzJe" style="width: 14%; text-align: right" title="Initial fair value at issuance"&gt;3,521,870&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z1DwZtMuWkli" style="width: 14%; text-align: right" title="Initial fair value at issuance"&gt;2,258,677&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zlWxhKHlVtD2" style="width: 14%; text-align: right" title="Initial fair value at issuance"&gt;5,780,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zxwm5JtkoSxi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(1,905,870&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxKYSGFygD4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(1,730,725&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z3MTrlLBzOrb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(3,636,595&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMjpHJPMYFCh" style="text-align: right" title="Beginning balance"&gt;1,616,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5RX6lbVUhqk" style="text-align: right" title="Beginning balance"&gt;527,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zsnrp3pkvSui" style="text-align: right" title="Beginning balance"&gt;2,143,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcqo6J3Iufd3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(858,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbus30l94wfd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(280,952&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zPZIPMXD5OSg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(1,139,452&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgAtIztGvnJa" style="text-align: right" title="Beginning balance"&gt;757,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zAinMA6aMoLk" style="text-align: right" title="Beginning balance"&gt;247,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zoi4DoxsH0g" style="text-align: right" title="Beginning balance"&gt;1,004,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7iD7sBnVLB1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(353,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zg5ZLeIj6He3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(118,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zihHLQZOYDZd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(471,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of September 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z22mlIrpvDzi" style="text-align: right" title="Beginning balance"&gt;404,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zMTyxZ0la7Mb" style="text-align: right" title="Beginning balance"&gt;129,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zvkWjznTQL6k" style="text-align: right" title="Beginning balance"&gt;533,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zm0OF5ZcsLgg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;42,420&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ztq2KfsXNqi1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;14,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zU8nnSUYWGU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;56,420&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuNRYsE2pMv9" style="text-align: right" title="Beginning balance"&gt;446,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zOnBX3nNM0f7" style="text-align: right" title="Beginning balance"&gt;143,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zAjBDQ3RdICk" style="text-align: right" title="Beginning balance"&gt;589,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zhlIcHSpkWoe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;58,580&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zgXpwvXdwbS8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;20,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z8CfLV9zo6Da" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;78,580&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z747OAysoByl" style="text-align: right" title="Beginning balance"&gt;505,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zPvSDxXFfYVi" style="text-align: right" title="Beginning balance"&gt;163,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zG5ctc2KhBwf" style="text-align: right" title="Beginning balance"&gt;668,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zsCjyvl8T6o7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(220,180&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zJ5V073Zrfk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(71,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zMWBTSKhBbbg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(291,180&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUavEazgfMoi" style="text-align: right" title="Beginning balance"&gt;284,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zsdGhl7zi4je" style="text-align: right" title="Beginning balance"&gt;92,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zIz0ZrdIElo7" style="text-align: right" title="Beginning balance"&gt;376,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSuc8wJCxUj8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;48,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z70Dx1pLPZzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;16,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z0nBpgYbN8hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;64,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Derivative warrant liabilities as of September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7XGXEv1FLrd" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;333,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDSizcf5br8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;108,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zkIkdqCM81Yb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;441,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_C05_gL3FVLMORBUIR-CPH_zZKsCxvjiaNk"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
Measurement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company established the initial fair value for the warrants on February 9, 2022, the date of the completion of the Company&#x2019;s IPO.
The Company used a Black Scholes Merton model to value the warrants. The Company allocated the proceeds received from (i) the sale of
Units (which is inclusive of one Class A Ordinary Share, one Public Warrant and one right to receive one-tenth of a Class A ordinary
share upon consummation of an initial business combination), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class
B Ordinary Shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds
allocated to Class A Ordinary Shares subject to possible redemption (temporary equity), Class A Ordinary Shares (permanent equity) and
Class B Ordinary Shares (permanent equity) based on their relative fair values at the initial measurement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-TZRS_zQShlPTDOnU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs into the Black Scholes Merton model formula were as follows at February 9, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zt5f0kGmw2Z6" style="display: none"&gt;SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Private Placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Ordinary Share price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zuktzM4J1VX1" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;9.08&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zp0zHjqqyWq4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate of interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ziRclMY3UQvk" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;1.80&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHj8xkDcreh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;9.43&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zENdeyDcOmib" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;5.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant to buy one share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zBPRmOTVN4j2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zSrI2W5Ump7h" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zLHFwktJOZLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsequent
Measurement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values the Private Placement Warrants relative to the market prices of ordinary share and the Public Warrants, which are both actively
traded on a public market. The valuation model for the Private Placement Warrants is a risk-neutral Monte Carlo simulation. As of September
30, 2023, the measurement of the Public Warrants was valued using an observable market quote in an active market under the ticker ATAKW.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs into the Monte Carlo simulation model were as follows at September 30, 2023 and December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_C07_gL3FVAALMORAN-TZRS_zcX8P1iueOb6"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C0C_gL3FVAALMORAN-TZRS_zdmMpGs5GbJf"&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zq0JWE1vTZ6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;December 31,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Ordinary Share price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMdUV0T19Iif" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;10.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk02Y9p3unUl" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;10.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ztp1y6L9hRP4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcajHRr5ONx5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate of interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpnBjcQSIfM8" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;4.55&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zDLfN9CWdDdh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;3.94&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z1LF6V0RVsAf" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zXoC6C2Pss8g" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zw7FkrY1Uw1d" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;5.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTX7fIxpqkA5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;5.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant to buy one share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zow9dOFzrUe" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIGyt4fTbSN2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziOxtRzZN6Ai" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSQiBRQBJN4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_C0F_gL3FVAALMORAN-TZRS_zrGVFZkIFN74"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
risk-free interest rate assumption was based on the linearly interpolated Treasury Constant Maturity Rate Curve between five and seven
year rates, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) six years after the
completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in
isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2023-09-30" decimals="0" unitRef="USD">441300</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">589420</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-CPH_zD5cUhCEa5G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zTQjK1biSbR9"&gt;SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Private&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Public&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Warrant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Derivative warrant liabilities at December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAAW9yvaFCI5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBJzhpVJpDW6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220101__20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zjkR2Mp5EXyi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1203"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 1.5pt"&gt;Initial fair value at issuance of public and private placement warrants&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcautWchdM11" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants"&gt;3,521,870&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPUaYY8buI58" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants"&gt;2,258,677&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwi5VWCHxiK7" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Initial fair value at issuance public and private placement warrants"&gt;5,780,547&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zJ6ACioAM5C5" style="text-align: right" title="Change in fair value"&gt;(1,905,870&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zYWePiQpVVgf" style="text-align: right" title="Change in fair value"&gt;(1,730,725&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zaQWyTYRhrh" style="text-align: right" title="Change in fair value"&gt;(3,636,595&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Transfer of public warrants to Level 1 measurement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zR4yEiDOuKkg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"&gt;(1,616,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_z9W2JM0r1QC9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__custom--TrancheAxis__custom--TrancheOneMember_zIplz2uZgEY6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of public warrants to Level 1 measurement"&gt;(1,616,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk35ZPQJCoX7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1223"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuiqX6BjD9A5" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;527,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z2vE14XdjkQl" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;527,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z0lzc9YO1OB4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1229"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVSK2fdxPwu2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(280,952&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zaBexgiz6SD4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(280,952&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmJTHnEftI1j" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1235"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlGdKKEfZs3i" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;247,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_ztHgU0al2dre" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;247,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zvbpohzSkmE5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbit6K09oeg6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(118,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zxtkvJDzYeZa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(118,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of September 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNfqDo9nRbVf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z62F0CUYCOo3" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;129,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zeY4B19DBa66" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;129,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMXPPrCSeCHj" style="text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1253"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zVJzQGYcYjxc" style="text-align: right" title="Change in fair value"&gt;14,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zsutCbF2VPb5" style="text-align: right" title="Change in fair value"&gt;14,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Transfer of Private Placement Warrants to Level 2 measurement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_z4EZ1dRZY6oa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1259"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__custom--TrancheAxis__custom--TrancheTwoMember_zsoZT2Mvnmdi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"&gt;(143,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_c20221001__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember__custom--TrancheAxis__custom--TrancheTwoMember_zfINuQwZ7j99" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transfer of private placement warrants to level 2 measurement"&gt;(143,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5rkpQNhkq3" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1265"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZS2C3AJDrkf" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1267"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zrjaYmZ89xzc" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1269"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTqEyRStrWk3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z2rlvsLI1no1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1273"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zOFg2Kn1tMC8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1275"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zs5s8rddgc5h" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1277"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zItxLcHXcHa7" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1279"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zTF7FfZOHWub" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zLxLA71OMLLj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUypW4OnZY1g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1285"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zCiEM6DJpA22" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1287"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Level 3 derivative warrant liabilities as of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzHseD5ond3g" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1289"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIpO0PQXXyK" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_z1ahTQKItRh6" style="text-align: right" title="Derivative warrant liabilities, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1293"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zEQyCr1lmi27" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1295"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zIcy9iXVC5ff" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1297"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zoW9aiFeNFM" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1299"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Level 3 derivative warrant liabilities as of September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGMd85PfYbol" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1301"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zA84LOaPHYB8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1303"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20230701__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantLiabilityMember_zo8I0YtjQoUj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative warrant liabilities, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1305"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_300_134_zXvobzVu7bj4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Public Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Private Placement &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total Derivative Warrant &lt;br/&gt; Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Fair value at August 6, 2021 (inception)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoHDbRua9gO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1345"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zaDW6fPMSV3j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1347"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zEtGHsMFZuE8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value at August 6, 2021 (inception)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zfGLRHvw1C53" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1351"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zCpInILvqkAb" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1353"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210806__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z2TLeaOuA2P1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1355"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Derivative warrant liabilities as of December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaPoTc5OGa72" style="text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1357"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zvTJB4eFFOrj" style="text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1359"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z5NGqrpyZjq6" style="text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1361"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Initial fair value at issuance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zusAqYCMyzJe" style="width: 14%; text-align: right" title="Initial fair value at issuance"&gt;3,521,870&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z1DwZtMuWkli" style="width: 14%; text-align: right" title="Initial fair value at issuance"&gt;2,258,677&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zlWxhKHlVtD2" style="width: 14%; text-align: right" title="Initial fair value at issuance"&gt;5,780,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zxwm5JtkoSxi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(1,905,870&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxKYSGFygD4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(1,730,725&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20220331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z3MTrlLBzOrb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(3,636,595&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMjpHJPMYFCh" style="text-align: right" title="Beginning balance"&gt;1,616,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5RX6lbVUhqk" style="text-align: right" title="Beginning balance"&gt;527,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zsnrp3pkvSui" style="text-align: right" title="Beginning balance"&gt;2,143,952&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcqo6J3Iufd3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(858,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zbus30l94wfd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(280,952&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220401__20220630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zPZIPMXD5OSg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(1,139,452&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgAtIztGvnJa" style="text-align: right" title="Beginning balance"&gt;757,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zAinMA6aMoLk" style="text-align: right" title="Beginning balance"&gt;247,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zoi4DoxsH0g" style="text-align: right" title="Beginning balance"&gt;1,004,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7iD7sBnVLB1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(353,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zg5ZLeIj6He3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(118,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220701__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zihHLQZOYDZd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(471,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of September 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z22mlIrpvDzi" style="text-align: right" title="Beginning balance"&gt;404,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zMTyxZ0la7Mb" style="text-align: right" title="Beginning balance"&gt;129,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zvkWjznTQL6k" style="text-align: right" title="Beginning balance"&gt;533,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zm0OF5ZcsLgg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;42,420&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ztq2KfsXNqi1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;14,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20221001__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zU8nnSUYWGU4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;56,420&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuNRYsE2pMv9" style="text-align: right" title="Beginning balance"&gt;446,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zOnBX3nNM0f7" style="text-align: right" title="Beginning balance"&gt;143,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zAjBDQ3RdICk" style="text-align: right" title="Beginning balance"&gt;589,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zhlIcHSpkWoe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;58,580&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zgXpwvXdwbS8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;20,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z8CfLV9zo6Da" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;78,580&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z747OAysoByl" style="text-align: right" title="Beginning balance"&gt;505,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zPvSDxXFfYVi" style="text-align: right" title="Beginning balance"&gt;163,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zG5ctc2KhBwf" style="text-align: right" title="Beginning balance"&gt;668,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zsCjyvl8T6o7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(220,180&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zJ5V073Zrfk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(71,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230401__20230630__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zMWBTSKhBbbg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;(291,180&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Derivative warrant liabilities as of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUavEazgfMoi" style="text-align: right" title="Beginning balance"&gt;284,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zsdGhl7zi4je" style="text-align: right" title="Beginning balance"&gt;92,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeNet_iS_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zIz0ZrdIElo7" style="text-align: right" title="Beginning balance"&gt;376,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSuc8wJCxUj8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;48,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z70Dx1pLPZzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;16,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_z0nBpgYbN8hj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"&gt;64,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Derivative warrant liabilities as of September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7XGXEv1FLrd" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;333,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDSizcf5br8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;108,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_c20230701__20230930__us-gaap--ClassOfWarrantOrRightAxis__custom--DerivativeWarrantLiabilityMember_zkIkdqCM81Yb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;441,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">3521870</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">2258677</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">5780547</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember"
      decimals="0"
      unitRef="USD">-1905870</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember"
      decimals="0"
      unitRef="USD">-1730725</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember"
      decimals="0"
      unitRef="USD">-3636595</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember"
      decimals="0"
      unitRef="USD">-1616000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="From2022-01-012022-03-31_custom_WarrantLiabilityMember_us-gaap_FairValueInputsLevel3Member_custom_TrancheOneMember"
      decimals="0"
      unitRef="USD">-1616000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">527952</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-03-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      decimals="0"
      unitRef="USD">527952</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">-280952</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-04-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-280952</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">247000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      decimals="0"
      unitRef="USD">247000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">-118000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-012022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-118000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">129000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-09-30_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      decimals="0"
      unitRef="USD">129000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">14000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember"
      decimals="0"
      unitRef="USD">14000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_PrivatePlacementWarrantsMember_custom_TrancheTwoMember"
      decimals="0"
      unitRef="USD">-143000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="From2022-10-012022-12-31_us-gaap_FairValueInputsLevel3Member_custom_WarrantLiabilityMember_custom_TrancheTwoMember"
      decimals="0"
      unitRef="USD">-143000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_893_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxL5juBT1i5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth by level within the fair value hierarchy the Company&#x2019;s assets and liabilities that were accounted for
at fair value on a recurring basis at September 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zjDZeVmZNQj8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SUMMARY
OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Cash and marketable securities held in trust account&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4gawblzyND5" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;57,481,369&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjL6ihv07bGi" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230930__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKfKmzxa0mKj" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1313"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zUpVGrwowabe" style="text-align: right" title="Public Warrants"&gt;333,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z2UzQA5ORCXk" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1317"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zmX9FjgKRCIf" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1319"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z5rPXzSJlan7" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1321"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zlq4icCL71K5" style="text-align: right" title="Private Placement Warrants"&gt;108,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUeBNa89tspk" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1325"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth by level within the fair value hierarchy the Company&#x2019;s assets and liabilities that were accounted for
at fair value on a recurring basis at December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Cash and marketable securities held in trust account&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKO5NLuAMp7k" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;206,879,903&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgIGL1Zf3wId" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1329"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqnmllIx2U" style="width: 14%; text-align: right" title="Cash and marketable securities held in trust account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1331"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziIb67mCZpRe" style="text-align: right" title="Public Warrants"&gt;446,420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zAp98Oyxi5E3" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1335"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zC3EnF8U5du7" style="text-align: right" title="Public Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1337"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private Placement Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zxyU81j4Q092" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1339"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zDbWrxtK1Era" style="text-align: right" title="Private Placement Warrants"&gt;143,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zUhcMt9t0x7d" style="text-align: right" title="Private Placement Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1343"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-09-30_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      unitRef="USD">57481369</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">333300</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-30_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">108000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      unitRef="USD">206879903</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">446420</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">143000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">3521870</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">2258677</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="From2022-01-012022-03-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">5780547</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-03-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">-1905870</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">-1730725</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-03-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-3636595</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-03-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">1616000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">527952</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-03-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">2143952</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-04-012022-06-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">-858500</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-04-012022-06-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">-280952</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-04-012022-06-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-1139452</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-06-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">757500</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-06-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">247000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-06-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">1004500</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-012022-09-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">-353500</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-012022-09-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">-118000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-012022-09-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-471500</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-09-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">404000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-09-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">129000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-09-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">533000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-10-012022-12-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">42420</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-10-012022-12-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">14000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-10-012022-12-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">56420</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-12-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">446420</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">143000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-12-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">589420</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-03-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">58580</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-03-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">78580</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-03-31_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">505000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">163000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-03-31_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">668000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-04-012023-06-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">-220180</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-04-012023-06-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">-71000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-04-012023-06-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-291180</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-06-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">284820</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-06-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">92000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-06-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">376820</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-07-012023-09-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">48480</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-07-012023-09-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">16000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-07-012023-09-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">64480</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-09-30_custom_PublicWarrantsMember"
      decimals="0"
      unitRef="USD">333300</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-09-30_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      unitRef="USD">108000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-09-30_custom_DerivativeWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">441300</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-TZRS_zQShlPTDOnU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key inputs into the Black Scholes Merton model formula were as follows at February 9, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zt5f0kGmw2Z6" style="display: none"&gt;SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Private Placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Ordinary Share price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zuktzM4J1VX1" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;9.08&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zp0zHjqqyWq4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate of interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_ziRclMY3UQvk" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;1.80&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zHj8xkDcreh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;9.43&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zENdeyDcOmib" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;5.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant to buy one share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zBPRmOTVN4j2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20220209__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zSrI2W5Ump7h" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zq0JWE1vTZ6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;December 31,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Ordinary Share price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMdUV0T19Iif" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;10.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zk02Y9p3unUl" style="width: 16%; text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;10.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ztp1y6L9hRP4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zcajHRr5ONx5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate of interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpnBjcQSIfM8" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;4.55&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zDLfN9CWdDdh" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;3.94&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z1LF6V0RVsAf" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zXoC6C2Pss8g" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zw7FkrY1Uw1d" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;5.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTX7fIxpqkA5" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;5.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant to buy one share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zow9dOFzrUe" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputProbabilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIGyt4fTbSN2" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziOxtRzZN6Ai" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSQiBRQBJN4" style="text-align: right" title="Warrants and Rights Outstanding, Measurement Input"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_us-gaap_MeasurementInputSharePriceMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">9.08</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_us-gaap_MeasurementInputExercisePriceMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">1.80</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_us-gaap_MeasurementInputPriceVolatilityMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">9.43</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_us-gaap_MeasurementInputExpectedTermMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">5.99</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_custom_MeasurementInputProbabilityMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.35</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-02-09_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">10.85</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputSharePriceMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">10.23</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExercisePriceMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">4.55</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">3.94</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">5.25</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExpectedTermMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">5.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_custom_MeasurementInputProbabilityMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="Pure">0.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-01to2023-09-30">&lt;p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zzDMwwIEYqG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTE
10. &lt;span id="xdx_82B_zqeghYTWnHpc"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or
disclosure in the condensed financial statements, other than the below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On October 9, 2023, the Company extended the Combination
Period from October 9, 2023 to November 9, 2023 by depositing $&lt;span id="xdx_90C_eus-gaap--AssetsHeldInTrustCurrent_iI_c20231009__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztsZl6Kuh6Pe" title="Trust account"&gt;135,000&lt;/span&gt; into the Trust Account on October 2, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On October 24, 2023, the Company issued an unsecured
promissory note (the &#x201c;Seventh Working Capital Note&#x201d;) in the amount of $&lt;span id="xdx_901_ecustom--UnsecuredPromissoryNote_c20231023__20231024__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zea3ezA55Tt3" title="Unsecured promissory note"&gt;75,000&lt;/span&gt; to the Sponsor. The Seventh Working Capital
Note does not bear interest, and matures upon the earlier of two days following the date on which the Company&#x2019;s initial business
combination is consummated or the date of the liquidation of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On November 9, 2023, the Company extended the Combination Period from November
9, 2023 to December 9, 2023 by depositing $&lt;span id="xdx_901_eus-gaap--AssetsHeldInTrustCurrent_iI_c20231109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zN2nxdVyd6ye" title="Deposit trust account"&gt;135,000&lt;/span&gt; into the Trust Account on November 3, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On November 17, 2023, the Company issued an unsecured
promissory note (the &#x201c;Eighth Working Capital Note&#x201d;) in the amount of $&lt;span id="xdx_90B_eus-gaap--UnsecuredDebt_iI_c20231117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zksO27DF3rud" title="Unsecured promissory note"&gt;50,000&lt;/span&gt; to the Sponsor. The Eighth Working Capital Note
does not bear interest, and matures upon the earlier of two days following the date on which the Company&#x2019;s initial business combination
is consummated or the date of the liquidation of the Company.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2023-10-09_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:AssetsHeldInTrustCurrent>
    <ATAK:UnsecuredPromissoryNote
      contextRef="From2023-10-232023-10-24_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">75000</ATAK:UnsecuredPromissoryNote>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2023-11-09_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">135000</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:UnsecuredDebt
      contextRef="AsOf2023-11-17_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:UnsecuredDebt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>47
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0[[2"VG"\__14W&N;_50N.:"IF6P;$$:9\5?_%QVQ*N 856 4P8X;P)LKR+
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M*A.Q>)$^)0+<K-,'PHSV8!'+LON>[?B6T2 8V]2@YAL;I(>MP2EYC+F0<ZM
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M?M]=WRA15*^,'X12(JLNEYS!AJ,-X/N%@(C7-_HM].:_#F;_ 5!+ P04
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MKVX>'T<_7P/RM)730S?<%:%7$LKU:#]S_(EM6=/Q_M1%%8;@Q+8[L% #"[S
MM>$Y+E)Q$$'+L5K<F7ZGT>\8]?]&BP*L&,T ;6:^3G3%XIZDO]*JUN"TLG4X
MK6X-T"C<;82[9:1]0?A[OB$,)/F29@2\2H4-KV]TPEV3?;*<W11;O"2W(U&O
M"L+V9#3[X3OH63_JWJPAR<(AR:*!R,Z&PFN&PC/.P?D&YVLBQ@*L<,+ 'J<[
M(M?B V8,YQRD"5XD:<(_Z\;'4^>'YSA!=UZJ,,>';G?ZABH,.@%$'5BDPESD
M^*[CZ^>DWQCA&XWX66QP@%B*R)-<@W9)L9%U25I!]X1=X32EO+QC=,280S^4
M0#=9!^()!^*)?,5TY :.8^D]#QK/@Z_TW&ARH#R,#1WD!)UI9\S]# _[I8N^
M/=V9AY/&PXG1PS#9)V(W%1^74V&GV'T_$HX7*0$%6>Y8PA-2@ U))0C\SL0.
M#]PMEW27<YV]$T6O[T+/Z]JKPB86\GRW\U:K,.1#W_=1QSX5!Z'K!M#33S%H
MM9M-RVC0:;%Y W*BU5QSG*6W+.C87D>U#FC[#E1T:X V# 1E=SW3 #W/$U#[
M@O*3;38T*G\G>KY*MU8R5'8U+D)05:SBQ,@X@:,H5H$V%&5JTA6L2>RXPAAT
M03!J!2-S,:-9)N;_/,5B8W4'_GI+L@5A?VO5&YF>N[<8E"T<E"T:BNU\3-H]
M/K0'V>M!8Z_P[ $9DBT<E"T:BNU\0-JF YJ[CGM<)$MP*'_-$"TX%KL;+':
MQ0:+;(#N>,%%.R;JL5@L:7[%2$Q(5A83RL1MS#[76.THJBV#ZX@%LKL\SC5
MT55:\E]W65&1ON=.'*5;T0"A+TMU<*F&M/T*-.[!19%-=]*LEW+-[>N:"KSD
MFHJ\X)H*_()K;6L!S;U%-=-$Q:W?^^,J()K=RHPWS5+=,0D4N\4_9,D!IT!:
MF6UE<ZRUKGH$_^3QK6M+\:T/*M2CNAL5+0HY%\QJVP]H[C^.4^R%[?)[V=4'
M%>I1BETZU$6[VLX!FEN'=S0_><?JPO_ Z?+17/:_8I=NJ#)#LH6#LD5#L9V/
M3]N5P,DP9=_8W3Q[0(9D"P=EBX9B.__=N6V#D+D->M&RC]0>QK5=6RE+\[[
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M!^C9L3PA%9'&\*PU6#NDF6<-/9U>G9^GO&OP.6#)8+>[Y@F:!PFY^4;GQ;)
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M8\F8DG'@DKFN YTZ;/NI XL]KP[YAP@(P!;VYXE1@E3<9(4EMLJ8X.UT1,L
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M8E4]K.N[TW7QR.GZ:?H=!^7'3A7 Q;),-L6*3^=HS=CB7,.4&^( RIVZOU7
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MC\ 2W30AC=?SR%>#$]^#06];E%;$"D :C$&]3^.3XV/X>!J/P"P,1B,UB8]
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MI!IV+J7&$M8%@O %3%!9DW!@O\2RK8*,5V?22?%I9IT'LD1Z)PA%V@:FR]4
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MB!<\L22!X>.9W_*B($&HQI=&YJ [DAC[_UOI'YSM:,N2&7ZKBI]%:O.KP?D
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MMWK?(H&!.<I/D5UOH/$"'L(*0\<2(#PU\ 8F\8BPCC!K8#*+X$&K$EVA]"9
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MSAEF$Q'@^TRARLV"#N@^T%W_"5!+ P04    " #Z@717W^RJX>('  "G%
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M7*4PE)@GD\]E5>F<.'M,85B*!Y@#=/JO2(.@RHYX10^QI> &QJE2*=7@*B^
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M9A,%3]IX2ILO$,,;S*1$8*00V!"C8Z")/Z!2O"$P>%J(Q!0=@<'A)-ZIW'9
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MF'M:7/=URM_ [YZBSVU" G@DY,8)B%5[L!A;:C\Y&]J:YT=N=M2I7B&H7[T
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MP:TV$\+1U$X/-,<>MR[,,X&9B;-\L#UCQ6SMK!D"?DB\V2RE$>.0=\#?.,Z
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MK\Z&LZ)G<Z'\VVDG?>RU_S>>3>/Q&@$>'3P<A<2K![BU-[^'UE,G-2R=,/#
MJY/ P\-%H_8?M!X?+UBDWT/K\?P&\1H-,R)^O4'<9O#=-!\\]T=U[U]O/K[]
M\\.#I\_JSJLZIL/<?I!08%\_R[?V[=/M-X]V^:K_+%Y^,'F@<LYS!2F;H:I[
M6<?#I2P_0I0W6BSMB_]4:"TR.UPPFC!I!'!^)H3>W!@#VR]!K;\!4$L#!!0
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MR1,^Q&))CY](:9"7\6UHS//_X%AB+0-L#ES0I!26.TBBM/C$7TI'G E('K6
M70K8=0'WBH!3"CA=-;BE@-M5@U<*Y*:;A>VYXQ 6>#QD] A8AI9LV47N_5Q:
M^BM*LT19"2:_C:2<&*\>Y_/)\C=P_Q%,)ZN[&9@L$$!W/S]^#A!8!)_!W6)V
M/P_ 0[ $]TMTM\C JT^390#>(2)P%//WX -X7"'P[OOW0U/(/67,YJ;4/RWT
MVU?T.V!.4['C($A#$BKD4;O\H$7>E+ZH'&*_.F1JMQ*NR/X&.-:/P+9L1[&?
M67=Q6V7.V[0'7ZW]PAE.E1U.SN=>X5N2D,C"M(X)F,68<S !]RR,4EE2P&J'
M&>'@]SE)UH3]H0I]*WE6 F_Y'F_(R) UCA/V0HSQ#]_!GO63RN\ZR9!.LD 3
MV46$W"I";L[N7(G0XI 0A@5EMR!*-S0A  O!HO5!Y%$3%*0T_<":<<1I6%Y/
M 7V-*<]CJ@JEJS.4.LF03K) $]E%*+TJE%[KCVTAVX)O&L-"?2]7GS40+V.[
M9WNN+!0OY]%IP@;0'MCP$H::,.@[;AT6-&$N[#N.-:AP%\[J5<[JM>8](BF5
MC\,B\X]Y.T!"@%_DCV%+-/FKIS/G=9(AG62!)K*+,/:K,/9;<WZ*>;1IQJ^(
M"9"-+1<R:%&Z5<6GH/;.4LMSH=/O>[6$;N+DX]'*_FHIW03V>][ =>HYW<3)
ME(:N[??42>U7WO!;O8&B^)"YX2O]X7?T1Q-WQ1]-H-H?35R[/P:5/P8=LB,]
MU<4]884O5.877/VS75@W5MWV+B"D!-7*9* "V:[:8&B=VG&K4PIT-;JD^P>K
M.Z&0&E6W6XFZ:OC9' +;GWXT/:_8-$GD&+D2=//<VF*VL_[;(JV5#6EE"W2Q
M7<;'/L7'_E\TFN4V= 54)QO2RA;H8KL,Z&FT@^VSW3=O-TO]%_VF-Y#/CWIQ
M4N!<.+#=>GEJXJ#M0]^O%R@5KN]; ^=*C3K-6K!]V/HOFDZH==+2RH:TL@6Z
MV"Z#>9JV8/NX]:;6L^2^Z+4<SVFT4+.N0-05&"B!ENWUX97T/HU4L+75?VO[
M6;)W\$E'(.H*#)3 -I^<YA/894#IW(WU.W5C75!(C6IT8RK4U6[L-(C ;I-(
M9\/]3H9W02$UJF&X"M4PW#Q[,R[[EVU^),'!AAY24;P&K5:K8X])_K*_MCZ%
MMS.H6$?9,4G^)OY$7YRQS#';1BD',7F2JJR;OLQ.5AQ;%#>"[O/W\FLJ!$WR
MRQW!(6$90'[_1*EXO<D45(='X[\!4$L#!!0    ( /J!=%>"9T?-'PH  )AJ
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;,6=:V_;R!F%_\I 712[
M0#8B1_?4-N"(=]87Q'&#HN@'BAI9[/*B'9+V&NB/W^'%HBA18RDY1;\D$JWW
M>6>D.9K;&?'B)>&_I6O&,O)'%,;I96^=99M/_7[JKUGDI1^3#8O%7U8)C[Q,
M/.5/_73#F;<L@Z*P3Q5EW(^\(.Y=7937[OG519)G81"S>T[2/(H\_OJ9A<G+
M94_MO5WX$CRML^)"_^IBXSVQ!Y8];NZY>-;?4I9!Q.(T2&+"V>JR=ZU^<@>T
M""A?\8^ O:0[CTE1E462_%8\L9>7/:4H$0N9GQ4(3_SWS.8L# N2*,?O-;2W
MS5D$[CY^HQMEY45E%E[*YDGX+5AFZ\O>M$>6;.7E8?8E>;%87:%1P?.3,"W_
M)2_U:Y4>\?,T2Z(Z6)0@"N+J?^^/^HW8"5"'1P)H'4!/#1C4 8-3 X9UP' _
M8'0D8%0'C$[-,*X#QJ<&3.J R:E%FM8!TU,SS.J V:D!JO+VR2DGAVP_[*K1
M5:VD;&*:EWE7%SQY(;QXO> 5#\IV6L:+EA7$A:0>,B[^&HBX[.KA\>;F^LL_
MR9U!'FSSUC;L^?7M5W(]G]\]WGZU;TUR?_=W>V[K#^1GC65>$*;DUN/<*Y3P
M"_F5/#YHY.>??KGH9Z(T!;/OUYGU*C,]DGE ;I(X6Z=$CY=LV1%OR>-GDOB^
M>!>V;P5]>RL^4RG0R<./A$X_$*K004=YYO)P@RT^$F5V-%P[/9QVO9OR\ >V
M^4@&RM'LACS\QN,B7#T:;IX>WE5XZ\<*;Y\>WI7=.>6=/UYW5QZN,?]8W5O-
M<+!5Y*#D#8_PYEZZ)NSW/'CV0A9G:4>)/DL)12_\*=UX/KOLB6XV9?R9]:[^
M^A=UK/RMJUDC81H2IE>P<0DKQ@;/5\I%_WFW52/3F4B8]6[9;60Z!PES965O
MM>GAMDT/I6WZ5HP--SSQ&5NFQ(N2/,ZZFK44<FZS1L(T)$Q'P@PDS$3"K.^
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MI>E0F@&EF5":!:794)H#I;DH6EMGC8% E3L(?GR!;WRX[SBFTX&ZOQH!-0M
M:3J49D!I)I1F06DVE.9 :2Z*UM95XRU0Y>:"KT)5"2\D5'B=L]<W"9$DS]+,
MBX6^GCKE=+B-/QHH$SH[6-V#F@>@-/W42AC0M":49IU:"1N:UNE**P:/*MU;
MLW4[7D@KV^@1-[/:;/ZK\MU_>T6^,:(EY#;)B!B);4*6,7*7<V*+B4S@A>3S
MFQUSOF/'E [2H!8!*$V#TG0HS8#23"C-@M)L*,V!TEP4K:W'QG2@RET']]4J
MPDN0K8.8O*P#?]UMB!9]3!@6_ND=2S19\20J%R.V%^O17E"+N39@)ZL5XYW:
MA=H9H#0-2M.A- -*,Z$TZYT61X<D*H\?=BH5ZH2 TEP4K7W$LO%+4+E?XGI1
MF$C+KK+N-XN5P.OX^SM.><)SQ0>E:5":#J494)H)I5E0F@VE.5":BZ*UY=B8
M+*C<9/%_[CCEI3M;NTB:!J7I4)H!I9E0FO5.BY-VG-"2.%":BZ*UE=I8/:C<
MZF'?W\F[0:BC TK3H#0=2C.@-!-*LZ T&TISH#0716N+JW&'4+D[Y,3SZ7+*
MV1J#&D3HX:'](\>D=6AB THSH30+2K.A- =*<U&TMH :]P>5NS^^,AY5QP33
MC =^5AY,?Q9/HF,_82('GJTEJ+'CG<JJTQ%9>J]=U=*A!3&@-!-*LZ T&TIS
MH#0716MKJW%Z4+G3XZZ8/16K)'Z2'M$2U. !I6DUK=4OS=09G4PG^]T2U+P!
MI9E0F@6EV5": Z6Y*%I;.HUY@\K-&X_%\=P7'I2+C"O6;="0,\Y6#]3&00_-
M(W14>K_WQ0-U:$!I)I1F06DVE.9 :2Z*UA9/X]"@<H>&QD2_P]FR.N3^KHJ@
M/_P I6GTT DP43K\ICHTK0&EF5":!:794)H#I;DH6EM%C56$RJTBUWZ6>V&U
M!"X?Q$$-(%":1@]_)6*B4C&(V]</U-H!I9E0F@6EV5": Z6Y*%I;/XVU@T)^
M4$)..5L]4 M&36N?=QA-E>F^>J#F"BC-A-(L*,V&TAPHS471VC\EW-@M!N_8
M+9;_R>M%N.*'([WE,BCV:(NM62^H?SQR$V1>^.'MD%9]1JM+8_)<YVH,2M-J
M6NLL?_';6*/1;$]ET+P&E&9":1:49D-I#I3FHFAME34NBH%\3WMW;Y;\E]SS
MX%GT5^0^%"G+'YX\Y?2Q/,?9ZH)Z(: T'4HSH#032K.@-!M*<Z T%T5K*[!Q
M1PSD[HC_T>EC>=:S-0DU54!I.I1F0&DFE&;5M-W1^'C8=?@8FM:!TEP4K9);
M?^?^,1'C3^4MC@K_7QYGU8TKME>WMU&Z+F\>M'==5S^9:L=U2_UD5_>K:?#5
M/9MN//X4Q"D)V4JD4CY.Q.?"J]L@54^R9%/>O6:19%D2E0_7S%LR7KQ _'V5
M)-G;DR+!]F945W\"4$L#!!0    ( /J!=%<]1LBGQ@0  )P4   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;+58VV[;.!!][U<,W*)H ->Z.+ZD<0PD
M;K)K(!>C:;</Q3[0TB1B*XDJ2<4ML!^_0TJ6[4)1-UGYQ18ISN&<(6=TR,E*
MR&\J0M3P(XE3==*)M,[>.8X*(DR8ZHD,4WIS)V3"-#7EO:,RB2RT1DGL^*X[
M=!+&T\YT8OL6<CH1N8YYB@L)*D\2)G^>82Q6)QVOL^[XP.\C;3J<Z21C]WB+
M^E.VD-1R*I20)Y@J+E*0>'?2.?7>S;RQ,; C_N*X4EO/8*@LA?AF&O/PI.,:
MCS#&0!L(1G\/.,,X-DCDQ_<2M%/-:0RWG]?H%Y8\D5DRA3,1?^:ACDXZXPZ$
M>,?R6'\0JS^Q)#0P>(&(E?V%53%V,.I D"LMDM*8/$AX6ORS'V4@M@S&[B,&
M?FG@_V) $]<;]$N#OB5:>&9IO6>:32=2K$":T81F'FQLK#6QX:E9QELMZ2TG
M.SV=7\\_SD\O8?'I['(^@YN+B_,/\^L_X,U[U(S'"JZ9E,R$^@#>PBMP0$5,
MHIHXFF8W&$Y0SC0K9O(?F>D(KD2J(P7G:8CAKKU#7E>N^VO7S_Q&P M<]L ]
MZH+O^GZ=/\WFMYCUH.]:\WZ#._TJDGV+=_@(WDPD">W+6<R4@E/X<H7)$N7?
M-8Z=-0*9Q'VG,A;@28<R4Z%\P,[T]4MOZ![7L6P);(?S8<7YT*+W'XMAOE0\
MY)3_7;AE,8*X@ULM@F_PY9*&PEQCHFI#<-AF"%H"VPG!H K!H''9U[25H=V%
M3/( (4-9Y$D=]0)O:/%,E7V8>N[$>=@FU#CE,PD-*T+#1D+SQ4WCYFVT?NK*
MM02V0W14$1WM:?..V@Q!2V [(1A7(1@W;UY+ERN58PAA+GEZ;_8N%V&WK/-=
M2.E3;$?4U?RS1ORGAJ( &VQE1M_MN^XF.W9('E4DCYI)&B)%8M8Q*(Q'.^G8
M\WY)R,89GKE(GKOY1KN-##ZB3,SN)&Q--#0M%D\?J$%Z2M<NRV\ O?$ 0O:S
M_BO>:/I<KEMZQ/O/Y0?^@2=\59N!G[H7VT+;#8._"8._I^)4 K<5AI;0=L.P
MT51>LZCZ_P6JG&"[J)#@<]WMLE)2W8>2\C92RFN4*6O]6.J(0%""2WM8HE,*
MKZ?6#'C.@@@^I5P;,(+0RFPBD>*+=38)&?*4ME@1RJYY1S4F1#HI+FG+K8ST
M3S6\08.TBL2FKPL,7K\<^[Y[O,B7,0_@<_'"=GK'!S0@#0M <Y "+0@Y0#I'
MF,ZWF@I7]*)P!^K=@3PC\CI"Z[XY9=IS']F8/HI6QM*?9CIO=*RH'G+-60QG
MN:(P$!P-6!*:L>F!#85>"=AU5@&YP76,+PPD\0M)MY&G62Z#B,Z&3=XQ30P!
M?Z ,N"H_+\:Y5Y[7&[@;!4C[-%]^I4.K 6;AU[RHVO!&(<*UT CC@]K$VX>H
M]3:JUFN6M3>T^]Z>QK$HO+W);/"?69A;DK-E8/8ACKV-.O:&^RK,K2KGMM!V
MP[#1SEZC+FVC,(]J"G-=6=Z'0/8V"MG[C41^\OFN!&P\X#5/^E12SM;]3X+R
MWEZ+*:J;>:J+JZ"JM[IZ.[473LYF>'%O=\7D/4\5Q'A'IFYO1.LCBZNPHJ%%
M9F^3ED)KD=C'"!D53C. WM\)JFEEPTQ074A._P502P,$%     @ ^H%T5V#L
M_\U! P  ,@P  !D   !X;"]W;W)K<VAE971S+W-H965T,C4N>&ULM9=K;]HP
M%(;_RE$V39O4D1!N;0=(+;1:I;5"99</TSZ8Y #6G#BS'>C^_8Z=- ,UC4;%
M^J'Q[;PYS^OCR RW4OW4:T0##XE(]<A;&Y.=^[Z.UI@PW9(9IC2SE"IAAKIJ
MY>M,(8M=4"+\, CZ?L)XZHV';FRFQD.9&\%3G"G0>9(P]?L2A=R.O+;W.'#/
M5VMC!_SQ,&,KG*/YDLT4]?Q*)>8)IIK+%!0N1]Y%^WS2#FR 6_&5XU;OM,&B
M+*3\:3LW\<@+;$8H,#)6@M%C@Q,4PBI1'K]*4:]ZIPW<;3^J7SMX@EDPC1,I
MOO'8K$?>J0<Q+EDNS+W<?L02J&?U(BFT^P_;<FW@091K(Y,RF#)(>%H\V4-I
MQ$Y N_M,0%@&A/\:T"D#.@ZTR,QA39EAXZ&26U!V-:G9AO/&11,-3^TVSHVB
M64YQ9CR[O_EZ\?D*9I\N)E>W5W>?X>T4#>-"PQU3BEF3W\%[F"F^809A)EB$
MM(T&OMEI>GZ_Q62!Z@<M^C*?PMO7[X:^H<RLOA^565P6683/9'&-BQ8$9R<0
M!F%8$SYI#I]CUH).X,([^^$^^5&9$E:FA$ZO^XS>1"8)E=A$,*WAHB*LXVH4
MLF?P7&?DV,BC0Z91;= ;OWG5[@<?ZBB/)+;'W*F8.TZ]\PSS%)<T$L,EIM0R
M=J-3F'(=":ESA?#]$TW#C<%$UQK1.:811Q+;,Z);&=%MWGRWZW()V[+ I0)E
M/P8GD.:V#NR<QBA7W'#4$#$AR+?%;T 6K9]$U7G5F,"A7A5B/2=F/]J;<7OH
M;VH,Z%4&]%YJ #Z@BKA&R!2/<&>-KA;I.N#&%QX*7(@-=H';K5X]<[]B[C<R
MSS.9:D)H.NJ-"H="'$EL#W90P0[^ZU$?'-.((XGM&7%:&7%Z4*7O5/'?(:YU
M3F;%=-[3%9@U%3\J+F/(4UY?[:=/3F2_.PCHKZK1 KTQN1>BGU7H9T=#+PX[
M43_.U$$7K^O7?H8*W,:$7HC;#O[><X)&X)F2$6*L8:EDXLA8NO\)J[VV!$^P
MZO>R^>V'TOD[%SI[F[YE:L53#0*7)!^T!E1<JKB@%ATC,W?'6TA#-T;77-.E
M'I5=0/-+*<UCQUX;JY\)XS]02P,$%     @ ^H%T5Q\4,(;H%0  5*D! !D
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M/[8+5MM/Y9NEC^4V #?+JJQ8SE>;.Y^"$-L5K,YF@@:F44U!-175-%334<U
M-1/5K'=>X,/!]E7<V3C0!#6JN:CFH9J/:@&JA:@6H5J,:@FEM1M'DZ">BA/4
M3>/X2\T"#4^CFH)J*JIIJ*:CFH%J)JI9[[RH1X)F@4:J4<U%-0_5?%0+4"U$
MM0C58E1+**W5+,Z:2/69.%*=W-?J?;Z82:O>;4.Z+?)EO565;49=K\O:+LOZ
M<&5Y/5^EF_6MKL8B?D!]&PNJ*:BFHIJ&:CJJ&:AFHIKUS@^ /#G<6= 'XJ":
MBVH>JOFH%J!:B&H1JL6HEE#:4V<Y+>^SK%+2*KW\LLR*N^Q;MEAL)OOUJMJ\
M\_'J7JG(;NO.(W^^&IZ<[MUORY\=N>-^5_[L;>\_;?C++P_I7>:FQ=U\54J+
M[+8N-?CE;'(B%?.[^Y<OJOSAZXE\(EWG594OMS?OLW26%9L-ZN_?YGGU_,6F
MP,^\^+Y].I?_#U!+ P04    " #Z@717G)]2$:0%  #&+P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970R-RYX;6RUFEUOVS84AO\*X0[%!G261'^GCH'$(I$4
M[1;$W791[(*Q&5N()+H4;3?#?ORHCUAF+--2<):+V+)TGJ.C5Z2/7G.\$_(I
M67&NT(\HC)/+UDJI]87C)/,5CUC2%FL>ZSV/0D9,Z4VY=)*UY&R1!46A@UVW
M[T0LB%N3<?;9G9R,Q4:%0<SO)$HV4<3D\S4/Q>ZRY;5>/K@/EBN5?N!,QFNV
MY#.N_EC?2;WE["F+(.)Q$H@82?YXV;KR+BCNIP'9$7\&?)<<O$=I*0]"/*4;
MMXO+EIN>$0_Y7*4(IE^V?,K#,"7I\_A>0%O[G&G@X?L7.LV*U\4\L(1/1?A7
ML%"KR]:PA1;\D6U"=2]V-[PHJ)?RYB),LO]HEQ_;&[70?),H$17!^@RB(,Y?
MV8_B0AP$>-T3 ;@(P'4#.D5 IVY MPCHU@WH%0&]N@'](B 3T\DO5G:E?:;8
M9"S%#LGT:$U+WV1R9='Z @=Q>F?-E-1[ QVG)K.;JWMR\_MGG]S/WK\;8F_P
M$?F$WDYOOZ*??:Y8$";H-R8E2^^ 7]"OZ"?DH&3%)$_&CM)GD'*<>9'M.L^&
M3V7CZS;JN!\0=G&G(GQJ#_^T"=L(#T^&^_9PRA_:R/5.AA-[N,_G^N3S<%P1
M3NWA5YNESC[(PCTSW-&B[97#>^5PQNN<X$U#EB1(/**9$O,G].VSWH]N%8^2
MOZN$R6'=:E@Z?UTD:S;GERT]025<;GEK\OZ=UW<_5LD$"?,A80021H%@AKR=
MO;P=&WURIV=8+B5?H"35]T,QYA#;J)60P3]\4:5RSNQES/1+93OIN=G?V-D>
M"FC-W51 2!BI60$%2FIHT]UKTVVFS9I))/3WM6)*?[AEX8:C-9>Y9E4ZY?SA
M095N6]?HO9+)>AI-98*$D7H%4*"<ADJ]O4J]-XV@($DVU:.G=W3OO1XWUHQ-
M!8&$D;/G3H'2&5KT]UKTWZ2%[G7UH(D70;RL$J1_5A!KVJ:"0,+(V7.G0.D,
M009[00960:8BBG1CGS<15^C;%QX]<%G9.5A!33L'2)@/"2.0, H$,Z0=[J4=
M0C:&0TAY(6$^)(Q PB@0S)!WM)=W5&?D9O-HO:9P=*JE.FH+K9F;R@<)([5K
MH$!I#6T\MWR<=NNKD[:%-9K! GFV&[2G;BH/*(W4K(%"937E.7 [O,:#YW0_
M6, .[[J.VSD>-O:DC86!I)&:-5"HK*8PI9GA61^F*X4YTQP6Q//J@+H5H#12
MLP8*E=54I_0B/+L9\95':R&9?$;\^R90SW45JGB8[[@#/,*O):IYH%]U8'_@
M>JF?MS4N[/&!V,55WQ?VTM]Z:4LKP;-[":<NK656ZM:]JJ#V 2B-5!1Q2I__
MPT/P2A/!L[L()QZ4T+^(BDV\T-_KLUPPVR.4/4?3)AN4YH/2""B-0M%,[4O3
MPNM#/DEYD/[!%)3F@]((*(U"T4R52R?$JV6%%,:46ND<*Q$NTIY]SF/%EASI
MW7,1;[G,?E#5-X3E![ \V<AHA(]F9E ;!)1&0&D4BF9J6UHAGO51W)R]K^US
M-*@1 DKS06D$E$:A:*;"I1OBC4#G:$A78@I*\T%I!)1&H6CF3]VEK8(;V"JU
M3*\"6.48O9J,[:D;_YH-:JO4KH)"Y34%*HT5W,!8J>E[%<BSOI<]=6.!0.V5
MFC50J*RF/ =K19K;*Z>?,/&Q*]%S>U5#!W8A".Q*D)I%4*BTIC2EMX+MWLH;
MG"]<M4BB4A_0=1Z@-%*W" J5UM2G-&BPW: YT4(V,P#L.1HOOP(U=D!I!)1&
MH6BF]J7Y@WN0S24&M7E :3XHC8#2*!3-5+FT>;!]<4IS"]8.;"PTJ-,#2B.@
M-(J/%\6\GO-S#9V#%<WI"O<O3"Z#.$$A?]21;GN@$3)?-)YO*+'.%CD_"*5$
ME+U=<:9GY_0 O?]1"/6RD:Z;WB_=G_P'4$L#!!0    ( /J!=%<+\=L]E04
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MB/Z]2%,FR9<K,+/42AZOQQW),VCB&>R)\H,]H#YN4!][9Z%!O72H+>$/"#R
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M+3)[N0"6@#0-\/U,"/UT8QPTAU+C_P%02P,$%     @ ^H%T5\#?%T<9!0
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M)BR=V=@OHC==28FJVU1S[3E:;VHZK@W'OSPFYN$XU(R$TGPHC4)I#$KC4)J
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M[!"UO6B;[47(0P'F&BUF]Z% /@I$[6UGS;(/-*.)[3C;'6@&$]MQGCW0C"5
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MQ=SW0C*AP.(@P/3G)?&C7=^PC9<+4^]IS9,+YJ"WP4]D1OA\,Z'BS,Q05EY
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MGROSH#3'#>;4;G[.9Q[R!TWF7<5631FN*<,E7K@#;\Q9OA9<#7Z)+M+56GY
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M&IA6:>VZLG074R\<<I*@ J:V2=JWGPT4)0MAB>0;L+'_SS[_"2?&VQ#ZR%8
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MR8G;YL155X/<O;+A[A?+2>^"IQJM$A8J@M5&ZUO'2OG1<(WI,LD92F$A\,;
M%:\:K0_B=8>3HCIIS@@7Y]:JN1+?+D#E!#&^(,+VIB,/K^W7D/\74$L#!!0
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M>TNB*$G\"&!^!U&$(? VX@CF #Q@2!15^^#>?A0V^U2X^95K_ 102P,$%
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M3M!J@6F&DBD:%QFA%N0G /*36\BL6"YQ>FNH,C*C9$HB3'.$HR@I:$XLR,\
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M3?^3K!]:+__Z9V2[)K54S<&?=7]\9U]02P$"% ,4    " #Z@717!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( /J!=%=_2,;,[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( /J!=%>97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M^H%T5QA<7VT;"   9S0  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( /J!=%>D_S>TF 8  ($@   8
M          " @5X0  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    " #Z@7176="20;0#  !^$0  &               @($L%P  >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ ^H%T5_7>A^GL!0  ;Q\
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M965T."YX;6Q02P$"% ,4    " #Z@7179D)^9RL#  #W!@  &
M    @('=9@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M^H%T5RW:0 *2 @  H 4  !D              ("!/FH  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    " #Z@717LRZW%& '  "L$P  &0
M            @($';0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( /J!=%??[*KAX@<  *<4   9              " @9YT  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ ^H%T5SLU(Y^A!0
MH0T  !D              ("!MWP  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    " #Z@717_T4LEB,'  #M$   &0              @(&/
M@@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( /J!=%?H
MA90,\ H  -8B   9              " @>F)  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ ^H%T5X4ES)-G P  * @  !D
M     ("!$)4  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /J!=%=8-5C*$04  .8A   9              "
M@7W3  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ ^H%T
M5\NRZ-K"!   2!H  !D              ("!Q=@  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    " #Z@717@F='S1\*  "8:@  &0
M        @(&^W0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( /J!=%<]1LBGQ@0  )P4   9              " @13H  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ ^H%T5V#L_\U! P  ,@P
M !D              ("!$>T  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    " #Z@717'Q0PAN@5  !4J0$ &0              @(&)\
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( /J!=%><GU(1
MI 4  ,8O   9              " @:@& 0!X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ ^H%T5POQVSV5!0  H!H  !D
M ("!@PP! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #Z
M@717P-\71QD%  "E(P  &0              @(%/$@$ >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( /J!=%>AO,=2C H  "N*   9
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M970S-"YX;6Q02P$"% ,4    " #Z@717>JH'\-\"   9#0  &0
M    @($#-P$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M /J!=%? Z=%Y*P,  /(2   -              "  1DZ 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ ^H%T5Y>*NQS     $P(   L              ( !
M;ST! %]R96QS+RYR96QS4$L! A0#%     @ ^H%T5\YOS0VP P  XA<   \
M             ( !6#X! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /J!
M=%=+BJ +<P$  ' 5   :              "  35" 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /J!=%??(2<;D@$  /D5   3
M          "  >!# 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     K "L
*I L  *-% 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>331</ContextCount>
  <ElementCount>223</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>63</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/BalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Statements of Changes in Shareholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit</Role>
      <ShortName>Condensed Statements of Changes in Shareholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations</Role>
      <ShortName>ORGANIZATION AND PLANS OF BUSINESS OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/InitialPublicOffering</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/PrivatePlacement</Role>
      <ShortName>PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - SHAREHOLDERS??? DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/ShareholdersDeficit</Role>
      <ShortName>SHAREHOLDERS??? DEFICIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/Warrants</Role>
      <ShortName>WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://auroraspac.com/role/FairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative</Role>
      <ShortName>ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SUMMARY OF TEMPORARY EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfTemporaryEquityDetails</Role>
      <ShortName>SUMMARY OF TEMPORARY EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/InitialPublicOffering</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/PrivatePlacementDetailsNarrative</Role>
      <ShortName>PRIVATE PLACEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/PrivatePlacement</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/RelatedPartyTransactions</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SHAREHOLDERS??? DEFICIT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative</Role>
      <ShortName>SHAREHOLDERS??? DEFICIT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/ShareholdersDeficit</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - WARRANTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/WarrantsDetailsNarrative</Role>
      <ShortName>WARRANTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/Warrants</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails</Role>
      <ShortName>SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails</Role>
      <ShortName>SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails</Role>
      <ShortName>SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails</Role>
      <ShortName>SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://auroraspac.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://auroraspac.com/role/SubsequentEvents</ParentRole>
      <Position>35</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>atak-20230930.xsd</File>
    <File>atak-20230930_cal.xml</File>
    <File>atak-20230930_def.xml</File>
    <File>atak-20230930_lab.xml</File>
    <File>atak-20230930_pre.xml</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="form10-q.htm">form10-q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="672">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>52
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form10-q.htm": {
   "nsprefix": "ATAK",
   "nsuri": "http://auroraspac.com/20230930",
   "dts": {
    "schema": {
     "local": [
      "atak-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "atak-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "atak-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "atak-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atak-20230930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-q.htm"
     ]
    }
   },
   "keyStandard": 165,
   "keyCustom": 58,
   "axisStandard": 15,
   "axisCustom": 4,
   "memberStandard": 24,
   "memberCustom": 36,
   "hidden": {
    "total": 167,
    "http://fasb.org/us-gaap/2023": 128,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://auroraspac.com/20230930": 35
   },
   "contextCount": 331,
   "entityCount": 1,
   "segmentCount": 63,
   "elementCount": 403,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 672,
    "http://xbrl.sec.gov/dei/2023": 41
   },
   "report": {
    "R1": {
     "role": "http://auroraspac.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://auroraspac.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Balance Sheets",
     "shortName": "Condensed Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://auroraspac.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Balance Sheets (Parenthetical)",
     "shortName": "Condensed Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:TemporaryEquityRedemptionPricePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:TemporaryEquityRedemptionPricePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://auroraspac.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Condensed Statements of Operations (Unaudited)",
     "shortName": "Condensed Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "ATAK:FormationAndOperatingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "ATAK:FormationAndOperatingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
     "longName": "00000005 - Statement - Condensed Statements of Changes in Shareholders' Deficit",
     "shortName": "Condensed Statements of Changes in Shareholders' Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2021-12-31_us-gaap_CommonClassBMember_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-03-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember_us-gaap_CommonClassAMember",
      "name": "ATAK:RemeasurementOfRedemptionValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://auroraspac.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:Investmentincomedividends",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations",
     "longName": "00000007 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS",
     "shortName": "ORGANIZATION AND PLANS OF BUSINESS OPERATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://auroraspac.com/role/InitialPublicOffering",
     "longName": "00000009 - Disclosure - INITIAL PUBLIC OFFERING",
     "shortName": "INITIAL PUBLIC OFFERING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:DisclosureOfInitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:DisclosureOfInitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://auroraspac.com/role/PrivatePlacement",
     "longName": "00000010 - Disclosure - PRIVATE PLACEMENT",
     "shortName": "PRIVATE PLACEMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:DisclosureOfPrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:DisclosureOfPrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://auroraspac.com/role/RelatedPartyTransactions",
     "longName": "00000011 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://auroraspac.com/role/ShareholdersDeficit",
     "longName": "00000012 - Disclosure - SHAREHOLDERS\u2019 DEFICIT",
     "shortName": "SHAREHOLDERS\u2019 DEFICIT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://auroraspac.com/role/Warrants",
     "longName": "00000013 - Disclosure - WARRANTS",
     "shortName": "WARRANTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://auroraspac.com/role/CommitmentsAndContingencies",
     "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://auroraspac.com/role/FairValueMeasurements",
     "longName": "00000015 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://auroraspac.com/role/SubsequentEvents",
     "longName": "00000016 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:DisclousreOfTemporaryEquityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ATAK:TemporaryEquityPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "ATAK:DisclousreOfTemporaryEquityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ATAK:TemporaryEquityPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://auroraspac.com/role/FairValueMeasurementsTables",
     "longName": "00000019 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
     "longName": "00000020 - Disclosure - ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)",
     "shortName": "ORGANIZATION AND PLANS OF BUSINESS OPERATIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2022-02-092022-02-09",
      "name": "ATAK:OverallotmentOptionLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-02-09",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R21": {
     "role": "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
     "longName": "00000021 - Disclosure - SUMMARY OF TEMPORARY EQUITY (Details)",
     "shortName": "SUMMARY OF TEMPORARY EQUITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-07-282023-07-28",
      "name": "us-gaap:StockRedeemedOrCalledDuringPeriodValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ATAK:TemporaryEquityPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-09-30_custom_CommonClassASubjectToRedemptionMember",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ATAK:DisclousreOfTemporaryEquityTextBlock",
       "ATAK:TemporaryEquityPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R22": {
     "role": "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails",
     "longName": "00000022 - Disclosure - SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)",
     "shortName": "SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30_custom_RedeemableClassAOrdinarySharesMember",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CashEquivalentsAtCarryingValue",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R24": {
     "role": "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
     "longName": "00000024 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)",
     "shortName": "INITIAL PUBLIC OFFERING (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "AsOf2022-02-09_us-gaap_CommonClassAMember",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-02-092022-02-09_us-gaap_IPOMember_us-gaap_CommonClassAMember",
      "name": "us-gaap:CommonStockConversionBasis",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "ATAK:DisclosureOfInitialPublicOfferingTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R25": {
     "role": "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
     "longName": "00000025 - Disclosure - PRIVATE PLACEMENT (Details Narrative)",
     "shortName": "PRIVATE PLACEMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ATAK:DisclosureOfPrivatePlacementTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_us-gaap_CommonClassAMember_custom_PrivatePlacementWarrantMember",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ATAK:DisclosureOfPrivatePlacementTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30_us-gaap_RelatedPartyMember68554234",
      "name": "us-gaap:OtherLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_RelatedPartyMember68554250",
      "name": "us-gaap:OtherLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:OtherLiabilitiesCurrent",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R27": {
     "role": "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
     "longName": "00000027 - Disclosure - SHAREHOLDERS\u2019 DEFICIT (Details Narrative)",
     "shortName": "SHAREHOLDERS\u2019 DEFICIT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_custom_FounderSharesMember_us-gaap_CommonClassAMember",
      "name": "ATAK:CommonStockThresholdPercentageOnConversionOfShares",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://auroraspac.com/role/WarrantsDetailsNarrative",
     "longName": "00000028 - Disclosure - WARRANTS (Details Narrative)",
     "shortName": "WARRANTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ATAK:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ATAK:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-09-30",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-09-30_custom_UnderwritingAgreementMember",
      "name": "us-gaap:PaymentsForUnderwritingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
     "longName": "00000030 - Disclosure - SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)",
     "shortName": "SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-03-31_custom_PublicWarrantsMember",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-03-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails",
     "longName": "00000031 - Disclosure - SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)",
     "shortName": "SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_us-gaap_FairValueInputsLevel1Member_custom_PublicWarrantsMember",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
     "longName": "00000032 - Disclosure - SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)",
     "shortName": "SUMMARY OF FAIR VALUE INFORMATION ASSETS AND LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_custom_PublicWarrantsMember",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_custom_PublicWarrantsMember",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails",
     "longName": "00000033 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)",
     "shortName": "SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "AsOf2022-02-09_us-gaap_MeasurementInputSharePriceMember_custom_PrivatePlacementWarrantsMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-02-09_us-gaap_MeasurementInputSharePriceMember_custom_PrivatePlacementWarrantsMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative",
     "longName": "00000034 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)",
     "shortName": "FAIR VALUE MEASUREMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:DerivativeLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:DerivativeLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://auroraspac.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2023-11-09_us-gaap_SubsequentEventMember",
      "name": "us-gaap:AssetsHeldInTrustCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-11-09_us-gaap_SubsequentEventMember",
      "name": "us-gaap:AssetsHeldInTrustCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of promissory note \u2013 related party",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r336"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of Class A ordinary shares",
        "verboseLabel": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of redemption on Class A ordinary shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/Cover",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r116",
      "r117",
      "r118",
      "r135",
      "r155",
      "r156",
      "r159",
      "r161",
      "r164",
      "r165",
      "r172",
      "r181",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r208",
      "r209",
      "r212",
      "r215",
      "r222",
      "r272",
      "r333",
      "r334",
      "r335",
      "r336",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r373",
      "r395",
      "r417",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r567",
      "r571",
      "r577"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance initial public offering",
        "verboseLabel": "Gross proceeds from initial public offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForUnderwritingExpense",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting fees",
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A ordinary shares",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r75",
      "r95",
      "r341",
      "r417",
      "r506",
      "r545"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale Private Warrants",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r534"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note \u2013 related party",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r293",
      "r294",
      "r295",
      "r524",
      "r525",
      "r529",
      "r530",
      "r531"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A ordianry shares, shares",
        "verboseLabel": "Stock issued during period, shares, new issues",
        "terseLabel": "Maxim IPO shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r75",
      "r95",
      "r333",
      "r417",
      "r506"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r133"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities Held in Trust Account",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r357",
      "r358",
      "r359",
      "r362",
      "r425",
      "r434",
      "r448",
      "r456",
      "r469",
      "r480",
      "r481",
      "r497",
      "r501",
      "r502",
      "r503",
      "r504",
      "r538"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r285",
      "r286",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r391",
      "r393",
      "r424",
      "r595"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption of marketable securities held in Trust Account",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r55"
     ]
    },
    "ATAK_ClassOfWarrantOrRightMinimumNoticePeriodForRedemption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ClassOfWarrantOrRightMinimumNoticePeriodForRedemption",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrant right minimum notice period for redemption",
        "documentation": "Class of warrant or right minimum notice period for redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided (used) in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted net (loss) income per share, Class A ordinary shares subject to redemption",
        "verboseLabel": "Diluted net income per share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r155",
      "r159",
      "r160",
      "r161",
      "r162",
      "r262",
      "r263",
      "r311",
      "r322",
      "r519"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash Investing Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate debt",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r99",
      "r604"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r87"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://auroraspac.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF CHANGE IN FAIR VALUE OF DERIVATIVE WARRANT LIABILITIES",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r55"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Administrative support agreement expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r167",
      "r169",
      "r171",
      "r521"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r341",
      "r574",
      "r575",
      "r576",
      "r590",
      "r611"
     ]
    },
    "ATAK_UnsecuredPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "UnsecuredPromissoryNote",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured promissory note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, redemption price per share",
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r40"
     ]
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/Cover",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_AssetsHeldInTrustCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsHeldInTrustCurrent",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposit trust account",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r48",
      "r49",
      "r50",
      "r51"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r270"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Derivative warrant liabilities, beginning balance",
        "periodEndLabel": "Derivative warrant liabilities, ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders\u2019 Deficit",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r78",
      "r79",
      "r89",
      "r375",
      "r392",
      "r418",
      "r419",
      "r534",
      "r546",
      "r573",
      "r581",
      "r593",
      "r611"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsHeldInTrustNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable securities held in trust account",
        "verboseLabel": "Cash and marketable securities held in trust account",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrant or right, exercise price of warrants or rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://auroraspac.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF FAIR VALUE MEASUREMENTS INPUTS",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_TrancheDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TrancheDomain",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeNet",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Derivative, Fair Value, Net",
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ORGANIZATION AND PLANS OF BUSINESS OPERATIONS",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r96",
      "r329",
      "r330"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "verboseLabel": "Operating cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r315",
      "r352",
      "r381",
      "r534",
      "r546",
      "r568"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted weighted average shares outstanding, non-redeemable ordinary shares",
        "verboseLabel": "Diluted weighted average shares outstanding",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r161"
     ]
    },
    "ATAK_TrancheAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TrancheAxis",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche [Axis]",
        "documentation": "Tranche [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic net (loss) income per share, Class A ordinary shares subject to redemption",
        "verboseLabel": "Basic net income per share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r152",
      "r155",
      "r159",
      "r160",
      "r161",
      "r162",
      "r262",
      "r263",
      "r311",
      "r322",
      "r519"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic weighted average shares outstanding, non-redeemable ordinary shares",
        "verboseLabel": "Basic weighted average shares outstanding",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r161"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r24",
      "r110",
      "r126",
      "r127",
      "r128",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r151",
      "r163",
      "r173",
      "r174",
      "r224",
      "r237",
      "r238",
      "r239",
      "r247",
      "r248",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r324",
      "r325",
      "r326",
      "r341",
      "r417"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r151",
      "r173",
      "r174",
      "r237",
      "r238",
      "r239",
      "r247",
      "r248",
      "r254",
      "r256",
      "r257",
      "r259",
      "r261",
      "r324",
      "r326",
      "r341",
      "r611"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Redemption of Class A ordinary shares, shares",
        "label": "Redemption of Class A ordinary shares, shares",
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, par or stated value per share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r40"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r163",
      "r298",
      "r331",
      "r353",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r396",
      "r397",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417",
      "r539"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r105"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ATAK_MeasurementInputProbabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "MeasurementInputProbabilityMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Probability [Member]",
        "documentation": "Measurement Input Probability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares, issued",
        "verboseLabel": "Common stock shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ATAK_AccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "AccruedOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued offering costs",
        "documentation": "Accrued offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ThresholdNumberOfTradingDaysForDeterminingSharePriceFromDateOfBusinessCombination",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Threshold number of trading days for determining share price from date of business combination",
        "documentation": "Threshold number of trading days for determining share price from date of business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_TemporaryEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TemporaryEquityPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Ordinary shares Subject to Possible Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DeferredUnderwritingCommissionPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DeferredUnderwritingCommissionPerUnit",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting commission per unit",
        "documentation": "Deferred underwriting commission per unit."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ShareRedemptionTriggerPriceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ShareRedemptionTriggerPriceAxis",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Redemption Trigger Price [Axis]",
        "documentation": "Share Redemption Trigger Price [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_RelatedPartiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "RelatedPartiesPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties",
        "documentation": "Related parties [policy text block]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_CommonStockThresholdPercentageOnConversionOfShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "CommonStockThresholdPercentageOnConversionOfShares",
     "presentation": [
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, threshold percentage on conversion of shares",
        "documentation": "Common stock threshold percentage on conversion of shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r208"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r317",
      "r534"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares, outstanding",
        "verboseLabel": "Common stock shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r75",
      "r373",
      "r392",
      "r611",
      "r612"
     ]
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r67",
      "r68",
      "r69",
      "r72",
      "r135",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r251",
      "r252",
      "r253",
      "r272",
      "r583",
      "r596",
      "r597"
     ]
    },
    "ATAK_ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ClassOfWarrantsOrRightsWarrantsIssuedPricePerWarrant",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrants or rights warrants issued issue price per warrant",
        "verboseLabel": "Class of warrants or rights warrants issued price per warrant",
        "documentation": "Class of warrants or rights warrants issued price per warrant."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_WarrantyLiabilityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WarrantyLiabilityPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warranty Liability",
        "documentation": "Warranty liability [policy text block]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DisclousreOfTemporaryEquityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DisclousreOfTemporaryEquityTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF TEMPORARY EQUITY",
        "documentation": "Disclousre Of Temporary Equity [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrants or rights warrants issued during the period units",
        "documentation": "Class of warrants or rights warrants issued during the period units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of marketable securities held in Trust Account",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "ATAK_EmergingGrowthCompanyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging Growth Company",
        "documentation": "Emerging growth company [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_TransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs",
        "documentation": "Transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r373"
     ]
    },
    "ATAK_DeferredUnderwritingCommissionsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DeferredUnderwritingCommissionsNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting commissions",
        "documentation": "Deferred underwriting commissions noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r373",
      "r392",
      "r611",
      "r612"
     ]
    },
    "ATAK_FormationAndOperatingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FormationAndOperatingCosts",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Formation and Operating expense",
        "documentation": "Formation and operating costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/Cover",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r116",
      "r117",
      "r118",
      "r135",
      "r155",
      "r156",
      "r159",
      "r161",
      "r164",
      "r165",
      "r172",
      "r181",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r208",
      "r209",
      "r212",
      "r215",
      "r222",
      "r272",
      "r333",
      "r334",
      "r335",
      "r336",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r373",
      "r395",
      "r417",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r567",
      "r571",
      "r577"
     ]
    },
    "ATAK_OverallotmentOptionLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "OverallotmentOptionLiability",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-allotment option liability",
        "verboseLabel": "Overallotment option liability",
        "documentation": "Overallotment option liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_GainsLossesOnExtinguishmentOfOverAllotmentLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "GainsLossesOnExtinguishmentOfOverAllotmentLiability",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows",
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on extinguishment of over-allotment liability",
        "negatedLabel": "Gain on extinguishment of over-allotment liability"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_RemeasurementOfRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "RemeasurementOfRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of Class A ordinary shares to redemption value",
        "documentation": "Remeasurement of redemption value."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ActualOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ActualOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actual offering costs",
        "documentation": "Actual offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "StockIssuedDuringPeriodRepresentativeSharesIssuedValue",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Representative Shares",
        "verboseLabel": "Issuance of representative shares",
        "documentation": "Stock issued during period representative shares issued value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ATAK_StockIssuedDuringPeriodRepresentativeSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "StockIssuedDuringPeriodRepresentativeSharesIssued",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Representative Shares, shares",
        "documentation": "Stock issued during period representative shares issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (loss):"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_RightsUnderlyingTheUnitsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "RightsUnderlyingTheUnitsValue",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights underlying the Units",
        "documentation": "Rights underlying the units value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par or stated value per share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r208"
     ]
    },
    "ATAK_TermOfRestrictedInvestments": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TermOfRestrictedInvestments",
     "presentation": [
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term of restricted investments",
        "documentation": "Term of restricted investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r605"
     ]
    },
    "ATAK_BusinessCombinationExtensionOfBusinessCombinationPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "BusinessCombinationExtensionOfBusinessCombinationPeriod",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination extension of business combination period",
        "documentation": "Business combination extension of business combination period."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheConsummationOfInitialPublicOffer",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Period within which business combination shall be consummated from the consummation of initial public offer",
        "documentation": "Period with in which business combination shall be consummated from the consummation of initial public offer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "ATAK_Investmentincomedividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "Investmentincomedividends",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividend income on marketable securities held in Trust Account",
        "documentation": "Amount of dividend income on nonoperating securities.",
        "label": "InvestmentIncomeDividends"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r55"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "ATAK_MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum lock In period for transfer, assign or sell warrants after completion of IPO",
        "documentation": "Minimum lock in period for transfer assign or sell warrants after completion of ipo."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DescriptionOfBusinessCombinationExtendedPeriodTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DescriptionOfBusinessCombinationExtendedPeriodTerms",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of business combination extended period terms",
        "documentation": "Description of business combination extended period terms."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r266",
      "r293",
      "r294",
      "r295",
      "r524",
      "r525",
      "r529",
      "r530",
      "r531"
     ]
    },
    "ATAK_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of fair market value of target business to asset held in trust account",
        "documentation": "Percentage of fair market value of target business to asset held in trust account."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_NumberOfDaysWithinWhichPublicSharesShallBeRedeemed": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "NumberOfDaysWithinWhichPublicSharesShallBeRedeemed",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of days within which public shares shall be redeemed",
        "documentation": "Number of days with in which public shares shall be redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ATAK_DeferredUnderwritingFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DeferredUnderwritingFeePayable",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting fee payable",
        "documentation": "Deferred underwriting fee payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "MinimumPublicSharePriceDueToReductionsInTheValueOfTheTrustAssetsLessTaxesPayable",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum Public Share price due to reductions in the value of the trust assets less taxes payable",
        "documentation": "Minimum public share price due to reductions in the value of the trust assets less taxes payable."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_AllocationOfDeferredOfferingCostsForWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "AllocationOfDeferredOfferingCostsForWarrantLiability",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of deferred offering costs for warrant liability",
        "documentation": "Allocation of deferred offering costs for warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial measurement of Class A ordinary shares subject to possible redemption",
        "documentation": "Initial measurement of Class&amp;#160;A ordinary shares subject to possible redemption."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_NetWorkingCapitalSurplusDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "NetWorkingCapitalSurplusDeficit",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital (deficit)",
        "documentation": "Net working capital surplus deficit."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial measurement of public warrants and private placement warrants",
        "documentation": "Initial measurement of public warrants and private placement warrants."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred offering costs included in accrued offering costs",
        "documentation": "Deferred offering costs incurred included in accrued offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_FairValueAllocatedToRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FairValueAllocatedToRights",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value allocated to rights",
        "documentation": "Fair value allocated to rights."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_OverAllotmentOptionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "OverAllotmentOptionPeriod",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over allotment option period",
        "documentation": "Over allotment option period."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of Class A ordinary shares subject to possible redemption",
        "documentation": "Re-measurement of Class A ordinary shares subject to possible redemption."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ForfeitureOfRepresentativeShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ForfeitureOfRepresentativeShares",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeiture of Representative Shares",
        "documentation": "Forfeiture of representative shares."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_NumberOfTradingDaysForDeterminingSharePrice": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "NumberOfTradingDaysForDeterminingSharePrice",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of trading days for determining share price",
        "documentation": "Number of trading days for determining share price."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of Representative Shares",
        "documentation": "Stock issued during period representative shares issued value class A.",
        "label": "Stock issued during period representative shares issued value class A"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_TriggeringEventAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TriggeringEventAxis",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Triggering Event [Axis]",
        "documentation": "Triggering Event [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_PeriodAfterWhichSharesAreRedeemableAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PeriodAfterWhichSharesAreRedeemableAxis",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Period After Which Shares Are Redeemable [Axis]",
        "documentation": "Period After Which Shares Are Redeemable [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DisclosureInitialPublicOfferingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DisclosureInitialPublicOfferingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DisclosureOfInitialPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DisclosureOfInitialPublicOfferingTextBlock",
     "presentation": [
      "http://auroraspac.com/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INITIAL PUBLIC OFFERING",
        "documentation": "Disclosure Of Initial Public Offering [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument convertible into warrants",
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ATAK_PeriodAfterWhichSharesAreRedeemableDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PeriodAfterWhichSharesAreRedeemableDomain",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ATAK_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated": {
     "xbrltype": "percentItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of public shares to be redeemed in case business combination is not consummated",
        "documentation": "Percentage of public shares to be redeemed in case business combination is not consummated."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DisclosurePrivatePlacementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DisclosurePrivatePlacementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DisclosureOfPrivatePlacementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DisclosureOfPrivatePlacementTextBlock",
     "presentation": [
      "http://auroraspac.com/role/PrivatePlacement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PRIVATE PLACEMENT",
        "documentation": "Disclosure Of Private Placement [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r250",
      "r252",
      "r272",
      "r583",
      "r584",
      "r596"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument conversion price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r192"
     ]
    },
    "ATAK_DisclosureWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DisclosureWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r560",
      "r561"
     ]
    },
    "us-gaap_OtherUnderwritingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherUnderwritingExpense",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting discount",
        "verboseLabel": "Underwriting fees",
        "documentation": "Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r606"
     ]
    },
    "us-gaap_PaymentsToAcquireRestrictedInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireRestrictedInvestments",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfCashFlows",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment of cash in Trust Account",
        "label": "Net proceeds amount",
        "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ATAK_TriggeringEventDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TriggeringEventDomain",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ATAK_NumberOfConsecutiveTradingDaysForDeterminingSharePrice": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "NumberOfConsecutiveTradingDaysForDeterminingSharePrice",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of consecutive trading days for determining share price",
        "documentation": "Number of consecutive trading days for determining share price."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://auroraspac.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WARRANTS",
        "documentation": "Warrants Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ShareTransferTriggerPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ShareTransferTriggerPricePerShare",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share transfer, trigger price per share",
        "documentation": "Share transfer trigger price per share."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r292"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r534",
      "r610"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r226",
      "r231",
      "r266",
      "r294",
      "r524",
      "r525",
      "r529",
      "r530",
      "r531"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r226",
      "r231",
      "r266",
      "r293",
      "r529",
      "r530",
      "r531"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r316",
      "r534"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r266",
      "r295",
      "r524",
      "r525",
      "r529",
      "r530",
      "r531"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "ATAK_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum lock in period to become effective after the closing of the initial business combination",
        "documentation": "Minimum lock in period to become effective after the closing of the initial business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ShareRedemptionTriggerPriceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ShareRedemptionTriggerPriceDomain",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ATAK_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercisable term from the date of completion of business combination",
        "documentation": "Warrants exercisable term from the date of completion of business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "MinimumLockInPeriodforSecRegistrationFromDateOfBusinessCombination",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum lock in period for SEC registration from date of business combination",
        "documentation": "Minimum lock in period for sec registration from date of business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ClassOfWarrantsRedemptionPricePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ClassOfWarrantsRedemptionPricePerUnit",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrants redemption price per unit",
        "documentation": "Class of warrants redemption price per unit."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ClassOfWarrantsRedemptionNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ClassOfWarrantsRedemptionNoticePeriod",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrants, redemption notice period",
        "documentation": "Class of warrants redemption notice period."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ShareRedemptionTriggerPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ShareRedemptionTriggerPrice",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share redemption trigger price",
        "documentation": "Share redemption trigger price."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "ATAK_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity": {
     "xbrltype": "percentItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum percentage gross proceeds required from issuance of equity",
        "documentation": "Minimum percentage gross proceeds required from issuance of equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption of Class A ordinary shares",
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r93",
      "r94",
      "r95",
      "r116",
      "r117",
      "r118",
      "r164",
      "r208",
      "r209",
      "r210",
      "r212",
      "r215",
      "r220",
      "r222",
      "r333",
      "r334",
      "r335",
      "r336",
      "r528",
      "r567",
      "r571"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r164",
      "r208",
      "r209",
      "r210",
      "r212",
      "r215",
      "r220",
      "r222",
      "r333",
      "r334",
      "r335",
      "r336",
      "r528",
      "r567",
      "r571"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses payable on dissolution",
        "documentation": "Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeiture of Class B shares issued to Sponsor",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income per Ordinary Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeiture of Class B shares issued to Sponsor, shares",
        "verboseLabel": "Shares issued, shares, share based payment arrangement, forfeited",
        "terseLabel": "Shares issued, shares, share-based payment arrangement, forfeited",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of deferred offering costs",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "label": "Net income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r87",
      "r101",
      "r111",
      "r123",
      "r124",
      "r128",
      "r135",
      "r142",
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r157",
      "r166",
      "r167",
      "r169",
      "r171",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r263",
      "r272",
      "r321",
      "r394",
      "r415",
      "r416",
      "r521",
      "r544",
      "r583"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator: weighted average non-redeemable Class A and Class B ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://auroraspac.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE MEASUREMENTS",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "us-gaap_RightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightsMember",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights [Member]",
        "documentation": "A security giving shareholders entitlement to acquire new shares issued by the entity at an established price in proportion to the number of shares already owned. Generally, rights expire within in a short time after issuance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income attributable to non-redeemable Class A and Class B ordinary shares",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r144",
      "r145",
      "r146",
      "r147",
      "r152",
      "r153",
      "r158",
      "r161",
      "r166",
      "r167",
      "r169",
      "r171",
      "r521"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expense",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued during period, shares, issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock shares issued during the period for services shares",
        "verboseLabel": "Stock issued during period, shares, issued for services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r115",
      "r135",
      "r166",
      "r168",
      "r170",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r250",
      "r252",
      "r272",
      "r313",
      "r386",
      "r534",
      "r546",
      "r583",
      "r584",
      "r596"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r175",
      "r176",
      "r517"
     ]
    },
    "ATAK_TrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TrancheTwoMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche Two [Member]",
        "documentation": "Tranche Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r135",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r251",
      "r252",
      "r253",
      "r272",
      "r371",
      "r520",
      "r546",
      "r583",
      "r596",
      "r597"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Note 8)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r62",
      "r314",
      "r372"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ThirdWorkingCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ThirdWorkingCapitalMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Working Capital [Member]",
        "documentation": "Third Working Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_FourthWorkingCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FourthWorkingCapitalMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fourth Working Capital [Member]",
        "documentation": "Fourth Working Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders\u2019 Deficit",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r100",
      "r320",
      "r534",
      "r573",
      "r581",
      "r593"
     ]
    },
    "ATAK_FifthWorkingCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FifthWorkingCapitalMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fifth Working Capital [Member]",
        "documentation": "Fifth Working Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders\u2019 Deficit"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ThirdExtensionNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ThirdExtensionNoteMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Extension Note [Member]",
        "documentation": "Third Extension Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebt",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unsecured promissory note",
        "label": "Unsecured Debt",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r99",
      "r604"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_WorkingCapitalNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WorkingCapitalNotesMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working Capital Notes [Member]",
        "documentation": "Working Capital Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Offering costs allocated to Class A ordinary shares subject to possible redemption",
        "label": "Adjustments to additional paid in capital, warrant issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r36",
      "r95"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      },
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows",
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of warrant liability",
        "label": "Change in fair value of warrant liabilities",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r6"
     ]
    },
    "ATAK_WorkingCapitalAndSecondExtensionNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WorkingCapitalAndSecondExtensionNoteMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working Capital And Second Extension Note [Member]",
        "documentation": "Working Capital And Second Extension Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_WorkingCapitalLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WorkingCapitalLoanMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working Capital Loan [Member]",
        "documentation": "Working Capital Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_OfficeSpaceAdministrativeAndSupportServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "OfficeSpaceAdministrativeAndSupportServicesMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Space Administrative And Support Services [Member]",
        "documentation": "Office Space Administrative And Support Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_AdministrativeSupportAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "AdministrativeSupportAgreementMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Administrative Support Agreement [Member]",
        "documentation": "Administrative Support Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_RedemptionOfWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "RedemptionOfWarrantsMember",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption Of Warrants [Member]",
        "documentation": "Redemption Of Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_DerivativeWarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "DerivativeWarrantLiabilityMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Warrant Liability [Member]",
        "documentation": "Derivative Warrant Liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r137",
      "r285",
      "r286",
      "r287",
      "r288",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r391",
      "r393",
      "r424"
     ]
    },
    "ATAK_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "SharePriceEqualOrExceedsEighteenRupeesPerDollarMember",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]",
        "documentation": "Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member]",
        "documentation": "Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/Cover",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "ATAK_UnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "UnderwritingAgreementMember",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Agreement [Member]",
        "documentation": "Underwriting Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows",
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on extinguishment of liability",
        "negatedLabel": "Gain on extinguishment of liability",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r38",
      "r39"
     ]
    },
    "ATAK_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liability [Member]",
        "documentation": "Warrant Liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "verboseLabel": "Common stock shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r373"
     ]
    },
    "ATAK_TrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "TrancheOneMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche One [Member]",
        "documentation": "Tranche One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r163",
      "r298",
      "r331",
      "r353",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r396",
      "r397",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417",
      "r539"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrant or right exercise price adjustment percentage higher of market value",
        "documentation": "Class of warrant or right exercise price adjustment percentage higher of market value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r110",
      "r126",
      "r127",
      "r128",
      "r139",
      "r140",
      "r141",
      "r143",
      "r149",
      "r151",
      "r163",
      "r173",
      "r174",
      "r224",
      "r237",
      "r238",
      "r239",
      "r247",
      "r248",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r324",
      "r325",
      "r326",
      "r341",
      "r417"
     ]
    },
    "ATAK_NonredeemableCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "NonredeemableCommonStockMember",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations",
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonredeemable Common Stock [Member]",
        "documentation": "Nonredeemable Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r285",
      "r286",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r391",
      "r393",
      "r424"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r357",
      "r358",
      "r359",
      "r362",
      "r425",
      "r434",
      "r448",
      "r456",
      "r469",
      "r480",
      "r481",
      "r497",
      "r501",
      "r502",
      "r503",
      "r504",
      "r538"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r271",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r364",
      "r387",
      "r389",
      "r390",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r518",
      "r608"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrant or right, number of securities called by each warrant or right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ATAK_SecondWorkingCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "SecondWorkingCapitalMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Working Capital [Member]",
        "documentation": "Second Working Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, face amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r190",
      "r280",
      "r524",
      "r525"
     ]
    },
    "ATAK_SponsorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "SponsorMember",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sponsor [Member]",
        "documentation": "Sponsor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "ATAK_OrdinarySharesSubjectToPossibleRedemptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "OrdinarySharesSubjectToPossibleRedemptionMember",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares Subject To Possible Redemption [Member]",
        "documentation": "Ordinary Shares Subject To Possible Redemption [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_CommonClassASubjectToRedemptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "CommonClassASubjectToRedemptionMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A Subject To Redemption [Member]",
        "documentation": "Common Class A Subject To Redemption [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "ATAK_PrivatePlacementWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PrivatePlacementWarrantMember",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrant [Member]",
        "documentation": "Private Placement Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding value under the note",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r312",
      "r367",
      "r368",
      "r546",
      "r609"
     ]
    },
    "ATAK_AmendmentNoOneToInvestmentManagementTrustAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "AmendmentNoOneToInvestmentManagementTrustAgreementMember",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment No One To Investment Management Trust Agreement [Member]",
        "documentation": "Amendment No One To Investment Management Trust Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "ATAK_IfWeDoNotCompleteOurInitialBusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "IfWeDoNotCompleteOurInitialBusinessCombinationMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "If We Do Not Complete Our Initial Business Combination [Member]",
        "documentation": "If We Do Not Complete Our Initial Business Combination [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_AbsentOurCompletingAnInitialBusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "AbsentOurCompletingAnInitialBusinessCombinationMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Absent Our Completing An Initial Business Combination [Member]",
        "documentation": "Absent Our Completing An Initial Business Combination [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails",
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrants [Member]",
        "documentation": "Public Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r13"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_PrivatePlacementWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PrivatePlacementWarrantsMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails",
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants [Member]",
        "documentation": "Private Placement Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r95",
      "r319",
      "r327",
      "r328",
      "r337",
      "r374",
      "r534"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party payments",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r285"
     ]
    },
    "ATAK_RedeemableClassAOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "RedeemableClassAOrdinarySharesMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Class A Ordinary Shares [Member]",
        "documentation": "Redeemable Class A Ordinary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in current assets and current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Change in Cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r85"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_FounderSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FounderSharesMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Founder Shares [Member]",
        "documentation": "Founder Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash \u2013 Beginning of the period",
        "periodEndLabel": "Cash \u2013 End of the period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r85",
      "r132"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_SharePriceMoreThanOrEqualsToUsdTwelveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "SharePriceMoreThanOrEqualsToUsdTwelveMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price More Than Or Equals To Used Twelve [Member]",
        "documentation": "Share Price More Than Or Equals To Used Twelve [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "PromissoryNoteMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note [Member]",
        "documentation": "Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r99",
      "r206"
     ]
    },
    "ATAK_FirstWorkingCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FirstWorkingCapitalMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Working Capital [Member]",
        "documentation": "First Working Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r398",
      "r399",
      "r402"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r286",
      "r289",
      "r338",
      "r339",
      "r340",
      "r400",
      "r401",
      "r402",
      "r421",
      "r423"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r191"
     ]
    },
    "ATAK_FirstExtensionNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "FirstExtensionNoteMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Extension Note [Member]",
        "documentation": "First Extension Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ATAK_SecondExtensionNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://auroraspac.com/20230930",
     "localname": "SecondExtensionNoteMember",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Extension Note [Member]",
        "documentation": "Second Extension Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r402"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related parties current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r534"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://auroraspac.com/role/ShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 DEFICIT",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r134",
      "r207",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r224",
      "r260",
      "r420",
      "r422",
      "r510"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails",
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares issued",
        "verboseLabel": "Temporary equity shares issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_MinimumNetWorthRequiredForCompliance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinimumNetWorthRequiredForCompliance",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Banking regulation, mortgage banking, net worth, minimum",
        "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r514"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transfer of private placement warrants to level 2 measurement",
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://auroraspac.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF FAIR VALUE HIERARCHY OF ASSETS AND LIABILITIES ON RECURRING BASIS",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from promissory note \u2013 related party",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_CapitalUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalUnitsMember",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Units [Member]",
        "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/PrivatePlacementDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails",
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r291"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r537",
      "r538",
      "r540",
      "r541",
      "r542",
      "r543",
      "r574",
      "r575",
      "r590",
      "r607",
      "r611"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares outstanding",
        "verboseLabel": "Temporary equity shares outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepurchaseOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds allocated to private warrants",
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockConversionBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockConversionBasis",
     "presentation": [
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, conversion basis",
        "documentation": "Description of basis for conversion of convertible common stock."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of underwriting fee",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfBasicAndDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator: income attributable to non-redeemable Class A and Class B ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "documentation": "Different names of stock transactions and the different attributes of each transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal depository insurance coverage",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeDividend",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend income on marketable securities held in Trust Account",
        "documentation": "Amount of dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Deficit:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r113",
      "r135",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r251",
      "r252",
      "r253",
      "r272",
      "r534",
      "r583",
      "r596",
      "r597"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Re-measurement of Class A ordinary shares subject to possible redemption",
        "documentation": "Value of accretion of temporary equity to its redemption value during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://auroraspac.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrants or rights outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsDisclosureTextBlock",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r523",
      "r592"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r270"
     ]
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock, price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r291"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://auroraspac.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r332"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheetsParenthetical",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/ShareholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par or stated value per share",
        "verboseLabel": "Common stock par value per share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_SubsequentEventDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventDescription",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent event, description",
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r286",
      "r595"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r291"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r103",
      "r104",
      "r106",
      "r107"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r291"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r138",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r280",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r572"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets",
      "http://auroraspac.com/role/SummaryOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, 5,307,292 and 20,200,000 shares subject to redemption issued and outstanding, at redemption value of $10.83 and $10.24 per share, as of September 30, 2023 and December 31, 2022, respectively",
        "verboseLabel": "Class A ordinary shares subject to possible redemption, September 30, 2023",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r240",
      "r318"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r291"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Costs",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsTable",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investments [Table]",
        "documentation": "Disclosure of information about investments owned by investment company."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredTransactionCost",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs",
        "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r587",
      "r588",
      "r589"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r225",
      "r233",
      "r234",
      "r235",
      "r236",
      "r296",
      "r297",
      "r323",
      "r363",
      "r364",
      "r428",
      "r447",
      "r452",
      "r453",
      "r491",
      "r515",
      "r516",
      "r522",
      "r528",
      "r532",
      "r535",
      "r538",
      "r582",
      "r585",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://auroraspac.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://auroraspac.com/role/InitialPublicOfferingDetailsNarrative",
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsLineItems",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://auroraspac.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r120",
      "r135",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r250",
      "r252",
      "r272",
      "r534",
      "r583",
      "r584",
      "r596"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://auroraspac.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r70",
      "r71",
      "r98",
      "r99",
      "r138",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r280",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r572"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r233",
      "r297",
      "r323",
      "r363",
      "r364",
      "r428",
      "r447",
      "r452",
      "r453",
      "r491",
      "r515",
      "r516",
      "r522",
      "r528",
      "r532",
      "r535",
      "r585",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r225",
      "r233",
      "r234",
      "r235",
      "r236",
      "r296",
      "r297",
      "r323",
      "r363",
      "r364",
      "r428",
      "r447",
      "r452",
      "r453",
      "r491",
      "r515",
      "r516",
      "r522",
      "r528",
      "r532",
      "r535",
      "r538",
      "r582",
      "r585",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfChangeInFairValueOfDerivativeWarrantLiabilitiesDetails",
      "http://auroraspac.com/role/SummaryOfFairValueInformationAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial fair value at issuance public and private placement warrants",
        "verboseLabel": "Initial fair value at issuance",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://auroraspac.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://auroraspac.com/role/Cover",
      "http://auroraspac.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r537",
      "r540",
      "r541",
      "r542",
      "r543"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://auroraspac.com/role/OrganizationAndPlansOfBusinessOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r233",
      "r297",
      "r323",
      "r363",
      "r364",
      "r428",
      "r447",
      "r452",
      "r453",
      "r491",
      "r515",
      "r516",
      "r522",
      "r528",
      "r532",
      "r535",
      "r585",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueHierarchyOfAssetsAndLiabilitiesOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://auroraspac.com/role/SummaryOfFairValueMeasurementsInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://auroraspac.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r579",
      "r594"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://auroraspac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "SubTopic": "30",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480034/205-30-25-6"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "c(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(27)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "720",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479448/944-720-25-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481586/948-10-50-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481586/948-10-50-5"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481586/948-10-50-5"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481586/948-10-50-5"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>53
<FILENAME>0001493152-23-042105-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-042105-xbrl.zip
M4$L#!!0    ( /J!=%?:>OD.:A$  +ZL   1    871A:RTR,#(S,#DS,"YX
M<V3M75N3XCJ2?M^(_0_>VHB=GMBHHBZG^YRNTS43+J"Z'0N8!=,U9UXFC"U
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M^*MN&>9(TT<];3S01U/-?-#N9U-CU)_"YW%_(LJG)TQK1V"X7MOTU5Q,\9+
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MXC;(WT2@C@)-%M1(H8(*U@K31@V:"%10 *9^&JP:1W$3A1(JX,4.#1H(5%!
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M<V936 +F51KFK[I%;3FKUXHB;SY(P'R;AMD=#X?FC 7I-,IWW7&4#XQ1[<F
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M\H8T?;-N\Z:T@^;YWG[LM1>M7%^2Z6/J%CC.OO1ZA58/]!I(BMU]TN9Y=8-
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M#N'8C[_>8$3.LPG"*$[&;B*-)-R'*L?SR8!R1-+/"7TH0#82/T<!,=:8UP>
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M!G&*HWF0IS31SRP,]]L].ZJMIE[%%[!A= DN^X9T<6;F @,Y:U4E 1PU(8J
MA***OJ&U$^G;*[?SQF'M\RGUDV_WO9$@9FF<MWFG4\$&*3+?L(DLY8&%.$MM
MC=O-?]I@_,'.TVV0+W.6+R9B7N@MSIGV=OM6:FZ/>XFF)FEV$%6L8";C<?H*
M**^Y$6;L9VRIFN6H8"*J;;IF1PX:5OD G#4K:+MO)')YQ*:J"1I,#EF@8E&A
MIQF#PLX(3-RQ0G>C,%=S>,=;7W4CUC@Y;)SU=+3&&-]L@XDO=499>S;O2%-D
ME;7E@8TY<V99)? @;>T.VM;ZKK=Y'(YT )7,'I%H:) &CPI.J*C4JVO&9N>
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M5@,Z-;E+P)F4[H)-10O-H!GTU!BSMP&TUF WBR*[671([F<&E2LMGSW[M-"
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M<264_L&DTN/M $XAW>'.@RH_D90,5J=J=51<.T4-M=]DE33((0AIR^0C;T@
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M3LU2GE'D/Z$!#Q"?!9[:YNRWA2)@SUE9SC4*!'/W:>BS<><Y>%QR:B2$)%!
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M2I$W(205@"4@P9%I 8>Q4T4K.*08G*;14V$&1LI8<+"&07L!J%P'[ET0!FE
M$B?R\T/O,@Z9A)/![QDOAJ5<FN ] )$U%VP,/5[J"@7=,E8&##Y]RFC 1U!3
M4&DC( 30UB-J&:>;3-QG[O96;]\%[:%0&7,7 &0=@SBQ!QB:,?N]QY84&Q$)
M%!YC;H8V\,CY/Q0A-W6_YF)_^_.'M[GHG;GSS[7<\S)$/-PP3AIW"[QM<U.H
MJ(VY%."B%C-AR208Q2D!FZ;&QE TC#D8M!5?PC,Z'CK6Z! S9,Q-H(T&R/Z<
M\&Y;Q_NC((.":\S7T-UNS6(7T24STX\NSWQN'*\8/24A%#]CS@D8 +$>5T8W
M"Y?EO+_EE0N_T;SF)[^/#1)>[%8."^] @QZ*CC&'A!8ZFLQ9,K<T9]2!\\B8
M@Z'-/(+.GA->ZD! :ES(VK^,O0#\<H-1)+4P8?3C/*681)X43RD1%-]C>"K:
MX N0"+HAG9,53RRBSP5'?9?29S9*9\4]+DZ:TN N2_D!9QY/7+F1;=$5%.%C
M.#O:(-Q:>NBXMW'<=^"J-_=DUH%(GH#/?K)>$/*Q?G;#3)+"U=@8"I*Y?'!=
M6"0\H^-1R:95@+'?$HJ$N8SO-HM9$[?H,#B^GZ< NN'$#?QAU'<?@K3QV8JU
MOUI$  7%7%JW+B@*WM&QF9+4#2+B#UP:\=H CN=EJRQ/EF%G3O[TAA@F""T4
M,7,YW;J(P26"#MX^;SI; S@XYJJV';X)> 'G,M7&J'V@!ASB8SA0#CR!2V73
M*?S()1F*@\B2I(%762EVZC-\ -9GZ/UII[/_.M=K,,39N5[#N5[#=UZOX9S(
M+$QDQBN^<$YD_LX2F8VYVL^)S/B9.2\AD;GFD6?[TS'-Y[>?>ZTFA.:5[\"W
M&.(.3B7U65,BMB%8%"ITLG09T^ _VT./$KE]0FP;UQ8RD0CLA"I_BT87IC41
M=H[U81#MLFXG//("J#+NVI1 -5?.^2"@3-<][0"M*?'9#_(:^33P]!<N(3UV
M'G=;Y!0"0<=O]ZI2?^,!I<?>)8+QTQ.(9?C!MQTJ.NR\[I9X6;OI:!JF:L\A
MH\%.]#X('\MV'$U#!&TXE(382=X'H63C=J,2SZ&_5H&(3R9[6T,4-L$&7Z*D
M1.BIVVUPLG9UVANC:FD2$J#G:;?'Q;)52?,1$!%7;=8C<VG:[=&!K4;'CU+8
M/C ]7HP?",V[%;P@\:,P0F';2R]>]+;]]/YT&[G%P]9(<0K\%8\5V8Q/'9H@
M)#A'(^C/%X7TSP$(1T'A'(!P#D#H=&D_!R!\7P$(5EU^=QR ($A='\41)3XA
MJ[S.R'8W)Y0RIU(181_.U>*&<&%4[E<Q717RB/QR'RFO,B0CL#Y:0,6 )6>Y
MS;"*_=QUW/B0?-FZL?')1 %(6#WA= 0VI>-=QLHJV>KS$(#T9.('P&) GW%7
M;D!S7ZCC_SLK7JT<+[ZXE+J1K#JK@@P[?@ N_UB'K;;3\^=B>D;DGKN>#YF@
M@L7L(UMA$VY"2#*.!D^<[2Q(EL7XQX^$.F$8IX7F%CDQ38E!O*M6/6$''6C#
MW9I32V:M=.R7Y$YB9@&DV)OUMK,7+!5T_+9/!!?\70:/@4\BR46"F ([ J$M
M6BH9H(,D9*S%'@8_$*$M3$HIG/)NE:20@T:MV<D$*S2R=\)P?2'!_9)MH!RV
M.+OW9)1Q-\%XL7?O=>$F@2>&4[,;;%\*&.Y6XD&WLH)17P9AQGZJ<:.KW='I
MA$:TE!$ZMNLR&.LX&\7$%#0_G5 )*;_6H5&J#QR/#<'IA$<H>+8N,J*_=*-[
MD@RC?+1EM8IZZ9B=6(F?@+$29<^](.I5^_ZC^Q G?^NM/X%=XJ%=X3H0^3FL
MXJ B#RW*[9R#+(QB<L)!%F5!S7CU$$?<0 $#+9K)3A&69D[0 RYJPU+%7 B:
M6P:(3-GJVX5FABHNM"Z]]F/*=NLN+;,69]G=OXF7SN,).ZT'3(>V*7'26 #M
M7JRY(H4 TXI#2S;<D&B.G;"3-C$<YO?8&O/'6!"'J3JB*EP49-@77VTP DD"
M':]Z)4T54*+VV'=9;1"2\XX.S3E45A@J^_X<*FM+J&SKS=JIQ,J:WY]!0?CN
M:W:9KX.B#X5MI;N.5&\:_Q+ 0)WA!T*#V&<CH"GJ!:S&;5S[^S;\2P/(A=J)
M LAU<YK'W!-_3/MN&!+_,N,/SD[R(2J>NH#26V,W09,5+! [C*ALN(7J'@#@
MN@-K3K8'([@K$@N#=Z=LY&Z2T?*B9>O.$DU&3J4BLN;<*\0/PH4ET\YHG!A^
M:2A5G!BBK2MJ3>P9Y!'YEO]&9>G4Y-AAF7IV#BH.6\$K;'%[]/;H3R864T\@
MMN*7:]LZM(GXW)M)HB27]E5,%R20QA,=U.G)A&%V(#I;X2\OX#K&']CKZ81K
M=B$]0UG/@J%-R5::CZ1:YDFV!VW;V0D$=!["GET =H7=241]MN3,*&)3'KN=
MW$9,."%_/GB^)+=1D";2TYV<!HH$HG\%P(5-:UUKQ_1O[^%P6.(LV1M_)\[-
M0720;P35-ZT#(G[E[<;A&\(0.1K>39978?Q-4";PS]#0=]9-+^\'OTQ@):)Z
MPYU6B'L#%9I3C(]E0F.>M^M?/-\RR0^C35T3QV,+;?'XIKKV1XN^;*FY(P%R
MW\_64F+HBZ11#ZBQ??X! C\%#^FV2$DRCZ?$BR,O",G.6.=Q9W/4S->P+X4[
M4Q&38!@ZF6PK, 3Y&/VR H.H IJD/?:%KU'IQR 16'N_R.O8>#D2O I*,:3Q
M@OVY+O]V%=.RQI&J.E"[KK#ODH^E'(<(&GTQ02T$9NQ0=0SH89(P:LE/H_Z7
ML9ON8TWP;DJ&'7U=>!GEQHQ=P1_11K2I4'9ZZL+D1HF;D$M2_%F15)EL!'H=
M =P'=A# $15(7[3H&XO](4\H>7 #7UE-34V)'130 @X5GLW">6'VP/&\.&/3
M9>(^\WPK)_+93VC&QEFNFX$L.*AM?^@1! ;414>2Z*8 [FSIPE5L0:!!EPY(
M3<F=<)T_ ;.%[Z6;FP5I7^B!#J;5!B!)=%O!#%JYHW*\W[. DBD;,@V\E#.P
M=L))[ 24'CV6X@",XE8<OX =Q1ZK-R[]2E*^ LZ(EU'%&@(D1X_K,*<:,GF=
MMF;0V"/$3ZZ8+&=NOB&Z<5/.X?-XH:DE^EVA!Y%TIS%MY8B^<,!%T,6N 8ZY
MN0+L76&N+[F7M\F\"B(W\KK99$K[@JJ-N8+PAC>9 $FBVXJJE>/!P&S 9+RH
M5+&"K0X"4BC$QAR3!R C7@VD<K(4T0D-'MG69!*Z7AZSI0OK/CT46V.N1\/8
MBB2&#W"YE2V+H:Q'+'JYK[8!;J8"!R'9#R9 .B]F?S\E(1_/Q*7IL_P64DX%
MA?_8;L+#YK)(.N@S>$H>-EIZ'4?W<T)7<OC$%%#HCNVJTX=.)973GK4;UC:"
M 1OL.@44\F,[[ XQULU2>1&07\64J79&O:6;@/?6 %JH&AS;.==>#=22.FF%
M@,NKBX,V7$&.[8O35Q!]R9VP7X9SRO_/TQ,?W9!/C.T]!O^%$_F[/ZBT+%)]
M]V_)O3#CB7*#)R]_!67*)L-@L2 RG\ZQQP%55_/E@N )33A8?:_*;4A7X:IG
MO@C2D53O8$VRI9ZCC?JDD4S]WGQ=IB-IU(M)HU]+:Q1''OOK]NXG\AOV&Y=!
MXH4Q+^"GOB0YO&>H5IFO :6G55W(TU@*(/LN?_RA4H4Q+Q_M@A]=:4"\R)3K
MH&=P6J$IQ#N#+^Y8,D?7BDEV%P;>.I^)\5^_(9#DBHFXUN@3J@G&?+3'T@1M
M.1O2@74"8UZ^YQN/\8CNKP@IXXP%(*N(H"@:<]>:0!$F*5/5I78KZ!:O,!QJ
MNP_M% JS,1>M"9B[D;0A-2CK![+1\2K*^Y7.!$"KR:!0&G.SFH 2*BU;:OCE
M:<6%P@F /*Q+*,C&7*4F0.Y"RJT/<X^$WL4),5#-H;&PP##R,O[#PGO&_RRS
M@'9:*1;M5CU"5<>8V]+DBGZ C!M,Q_%KJ8WIO1L%_RG 8#O)T(V2\>(B2X*(
M)$D9Z1='@O)J?^F][FWEQ?XQGGYT1L/_<>;#\:CGC"Y[DVMG-.N-KWH7M[/A
M:#!C?Y\,IOGO9SCEU:H<]QEG<1CX&_8KLMU<N;KAME:<VH?14?<XKIV#!K]5
MA#E3PXM0>G_;_9>0B[UUJE8U#Y$I6*RP0+-LM6+;X_%B%MQ'P2+PV,FU3%GE
M*S+CU:M>6^[8G[_6[<_L]N;&F?[*#<YL^'$TO!KVG=&\Y_3[X]O1?#CZV)N,
MKX?]X0#)^.PS!JBJ)J%!*J0J0PHP^:'TR%-:#5:][*J67*R8?:5_J7 IK;<I
MS9/MY_ID&XZ&\Z%SW9O<7K YQ>;<U6#*IEBKF27:RFZ^USA0R>3)-VE0ZDYW
MWYN/CA>-GY5-D-U1JSO FB%:TFW8/6O+R(K)(HQXK\Z3=V_K\V0R'7YVY@.^
M%^X/;@:CN9D94A\=>'*("4W-B_H7=::$A-:.V:#"0301E$*Q8@Y48\;GE)T6
M&6?" ^*[=_6Y,!U<LZG SH7.=/YK;SYEIT.GCW@:%+&CWI:I*;%BYYO'I74\
MT^H$>9L&A7 OFEY;3E9,P-P?63[0<$G8;C,0K$/O]PY'GYSIX-/X^G(PG?WQ
M#W]]_^XO?^M=#M@1:=AN13I858OW)=13K=[.EE= 1G%*M*:51A?(DZH9&N5;
M(0J)6#&!]F['=V;-A_JL^>),V2HU;[<^*?="FUM\Z&9MGZ#+3=JZ=YA6<Q(I
MA1T;,I&,JQLQ .-6*"]/^0B*,CU.Y/?CW,5 (J&+[-V/=7WNCV]NAG-^#)GE
M'OK^.'>,#49X7C$)4UKA@WK=($5/;@>IM72HZ)#7BU80U@,A0:*Q8AIN*GE7
M K,$$_"G^@2\<H;3WF?G^G;0NQDXL]MI[A- FGH;1K9#!)Q]Y%3(U>DK8P+,
M*P49\K2"P",J,B^3@Q63:);=)>3WC'4X>!3/GS_OW_%<S ;_NF5SIC?XC#=S
MZJ,'/-$EI$ ZT-3& SG B$FP']M2P%$_NJAXMV2&0.Y&I7>D[_9B-.!WI+T_
MK;M&>@KO95R77KA)D(P7M8$]%_\%3#HH_:E=E^K)Q5"DY6!%Z#W[]D<:?TN7
M_,%M-P) PVEAI-@OW,%A@?/4#2('3ZQ;7@1AD*3!RDUE-0'J[;!?E-.>*<V,
MHLN_3'FL9VU#[1J0'/WA.%VTM,2"#F)3I=9BK&+D9#3H3[GIPJ46 #I&ZVCC
M_M*E]P0^PU1TZ&^OZ6(%$X2AK<*<K![8%IT^%W<=L$V"B@C]832M[0%,!.CS
MI7A5:>X^@6>*F +][3'=.:)B'AV=@4LCQ@XO[Y)?9H-!4A*B/_.EBQ50%,8R
M0S<A$ %D52ER'*4TV,]MZ9DSD #0YTL_CCS&>9&),PV2KWVV @8I_YOLODA"
MA/[,E?Z>6BT#=)PVGO=*'L8P8FQEJ^T! ' 3(2='?[%*&SLMN=B#8N5J3]-A
MI]$%^D-2[=&$RL?0XE5&;#QOWM&%K5]J,O3GGO36,*@<T"?6B'RK<$;CB/VU
MB'1.-.>7?D_H[S1I3[.VTCJA>ZLY][D(;JT.R.SK_:GH^'N^LY+&'68)3S>H
M'>5A*1@JTI.Y@H*S9(GUG'E+XF<AOP>HG1GY-9KG1/YE$&;L,),K/^0JOVV'
MIW.A=2BG%EG4QH SF0'=R]84A)TA6\L7&']6>5:Y!,L?1U-^M< S&_-+[]LH
MODL(?>22'T8/6;I^$C[(U47GB-'IUTXXVLV U"VR^1LVG20A>8@M@%_]E:"3
MSV"O#RVTR(B@T=5'EQ?68!1'=(<U3E_.#F\9!;]G!*Q61_H\=C#'(4;K&,!8
ML7V!EIFZ)*D;A,F(^S1X\;7&O<W[O0Q[K;)3O3^57^EM/H.T^3F7HH*L??TX
M9+S%!5(.=W;=DW6B"2_I)OAU-:=W+BA(NV?^N_N6RBSM34XCQLED52H34JM>
M/&%=MAW,"S.79,AD*'L^H=.OV*%KYF;LWEU@E\*KOMR)EX<1^ &O$>QR\>5I
MU<Y3(-$?"<EWI@P2250.&DC ;D<T<E?<R[AEZC)>N4%3=>TU7P!:2Z!6J6\=
M,0!G6T<#4@#99'Q#5G>$B@&J-,$^\<+UK!XJ5F<3_<PZ?B34"<,X3P,>YW71
M54!(2+#/AJV!48H!':C--C$OAPU;M,0DEEBRHRU:8DE45!)I UP9DFJ1:FIK
M"90J]:SO*1LXP5Z$BN==BW+S*B/8U!9[61)K4D/AAV9&T<U<96@7&AA<Z&)@
M+"2Y#0@7EH$@*M5V\5S]C7SQT>G#$A-VK-5(1S259#M\75 M3TUM[<!67Z,E
MF'6T7HF>HGG@?D,J-'[Y0RJ[;;#3RL0ZLO/Z2Q-CZ+:NM-=E5.>83H/[92HW
M;1(2.[3]>)Y!L20J::<6 0O<8#<3V0&N4F$A&)DU88+W$:4F34&#;>( VE2U
M=2 )F+%]"4TKTX/]:SLUV#]^F_(Y+K!O[/>57]NA[N9MV2[7%44Z,BC"Z;$>
M('0N& 9F5U[-LEP/U<B17B',FR *5ME*)LY:$[STO+J\]J39R R*X;AQGY1B
MW6V"ESFG%FL3,^A[T3GK>[RHV"[Y/E30_'NQVW(I5.HXX("YSZG;S)S*S:7=
MD1T*(%7F&H;:+)K9MSKL<S[_Y"@>1V0>%R]7\A_<N)&['DV6I,X])?F_I%O:
M]MWA9ZFV4][J%OA08:);8\%KM<7[M"/R+?^5]/H-1H]>2;K[ *RF=PO DJP
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M ,/1U7AZX\R'XY$H%.!\[V]RCZFXQI?1V+'#;'$K+V,*_Y(=]K(=$*IKVZ[
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MIX)Z<LS'Q7]$TN( 6D1)J.8"=V<390LS_R0= -_/,)9RZ=%8/WS#U6LJYVV
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M9<0Z,X$.KDC("$MG/#W?V[A>-RTOZ6GSN%KIL1F?"Y:(N10+X6'NI6;W&4\
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M<H/,PY@ UT:2:T"F)*Z+@0W"->$]"%; K58*S.@MVU@<GB&\&J$J"]  :%5
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M),RY,G!H?E,H %O+R[&,YBJ8"ZK)$9\6OXTDQ5&T".- +07N+F8J)V;^U7(
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M4>7E:5'7KWGR]S[Z]="?4$L#!!0    ( /J!=%<LPT[_9 0  )\8   *
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M7JO+K\!Z/7S2!_0H^-?T,[%C_+__QQ78CYLC_9]LEKF4P5@Z9]JS,<C>BO>
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MMQ+&[I)X59->+P8JN)/_8I%$";YI N\;2>)\#D0-*&X"N3:PL\\=,#6LW)W
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M<5U[PL[.M;?#4"G'L?GC%*QW]HS?OE&'S%2#/)2GXI@!+V P0T>ZPL@$.DM
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M SO/OQ>6?;NH (<7X!490;B'D)_(A@&%!(PA]#550<[H>,X Z)C.F0;2F^+
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MZL^[65O/O^@<V,MVKS1;?<^[5[-L6P.H=$I?NO(7Y<>OXMX!K*?,=BP2^Z*
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M^O!P\(AJ_YT5/+HG[/$@G#'9>]1PKVBD:K(IGLM%!'/9-W#>1[^.A:[H?Z[
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MN44A14%@]S=D;_V]_?/G>_%+EQU'E##?;+-^(VJ#$2/87=:9=S-%G$FHS/"
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MS.H3ZUZ#5_T;*\R5R;5QW-J3S-T)QR4?QZ(_"=HO00$291U9,5 C$\J-<-S
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M+-"CW1#H3*IF(OD:#QUC&$)FQ9BDOX?/8VE&;:R,M >4H6877RG?C-3Q$;#
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M9X*( F@93(;I \*IAGZK9(&/GA;TQ[7'V0P7T3@94BE<%L%G6*WD/6&$CS5
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M.UB"@M7BQF F_,1QT6$*"BIP"I5WU(.Q2(8$NQ*TD1!DA-O>1)\EZ.R><N#
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M0DF/S>9V<]-R',/RI.\]PQ!H1:;Z/*&6%[?3Y;:_E ; ^I-E,Y,-RG:56I"
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M TJV9I420Z<&:)@P*;X[9"P$A/_&M,?-F7Y=W-5L)DB!0 CXRRR(Z8S;XXB
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M%QSQ^K%_U#?N&\>E[E%O8]P]I(T$]904%G#G#E%1$2W!)I:D^0S2?@]73,=
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M&F$SX:R:2JFCX7@F6DB" "",N@4".SH"0T@"RH4F1W#\_X"6+ I3EY=GR5$
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MM<++6^XY5?R9MA#I2E-[1VBCF8BT)($A(* I/I7FWP6H6*O]5'X\7-T5LOZ
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M0'HCFI]M-N3:+33JQ&IN#C%)PH6!Z)VC*&B.QK :61JYLGHU*ET^VZ*@X6Q
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M%;!VHRHG* K.8!CA*O!XFSY-OFHS)#!?@CC@>*%?RI[G<YXZ/[SZE8Z:8E.
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M[B!4V=-9:R9;LT3I2_T-G]K;CL!O$"/K",=_$>\'DIZ /?$F)+PS<B<LH&%
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M4S!/-P ],"H"QP9@>CK632+7UO1_.+W7_II*9A*I="&1RF:_K4!73)_ZSOD
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M41.?+AUANCLVRTA/6T5?Z; *B6^%UXHPZW6OM9C9MU%UZ4@5,HE"/+(Y<CM
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M!2+ @KZI#[FXD!=N^0QV7&4;;<#&HZ RN=%1KA_2MS]?GS\FE2TYR,B)[3A
MYL,B<OX5A4"ZT]"K@Y&7L$FF'!>2(7S4WF<4U'+Q5'A[/NWH4O]C$HOW$4:O
MR&72.Z*3925.+4D?A$TLA;@02^5M*'5&DHB;C()2*C51FIYVZ@.Y_3%)Q>,
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M24:]7*XO/\$[)8) (H^@1 8RV.4$"[;>]E69@<8QLB=G81X2_)IYJBKR*,Z
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M"G!8TI9D@6+^A4,R)43A^#.]5JFW'5%O*U'?:++Y4@G>,:8AG+2DG<H\1>
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MQ3@@<=@2'?,M7X\@G10LN82*J>4YCM]UZD=_*I0DI6?8P\2*('V*TM<I*1S
MNO0!*7LW&>_O40*APM\^#0/] ID@$%^DCW*KZFFR:R2FPV$L>#T?XSVJ\]]*
M(8AP%I(2U&<[SNX:2PM"EGACDENL?MF'D))3<S@FZMA,.^#T;TP:\V?9I$)#
MOBUDLU=J'X*CJ"69(Z3,Y8F^,'1N- )#06P(6:7>L5+T9>DN28_C#I1/4MXL
M*C/VTC&HJ>OQHC+Q$0O%5@*[&Z$_$1\IB+TCM"=O<<TCS.3B[R18>#..IF+M
MH3@UG(LU)X798G^2#1CGHS&XF,YQZ(8\'G+ 1X"XIF2,MM<W*?QDY8PKP*]2
M^RJ.!<YC'CLM2B=1V&+&O5'<$!9,S:TF,I24 <@IVWUL %6PGIV2BZ=DPB=D
M(YPIJ_,T9W5F4,L+96T]V>T^1S5 $%54 5@XAO9K,HR# 4KV0?3--QN" A]G
M/7G*_(RE;H:8OESYY94X3 77;G]/^79K7:F\$2J0F<1LHL>] C%L1? 8"U,>
M$8Z<O06+_ZO/PGKA^^0Z"O1QDRT^JEQJ]&KU=A:S?ZP&/"<5XF&[B(>3"O'P
M%&7V V;A6CH+][E_<;6_=W8F90+G5W^\N[#./KT_O_C8OSH[__1D=_R\+JQ=
M2)LZ->L#V.033L/Y*,TJM_A'[*%MMV6(PH?JD]&LUYHX7&3]KHX:C5KS9RCT
MIT-J!;;J%-FJ7R,0E_7>':917+'4#K&48+GRC;3+LB)2/T4MH7QJM)N.,5P=
MW2@W)$-5A48&A+V21*&7$$IDC9@.#'\&^Y&KF,P$8R<4D)YC/F#B&[FZRW>G
MN6&>/'FK0<&DJ7NKL^GF:REIK5X9Q=EWC,".^AA;F8"_A:ER7' PU?Z4-,.
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MHOA*<2)<DOHSBK5X/FZG2+'6)>U!/B54$U>92XY7C-B0T*??3.-53?GQ%_F
ML2ST&.R2 %X"?5ZR/\/(35!/8YF =&3EJ).YU#.9X_I-.I48J^;R1G/AM'EE
M#I#N2L!1\@4GGG.EY,R,6;6+UV[CS.!4 71HOJSGET!T4/LQ6; 1@,L(I7Z$
MU\?E#(4#HX(34K?X<O0G<)ZMC:;/@(;B"*P,RQ.QO(2./<;3A97PASQ,5HR$
M_.-MQ'ORJ>5?2]Z8!RIW1B3E4Z$%/$L1D=!<*:UQ38<\5T)PV-GP'H?[J,JS
MDI<;NR.W%A82ZW)B['$!,@'!C#<Q-FO!\')J3*E 4A)/X!-\ !3QP8>OQ=HC
M(/H38H.UTP\5[,6L5PY"@V?%09>??1!ZP@H*J]UHUP^&AP?.(1<2*<TM'&'8
M AB\)E)?#8Q1N.FRDHJ"@];,[3?_B#\=O>4L.IT7E[JN VSH:4#HQ-P#LS^K
M1S'XD ]V?X]/EGTE+K"PQ4@O.2C&HY)L[]2Q>YJ/4$P9A:U:AIO3.W/7QY'[
MP13[M&F<*"(F,55@L#\A0+4IQ;A[!K+CC[2J0H%Z38/#W#!K!4=C(F;X9*S<
M7K;$>2$WHH^=52H/2?L$(I(J7QK9N&:U8(.N*%/!20UJJ56X020,8@'5Z0TC
M1G/1*.P!4D4/5E8,;U7$K'@F^OK+;@6TL:\O' S8ST!MUMD9:#[P?ZUV3?HB
MGF55?FAPJJY;R_)#BJ+W]_1NIJ@)C6+!RGO9*>\EG[/M%G*V#9P:B6'H)"6(
MWR5U1ROMW(9$^(7C%H*;^%FZ5I!>3_E*?P9DHKJ-G[[V G?U%GOAO/5'+L7,
MO^#PA4L_#$!D7II>_E/<=\5!+_PV'I")3A:;G'P,0K!QW9$/&LGH'U5=U^XP
M3\IU8YQ"J2[F@0'5>99QZ@66*;?N=W];SY SJF!'%>QX$<$..I-M1CPP05]X
MT9J(Q[,2'/<H_FK6J^*OK19_->M5\=>.*_4'M*J<@E75J8&N&0>#(*U*&W9(
M4-)(P9'N*^O+%1%4EO41&#0(<")4*T&!='[=XVDW(Y^'8>+H/[L\\/WZ00N2
M'OZ*,Q%NBNRB2+_SEG(2?:GD_X4$ER'?-W]!B2;X18G!3/H7]-I@4:_=>4OU
M6A<(-4_1K%BVVB^4J94W],E ?H%V6=CE/?;@X!;DAO7QT,$\(,F5K7V;-_2P
M5_*6JI5F.9]9Z?H')N--G[?-[39JSE:([B?3T_VHY2&BEZXU!@WR]U_&:3I+
M7A\?W]S<U!)_6+N.OAWWP<W%WCK'OG?MQL?@<;G'3J_7[/9ZQ_4ZF!@G3:?1
M;C3K;:?3<(Z]5L?I.DW/_]YP:N-TJ@7R$3SP"/:!<X%>*Q7WR^]O%.#TU "<
M]J]C7SI:>MRLE1)ZNI:NT5&^W( SRXSO[L]C4(G6E3\<A]$DND;@;0;'/@6-
M6;-+OO31CZ_!0;R<#]1W:)S>V1_6']&$\-=?+FWK+!S6K .MC47J64!["A%]
M*B/D"K&$WM%_KJL-;'!Q8//PMV/W]Y? L<V*8W> 8QOM;K=U[#6Z]5[K!#BV
MN1'']M6@+*1[^H?4^^#H,^+6C_X46"STYCR<JH]4*#GYOG3SIPC7 C,UM\%,
MG1?'2XV*EQZ+EUK 2^T&\5+OI',,/'2T$1-=^MA(V=I17OKG')Q&%=I^,8SD
MU"NMM(-:R:G?42WAE&5GB>78-)( ^6HMZV/6VUB&\*RQ0KNJ$''@IS?83,*<
M$JFF(8-Q&Z8X'32-P%N\PJHS;&;Y'^YT]JN\1WY"62N:RN[[)?R,U%DIQWOP
M=*4==X"G>YUZ_=AKGCB=[AUX^G,<8=XS L+]%/'TB_Y5_]2ZG$4A_-7Z\.'T
MP3BE]_(XI5EQR@YR2N-!.:51<<H].*4E"ZGXY;'YI1AUW%"S*+ZXG,^(W!=L
MO>W$&@LLR)%%U;' + !],#7VXD*+<&SMBCMWECLWTF;D+#%G/#"'ED7YRW($
M)3_-L7*VX"6LO 4]^Q)9N5.Q\LZR<G,35B;BQF!E67#S@JKVN F7=8%SLY*,
MS\OYJ%GQT7WXJ%MQT*-S4*?=;#70M>MV3EH['01A;/O)RV.37L4FC\XF)ZU.
M&]BDY=1;G>Y.LTE_%@<3ZP5JDY.*31X]X>RT.T[C&-ECLXSSHZB16ZO]\KC#
MJ5?L\>CLT6C5FR>[S1Z$LGB!VL.I4!8[P!^"5]J4/_+PBD8>$D&4K-SJEX:M
M>+E@J0I9L0-\#,Y2>]MZ;GEY&7P]QS08V5L?+-?=+N_N8LVOD8T%MG58VVWV
MPB-I_B@W*!I^".)=+-%],,)L.IU.[_D2IAXRJST<H<W9KA)FJR),)LR>T^H^
M7\(\'Z81];MH/1&Z;.\R76Z%XEK.27WKONCN4)QNL>)T\R2W<^2VQ:(;I^;\
MK3)_MV'^8MV9\,7OIWCANH<4M6D%.@]FX.2]^^X/Y]1S_QRG=0&Y?9['R=SE
MVAFCH9)NIH135ZBKCN4TW2.G=>!*9R@>N%+\/;T2#&K5]NC2C0=NZ"='Y]\G
MOI[ATJC7&[MMA&Z5R!L5D6^/R!MKB?R]'O)4$?G/(O(&2/**RK=%Y8T[B7*3
M.IV>]:5V63NM:3IUFNWZ6F(^J7<J8C:(N5$1\Q:)^4=%]A:)VGJQ5(T(D+-/
MEQ5=_\A:S\))$/J\OO]Z<_'!.@N3E#I2OHV&<TS%D ?8^!6)+E"?>?(9_ >\
M#=NQNK.9[^HAA6?8NLBE^9'66W" @1TF.%I]Z.)\2.QA1N]*W6ON9H:.HD?]
M4W$=Z$GJ!^'R^-OJI2^%MB]/_ZAH>ZNT?>5^C\)H>@NF1NJ'U$_W<CCVIZXF
M]I="6Z?]#Q5M/31MG;J3H9H$^R$(OP[<Q']QE/;VW?N*TAZ:TM[Z(QK5^Y()
M[4/_345H#TUH']R!/TE>+I%]OGA7$=E#$]GGV$\0PO62Y5FK(K,?6>LI3I?F
MY5$;^7*'](!GR C0T/0UJ8H7'NK"7SST:K/4J7-83H'2++_JF?[3EO^W_;WW
ME'H>^[&/08.?.R?CL6=B.-5,C.W.Q'"JF1B[)E+XT.#K"[1*?WO8?NF%J1D-
M/37C\NP?G_I77R[>73[4[(1:K_WP^]N%D1G;'FI\%N[ON<,A2*7\6*48N#F(
MJ;8@T3F4)8ES^-@Y:;8X'<,-"FQY"#<F"%.+(MD>3]2(&1*51M; MQ+8+GP0
MP3HPSCWPQ^YDA$@L? !-W^)OT!-C?Q["SSRL%7#GZ3B*82O>BY@S_;S'=NR:
M?0X;QS___9?&G<]TFTOL?[DXO^CSLJ[>G?[QZ?S#^3_^V^J?_OGE[/+LZNS\
MDW5Z?O&YMJL^GJ:O-AD9N^E:J27N_ I;#[W$W2*=!Q]6 XZM_YH7N##?<$LW
M]^![>'/[>N52MS=M9ZN68O#[<7+,B_T?%TR)^-;Z%]@3OQT'+P**L47IL,UE
MD8>W<ZL2 N&U,)54%/)(R[H*TLD.DLCI./!'O)(%@'M%+=6R*L.G,GQVSO Y
M==-Q?!M:IV,_K R?RO!9U&I,($(M1"45A52&SQ+#9Q%!_SAYUQ@;T#YVKJ_Q
MJW5.@UN3U]8'-TFKA-\V$GZ-^R;\7G)*;B-FV?9;MFJSF"?QV_$@\F[I/\;I
M= +_\?]02P$"% ,4    " #Z@717VGKY#FH1  "^K   $0
M@ $     871A:RTR,#(S,#DS,"YX<V102P$"% ,4    " #Z@717?R<@?L8,
M  "?CP  %0              @ &9$0  871A:RTR,#(S,#DS,%]C86PN>&UL
M4$L! A0#%     @ ^H%T5R5QTY.X.   4>$# !4              ( !DAX
M &%T86LM,C R,S Y,S!?9&5F+GAM;%!+ 0(4 Q0    ( /J!=%=TGGL575L
M "K@!  5              "  7U7  !A=&%K+3(P,C,P.3,P7VQA8BYX;6Q0
M2P$"% ,4    " #Z@717,BLXDQH_   5/@0 %0              @ $-LP
M871A:RTR,#(S,#DS,%]P<F4N>&UL4$L! A0#%     @ ^H%T5[4$2VK]!P
M?3    H              ( !6O(  &5X,S$M,2YH=&U02P$"% ,4    " #Z
M@71770V8P_ '  #Y+@  "@              @ %_^@  97@S,2TR+FAT;5!+
M 0(4 Q0    ( /J!=%=GV/NB=00  "4:   *              "  9<" 0!E
M>#,R+3$N:'1M4$L! A0#%     @ ^H%T5RS#3O]D!   GQ@   H
M     ( !- <! &5X,S(M,BYH=&U02P$"% ,4    " #Z@717!,.AQI%L 0"'
M=Q  #               @ ' "P$ 9F]R;3$P+7$N:'1M4$L%!@     *  H
*90(  'MX @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
